02.10.2014 Views

Programma finale completo - SIF - Università degli Studi di Torino

Programma finale completo - SIF - Università degli Studi di Torino

Programma finale completo - SIF - Università degli Studi di Torino

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Senza titolo-3 1 28/05/2007 16.30.52


Senza titolo-1 1 27/05/2007 16.02.46


Senza titolo-1 1 27/05/2007 16.04.32


Senza titolo-1 1 27/05/2007 16.05.49


Senza titolo-1 1 27/05/2007 16.07.17


Senza titolo-1 1 27/05/2007 16.08.39


Wyeth:<br />

la ricerca<br />

nasce qui<br />

●<br />

Aprilia<br />

Sede legale<br />

Stabilimento Produzione Farmaceutica<br />

●<br />

Catania<br />

Stabilimento Produzione Farmaceutica<br />

Agricoltura Veterinaria<br />

Centro Ricerche:<br />

- Wyeth European Drug Safety and Metabolism Center<br />

La cultura della salute<br />

pag_dx.indd 1 28/05/2007 21.11.15


38<br />

pag_sx.indd 1 30/05/2007 7.17.11


Senza titolo-3 1 28/05/2007 15.35.35


Senza titolo-1 1 29/05/2007 16.27.32


Senza titolo-1 1 27/05/2007 16.12.47


Senza titolo-1 1 27/05/2007 16.14.33


Senza titolo-3 1 28/05/2007 16.03.23


Senza titolo-2 1 29/05/2007 20.49.12


Senza titolo-2 1 29/05/2007 18.50.39


Senza titolo-1 1 31/05/2007 12.26.36


pag_dx.indd 1 28/05/2007 20.08.22


Senza titolo-3 1 28/05/2007 16.08.00


Senza titolo-2 1 29/05/2007 20.56.14


Senza titolo-3 1 28/05/2007 16.13.10


Cre<strong>di</strong>ti ECM assegnati 5<br />

Corso <strong>di</strong> Aggiornamento<br />

Il contributo della farmacologia al trattamento della depressione<br />

SALA 5<br />

09.00-17.00<br />

Moderatori: Carpiniello B (Cagliari) Putzu P (Cagliari)<br />

26<br />

09.00/09.15 Carpiniello B (Cagliari)<br />

Apertura e introduzione<br />

09.15/10.00 Guazzelli M (Pisa)<br />

Diagnosi e classificazione dei <strong>di</strong>sturbi depressivi: vali<strong>di</strong>tà e limiti<br />

dell'approccio clinico-descrittivo<br />

10.00/10.45 Sorbi S (Firenze)<br />

Depressione in corso <strong>di</strong> malattie neurologiche: fattore negativo per la<br />

prognosi?<br />

11.15/12.00 Biggio G (Cagliari)<br />

Presente e futuro <strong>degli</strong> antidepressivi<br />

12.00/12.30 Discussione<br />

12.30/13.00 Workshop<br />

Guazzelli M (Pisa)<br />

Presentazione caso clinico A<br />

Sorbi S (Firenze)<br />

Presentazione caso clinico B<br />

14.00/15.00 Guazzelli M (Pisa) Carpiniello B (Cagliari)<br />

Elaborazione del caso clinico<br />

15.00/16.00 Sorbi M (Firenze) Putzu P (Cagliari)<br />

Presentazione del caso clinico<br />

16.30/17.00 Putzu P (Cagliari)<br />

Conclusioni e questionario ECM<br />

Realizzato con il contributo educazionale <strong>di</strong> Lundbeck<br />

pag_sx.indd 1 29/05/2007 23.41.25


Cerimonia Inaugurale<br />

AUDITORIUM<br />

18.00-19.00<br />

Saluto delle Autorità<br />

Lettura Inaugurale<br />

Moderatore : Biggio G (Cagliari)<br />

Sessione ECM<br />

Hokfelt T (Karolinska Institute, Stockholm)<br />

Three decades with three Swe<strong>di</strong>sh neuropeptides: focus on pain and depression<br />

AUDITORIUM<br />

19.00-20.00<br />

Cocktail <strong>di</strong> Benvenuto<br />

20.00-22.00<br />

27<br />

pag_dx.indd 1 29/05/2007 23.47.24


28<br />

Simposio<br />

Vecchi e nuovi antipsicotici a confronto<br />

(<strong>SIF</strong> - SINPF)<br />

Moderatori: Nivoli G (Sassari) Racagni G (Milano)<br />

08.30/08.50 Riva MA (Milano)<br />

Diversità dei meccanismi d'azione<br />

08.50/09.10 Altamura CA (Milano)<br />

Il trattamento acuto<br />

09.10/09.30 Bellantuono C (Verona)<br />

Il trattamento cronico<br />

09.30/09.50 Mencacci C (Milano)<br />

Antipsicotici e genere<br />

09.50/10.10 Aguglia E (Trieste)<br />

I farmaci antipsicotici nel BPSD<br />

10.10/10.30 Balestrieri M (U<strong>di</strong>ne)<br />

Antipiscotici e <strong>di</strong>sturbi <strong>di</strong> personalità<br />

10.30/10.45 Discussione<br />

10.45/11.00 Nivoli G (Sassari)<br />

Conclusioni<br />

Sessione ECM<br />

Cre<strong>di</strong>ti ECM assegnati 4<br />

Simposio<br />

Modulazione farmacologica dei recettori P 1<br />

(<strong>SIF</strong> - Gruppo Nazionale Adenosina)<br />

Moderatori: Borea PA (Ferrara) Caciagli F (Chieti)<br />

08.30/08.50 Baral<strong>di</strong> PG (Ferrara)<br />

Nuovi agonisti e antagonisti del recettore adenosinico A 2B<br />

AUDITORIUM<br />

08.30-11.00<br />

SALA 1<br />

08.30-11.00<br />

08.50/09.10 Popoli P (Roma)<br />

Ruolo dei recettori A 2A dell'adenosina nella modulazione <strong>di</strong> effetti neurotrofici in<br />

con<strong>di</strong>zioni fisiologiche e patologiche<br />

09.10/09.30 Melani A (Firenze)<br />

Neuroprotezione <strong>degli</strong> antagonisti A 2A durante ischemia<br />

09.30/09.50 Martini C (Pisa)<br />

Interazione funzionale tra recettori dell'adenosina e recettori dopaminergici: ruolo<br />

nella terapia antipsicotica<br />

09.50/10.10 Carta A (Cagliari)<br />

Antagonisti per i recettori A 2A adenosinergici: una promettente terapia sintomatica e<br />

neuroprotettiva per la malattia <strong>di</strong> Parkinson<br />

10.10/10.30 Varani K (Ferrara)<br />

Alterazione dei recettori dell'adenosina in pazienti con broncopneumopatia cronica<br />

ostruttiva<br />

10.30/10.50 Capecchi PL (Siena)<br />

Sistema adenosinergico e polimorfismi genetici: possibili implicazioni cliniche in<br />

ambito car<strong>di</strong>ovascolare<br />

10.50/11.00 Discussione<br />

pag_sx.indd 1 01/06/2007 14.56.01


Sessione ECM<br />

Simposio<br />

Efficacia e sicurezza <strong>di</strong> FANS tra<strong>di</strong>zionali e COXIB<br />

Moderatori: Mugelli A (Firenze) Patrono C (Roma)<br />

08.30/08.50 Patrono C (Roma)<br />

Farmacologia clinica <strong>degli</strong> inibitori delle ciclo-ossigenasi<br />

08.50/09.10 Lanas A (Saragoza)<br />

Clinical consequences of cyclooxygenase inhibition on the upper and lower<br />

gastrointestinal tract<br />

SALA 2<br />

08.30-11.00<br />

09.10/09.30 Baigent C (Oxford)<br />

Risk of myocar<strong>di</strong>al infarction, stroke and vascular death associated with coxibs and<br />

tra<strong>di</strong>tional NSAIDs<br />

09.30/11.00 Tavola Rotonda<br />

Quesiti aperti e priorità in tema <strong>di</strong> ricerca clinica e <strong>di</strong> scelte terapeutiche<br />

Simposio<br />

<strong>SIF</strong> e informazione in<strong>di</strong>pendente sul farmaco<br />

(Sezione <strong>di</strong> Farmacologia Clinica)<br />

Moderatori: Caputi AP (Messina) Velo GP (Verona)<br />

08.30/08.50 Ad<strong>di</strong>s A (Roma)<br />

L'Agenzia del Farmaco<br />

08.50/09.05 Moretti U (Verona)<br />

Focus (ISBD)<br />

Sessione ECM<br />

09.05/09.20 Polimeni G (Messina)<br />

www.farmacovigilanza.org: portale sulla farmacovigilanza<br />

09.20/09.35 Moschini M (Firenze) Vannacci A (Firenze) Tuccori M (Pisa)<br />

Segnalazione spontanea <strong>di</strong> ADR ed informazione <strong>di</strong> ritorno in Toscana<br />

09.35/09.50 Filippelli A (Napoli)<br />

L'esperienza del Centro Regionale <strong>di</strong> Farmacovigilanza della Campania<br />

09.50/10.05 Del Zompo M (Cagliari)<br />

La farmacologia <strong>di</strong> consultazione in Sardegna<br />

10.05/10.20 Tragni E (Milano)<br />

SEFAPNEWS<br />

10.20/10.40 Font M (Verona)<br />

Dialogo sui farmaci<br />

10.40/11.00 Discussione generale<br />

SALA 3<br />

08.30-11.00<br />

29<br />

pag_dx.indd 1 30/05/2007 0.53.23


Sessione ECM<br />

Simposio<br />

Dalle scienze <strong>di</strong> base alla scoperta <strong>di</strong> nuove terapie per l'epilessia<br />

(<strong>SIF</strong> - LICE)<br />

Moderatori: Perucca E (Pavia) De Sarro G (Catanzaro) Marrosu F (Cagliari)<br />

SALA 4<br />

08.30-11.00<br />

08.30/08.50 De Sarro G (Catanzaro)<br />

Gli attuali modelli sperimentali <strong>di</strong> epilessia sono appropriati per in<strong>di</strong>viduare nuovi<br />

agenti antiepilettici?<br />

08.50/09.10 Marrosu F (Cagliari)<br />

Meccanismi molecolari attivati dalla stimolazione vagale<br />

09.10/09.30 Simonato M (Ferrara)<br />

Fattori neurotrofici veicolati da vettori virali: un nuovo approccio?<br />

09.30/09.50 Perucca E (Pavia)<br />

Nuove molecole in sviluppo clinico: una visitazione critica<br />

09.50/10.10 Spina E (Messina)<br />

Utilità dei farmaci antiepilettici in altre in<strong>di</strong>cazioni terapeutiche: esperienze e<br />

prospettive<br />

10.10/11.00 Discussione<br />

30<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmacologia delle sostanze d'abuso<br />

Moderatori: Bertolini A (Modena) Cuomo V (Roma)<br />

SALA 5<br />

08.30-11.30<br />

Genedani Susanna 1 , Agnati L.F. 1 , Filaferro M. 1 , Carone C. 1 , Guidolin D. 2 , Roberts D.C.S. 3 ,<br />

Marcellino D. 4 , Fuxe K. 4<br />

1 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Modena; 2 Dipartimento<br />

<strong>di</strong> Anatomia e Fisiologia Umana, Università <strong>di</strong> Padova; 3 Department of Physiology and Pharmacology,<br />

Wake Forest University School of Me<strong>di</strong>cine, Winston-Salem, USA; 4 Department of Neuroscience,<br />

Karolinska Institutet, Stockholm, Sweden<br />

Influenza della cocaina sui recettori A2A e D2: stu<strong>di</strong> in vivo e in vitro.<br />

Fattore Liana 1,3 , Pons S. 4 , Cossu G. 2,3 , Tolu S. 4 , Porcu E. 2 , Changeux J-P. 4 , Fratta W. 1,2,3 ,<br />

Maskos U. 4<br />

1 Istituto <strong>di</strong> Neuroscienze CNR, Sezione <strong>di</strong> Cagliari; 2 Dipartimento <strong>di</strong> Neuroscienze, Università <strong>di</strong><br />

Cagliari; 3 Centro <strong>di</strong> Eccellenza "Neurobiologia delle Dipendenze", Università <strong>di</strong> Cagliari; 4 Unité<br />

Récepteurs et Cognition, URA CNRS 2182, Institut Pasteur, Paris Cedex 15, France<br />

Le subunità beta-2 e alfa-4, ma non alfa-7, del recettore nicotinico nella VTA sono necessarie e<br />

sufficienti per il rinforzo da nicotina.<br />

Fadda Paola 1,2 , Spano M.S. 1,2 , Cossu G. 1,2 , Fattore L. 2,3 , Fratta W. 1,2,3<br />

1 Dipartimento <strong>di</strong> Neuroscienze, Università <strong>di</strong> Cagliari e 2 Centro <strong>di</strong> Eccellenza "Neurobiologia delle<br />

Dipendenze", Università <strong>di</strong> Cagliari; 3 Istituto <strong>di</strong> Neuroscienze CNR, Sezione <strong>di</strong> Cagliari<br />

L’agonista GABA B baclofen previene le ricadute all’abuso <strong>di</strong> sostanze: evidenze precliniche.<br />

Mostallino Maria Cristina1, Mura M.L. 2 , Maciocco E. 2 , Murru L., Sanna E. 2,3 , Biggio G.<br />

1 Istituto <strong>di</strong> Neuroscienze CNR, Sezione <strong>di</strong> Cagliari; 2 Dipartimento <strong>di</strong> Biologia Sperimentale sezione<br />

Neuroscienze, Università <strong>di</strong> Cagliari; 3 Centro <strong>di</strong> Eccellenza "Neurobiologia delle Dipendenze",<br />

Università <strong>di</strong> Cagliari<br />

Astinenza da etanolo e plasticità del recettore GABA A.<br />

pag_sx.indd 1 04/06/2007 11.35.27


Tacchi Raffaella 1 , Vergoni A.V. 3 , Tosi G. 4 , Costantino L. 4 , Rivasi F. 2 , Bertolini A. 1 , Ruozzi B. 4 ,<br />

Forni F. 4 , Vandelli M.A. 4<br />

1 Struttura Complessa <strong>di</strong> Tossicologia e Farmacologia Clinica; 2 Sezione <strong>di</strong> Anatomia Patologica;<br />

3 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Sezione <strong>di</strong> Farmacologia;<br />

4 Dipartimento <strong>di</strong> Scienze<br />

Farmaceutiche, Università <strong>di</strong> Modena e Reggio Emilia<br />

Nanoparticelle polimeriche coniugate con un glico-eptapeptide come trasportatori <strong>di</strong> farmaci<br />

all'interno del sistema nervoso centrale.<br />

Solinas Marcello 1,2 , Scherma M. 2,3 , Fattore L. 4 , Stroik J. 2 , Wertheim C.E. 2 , Tanda G. 2 , Fratta<br />

W. 3 , Goldberg S.R. 2<br />

1 IBPC, CNRS-6187, University of Poitiers, France; 2 NIDA, NIH, DHHS, USA; 4 Dipartimento <strong>di</strong><br />

Neuroscienze, Università of Cagliari; 5 Istituto <strong>di</strong> Neuroscienze CNR, Sezione <strong>di</strong> Cagliari<br />

I recettori nicotinici come nuovi targets per il trattamento dell’abuso <strong>di</strong> cannabis.<br />

Pistis Marco 1 , Pillolla G. 1 , Perra S.Z., Melis M. 1 , Muntoni A.L. 2<br />

1 Dipartimento <strong>di</strong> Neuroscienze, Università <strong>di</strong> Cagliari; 2 Istituto <strong>di</strong> Neuroscienze CNR, Sezione <strong>di</strong><br />

Cagliari<br />

La stimolazione del me<strong>di</strong>al forebrain bundle induce mo<strong>di</strong>ficazioni a breve e a lungo termine<br />

nell’attività dei neuroni dopaminergici: coinvolgimento dei recettori cannabinoide e glutamatergico.<br />

Viganò Daniela G., Guidali C., Rubino T., Parolaro D.<br />

DBSF, Università dell’Insubria (VA)<br />

Ruolo del sistema recettoriale cannabico in un modello farmacologico <strong>di</strong> schizofrenia.<br />

Trezza Viviana 1 , Cuomo V. 2 , Vanderschuren L.J.M.J. 1<br />

1 Dept. Pharmacology and Anatomy, Rudolf Magnus Institute of Neuroscience, University Me<strong>di</strong>cal<br />

Center Utrecht, Utrecht, The Netherlands; 2 Dipartimento <strong>di</strong> Fisiologia Umana e Farmacologia,<br />

Università <strong>di</strong> Roma “La Sapienza”<br />

Farmaci attivi sul sistema cannabinoide: effetti prosociali e antisociali in ratti Wistar adolescenti.<br />

31<br />

Castaldo Pasqualina 1 , Magi S. 1 , Gaetani S. 2 , Cassano T. 3 , Ferraro L. 4 , Corcione E. 1 , Antonelli<br />

T. 4 , Cuomo V. 2 , Amoroso S. 1<br />

1 Sezione <strong>di</strong> Farmacologia, Dipartimento <strong>di</strong> Neuroscienze, Università “Politecnica delle Marche”,<br />

Ancona; 2 Dipartimento <strong>di</strong> Farmacologia e Fisiologia umana Università <strong>di</strong> Roma “La Sapienza”;<br />

3 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che Università <strong>di</strong> Foggia; 4 Sezione <strong>di</strong> Farmacologia, Dipartimento <strong>di</strong><br />

Me<strong>di</strong>cina Clinica e Sperimentale, Università <strong>di</strong> Ferrara<br />

L’esposizione prenatale all’agonista del recettore per i cannabinoi<strong>di</strong> WIN 55,212-2 riduce l’efflusso ed<br />

aumenta la ricaptazione <strong>di</strong> glutammato attraverso una sovraespressione dei trasportatori del<br />

glutammato glt1 ed eaac1 nella corteccia prefrontale <strong>di</strong> ratto.<br />

pag_dx.indd 1 30/05/2007 0.56.43


Simposio<br />

Asma e patologie correlate<br />

Moderatori: Rossi F (Napoli) Cirino G (Napoli)<br />

Sessione ECM<br />

08.30/08.50 Fabbri LM (Modena)<br />

Asma e BPCO: storia naturale <strong>di</strong> asma e BPCO (implicazioni terapeutiche)<br />

08.50/09.10 Brusasco V (Genova)<br />

Asma e rinite: due fenotipi dell'allergopatia respiratoria<br />

09.10/09.30 Di Maria G (Catania)<br />

Asma e apnea notturna: strategie per migliorare la vita dei pazienti<br />

09.30/09.50 Scaglione F (Milano)<br />

Asma e infezioni: relativi trattamenti appropriati<br />

09.50/10.10 Polverino M (Salerno)<br />

Asma e obesità: BMI e asma<br />

10.10/10.30 D'Agostino B (Napoli)<br />

Asma e reflusso gastroesofageo: ruolo delle fibre C (modelli animali)<br />

10.30/11.00 Discussione<br />

SALA 6<br />

08.30-11.00<br />

32<br />

Realizzato con il contributo educazionale <strong>di</strong> AstraZeneca<br />

Sessione ECM<br />

Simposio<br />

Modulazione farmacologica dell'infiammazione polmonare nella<br />

broncopneumopatia cronica ostruttiva<br />

Moderatori: Barnes PJ (Londra) Montuschi P (Roma)<br />

08.30/08.55 Folco G (Milano)<br />

Basi fisiopatologiche della broncopneumopatia cronica ostruttiva<br />

08.55/09.20 Geppetti P (Firenze)<br />

Canali TPR e patologia respiratoria<br />

09.20/09.45 Fabbri L (Modena)<br />

La terapia farmacologica della broncopneumopatia cronica ostruttiva<br />

SALA 7<br />

08.30-11.00<br />

09.45/10.10 Barnes PJ (Londra)<br />

Nuove strategie farmacoterapeutiche per la broncopneumopatia cronica ostruttiva<br />

10.10/10.35 Montuschi P (Roma)<br />

Meto<strong>di</strong>che non invasive nel monitoraggio dell'infiammazione polmonare e della terapia<br />

farmacologica nella broncopneumopatia cronica ostruttiva<br />

10.35/11.00 Discussione<br />

Realizzato con il contributo educazionale <strong>di</strong> Altana<br />

pag_sx.indd 1 30/05/2007 0.58.37


Sessione ECM<br />

Simposio<br />

Key research strategies in pharmacology: how to take water into<br />

dry pipe-lines<br />

(<strong>SIF</strong> - EPHAR)<br />

Moderatori: Weston A (Manchester) Drago F (Catania)<br />

08.30/08.55 Brunello N (Milano)<br />

Are anti-inflammatory drugs the antidepressants of the future?<br />

SALA 8<br />

08.30-11.00<br />

08.55/09.20 Edwards G (Manchester)<br />

Ca 2+ -sensing receptors in blood vessels: potential new targets in vascular <strong>di</strong>sease<br />

09.20/09.45 Buckingham J (Londra)<br />

Glucocorticoids: exemplars of multi-tasking<br />

09.45/10.10 Smits J (Maastricht)<br />

Molecular imaging of ischemic heart <strong>di</strong>sease: new pharmacological targets<br />

10.10/10.35 Sebastiao A (Lisbona)<br />

Adenosine receptors in neuroprotection<br />

10.35/11.00 Discussione<br />

Pausa caffè<br />

11.00-11.30<br />

33<br />

Lettura Plenaria<br />

Moderatore: Fratta W (Cagliari)<br />

Santarelli L (Palo Alto, USA)<br />

Ruolo funzionale della neurogenesi nell’adulto<br />

AUDITORIUM<br />

11.30-12.30<br />

Sessione Poster<br />

12.30-15.00<br />

Colazione <strong>di</strong> lavoro<br />

12.30-13.30<br />

Incontro con l’Esperto<br />

Moderatore: Fratta W (Cagliari)<br />

Grassi MC (Roma)<br />

La Vareniclina: nuove prospettive nella terapia del tabagismo<br />

Realizzato con il contributo educazionale <strong>di</strong> Pfizer<br />

SALA 4<br />

14.00-15.00<br />

pag_dx.indd 1 30/05/2007 1.09.57


Incontro con l'Esperto<br />

Moderatore: Scaglione F (Milano)<br />

Mazzei T (Firenze)<br />

Ricerca e sviluppo in antibioticoterapia: a che punto siamo?<br />

SALA 5<br />

14.00-15.00<br />

34<br />

Sessione ECM<br />

Simposio<br />

Nuove acquisizioni nella ricerca sui cannabinoi<strong>di</strong><br />

Moderatori: Fratta W (Cagliari) Parolaro D (Varese)<br />

15.00/15.20 Piomelli D (Irvine)<br />

Il sistema endocannabinoide alla soglia della terapia<br />

AUDITORIUM<br />

15.00-17.30<br />

15.20/15.40 Le Fur G (Parigi)<br />

Il ruolo del Rimonabant, un antagonista dei recettori CB 1 , nel trattamento dell'obesità<br />

e dei fattori <strong>di</strong> rischio car<strong>di</strong>ometabolici associati<br />

15.40/16.00 Di Marzo V (Napoli)<br />

Il sistema endocannabinoide nelle malattie neurodegenerative e nel dolore<br />

neuropatico<br />

16.00/16.20 Cuomo V (Roma)<br />

Un'alterata neurogenesi dei neuroni ippocampali è associata a deficit funzionali<br />

osservati nei ratti adulti esposti nel periodo prenatale ai cannabinoi<strong>di</strong><br />

16.20/16.40 Parolaro D (Varese)<br />

Il trattamento cronico con THC durante il periodo adolescenziale induce mo<strong>di</strong>ficazioni<br />

neurobiologiche <strong>di</strong> lunga durata nell'adulto<br />

16.40/17.00 Fratta W (Cagliari)<br />

Possibile ruolo del sistema endocannabinoide nelle reci<strong>di</strong>ve all'abuso <strong>di</strong> sostanze<br />

17.00/17.30 Discussione<br />

Realizzato con il contributo educazionale <strong>di</strong> Sanofi Aventis Recherce & Dev.<br />

pag_sx.indd 1 30/05/2007 1.12.14


Cre<strong>di</strong>ti ECM assegnati 4<br />

Simposio<br />

Modulazione farmacologica dei recettori P 2<br />

(<strong>SIF</strong> - Gruppo Nazionale Adenosina)<br />

Moderatori: Abbracchio MP (Milano) Pedata F (Firenze)<br />

15.00/15.15 Volpini R (Trieste)<br />

Progettazione e sintesi <strong>di</strong> nuovi ligan<strong>di</strong> dei recettori P 2<br />

SALA 1<br />

15.00-17.30<br />

15.15/15.30 Ferrari D (Ferrara)<br />

L'antibiotico polymyxina B è un potente modulatore allosterico del recettore P 2X7<br />

15.30/15.45 Verderio C (Milano)<br />

Ruolo del recettore P 2X7 nella funzione microgliale<br />

15.45/16.00 Volontè C (Roma)<br />

Recettori purinergici P 2 : nuove tendenze nel sistema nervoso centrale<br />

16.00/16.15 Ceruti S (Milano)<br />

ATP come molecola <strong>di</strong> segnalazione nel dolore trigeminale<br />

16.15/16.30 Pugliese AM (Firenze)<br />

Ruolo <strong>di</strong> ATP e dei recettori P 2 purinergici nella trasmissione sinaptica della regione<br />

CA1 <strong>di</strong> ippocampo <strong>di</strong> ratto sia in con<strong>di</strong>zioni normossiche che durante deprivazione <strong>di</strong><br />

ossigeno e glucosio<br />

16.30/16.45 Trincavelli ML (Pisa)<br />

Localizzazione dei recettori A1 e P 2Y1 nell'ippocampo e loro interazione funzionale<br />

16.45/17.00 Ballerini P (Chieti)<br />

Ruolo delle proteine ABC nella produzione me<strong>di</strong>ata dalle purine <strong>di</strong> fattori coinvolti<br />

nella fisiopatologia dell'aterosclerosi<br />

17.00/17.30 Questionario ECM<br />

35<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Giovani Farmacologi<br />

SALA 2<br />

15.00-20.00<br />

Moderatori: Concas A (Cagliari) Brunelleschi S (Novara) De Sarro A (Messina)<br />

Gunella Gabriele, Bardelli C., Amoruso A., Fresu L.G., Zeppegno P., Brunelleschi S.<br />

Dipartimento Scienze Me<strong>di</strong>che, Università del Piemonte Orientale “A.Avogadro”, Novara<br />

Sostanza P e Depressione: espressione del recettore NK1, attivazione <strong>di</strong> NF-B e rilascio <strong>di</strong> citochine<br />

in monociti <strong>di</strong> pazienti psichiatrici.<br />

Soldovieri Virginia 1 , Cilio M.R. 2 , Miceli F. 1 , Bellini G. 3 , Castaldo P. 1 , Shapiro M.S. 4 , Pascotto<br />

A. 3 , Annunziato L. 1 , Taglialatela M. 1,5<br />

1 Dipartimento <strong>di</strong> Neuroscienze, Università <strong>di</strong> Napoli “Federico II”; 2 Dipartimento <strong>di</strong> Neurologia<br />

Infantile, Ospedale Pe<strong>di</strong>atrico “Bambin Gesù” <strong>di</strong> Roma; 3 Cattedra <strong>di</strong> Neuropsichiatria Infantile,<br />

Seconda Università <strong>di</strong> Napoli; 4 Dipartimento <strong>di</strong> Fisiologia, Centro <strong>di</strong> Scienze del Benessere,<br />

Università del Texas, San Antonio, USA; 5 Università del Molise, Campobasso<br />

Nuove mutazioni responsabili <strong>di</strong> convulsioni benigne familiari neonatali alterano aminoaci<strong>di</strong> non<br />

carichi del segmento S4 delle subunità dei canali del potassio KCNQ2 e riducono la funzionalità della<br />

corrente Ikm me<strong>di</strong>ante alterazioni delle proprietà <strong>di</strong> apertura.<br />

pag_dx.indd 1 30/05/2007 1.15.35


DiPalma Antonella, Desaphy J-F., Conte Camerino D.<br />

Dipartimento Farmaco-Biologico, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Bari<br />

L’orfenadrina blocca i canali al so<strong>di</strong>o voltaggio-<strong>di</strong>pendenti attraverso il legame al recettore <strong>degli</strong><br />

anestetici locali.<br />

Lintas Alessandra, Panin F., Diana M.<br />

“G. Minar<strong>di</strong>” Laboratory of Cognitive Neuroscience, Dipartimento <strong>di</strong> Scienze del Farmaco, Università<br />

<strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Sassari<br />

L’aumentata eccitabilità dei MSN del Nucleus Accumbens nell’astinenza da morfina.<br />

Pisu Maria Giuseppina 1 , Dore R. 3 , Biggio G. 1,2,3 , Serra M. 1,2,3<br />

1 CNR Istituto <strong>di</strong> Neuroscienze, Sezione <strong>di</strong> Cagliari; 2 Centro <strong>di</strong> Eccellenza per la Neurobiologia delle<br />

Dipendenze, 3 Dipartimento <strong>di</strong> Biologia Sperimentale, Sezione <strong>di</strong> Neuroscienze, Università <strong>di</strong> Cagliari<br />

Effetto dell’etanolo nei ratti socialmente isolati: <strong>di</strong>fferenze <strong>di</strong> genere.<br />

Coluccia Addolorata, Belfiore D., Borracci P., Renna G., Giustino A., Carratù M.R.<br />

Dipartimento <strong>di</strong> Farmacologia e Fisiologia Umana, Università <strong>di</strong> Bari<br />

Esposizione ad acido retinoico durante la gravidanza: alterazioni neurofunzionali nella progenie<br />

maschile e femminile <strong>di</strong> ratto.<br />

36<br />

Grilli Massimo 1 , Patti L. 1 , Robino F. 1 , Zappettini S. 1 , Sofianos I. 1 , Raiteri M. 1,2 , Marchi M. 1,2<br />

1 Sezione <strong>di</strong> Farmacologia e Tossicologia, Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale, Università <strong>di</strong><br />

Genova; 2 Centro <strong>di</strong> Eccellenza per la Ricerca Biome<strong>di</strong>ca, Università <strong>di</strong> Genova<br />

Coesistenza e interazione funzionale tra recettori presinaptici nicotinici e muscarinici che modulano il<br />

rilascio <strong>di</strong> neurotrasmettitori da sinaptosomi striatali.<br />

Carta Mario, Murru L., Barabino E., Botta P., Talani G., Zaccheddu R., Sanna E.,<br />

Biggio G.<br />

Dip. Di Biologia Sperimentale, Sezione Neuroscienze e Centro <strong>di</strong> Eccellenza per la Neurobiologia delle<br />

Dipendenze, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Cagliari<br />

Uso dell’isoniazide, un inibitore dell'acido glutammico decarbossilasi, per lo stu<strong>di</strong>o in vitro del ruolo<br />

della trasmissione GABAergica nel controllo del circuito neuronale della corteccia cerebellare<br />

Leggio Gian Marco, Consoli D., Mazzola C., Micale V., Drago F.<br />

Dipartimento <strong>di</strong> Farmacologia Sperimentale e Clinica, Università <strong>di</strong> Catania<br />

Effetti comportamentali dell’agonista del recettore 3 adrenocettore sr58611a: prototipo <strong>di</strong> una<br />

nuova classe <strong>di</strong> farmaci antidepressivi/ansiolitici?<br />

Rocchitta Gaia 1 , Puggioni G. 1 , Dedola S. 1 , Bazzu G. 1 , Lowry J.P. 2 , O’Neill R.D. 3 , Serra P.A. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia, Università <strong>di</strong> Sassari; 2 Department of Chemistry, National University o<br />

Ireland, Maynooth, Co. Kildare, Ireland; 3 UCD School of Chemistry and Chemical Biology, University<br />

College Dublin, Belfield, Dublin 4, Ireland.<br />

Sviluppo <strong>di</strong> un nuovo sistema biotelemetrico per il monitoraggio in tempo reale <strong>di</strong> nitrossido,<br />

glutammato e acido ascorbico nello striato <strong>di</strong> ratti freely moving.<br />

17.15 – 17.30 INTERVALLO<br />

pag_sx.indd 1 30/05/2007 1.18.57


Moderatori: Taglialatela M (Campobasso) Amoroso S (Ancona) Guarini S (Modena)<br />

Simioni Carolina 1 , Merighi S. 1 , Benini A. 1 , Mirandola P. 2 , Gessi S. 1 , Varani K. 1 , Leung E. 3 ,<br />

Maclennan S. 3 , Baral<strong>di</strong> P.G. 4 , Borea P.A. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Clinica e Sperimentale Sez. Farmacologia, Università <strong>di</strong> Ferrara; 2 Dip. Di<br />

Anatomia Umana, Farmacologia e Me<strong>di</strong>cina Forense, Ist. Di Anatomia Umana, Osp. Maggiore,<br />

Università <strong>di</strong> Parma; 3 King Pharm. Res. and Dev., Inc., Cary, North Carolina, 4 Dipartimento <strong>di</strong><br />

Scienze Farmaceutiche, Università <strong>di</strong> Ferrara.<br />

L’ipossia inibisce l’apoptosi indotta da paclitaxel me<strong>di</strong>ante la fosforilazione <strong>di</strong> BAD <strong>di</strong>pendente<br />

dall’adenosina nelle cellule <strong>di</strong> glioblastoma.<br />

Poma Paola, Labbozzetta M., Notarbartolo M.,Maurici A., Rizzi M. * , Simoni D. * ,D’Alessandro<br />

N.<br />

Dipartimento <strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Palermo e *Dipartimento <strong>di</strong> Scienze<br />

Farmaceutiche, Università <strong>di</strong> Ferrara<br />

Le attività antitumorali della curcumina e del suo nuovo analogo isossazolico MR 39 non vengono<br />

ostacolate dalla con<strong>di</strong>zione <strong>di</strong> multifarmacoresistenza <strong>di</strong> cellule tumorali che esprimono sia la P-<br />

glicoproteina che <strong>di</strong>fferenti IAP.<br />

Menna Pierantonio, Salvatorelli E., Minotti G.<br />

Dipartimento Scienze del Farmaco - Centro Scienze dell’ Invecchiamento, Università “G.d’Annunzio”,<br />

Chieti<br />

Distribuzione, metabolismo e tossicità della doxorubicina in car<strong>di</strong>omiociti: Ruolo della mioglobina.<br />

Salvatorelli Emanuela, Menna P., Minotti G.<br />

Dipartimento Scienze del Farmaco - Centro Scienze dell’ Invecchiamento, Università “G.d’Annunzio”,<br />

Chieti<br />

Sviluppo <strong>di</strong> un modello traslazionale <strong>di</strong> cuore umano per lo stu<strong>di</strong>o <strong>di</strong> interazioni tossico-metaboliche<br />

tra doxorubicina o epirubicina e paclitaxel o docetaxel.<br />

37<br />

Tramentozzi Elisa 1 , Pagetta A. 1 , Monopoli M. 1 , Frasson M. 2 , Finotti P. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia e Anestesiologia, Università <strong>di</strong> Padova; 2 Dipartimento <strong>di</strong> Biochimica,<br />

Università <strong>di</strong> Padova<br />

Angiogenesi indotta dalla “heat shock protein” Glucose-regulated protein 94 (GRP94) con<br />

meccanismo simile a quello <strong>di</strong> una citochina.<br />

Rodolico Gabriella, Piegari E., Vitelli M.R., Damiano V., Rossi F., Berrino L.<br />

Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale, Sezione <strong>di</strong> Farmacologia “L. Donatelli”, Centro <strong>di</strong> Eccellenza<br />

delle Malattie Car<strong>di</strong>ovascolari, Seconda Università <strong>di</strong> Napoli<br />

Variazione dell’espressione genica in cuori isolati <strong>di</strong> ratto <strong>di</strong>abetico e non perfusi con una soluzione<br />

ad alta concentrazione <strong>di</strong> glucosio.<br />

Conti Valeria 1 , Corbi G. 2 , Boccuti S. 3 , Ferrara N. 2 , Carusio N. 3 , Rinal<strong>di</strong> B. 3 , Rossi F. 3 ,<br />

Filippelli A. 3<br />

1 Scuola <strong>di</strong> Specializzazione in Farmacologia, Seconda Università <strong>di</strong> Napoli; 2 Dipartimento <strong>di</strong> Scienze<br />

della Salute, Università del Molise e Fondazione S. Maugeri, Istituto Scientifico <strong>di</strong> Telese Terme;<br />

3 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale e Centro <strong>di</strong> Eccellenza delle Malattie Car<strong>di</strong>ovascolari,<br />

Seconda Università <strong>di</strong> Napoli<br />

L’esercizio fisico prolungato e moderato in ratti anziani potenzia l’attività della sirtuina 1.<br />

Amoruso Angela 1 , Bardelli C. 1 , Ribichini F. 2 , Ferrero V. 2 , Vassanelli C. 2 , Brunelleschi S. 1<br />

1 Dipartimento <strong>di</strong> Scienze Me<strong>di</strong>che, Università Piemonte Orientale, Novara; 2 Divisione <strong>di</strong> Car<strong>di</strong>ologia,<br />

Università <strong>di</strong> Verona<br />

Differenze <strong>di</strong> genere nell’espressione <strong>di</strong> PPAR-gamma in pazienti affetti da coronaropatie.<br />

pag_dx.indd 1 30/05/2007 1.20.32


Esposito Emanuela 1,3 , Mazzon E. 2,3 , Muià C. 2 , Meli R. 1 , Bramanti P. 3 , Caputi A.P. 2,3 ,<br />

Cuzzocrea S. 2,3<br />

1 Dipartmento <strong>di</strong> Farmacologia Sperimentale, Università <strong>di</strong> Napoli “Federico II”; 2 Dipartimento <strong>di</strong><br />

Me<strong>di</strong>cina Sperimentale e Clinica e Farmacologia, Università <strong>di</strong> Messina; 3 IRCCS Centro Neurolesi<br />

"Bonino-Pulejo", Messina<br />

L’inibizione genetica e farmacologica del TNF- riduce il danno da ischemia e riperfusione splancnica.<br />

38<br />

Cre<strong>di</strong>ti ECM assegnati 2<br />

Simposio<br />

Nuove prospettive terapeutiche nel trattamento della<br />

depressione. L'approccio melatoninergico: dalla farmacologia<br />

all'evidenza clinica<br />

Moderatori: Biggio G (Cagliari) Lorettu L (Sassari)<br />

15.00/15.10 Carpiniello B (Cagliari)<br />

Introduzione<br />

SALA 3<br />

15.00-17.30<br />

15.10/15.40 Aguglia E (Trieste)<br />

Il trattamento della depressione oggi: realtà clinica nell'uso <strong>degli</strong> antidepressivi<br />

15.40/16.10 Racagni G (Milano)<br />

Un nuovo step nella ricerca farmacologica: l'approccio melatoninergico<br />

16.10/16.40 Monteleone P (Napoli)<br />

Depressione e ritmi circa<strong>di</strong>ani: razionale per l'impiego <strong>di</strong> un antidepressivo<br />

melatoninergico<br />

16.40/17.10 Altamura AC (Milano)<br />

Depressione Maggiore: efficacia clinica e tollerabilità <strong>di</strong> un nuovo antidepressivo<br />

melatoninergico<br />

17.10/17.30 Biggio G (Cagliari)<br />

Conclusione e Questionario ECM<br />

Simposio<br />

Infiammazioni e sindromi coronariche acute: stato dell'arte<br />

SALA 4<br />

15.00-17.30<br />

Moderatori: Rossi F (Napoli) Golino P (Napoli)<br />

15.00/15.30 Biasucci L (Roma)<br />

L'attivazione del sistema immunitario nella placca è conseguenza <strong>di</strong> un evento<br />

infiammatorio sistemico<br />

15.30/16.00 De Palma R (Napoli)<br />

L'attivazione del sistema immunitario nella placca è conseguenza <strong>di</strong> un evento<br />

infiammatorio locale<br />

16.00/16.30 Berrino L (Napoli)<br />

Differenti patterns <strong>di</strong> espressione genica nelle placche instabili<br />

16.30/17.00 Tremoli E (Milano)<br />

Markers <strong>di</strong> attivazione piastrinica nella placca aterosclerotica<br />

17.00/17.30 Cattaneo M (Milano)<br />

Clopidogrel e sindromi coronariche acute: cosa c'è oltre l'effetto antiaggregante?<br />

pag_sx.indd 1 30/05/2007 7.07.50


Tavola Rotonda<br />

Farmacologia <strong>di</strong> genere: dal laboratorio alla società<br />

SALA 5<br />

15.00-17.30<br />

Moderatori: Franconi F (Sassari) Caporale C (Roma) Schirru A (Cagliari)<br />

15.00/15.10 Franconi F (Sassari) Caporale C (Roma)<br />

Presentazione della tavola rotonda<br />

15.10/15.40 Bellantuono C (Verona)<br />

Antidepressivi e rischio <strong>di</strong> malformazioni maggiori<br />

15.40/15.50 Marilotti L (Cagliari)<br />

Il <strong>di</strong>ritto alla salute<br />

15.50/16.10 Vella S (Roma)<br />

La farmacologia <strong>di</strong> genere nella ricerca pubblica ed in clinica<br />

16.10/16.30 Mazzaglia G (Firenze)<br />

Potenzialità della ricerca epidemiologica sui flussi correnti nella specificità <strong>di</strong> genere<br />

16.30/16.45 Cricelli C (Firenze)<br />

La farmacologia <strong>di</strong> genere e la me<strong>di</strong>cina <strong>di</strong> base<br />

16.45/17.05 Ruffilli MP (Roma)<br />

La farmacologia <strong>di</strong> genere e la ricerca industriale<br />

17.05/17.25 Linguiti D (Roma)<br />

La politica delle pari opportunità e la salute delle donne<br />

17.25/17.30 Franconi F (Sassari)<br />

Conclusioni<br />

39<br />

Simposio<br />

<strong>Stu<strong>di</strong></strong> <strong>di</strong> sicurezza dei me<strong>di</strong>cinali biologici (anticorpi monoclonali)<br />

(<strong>SIF</strong> - SITOX)<br />

SALA 6<br />

15.00-17.30<br />

Moderatori: Cantelli Forti G (Bologna) Riccar<strong>di</strong> C (Perugia)<br />

15.00/15.30 Ascione A (Roma)<br />

Biotecnologie immunologiche e loro applicazione<br />

15.30/16.00 Dempster A (Cambridge, USA)<br />

Non clinical safety evaluation of biotechnologically derived pharmaceuticals<br />

16.00/16.30 Bernar<strong>di</strong> C (Milano)<br />

I primati non umani nella ricerca dei me<strong>di</strong>cinali biologici<br />

16.30/17.00 Meneguz A (Roma)<br />

Le prospettive regolatorie dopo il caso TGN 1412<br />

17.00/17.30 Rossi P (Roma)<br />

Il nostro fantastico sistema immunitario<br />

pag_dx.indd 1 30/05/2007 1.25.58


Simposio<br />

La formazione specialistica in Farmacologia<br />

SALA 7<br />

15.00-17.30<br />

40<br />

Moderatore: Chiesara E (Milano) Caputi AP (Messina)<br />

15.00/15.15 Chiesara E (Milano)<br />

Presentazione del problema<br />

15.15/15.30 Frigo G (Pavia)<br />

Stato dell'arte<br />

15.30/15.45 Patrono C (Roma)<br />

Sperimentazione Clinica-Farmacologica in Italia<br />

15.45/16.00 Furlanut M (U<strong>di</strong>ne)<br />

Esperienze regionali<br />

16.00/16.15 Ad<strong>di</strong>s A (Roma)<br />

La formazione a <strong>di</strong>stanza (FAD) promossa dall'AIFA<br />

16.15/16.30 Cricelli C (Firenze)<br />

Il punto <strong>di</strong> vista della SIMG<br />

16.30/16.45 Del Tacca M (Pisa)<br />

Sbocchi professionali<br />

16.45/17.00 Cella S (Milano)<br />

Interventi preor<strong>di</strong>nati: esperienze ospedaliere<br />

17.00/17.20 Discussione<br />

17.20/17.30 Caputi AP (Messina)<br />

Conclusioni<br />

Sessione ECM<br />

Simposio<br />

Farmacoutilizzazione e appropriatezza d'uso dei farmaci<br />

Moderatori: Giusti P (Padova) Corrao G (Milano)<br />

15.00/15.20 Lucioni C (Milano)<br />

Consumo <strong>di</strong> farmaci: dosaggi empirici verso appropriatezza terapeutica<br />

15.20/15.40 Haycox A (Liverpool)<br />

Utilizzo <strong>di</strong> data base nelle realtà europee<br />

SALA 8<br />

15.00-17.30<br />

15.40/16.00 Zambon A (Milano)<br />

Fattori pre<strong>di</strong>ttori <strong>di</strong> <strong>di</strong>scontinuità e <strong>di</strong> fallimento della terapia con bisfosfonati:<br />

risultati da uno stu<strong>di</strong>o <strong>di</strong> coorte basato su <strong>di</strong> un'ampia popolazione<br />

16.00/16.20 Mazzaglia G (Firenze)<br />

Analisi della relazione tra l'aderenza alla terapia con antiipertensivi e l'insorgenza <strong>di</strong><br />

eventi car<strong>di</strong>ovascolari non fatali in comunità<br />

16.20/16.40 Chiroli S (Milano)<br />

Valutazione dell'efficacia comparativa nell'Unione Europea: dati e metodologia<br />

16.40/17.00 Chinellato A (Treviso)<br />

Epidemiologia e trattamento del dolore da cancro: stiamo uccidendo la morfina?<br />

17.00/17.30 Discussione<br />

Realizzato con il contributo educazionale <strong>di</strong> AstraZeneca, Amgen, Abbott<br />

pag_sx.indd 1 04/06/2007 11.42.57


Simposio<br />

Nuovi aspetti patogenetici e terapeutici della<br />

neurodegenerazione<br />

(<strong>SIF</strong> - ITINAD)<br />

Moderatori: Canonico PL (Novara) Caltagirone CF (Roma)<br />

Sessione ECM<br />

17.30/17.55 Copani AG (Catania)<br />

Il ruolo del ciclo cellulare nella malattia <strong>di</strong> Alzheimer: implicazioni per la<br />

neuroprotezione<br />

17.55/18.20 Di Luca M (Milano)<br />

Meccanismi molecolari <strong>di</strong> malattie neurodegenerative<br />

18.20/18.45 Borroni B (Verona)<br />

Modelli periferici e terapia<br />

AUDITORIUM<br />

17.30-19.30<br />

18.45/19.10 Ghiglieri V (Roma)<br />

Modelli sperimentali <strong>di</strong> malattia <strong>di</strong> Parkinson: un approccio comportamentale ed<br />

elettrofisiologico<br />

19.10/19.30 Memo M (Brescia)<br />

Attività cellulari della proteina beta amiloide<br />

Realizzato con il contributo educazionale <strong>di</strong> Bracco<br />

41<br />

Sessione ECM<br />

Simposio<br />

La neurobiologia ed i trattamenti farmacologici del poliabuso<br />

Moderatori: Nava F (Padova) Tagliamonte A (Siena)<br />

17.30/17.50 Tagliamonte A (Siena)<br />

Introduzione al fenomeno del poliabuso<br />

17.50/18.10 Nava F (Padova)<br />

Le basi neurobiologiche della clinica del poliabuso<br />

18.10/18.30 Ciccocioppo R (Camerino)<br />

La ricerca traslazionale nella polydrug ad<strong>di</strong>ction: il ruolo del recettore della<br />

nocicettina<br />

18.30/18.50 Diana M (Iglesias)<br />

Il ruolo del poliabuso nel paziente con doppia <strong>di</strong>agnosi<br />

18.50/19.30 Discussione<br />

SALA 1<br />

17.30-19.30<br />

Realizzato con il contributo educazionale <strong>di</strong> Laboratori Farm. CT<br />

pag_dx.indd 1 30/05/2007 1.29.27


Sessione ECM<br />

Simposio<br />

Farmaci inibitori della pompa protonica e danno <strong>di</strong>gestivo indotto<br />

da FANS: aspetti farmacologici e clinici<br />

Moderatori: Del Tacca M (Pisa) Tonini M (Pavia)<br />

17.30/17.55 Tonini M (Pavia)<br />

Meccanismi d'azione dei farmaci inibitori della pompa protonica<br />

SALA 3<br />

17.30-19.30<br />

17.55/18.20 Blan<strong>di</strong>zzi C (Pisa)<br />

Inibitori <strong>di</strong> pompa protonica e secrezione gastrica: determinanti farmaco<strong>di</strong>namici,<br />

farmacocinetici e farmacogenetici<br />

18.20/18.45 De Ponti F (Bologna)<br />

Effetti dei FANS sui meccanismi <strong>di</strong> protezione e riparazione della mucosa <strong>di</strong>gestiva:<br />

basi molecolari<br />

18.45/19.10 Scarpignato C (Parma)<br />

COXIB e apparato <strong>di</strong>gerente: una promessa mantenuta?<br />

19.10/19.30 Pilotto A (S. Giovanni Rotondo)<br />

Ruolo <strong>degli</strong> inibitori <strong>di</strong> pompa protonica nel trattamento <strong>degli</strong> effetti avversi <strong>di</strong>gestivi<br />

dei FANS<br />

42<br />

Realizzato con il contributo educazionale <strong>di</strong> AstraZeneca, Malesci<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmacologia del dolore e infiammazione<br />

SALA 4<br />

17.30-19.30<br />

Moderatori: Calignano A (Napoli) Maione S (Napoli)<br />

Colucci Mariantonella 1 , Maione F. 1,2 , Federica M. 3 , Di Giannuario A. 1 , Pieretti S. 1<br />

1 Istituto Superiore <strong>di</strong> Sanità, Dipartimento del Farmaco, Roma; 2 Dipartimento <strong>di</strong> Farmacologia<br />

Sperimentale, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Napoli “Federico II”, Napoli; 3 Dipartimento <strong>di</strong> Fisiologia e<br />

Farmacologia “Vittorio Erspamer” Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Roma “La Sapienza”, Roma<br />

Il ruolo del recettore dei pepti<strong>di</strong> formilati nel controllo della trasmissione nocicettiva: un contributo<br />

dai topi transgenici mancanti <strong>di</strong> tale recettore.<br />

Calignano Antonio, La Rana G., Russo R., Sasso O., D’Agostino G.<br />

Dip. Farmacologia Sperimentale, Facoltà <strong>di</strong> Farmacia, Napoli<br />

Gli agonisti PPAR- inducono analgesia attraverso l’attivazione dei canali del potassio ad ampia e<br />

me<strong>di</strong>a conduttanza.<br />

Lattanzi Roberta, Franchi S. 1 , Sacerdote P. 1 , Melchiorri P., Negri L.<br />

Dipartimento Fisiologia Umana e Farmacologia, Roma “La Sapienza”; 1 Dipartimento <strong>di</strong> Farmacologia,<br />

Milano<br />

Le prostaglan<strong>di</strong>ne contribuiscono alla sensitizzazione nocicettiva indotta da Bv8.<br />

pag_sx.indd 1 30/05/2007 1.31.40


Siniscalco Dario, Giordano C., Luongo L., de Novellis V., Rossi F., Di Marzo V. 1 , Maione S.<br />

1 Istituto <strong>di</strong> Chimica Biomolecolare, CNR Pozzuoli (NA); Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale, Sez.<br />

Farmacologia, Seconda Università <strong>di</strong> Napoli<br />

Espressione dei geni dell’Apoptosi in un modello murino <strong>di</strong> dolore neuropatico: ruolo del sistema<br />

endocannabinoide.<br />

Ghelar<strong>di</strong>ni Carla, Vivoli E., Norcini M., Bartolini A., Martinelli M. 1 , Petrillo P. 1 , Farina C. 1<br />

Dipartimento <strong>di</strong> Farmacologia, Università <strong>di</strong> Firenze, Firenze; 1 NiKem Research Srl, Milano<br />

Effetti anti-iperalgesici del derivato pirroli<strong>di</strong>nonico nik-13317 in modelli <strong>di</strong> dolore neuropatico.<br />

Moderatori: Filippelli A (Napoli) Bernar<strong>di</strong>ni R (Catania)<br />

Viaro Riccardo 1 , Marti M. 1 , Morari M. 1 , Franchi G. 2<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Clinica e Sperimentale, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Ferrara;<br />

2 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che e Terapie Avanzate, Sezione <strong>di</strong> Fisiologia Umana, Università <strong>di</strong><br />

Ferrara<br />

I recettori per la nocicettina/orfanina FQ localizzati nella sostanza nera reticolata modulano l’attività<br />

motoria e l’eccitabilità della corteccia motoria primaria nel ratto.<br />

Savani Clau<strong>di</strong>a 1,2 , De Filippis D. 3 , Scuderi C. 1,4 , Carnuccio R. 3 , De Stefano D. 3 , Iuvone T. 3 ,<br />

Esposito G. 1 , Steardo L. 1<br />

1 Dipartimento <strong>di</strong> Fisiologia umana e Farmacologia “Vittorio Erspamer”, Università “La Sapienza”,<br />

Roma; 2 Dipartimento <strong>di</strong> Fisiologia umana e Farmacologia, Università <strong>di</strong> Bari; 3 Dipartimento <strong>di</strong><br />

Farmacologia Sperimentale, Università <strong>di</strong> Napoli Federico II; 4 Dipartimento <strong>di</strong> Scienze<br />

Farmacologiche, Università <strong>di</strong> Palermo<br />

Proprietà antiinfiammatorie della PEA in cellule C6 stimolate con peptide beta amiloide.<br />

43<br />

Franchi Silvia, Panerai A., Negri L. 1 , Melchiorri P. 1 , Sacerdote P.<br />

Dipartimento <strong>di</strong> Farmacologia Chemioterapia e Tossicologia Me<strong>di</strong>ca, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Milano;<br />

1 Dipartimento <strong>di</strong> Fisiologia Umana e Farmacologia, Università La Sapienza, Roma<br />

Il sistema delle prokineticine/Bv8 come nuovo modulatore delle risposte immuni: rilevanza nelle<br />

malattie infiammatorie.<br />

Amantea Diana 1 , Gliozzi M. 2 , Corasaniti M.T. 2 , Bagetta G. 1<br />

1 Dipartimento Farmacobiologico, Università della Calabria, Rende (CS); 2 Dipartimento <strong>di</strong> Scienze<br />

Farmacobiolgiche, Università “Magna Graecia”, Catanzaro<br />

Le metalloproteinasi della matrice (MMPs) sono coinvolte nell’aumento precoce <strong>di</strong> interleuchina (IL-<br />

1) indotto da ischemia cerebrale focale transitoria nel ratto.<br />

Gianella Anita 1 , Nobili E. 1 , Gelosa P. 1 , Mussoni L. 1 , Bellosta S. 1 , Canadesi M. 1 , Abbate M. 2 ,<br />

Zoja C. 2 , Tremoli E. 1,3 , Sironi L. 1<br />

1 Dipartimento Scienze Farmacologiche, Università <strong>di</strong> Milano; 2 Centro Car<strong>di</strong>ologico Monzino IRCCS,<br />

Milano; 3 Ist. Mario Negri, Bergamo<br />

La rosuvastatina previene il danno renale spontaneo nei ratti SHRSP modulando il sistema<br />

plasminogeno/plasmina e l'espressione delle metalloproteasi.<br />

pag_dx.indd 1 30/05/2007 1.35.22


Simposio<br />

Targets cellulari e molecolari per lo sviluppo <strong>di</strong> nuove terapie in<br />

corso <strong>di</strong> neuroAIDS<br />

SALA 5<br />

17.30-19.30<br />

44<br />

Moderatori: Bagetta G (Cosenza) Pittaluga A (Genova)<br />

17.30/17.50 Pittaluga A (Genova)<br />

Interazione tra proteine del virus HIV-1 e recettori per il glutammato: loro ruolo in<br />

corso <strong>di</strong> neuroAIDS<br />

17.50/18.10 Viviani B (Milano)<br />

IL-1 beta e recettore NMDA: un pericoloso legame in corso <strong>di</strong> neuroAIDS<br />

18.10/18.30 Russo R (Cosenza)<br />

Definizione <strong>di</strong> un ruolo per la metalloproteasi della matrice (MMPs) nell'apoptosi<br />

neuronale indotta dalla gp120 del virus HIV-1 nel ratto<br />

Moderatori: Mollace V (Catanzaro) Marinovich M (Milano)<br />

18.30/18.50 Bezzi P (Losanna)<br />

Esocitosi Ca 2+ -regolata <strong>di</strong> glutammato da astrociti: un duplice ruolo nella<br />

comunicazione normale e patologica tra neuroni e glia<br />

18.50/19.10 Sgura A (Roma)<br />

Ruolo dello stress ossidativo nell'apoptosi me<strong>di</strong>ata dal virus HIV-1 e sulla lunghezza<br />

dei telomeri in una linea cellulare umana <strong>di</strong> astrocitoma<br />

19.10/19.30 Muscoli C (Cosenza)<br />

Modulazione farmacologica dello stress ossidativo nei <strong>di</strong>sor<strong>di</strong>ni neurodegenerativi da<br />

HIV<br />

Simposio<br />

Meccanismi farmacologici che regolano la proliferazione e il<br />

<strong>di</strong>fferenziamento delle cellule staminali<br />

SALA 6<br />

17.30-19.30<br />

Moderatori: Melchiorri D (Roma) Gorio A (Milano)<br />

17.30/17.50 Finocchiaro G (Milano)<br />

Cellule staminali da cancro<br />

17.50/18.10 Gorio A (Milano)<br />

Cellule staminali e lesioni midollari<br />

18.10/18.30 Reitano E (Milano)<br />

Terapia <strong>di</strong> sostituzione cellulare con cellule staminali<br />

18.30/18.50 Sartiani L (Firenze)<br />

Differenziamento car<strong>di</strong>omiocitario delle cellule staminali embrionali: proprietà<br />

funzionali e fattori <strong>di</strong> modulazione<br />

18.50/19.10 Melchiorri D (Roma)<br />

Ruolo dei recettori metabotropici del glutammato nel <strong>di</strong>fferenziamento delle cellule<br />

staminali<br />

19.10/19.30 Discussione<br />

pag_sx.indd 1 30/05/2007 1.39.57


Simposio<br />

Canali ionici come bersagli terapeutici per malattie genetiche e<br />

non-genetiche<br />

SALA 7<br />

17.30-19.30<br />

Moderatori: Conte Camerino D (Bari) Fontaine B (Parigi)<br />

17.30/17.50 Fontaine B (Parigi)<br />

Malattie dei canali del nervo e del muscolo<br />

17.50/18.10 Tricarico D (Bari)<br />

Coinvolgimento dei canali K + nelle patologie muscolari genetiche e non:<br />

dall'espressione genica alla terapia farmacologica<br />

18.10/18.30 Taglialatela M (Campobasso)<br />

Fisiopatologia e farmacologia molecolari dei canali KCNQ neuronali<br />

18.30/18.50 Sanna E (Cagliari)<br />

Recettori GABA A extrasinaptici: ruolo fisiologico, plasticità e nuove prospettive<br />

farmacologiche<br />

18.50/19.10 Evoli A (Roma)<br />

Canalopatie paraneoplastiche<br />

19.10/19.30 Cerbai E (Firenze)<br />

La corrente I f in cellule car<strong>di</strong>ache non-pacemaker: ruolo e implicazioni farmacologiche<br />

Sessione ECM<br />

Simposio<br />

La malattia <strong>di</strong> Parkinson: dalla biologia molecolare alla terapia<br />

(<strong>SIF</strong> - LIMPE)<br />

Moderatori: Corsini GU (Pisa) Ruggeri S (Roma)<br />

17.30/18.00 Morelli M (Cagliari)<br />

Fisiopatologia dei gangli della base<br />

18.00/18.30 Fornai F (Pisa)<br />

Nuovi aspetti patogenetici<br />

18.30/19.00 Maggio R (L’Aquila)<br />

Basi farmacologiche della terapia<br />

19.00/19.30 Bonucelli U (Pisa)<br />

Nuove terapie<br />

SALA 8<br />

17.30-19.30<br />

45<br />

pag_dx.indd 1 30/05/2007 1.41.07


Sessione ECM<br />

Simposio<br />

La cascata della via WNT come target delle patologie<br />

neurodegenerative<br />

Moderatori: Gaviraghi G (Siena) Pepeu G (Firenze)<br />

AUDITORIUM<br />

08.30-11.00<br />

08.30/08.55 Nicoletti F (Roma)<br />

L'induzione dell'antagonista della via <strong>di</strong> WNT, Dickkopf-1, come marker <strong>di</strong> morte<br />

neuronale eccitotossica<br />

08.55/09.20 Caricasole A (Siena)<br />

La via <strong>di</strong> WNT e la malattia <strong>di</strong> Alzheimer<br />

09.20/09.45 Casamenti F (Firenze)<br />

<strong>Stu<strong>di</strong></strong>o della cascata della via WNT in modelli animali <strong>di</strong> malattia <strong>di</strong> Alzheimer<br />

09.45/10.10 Hoozemanns J (Amsterdam)<br />

<strong>Stu<strong>di</strong></strong>o del pathway WNT in encefali postmortem in pazienti con malattia <strong>di</strong> Alzheimer<br />

10.10/11.00 Discussione<br />

46<br />

Tavola Rotonda<br />

La prima del farmaco sull'uomo<br />

Moderatori: Vella S (Roma) Velo GP (Verona)<br />

08.30/09.10 Breckenridge A (London)<br />

The day the sky fell in. TGN 1412 and what happened next<br />

09.10/09.30 Popoli P (Roma)<br />

"Piccoli" stu<strong>di</strong> crescono: la sperimentazione clinica <strong>di</strong> fase I in Italia<br />

09.30/09.55 Tomino C (Roma)<br />

La ricerca clinica: crocevia tra investimenti, costi ed opportunità <strong>di</strong> sviluppo<br />

09.55/10.20 Bonino F (Milano)<br />

Le strane coppie, i stu<strong>di</strong> investigator initiated and industry co-sponsored<br />

10.20/10.45 Ruffilli MP (Roma)<br />

La ricerca nell'uomo: un grande viaggio inizia dal primo passo<br />

10.45/11.00 Discussione<br />

SALA1<br />

08.30-11.00<br />

pag_sx.indd 1 30/05/2007 2.00.31


Sessione ECM<br />

Simposio<br />

Farmacologia dei recettori TRPV1 (vanilloi<strong>di</strong>) nel sistema nervoso<br />

centrale e periferico<br />

Moderatori: Di Marzo V (Napoli) Maione S (Napoli)<br />

SALA 2<br />

08.30-11.00<br />

08.30/08.50 Appen<strong>di</strong>no G (Novara)<br />

I composti naturali come prototipi per la scoperta <strong>di</strong> nuovi attivatori/inibitori <strong>di</strong> TRPV1<br />

e canali ionici correlati<br />

08.50/09.10 Geppetti P (Firenze)<br />

Sviluppo <strong>di</strong> potenti e selettivi ligan<strong>di</strong> del canale TRPV1 e loro potenzialità terapeutiche<br />

09.10/09.30 Di Marzo V (Napoli)<br />

Distribuzione, regolazione e ruolo fisiopatologico dei recettori TRPV1 nel cervello<br />

09.30/09.50 De Novellis V (Napoli)<br />

Gli endovanilloi<strong>di</strong> controllano l'attività del sistema <strong>di</strong>scendente inibitorio del dolore<br />

09.50/10.10 Wotjak CT (Monaco)<br />

Role of TRPV1 receptor in fear and anxiety<br />

10.10/11.00 Discussione<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmacologia car<strong>di</strong>ovascolare<br />

Moderatori: Cerbai E (Firenze) Desole MS (Sassari)<br />

SALA 3<br />

08.30-11.30<br />

Pierno Sabata 1 , Camerino G.M. 1 , Cippone V. 1 , Liantonio A. 1 , De Luca A. 1 , Kunic J. 2 , George<br />

A.L. Jr. 2 , Conte Camerino D. 1<br />

1 Sezione <strong>di</strong> Farmacologia, Dipartimento Farmaco-biologico, Università <strong>di</strong> Bari; 2 Dept. of Me<strong>di</strong>cine,<br />

Vanderbilt University, Nashville, TN, USA<br />

Meccanismi molecolari responsabili della mo<strong>di</strong>ficazione della conduttanza <strong>di</strong> membrana sostenuta dal<br />

canale al cloro clc-1 nel muscolo scheletrico <strong>di</strong> ratti trattati cronicamente con statine e fibrati.<br />

47<br />

Rinal<strong>di</strong> Barbara, Donniacuo M. 1 , Cappetta D. 1 , Capuano A. 1 , Romagnoli P. 2 , De Angelis A. 1 ,<br />

De Stefano D. 3 , Rossi F. 1 , Filippelli A. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale e Centro <strong>di</strong> Eccellenza delle Malattie Car<strong>di</strong>ovascolari, Seconda<br />

Università <strong>di</strong> Napoli, Italia; 2 Dipartimento <strong>di</strong> Anatomia, Istologia e Me<strong>di</strong>cina Legale sez. E. Allara<br />

Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Firenze, Italia; 3 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università <strong>di</strong><br />

Napoli Federico II Italia<br />

Il rosigliatazone riduce il processo infiammatorio indotto da un danno vascolare nel ratto.<br />

Di Francesco Luigia 1 , Piccoli A. 2 , Capone M. 1 , Evangelista V. 2 , Totani L. 2 , Patrignani P. 1<br />

1 Università G d’Annunzio, Chieti, Italy; 2 Mario Negri Sud, Santa Maria Imbaro Chieti<br />

Contributo delle isoforme della ciclo-ossogenasi alla produzione <strong>di</strong> prostaciclina e prostaglan<strong>di</strong>na E2<br />

da parte delle cellule endoteliali in risposta allo shear stress laminare.<br />

pag_dx.indd 1 30/05/2007 1.53.12


Benetti Elisa 1 , Collino M. 1 , Thiemermann C. 3 , Mastrocola R. 2 , Gallicchio M. 1 , Dianzani C. 1 ,<br />

Danni O. 2 , Aragno M. 2 , Fantozzi R. 1<br />

1 Dipartimento <strong>di</strong> Anatomia, Farmacologia e Me<strong>di</strong>cina Legale. Università <strong>di</strong> <strong>Torino</strong>; 2 Dipartimento <strong>di</strong><br />

Me<strong>di</strong>cina Sperimentale e Oncologia, Università <strong>di</strong> <strong>Torino</strong>; 3 Centre for Exp Med, Nephrology & Critical<br />

Care, William Harvey Research Institute, London, UK<br />

L’inibitore selettivo della Glicogeno Sintasi Kinasi-3b, TDZD-8, riduce il danno indotto da una parziale<br />

ischemia-riperfusione cerebrale nell’ippocampo <strong>di</strong> ratto.<br />

Rossoni Giuseppe 1 , Sparatore A. 2 , Moore P.K. 3 , Manfre<strong>di</strong> B. 1 , Tazzari V. 4 , Del Soldato P. 4 ,<br />

Berti F. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia, Chemioterapia e Tossicologia Me<strong>di</strong>ca, Università <strong>di</strong> Milano, Italia;<br />

2 Istituto <strong>di</strong> Chimica Farmaceutica e Tossicologica "Pietro Pratesi", Università <strong>di</strong> Milano, Italia;<br />

3 Dipartimento <strong>di</strong> Farmacologia, Università Nazionale <strong>di</strong> Singapore, Singapore; 4 CTG Pharma, Milano,<br />

Italia<br />

Effetto car<strong>di</strong>oprotettivo del solfo-<strong>di</strong>clofenac nel cuore ischemico-reperfuso <strong>di</strong> coniglio.<br />

48<br />

Deambrosis Paola 1 , Saramin C. 1 , Terrazzani G. 1 , Bader G. 2 , Scaldaferri E. 3 , Chinellato A. 1 ,<br />

Giusti P. 4<br />

1 Servizio farmaceutico territoriale, Ulss9 Treviso; 2 Outcome research, Pfizer Roma; 3 I° Centro<br />

Anti<strong>di</strong>abetico, Me<strong>di</strong>cina I, Ulss9 Treviso; 4 Dipartimento <strong>di</strong> Farmacologia e Anestesiologia, Università <strong>di</strong><br />

Padova<br />

Effetti della terapia con statine sui livelli <strong>di</strong> colesterolo e sui ricoveri ospedalieri per patologie<br />

car<strong>di</strong>ovascolari, nell’ULSS <strong>di</strong> Treviso.<br />

Marasciulo Flora L, Potenza M.A., Tarquinio M., Quon M.J. 1 , Montagnani M.<br />

Dipartimento <strong>di</strong> Farmacologia e Fisiologia Umana, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Bari ; 1 Diabetes Unit,<br />

National Center for Complementary and Alternative Me<strong>di</strong>cine, National Institutes of Health, Bethesda,<br />

MD 20892, USA<br />

Meccanismi molecolari coinvolti negli effetti acuti e cronici dell’epigallocatechina gallato, un polifenolo<br />

del tè verde, sulla regolazione della funzione vascolare in ratti spontaneamente ipertesi (SHR).<br />

Chiesa Giulia, Parolini C., Marchesi M., Diani E., RIgamonti E., Cornelli L., Sirtori C.R.<br />

Dipartimento <strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Milano<br />

Ridotta progressione <strong>di</strong> aterosclerosi in conigli alimentati con proteine <strong>di</strong> lupino.<br />

Vinci Maria Cristina, Bellik L., Parenti A., Ledda F.<br />

Laboratorio <strong>di</strong> Farmacologia Vascolare, Dipartimento <strong>di</strong> Farmacologia Clinica e Preclinica, Università <strong>di</strong><br />

Firenze<br />

Un biopolimero costituito da acido ialuronico (HYAFF-11) come supporto per la crescita <strong>di</strong> cellule<br />

progenitrici endoteliali umane.<br />

pag_sx.indd 1 30/05/2007 2.01.26


Sessione ECM<br />

Simposio<br />

Nocicettina/orfanina FQ: dagli stu<strong>di</strong> <strong>di</strong> base alla clinica<br />

Moderatori: Massi M (Camerino) Regoli D (Ferrara)<br />

08.30/08.50 Calò G (Ferrara)<br />

Il sistema nocicettina/orfanina FQ-recettore NOP e nuovi ligan<strong>di</strong> selettivi<br />

SALA 4<br />

08.30-11.00<br />

08.50/09.10 Ciccocioppo R (Camerino)<br />

Il sistema nocicettina/orfanina FQ come potenziale target per lo sviluppo <strong>di</strong> farmaci<br />

innovativi per la terapia dell'alcolismo<br />

09.10/09.30 Marti M (Ferrara)<br />

Il recettore della nocicettina/orfanina FQ come nuovo target per lo sviluppo <strong>di</strong> farmaci<br />

antiparkinsoniani<br />

09.30/09.50 Improta G (Roma)<br />

Ruolo del sistema nocicettina/orfanina FQ-recettore NOP nel controllo <strong>di</strong> attività<br />

secretorie e motorie gastrointestinali in con<strong>di</strong>zioni fisiologiche e patologiche<br />

09.50/10.10 D'Agostino B (Napoli)<br />

Ruolo della nocicettina e del suo recettore in un modello animale <strong>di</strong> infiammazione<br />

delle vie aeree<br />

10.10/10.30 Lazzeri M (Firenze)<br />

N-OFQ e recettore NOP: una nuova strategia nel trattamento dei <strong>di</strong>sturbi funzionali<br />

del basso tratto urinario<br />

10.30/11.00 Discussione<br />

49<br />

Sessione ECM<br />

Simposio<br />

Sistema nervoso - sistema immunitario tra interazione e<br />

integrazione: tempo per la neuro-immuno-farmacologia?<br />

(<strong>SIF</strong> - ISNIM)<br />

Moderatori: Cosentino M (Varese) Maestroni GJM (Locarno)<br />

SALA 5<br />

08.30-11.00<br />

08.30/08.50 Maestroni GJM (Locarno)<br />

Regolazione adrenergica <strong>di</strong>fferenziale della risposta immunitaria ai Pathogen<br />

Associated Molecular Patterns - Implicazioni nelle malattie infiammatorie e nei vaccini<br />

a base <strong>di</strong> cellule dendritiche<br />

08.50/09.10 Sacerdote P (Milano)<br />

La presenza <strong>di</strong> dolore modula la funzione immune e l’attivazione del sistema<br />

immunitario è coinvolta nella trasmissione nocicettiva<br />

09.10/09.30 Capellino SH (Regensburg)<br />

Meccanismi simpatoadrenergici nell'infiammazione sinoviale<br />

09.30/09.50 Marino F (Varese)<br />

Modulazione dopaminergica della funzionalità dei linfociti T regolatori: nuovi 'target'<br />

per la terapia farmacologica della sclerosi multipla?<br />

pag_dx.indd 1 30/05/2007 1.55.33


Comunicazioni<br />

Moderatori: Marino F (Varese) Lecchini S (Varese)<br />

D’Agostino Giuseppe 1 , La Rana G. 1 , Russo R. 1 , Sasso O. 1 , Iacono A. 1 , Esposito E. 1 , Cuzzocrea<br />

S. 2 , Meli R. 1 , Calignano A. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università Federico II <strong>di</strong> Napoli; 2 Dipartimento <strong>di</strong><br />

Me<strong>di</strong>cina e Farmacologia Clinica e Sperimentale, Università <strong>di</strong> Messina<br />

Il recettore PPAR-alfa centrale modula lo sviluppo dell’edema da carragenina nel topo.<br />

Lattanzi Roberta 1 , Giannini E. 1 , Campese A. 2 , Negri L. 1 , Melchiorri P. 1<br />

1 Dipartimento <strong>di</strong> Fisiologia Umana e Farmacologia, Università <strong>di</strong> Roma La Sapienza; 2 Dipartimento <strong>di</strong><br />

Me<strong>di</strong>cina Sperimentale e Patologia, Università <strong>di</strong> Roma La Sapienza<br />

Le prochineticine contribuiscono al dolore infiammatorio.<br />

Conti Silvia, Bertorelli R., Forlani A., Fredduzzi S., Nicolussi E., Reggiani A.<br />

Schering Plough Research Institute, Milano<br />

Ruolo del GW842166X, un agonista del recettore cannabico CB2, in <strong>di</strong>versi modelli <strong>di</strong> dolore<br />

neuropatico e infiammatorio nel ratto.<br />

50<br />

Cosentino Marco 1 , Zaffaroni M. 2 , Carcano E. 1 , Saporiti F. 1 , Ferrari M. 1 , Rasini E. 1 , Bombelli<br />

R. 1 , Perusin M. 1 , Grezzi A. 2 , Comi G. 2,3 , Marino F. 1 , Lecchini S. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Clinica, Sezione <strong>di</strong> Farmacologia Sperimentale e Clinica, Università<br />

dell’Insubria, Varese; 2 Centro per lo <strong>Stu<strong>di</strong></strong>o della Sclerosi Multipla, Ospedale <strong>di</strong> Gallarate, Varese;<br />

3 Istituto Scientifico S Raffaele Milano<br />

L’interferone-beta inibisce in vitro la funzionalità dei linfociti regolatori CD4+CD25+: ruolo <strong>di</strong><br />

meccanismi dopaminergici autocrini/paracrini.<br />

Simposio<br />

I nuovi farmaci target-specifici in oncologia<br />

SALA 6<br />

08.30-11.00<br />

Moderatori: Mantovani G (Cagliari) Mazzei T (Firenze)<br />

08.30/09.00 Fontanini G (Pisa)<br />

Patologia molecolare dei recettori dei fattori <strong>di</strong> crescita e delle chinasi nelle neoplasie<br />

solide<br />

09.00/09.30 Mini E (Firenze)<br />

Inibitori <strong>di</strong> EGFR e VEGF nella terapia dei tumori del tratto gastrointestinale<br />

09.30/10.00 Massidda B (Cagliari)<br />

Terapia target-specifica nel carcinoma polmonare non a piccole cellule<br />

10.00/10.30 Danesi R (Pisa)<br />

Integrazione <strong>di</strong> farmaci ad azione target-specifica con chemioterapia convenzionale<br />

10.30/11.00 Gebbia N (Palermo)<br />

Farmaci a bersaglio molecolare e pre<strong>di</strong>ttività della risposta<br />

pag_sx.indd 1 30/05/2007 2.10.01


Simposio<br />

Meccanismi d'azione <strong>degli</strong> antidepressivi: nuove acquisizioni<br />

SALA 7<br />

08.30-11.00<br />

Moderatore: Di Chiara G (Cagliari)<br />

08.30/09.00 Borsini F (Roma)<br />

Sviluppo delle teorie sul meccanismo d’azione <strong>degli</strong> antidepressivi<br />

09.00/09.30 Invernizzi R (Milano)<br />

Ruolo della triptofano idrosilasi-2 nella risposta agli SSRI: stu<strong>di</strong> comportamentali e <strong>di</strong><br />

micro<strong>di</strong>alisi nel topo<br />

09.30/10.00 Di Chiara G (Cagliari)<br />

Trattamento cronico con desipramina ed escitalopram su micro<strong>di</strong>alisi e ruolo dei<br />

recettori alfa2 e 5HT1A<br />

10.00/10.30 Demontis G (Siena)<br />

Mo<strong>di</strong>ficazioni dell’attività dell’asse ipotalamo-ipofisi-surrene in un modello<br />

sperimentale <strong>di</strong> depressione ed effetti dell’imipramina<br />

10.30/11.00 Spampinato U (Bordeaux)<br />

Interazione recettori 5HT2C e DA in corteccia<br />

Simposio<br />

Farmaci-farmacisti-farmacie<br />

Moderatori: Fioretti MC (Perugia) Fantozzi R (<strong>Torino</strong>)<br />

08.30/08.55 Diana P (Iglesias)<br />

La professione del farmacista<br />

Sessione ECM<br />

08.55/09.20 Fioretti MC (Perugia)<br />

SOT (OTC e SP): farmaci sicuri? Un'opportunità da non perdere in termini <strong>di</strong><br />

professionalità<br />

09.20/09.45 Massi M (Camerino)<br />

La formazione post-laurea del farmacista<br />

09.45/10.10 Fantozzi R (<strong>Torino</strong>)<br />

Il farmacista e le emergenze terapeutiche<br />

10.10/10.30 Filippi U (Milano)<br />

Il farmacista e la farmacia vista dall'industria<br />

10.30/11.00 Discussione<br />

SALA 8<br />

08.30-11.00<br />

51<br />

pag_dx.indd 1 30/05/2007 2.05.10


Sessione Plenaria<br />

La ricerca clinica in Italia: attualità e prospettive<br />

AUDITORIUM<br />

11.00-13.00<br />

Moderatori: Rossi F (Napoli) Scatigna M (Firenze)<br />

11.00/11.20 Tomino C (Roma)<br />

Attuale normativa e previsti cambiamenti nell'assetto regolatorio della<br />

sperimentazione clinica<br />

11.20/11.40 Scatigna M (Firenze)<br />

Ruolo dell'Italia nello sviluppo clinico farmaceutico<br />

11.40/12.00 Rossi F (Napoli)<br />

Il ruolo dell'Università nella ricerca clinica nazionale<br />

12.00/12.20 Vella S (Roma)<br />

La ricerca farmacologica nel VII programma quadro dell’Unione Europea<br />

12.20/12.40 Cricelli C (Firenze)<br />

La ricerca clinica in me<strong>di</strong>cina generale<br />

12.40/13.00 Discussione<br />

Realizzato con il contributo educazionale <strong>di</strong> Eli Lilly<br />

52<br />

pag_sx.indd 1 30/05/2007 2.07.46


FARMACOLOGIA DEL SISTEMA CARDIOVASCOLARE<br />

Pranzo riservato ai partecipanti<br />

SALA 3<br />

12.30-17.30<br />

12.30-13.00<br />

Simposio<br />

Appropriatezza nella terapia farmacologica car<strong>di</strong>ovascolare<br />

Incontro con l'Esperto<br />

Inibizione della corrente pacemaker IF: dall'elettrofisiologia alla<br />

pratica clinica<br />

13.00-14.30<br />

14.30-15.30<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmacologia car<strong>di</strong>ovascolare 15.30-17.30<br />

Simposio<br />

Appropriatezza nella terapia farmacologica car<strong>di</strong>ovascolare<br />

Moderatori: Biggio G (Cagliari) Lai C (Cagliari) Mugelli A (Firenze)<br />

13.00/13.30 Gaspardone A (Roma)<br />

Meccanismi <strong>di</strong> protezione vascolare <strong>degli</strong> inibitori dell'HMGCO-A reduttasi<br />

13.30/14.00 Caputi AP (Messina)<br />

Concetti <strong>di</strong> compliance, aderenza e continuità terapeutica nella patologia<br />

car<strong>di</strong>ovascolare: il punto <strong>di</strong> vista del farmacologo<br />

14.00/14.30 Colivicchi F (Roma)<br />

L'appropriatezza terapeutica nell'ambito delle statine: il punto <strong>di</strong> vista del clinico<br />

53<br />

Realizzato con il contributo educazionale <strong>di</strong> Pfizer<br />

Incontro con l'Esperto<br />

Sessione ECM<br />

Inibizione della corrente pacemaker IF: dall'elettrofisiologia alla pratica clinica<br />

Moderatori: Lai C (Cagliari) Mugelli A (Firenze)<br />

14.30/14.50 Mugelli A (Firenze)<br />

Inibizione della corrente pacemaker IF: il punto <strong>di</strong> vista del farmacologo<br />

14.50/15.10 Lai C (Cagliari)<br />

Inibizione della corrente pacemaker IF: il punto <strong>di</strong> vista del car<strong>di</strong>ologo<br />

15.10/15.30 Mugelli A (Firenze) Lai C (Cagliari)<br />

Discussione con gli esperti<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmacologia car<strong>di</strong>ovascolare<br />

Moderatori: Berrino L (Napoli) Tremoli E (Milano)<br />

Giuliani Daniela 2 , Colombo G. 1 , Sor<strong>di</strong> A. 1 , Lonati C. 1 , Mioni C. 2 , Leonar<strong>di</strong> P. 1 , Carlin A. 1 ,<br />

Bertolini A. 3 , Grieco P. 4 , Bazzani C. 2 , Catania A. 1 , Guarini S. 2<br />

1 Centro <strong>di</strong> Ricerca Preclinica, Fondazione IRCC, Ospedale Maggiore Policlinico, Mangiagalli e Regina<br />

Elena, Milano; 2 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Modena e<br />

Reggio Emilia; 3 Divisione Clinica Farmacologica, Università <strong>di</strong> Modena e Reggio Emilia; 4 Dipartimento<br />

<strong>di</strong> Chimica Farmaceutica e Tossicologica, Università Federico II <strong>di</strong> Napoli<br />

Basi molecolari dell’effetto protettivo conseguente a stimolazione del recettore melanocortinico MC4<br />

nello shock emorragico.<br />

pag_dx.indd 1 30/05/2007 2.11.58


Bitto Alessandra 1 , Minutoli L. 1 , Altavilla D. 1 , Polito F. 1 , Fiumara T. 1 , Di Stefano V. 1 , Giuliani<br />

D. 2 , Guarini S. 2 , Caputi A.P. 1 , Squadrito F. 1<br />

1 Dipartimento Clinico Sperimentale <strong>di</strong> Me<strong>di</strong>cina e Farmacologia, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong><br />

Messina; 2 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Modena e<br />

Reggio Emilia<br />

La terapia con simvastatina stimola la produzione <strong>di</strong> VEGF e migliora la cicatrizzazione delle ferite nel<br />

<strong>di</strong>abete sperimentale.<br />

Calabresi Laura 2 , Eberini I. 1 , Gianazza E. 1 , Gomaraschi M. 2 , Mombelli G. 2 , Breghi L. 3 ,<br />

Klugmann S 4 , Brusoni B 4 , Franceschini G 2 , Sirtori CR 2<br />

1 Dipartimento <strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Milano, 2 Centro Grossi Paoletti, Dipartimento<br />

<strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Milano; 3 Divisione <strong>di</strong> Car<strong>di</strong>ologia, Ospedale <strong>di</strong> Circolo <strong>di</strong><br />

Voghera; 4 Divisione <strong>di</strong> Car<strong>di</strong>ologia, Ospedale <strong>di</strong> Niguarda, Milano; 5 Divisione <strong>di</strong> Car<strong>di</strong>ologia, Ospedale<br />

Fatebenefratelli, Milano<br />

Degradazione dell’apolipoproteina A-I da parte <strong>di</strong> farmaci trombolitici in pazienti infartuati.<br />

Camera Marina 1,2 , Brambilla M. 1 , Colnago D. 2 , De Metrio M. 2 , Marenzi G.C. 2 , Gertow K. 2 ,<br />

Tremoli E. 1,2<br />

1 Dipartimento <strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Milano, 2 Centro Car<strong>di</strong>ologico Monzino IRCCS,<br />

Milano<br />

Caratterizzazione dell’espressione <strong>di</strong> Tissue Factor in piastrine, leucociti ed aggregati leucocitipiastrine<br />

<strong>di</strong> pazienti con malattia coronarica.<br />

54<br />

Tacconelli Stefania 1 , Di Febbo C. 1 , Douville K. 2 , Guglielmi M.D. 1 , Capone M.L. 1 , Porreca E. 1 ,<br />

Hwa J. 2 , Patrignani P. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina e invecchiamento G d’Annunzio, Università e Fondazione G d’Annunzio,<br />

Chieti; 2 Dartmouth Me<strong>di</strong>cal Sch, Hanover, NH<br />

Polimorfismi del recettore umano della prostaciclina e eterogenesi.<br />

Parenti Astrid, Vinci M.C., Bellik L., Filippi S., Ledda F.<br />

Laboratorio <strong>di</strong> Farmacologia Vascolare, Dipartimento <strong>di</strong> Farmacologia Preclinica e Clinica, Università <strong>di</strong><br />

Firenze<br />

La stimolazione dei recettori alfa-1D adrenergici induce effetti trofici sulle cellule endoteliali: ruolo<br />

dell’ipossia.<br />

Barbieri Silvia S 1,2 , Tremoli E. 2 , Weksler B.B. 1<br />

1 Division of Hematology-Me<strong>di</strong>cal Oncology, Weill Me<strong>di</strong>cal College of Cornell University, New York, NY,<br />

USA; 2 Dipartimento <strong>di</strong> Scienze Farmacologiche Università <strong>di</strong> Milano<br />

Il fumo <strong>di</strong> sigaretta coopera con IL-1 nell'alterare il trafficking <strong>di</strong> -catenina nell'endotelio vascolare<br />

con conseguente aumento della permeabilità e dell'espressione <strong>di</strong> cicloossigenase-2 in vivo e in vitro.<br />

Bucci Mariarosaria 1 , Roviezzo F. 1 , Brancaleone V. 1 , Di Lorenzo A. 1 , Rizzo G. 2 , Vellecco<br />

V. 1 , Fiorucci S. 1 , Cirino G. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università Federico II <strong>di</strong> Napoli; 2 Dipartimento <strong>di</strong><br />

Me<strong>di</strong>cina Clinica e Sperimentale, Laboratorio <strong>di</strong> Biologia Molecolare, Università <strong>di</strong> Perugia<br />

La vaso<strong>di</strong>latazione da testosterone è me<strong>di</strong>ata dal rilascio <strong>di</strong> H2S nell’aorta <strong>di</strong> ratto<br />

pag_sx.indd 1 30/05/2007 2.13.28


Sessione Poster<br />

13.00-15.00<br />

Colazione <strong>di</strong> lavoro<br />

13.00-14.00<br />

Sessione ECM<br />

Simposio<br />

Glucocorticoi<strong>di</strong>, meccanismi molecolari ed efficacia<br />

antinfiammatoria ed immunosoppressiva<br />

Moderatori: Fioretti MC (Perugia) Riccar<strong>di</strong> C (Perugia)<br />

15.00/15.25 Riccar<strong>di</strong> C (Perugia)<br />

Glucocorticoi<strong>di</strong> nel controllo della crescita cellulare: ruolo <strong>di</strong> GILZ<br />

AUDITORIUM<br />

15.00-17.30<br />

15.25/15.50 Parente L (Salerno)<br />

Inibizione da parte del desametasone dell'apoptosi indotta da TRAIL in cellule <strong>di</strong><br />

carcinoma tiroideo<br />

15.50/16.15 Grohmann U (Perugia)<br />

Il catabolismo del triptofano come nuovo meccanismo d'azione dei glucocorticoi<strong>di</strong><br />

nell'infiammazione allergica delle vie respiratorie<br />

16.15/16.40 Cuzzocrea S (Messina)<br />

L’assenza del recettore PPAR- funzionale inibisce l’effetto antinfiammatorio dei<br />

glucocorticoi<strong>di</strong><br />

16.40/17.05 Cirino G (Napoli)<br />

I glucocorticoi<strong>di</strong> donatori <strong>di</strong> ossido nitrico (NO) mostrano proprietà farmacologiche che<br />

si traducono in benefici clinici<br />

17.05/17.30 Discussione<br />

55<br />

Simposio<br />

Angiogenesi tumorale e terapia antiangiogenica<br />

SALA 1<br />

15.00-17.30<br />

Moderatori: Ziche M (Siena) Spano PF (Brescia)<br />

15.00/15.30 Kerbel R (Toronto)<br />

Terapia antiangiogenica e ottimizzazione dell'efficacia della chemioterapia<br />

convenzionale<br />

15.30/16.00 Mochly-Rosen D (Stanford)<br />

La PKC influenza le funzioni vascolari e la crescita del tumore della prostata<br />

16.00/16.30 Melillo G (Frederick)<br />

Hypoxia Inducible Factor 1 (HIF-1) come bersaglio per la terapia antitumorale<br />

16.30/17.00 Ziche M (Pisa)<br />

Angiogenesi e infiammazione: il circolo vizioso <strong>di</strong> PGE2 e recettori tirosin chinasici<br />

17.00/17.30 Mini E (Firenze)<br />

Sviluppo clinico <strong>di</strong> enzastaurin, un inibitore della protein chinasi C beta: attualità e<br />

prospettive<br />

Realizzato con il contributo educazionale <strong>di</strong> Eli Lilly, Cell Therap. Europe<br />

pag_dx.indd 1 30/05/2007 2.15.01


Sessione ECM<br />

Simposio<br />

Lo stress nella patologia mentale: comportamento, neurobiologia<br />

e trattamento<br />

Moderatori: Riva MA (Milano) Serra M (Cagliari)<br />

SALA 2<br />

15.00-17.30<br />

15.00/15.25 Maccari S (Villeneuve d'Ascq)<br />

Lo stress prenatale ha effetti sulla plasticità cerebrale nella <strong>di</strong>scendenza adulta:<br />

<strong>di</strong>fferenze sessuali<br />

15.25/15.50 Serra M (Cagliari)<br />

Influenza dello stress cronico sui livelli <strong>degli</strong> steroi<strong>di</strong> neuroattivi, sulla plasticità e la<br />

funzione del recettore GABA A<br />

15.50/16.15 Gass P (Mannheim)<br />

Modelling depression through glucocorticoid receptor transgenic mice<br />

16.15/16.40 Dazzi L (Cagliari)<br />

Controllo farmacologico delle alterazioni indotte dallo stress nel rilascio dei<br />

neurotrasmettitori<br />

16.40/17.05 Riva MA (Milano)<br />

Stress, plasticità neuronale e vulnerabilità alle malattie psichiatriche<br />

17.05/17.30 Discussione<br />

56<br />

Cre<strong>di</strong>ti ECM assegnati 2<br />

Simposio<br />

Atomoxetina, nuova alternativa terapeutica per il trattamento del<br />

<strong>di</strong>sturbo da deficit dell'attenzione e iperattività (ADHD)<br />

Moderatori: Biggio G (Cagliari) Zuddas A (Cagliari)<br />

15.00/15.30 Biggio G (Cagliari)<br />

Cosa succede nel cervello <strong>di</strong> un bambino con ADHD?<br />

15.30/15.55 Masi G (Pisa)<br />

Un bambino con ADHD sarà anche un uomo con ADHD?<br />

SALA 4<br />

15.00-17.30<br />

15.55/16.20 Bymaster F (In<strong>di</strong>anapolis)<br />

Atomoxetina, un nuovo farmaco non-psicostimolante per il trattamento del ADHD<br />

16.20/16.45 Zuddas A (Cagliari)<br />

Risultati <strong>di</strong> un trial a lungo termine sull'impiego <strong>di</strong> atomoxetina nella prevenzione delle<br />

reci<strong>di</strong>ve nel ADHD<br />

16.45/17.10 Dell'Agnello G (Firenze)<br />

Risultati preliminari <strong>di</strong> uno stu<strong>di</strong>o italiano sull'efficacia <strong>di</strong> atomoxetina in pazienti con<br />

ADHD e Disturbo Oppositivo Provocatorio (ODD)<br />

17.10/17.30 Discussione e Questionario ECM<br />

Realizzato con il contributo educazionale <strong>di</strong> Eli Lilly<br />

pag_sx.indd 1 30/05/2007 2.18.56


Sessione <strong>di</strong> Comunicazioni Orali<br />

Nuove acquisizioni sulla farmacologia <strong>di</strong> genere<br />

SALA 5<br />

15.00-17.30<br />

Moderatori: Eva C (<strong>Torino</strong>) Serra G (Sassari)<br />

Trabace Luigia 1 , Colaianna M. 1 , Castrignanò S. 1 , Cassano T. 1 , Tucci P. 1 , Cuomo V. 2<br />

1 Dip. Scienze Biome<strong>di</strong>che, Università <strong>di</strong> Foggia; 2 Dipartimento <strong>di</strong> Fisiologia Umana e Farmacologia V.<br />

Erspamer, Università <strong>di</strong> Roma “La Sapienza”<br />

Differenze <strong>di</strong> genere nella modulazione indotta da ossido nitrico della trasmissione dopaminergica<br />

nella corteccia prefrontale <strong>di</strong> ratto.<br />

Morale Maria Concetta 1 , Giaquinta G. 1 , Caniglia S. 1 , L’Episcopo F. 1 , Tirolo C. 1 , Testa N. 1 ,<br />

Arcieri P. 1 , Marchetti B. 1.2<br />

1 OASI Scientific Institute (IRCCS) Troina (EN), 2 Dipartimento Farmacologia Fac Me<strong>di</strong>cina Università <strong>di</strong><br />

Sassari<br />

Stato infiammatorio “pre-esistente”, genere e deficienza <strong>di</strong> estrogeni: una finestra terapeutica per il<br />

targeting farmacologico della malattia <strong>di</strong> Parkinson.<br />

Patacchioli Francesca Romana, Monnazzi P., Martelletti P. 1 , Simeoni S.<br />

Dipartimento <strong>di</strong> Fisiologia Umana e Farmacologia V. Erspamer, Università La Sapienza, Roma; 1 Dip.<br />

Me<strong>di</strong>cina Interna, Università La Sapienza, Roma<br />

Effetti della tossina botulinica tipo-A su in<strong>di</strong>ci ormonali <strong>di</strong> benessere fisico in donne affette da<br />

emicrania cronica.<br />

Zavatti Manuela, Montanari C., Geminiani E., Ricchi L., Corsi L., Zanoli P.<br />

Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Modena e Reggio Emilia<br />

Influenza della ferutinina sul comportamento sessuale del ratto femmina.<br />

57<br />

Canu Silvia 1 , Carta S. 1 , Loizzo S. 2 , Guarino I. 1 , Carru C. 3 , Zinellu A. 3 , Loizzo A. 2 , Franconi F. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia, Università <strong>di</strong> Sassari; 2 Istituto Superiore <strong>di</strong> Sanità, Roma;<br />

3 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Università <strong>di</strong> Sassari, Istituto Nazionale delle Biostrutture e<br />

Biosistemi (INBB), Osilo- Sassari<br />

L’handling neonatale induce un incremento nella curva <strong>di</strong> incremento <strong>di</strong> peso corporeo <strong>di</strong> entrambi i<br />

sessi.<br />

Moderatori: Pataccioli FR (Roma) Viano I (Novara)<br />

Vicentini Lucia M, Cattaneo M.G., Chini B. 1<br />

Dipartimento <strong>di</strong> Farmacologia, Milano; 1 CNR, Centro <strong>di</strong> Farmacologia Cellulare e Molecolare, Milano<br />

Nuovi possibili ruoli patofisiologici per l’ossitocina.<br />

Malorni Walter 1 , Coinu R. 2 , Carta S. 2 , Campesi I. 2 , Straface E. 1 , Matarrese P. 1 , Franconi F. 2<br />

1 Dipartimento del Farmaco, Istituto Superiore <strong>di</strong> Sanità, Roma; 2 Dipartimento <strong>di</strong> Scienze Fisiologiche,<br />

Biochimiche e Cellulari, Università <strong>di</strong> Sassari<br />

Cellule muscolari lisce vasali: stato redox e <strong>di</strong>fferenze <strong>di</strong> genere.<br />

Cignarella Andrea 1,2 , Bolego C. 1 , Vegeto E. 1 , Pelosi V. 1,2 , Meda C. 1 , Maggi A. 1<br />

1 Dipartimento <strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Milano; 2 Dipartimento <strong>di</strong> Farmacologia ed<br />

Anestesiologia, Università <strong>di</strong> Padova<br />

Il recettore alfa per gli estrogeni è implicato nella regolazione dell’omeostasi del glucosio e nella<br />

risposta vascolare alle citochine infiammatorie nel topo.<br />

pag_dx.indd 1 30/05/2007 2.20.37


Marini Herbert 1 , Minutoli L. 2 , Polito F. 2 , Bitto A. 2 , Altavilla D. 2 , Frisina N. 3 , D’Anna R. 5 ,<br />

Lubrano C. 5 , Adamo E.B. 1 , Caputi A.P. 2 , Squadrito F. 2<br />

1 Dipartimento <strong>di</strong> Scienze Biochimiche, Fisiologiche e della Nutrizione, Sezione <strong>di</strong> Fisiologia e<br />

Nutrizione Umana, Università <strong>di</strong> Messina, 2 Dipartimento Clinico-Sperimentale <strong>di</strong> Me<strong>di</strong>cina e<br />

Farmacologia, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong> Messina, 3 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Interna,<br />

Università <strong>di</strong> Messina, 4 Dipartimento <strong>di</strong> Scienze Ostetriche e Ginecologiche, Università <strong>di</strong> Messina;<br />

5 Dipartimento <strong>di</strong> Fisiopatologia Me<strong>di</strong>ca, Università “La Sapienza”, Roma<br />

Effetti del fitoestrogeno genisteina sul metabolismo osseo in donne osteopeniche, in post-menopausa:<br />

un trial clinico randomizzato.<br />

Aviello Gabriella 1 , Ernst E. 2 , Capasso R. 1 , Capasso F. 1 , Borrelli F. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università Federico II <strong>di</strong> Napoli; 2 Complementary<br />

Me<strong>di</strong>cine, Peninsula Me<strong>di</strong>cal School, Universities of Exeter and Plymouth, 25 Victoria Park Road,<br />

Exeter EX2 4NT, UK.<br />

Revisione sistematica sull’efficacia e sicurezza della Cimicifuga racemosa.<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmaci antitumorali<br />

SALA 7<br />

15.00-17.30<br />

58<br />

Moderatori: Baral<strong>di</strong> M (Modena) Onali PL (Cagliari)<br />

Ayrol<strong>di</strong> Emira, Bastianelli A., Marchetti C., Velar<strong>di</strong> E., Agostani M., Donato V., Bruscoli S.,<br />

Riccar<strong>di</strong> C.<br />

Istituto <strong>di</strong> Farmacologia, Dipartimento Med. Clinica e Sperimentale, Università <strong>di</strong> Perugia<br />

Gilz modula negativamente proliferazione e segnali oncogenici <strong>di</strong>pendenti dall’attivazione <strong>di</strong> ras.<br />

Baiula Monica, Di Toro R., Spampinato S.<br />

Dipartimento <strong>di</strong> Farmacologia, Università <strong>di</strong> Bologna<br />

L’espressione del fattore <strong>di</strong> trascrizione rest, ridotta in cellule <strong>di</strong> neuroblastoma esposte a pma, è<br />

stabilizzata da un inibitore delle proteasi, correlandosi in senso inverso al <strong>di</strong>fferenziamento neuronale<br />

Corsi Lorenzo, Geminiani E., Ricchi L., Baral<strong>di</strong> M.<br />

Dip. Scienze Biome<strong>di</strong>che Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Modena e Reggio Emilia<br />

CINSPAN Consorzio Interuniversitario Nazionale per lo <strong>Stu<strong>di</strong></strong>o dei Principi Attivi Naturali<br />

Coinvolgimento dei recettori periferici delle benzo<strong>di</strong>azepine nei processi proliferativi tumorali e nella<br />

produzione <strong>di</strong> ROS.<br />

Fimognari Carmela, Lenzi M., Cantelli-Forti G., Hrelia P.<br />

Dipartimento <strong>di</strong> Farmacologia, Università <strong>di</strong> Bologna<br />

Percorsi molecolari alla base dell’attività antileucemica del sulforafane.<br />

De Francia Silvia 1 , De Martino F. 1 , Pirro E. 1 , Piccione F. 1 , Sprio A.E. 1 , Di Carlo F. 1 , Mussa<br />

M.V. 2 , Daffara F. 3 , Reimondo G. 3 , Zaggia B. 3 , Terzolo M. 3 , Angeli A. 3<br />

1 Laboratorio <strong>di</strong> Farmacologia, Dipartimento <strong>di</strong> Scienze Cliniche e Biologiche, Università <strong>di</strong> <strong>Torino</strong>,<br />

2 Scuola Infermieri, Università <strong>di</strong> <strong>Torino</strong>, 3 Me<strong>di</strong>cina Interna, Dipartimento <strong>di</strong> Scienze Cliniche e<br />

Biologiche, Università <strong>di</strong> <strong>Torino</strong><br />

<strong>Stu<strong>di</strong></strong>o prospettico <strong>degli</strong> effetti biochimici della somministrazione <strong>di</strong> mitotane in pazienti con carcinoma<br />

corticosurrenalico.<br />

Rosa Arianna Carolina, Gallicchio M., Dianzani C., Brucato L., Collino M., Fantozzi R.<br />

Dipartimento <strong>di</strong> Anatomia, Farmacologia e Me<strong>di</strong>cina Legale. Università <strong>di</strong> <strong>Torino</strong><br />

Effetti del celecoxib sull'espressione <strong>di</strong> ICAM-1 e VCAM-1 nelle HT29.<br />

pag_sx.indd 1 30/05/2007 2.29.55


D’Acunto Cosimo Walter, Festa M., Tosco A., Rodriguez M., Petrella A., Parente L.<br />

Dipartimento <strong>di</strong> Scienze Farmaceutiche, Università <strong>di</strong> Salerno<br />

Effetti del nuovo inibitore <strong>di</strong> deacetilasi FR235222 in cellule promonocitiche umane U937: Ruolo della<br />

Annessina A1.<br />

Di Paolo Antonello 1 , Amatori F. 1 , Lencioni M. 2 , Bocci G. 1 , Orlan<strong>di</strong>ni C. 2 , Ciofi L. 1 , Lastella M. 1 ,<br />

Falcone A. 3 , Ricci S. 2 , Del Tacca M. 1 , Danesi R. 1<br />

1 Divisione <strong>di</strong> Farmacologia e Chemioterapia, Dipartimento <strong>di</strong> Me<strong>di</strong>cina Interna, Università <strong>di</strong> Pisa;<br />

2 Unità Operativa <strong>di</strong> Oncologia Me<strong>di</strong>ca, Azienda Ospedaliera Universitaria Pisana, Pisa; 3 Unità Operativa<br />

<strong>di</strong> Oncologia Me<strong>di</strong>ca, Ospedale Civile, Livorno<br />

L’esposizione a 5-fluorouracile è associata alla sopravvivenza libera da malattia in pazienti affetti da<br />

carcinoma colorettale in trattamento con chemioterapia a<strong>di</strong>uvante.<br />

Bellik Ly<strong>di</strong>a 1 , Parenti A. 1 , Vinci M.C. 1 , Gerlini G. 2 , Pantalone D. 3 , Ledda F. 1<br />

1 Laboratorio <strong>di</strong> Farmacologia Vascolare, Dipartimento <strong>di</strong> Farmacologica Clinica e Preclinica,<br />

2 Dipartimento <strong>di</strong> Scienze Dermatologiche, 3Dipartimento <strong>di</strong> Area Critico Me<strong>di</strong>co Chirurgica, Università<br />

<strong>di</strong> Firenze<br />

Effetto dei trattamenti convenzionali sulle cellule dendritiche in pazienti con cancro colorettale.<br />

Mognetti Barbara 1 , Berta G.N. 1 , Spadaro M. 1 , Cavallo F. 1 , Barberis A. 1 , Papotti M. 1 , Amici A. 2 ,<br />

Iezzi M. 3 , Musiani P. 3 , Forni G. 1 , Di Carlo F. 1<br />

1 Dipartimento Scienze Cliniche e Biologiche, Università <strong>di</strong> <strong>Torino</strong>; 2 Dipartimento <strong>di</strong> Biologia Molecolare,<br />

Cellulare e Animale, Università <strong>di</strong> Camerino; 3 Centro <strong>di</strong> ricerche sull’invecchiamento Fondazione<br />

Università “Gabriele D'Annunzio Chieti<br />

Valutazione preclinica <strong>di</strong> un nuovo approccio terapeutico: la vaccinazione a dna protegge dal<br />

carcinoma squamoso orale chimicamente indotto.<br />

59<br />

Simposio<br />

I modelli animali nella ricerca biome<strong>di</strong>ca<br />

(<strong>SIF</strong> - EBRA)<br />

SALA 8<br />

15.00-17.30<br />

Moderatori: Jori A (Milano) Drago F (Catania)<br />

15.00/15.20 Meneguz A (Milano)<br />

L'impiego dei modelli animali nella ricerca preclinica secondo le GLP<br />

15.20/15.40 Collu M (Cagliari)<br />

Modelli animali in psichiatria e neuropsicofarmacologia: vali<strong>di</strong>tà e limiti<br />

15.40/16.00 Cerbai E (Firenze)<br />

I modelli animali nella ricerca in area car<strong>di</strong>ovascolare<br />

16.00/16.20 Blan<strong>di</strong>zzi C (Pisa)<br />

Modelli animali in gastroenterologia<br />

16.20/16.40 Morigi M (Bergamo)<br />

Cellule staminali e modelli animali <strong>di</strong> danno renale<br />

16.40/17.30 Discussione<br />

Assemblea dei soci<br />

AUDITORIUM<br />

17.30-19.30<br />

pag_dx.indd 1 30/05/2007 2.32.10


Simposio<br />

Target molecolari del dolore cronico<br />

SALA 1<br />

08.30-11.00<br />

Moderatori: Canonico PL (Novara) Sortino MA (Catania)<br />

08.30/08.50 Negri L (Roma)<br />

Meccanismi peptidergici della nocicezione<br />

08.50/09.10 Maione S (Napoli)<br />

Meccanismi <strong>di</strong> plasticità nei nuclei sopraspinali che regolano la soglia del dolore<br />

09.10/09.30 Nicoletti F (Roma)<br />

I meccanismi periferici e midollari <strong>di</strong> sensibilizzazione nocicettiva come target <strong>di</strong><br />

farmaci analgesici<br />

09.30/09.50 Cipollone F (Chieti)<br />

Espressione <strong>di</strong> COX-2 in piastrine e monociti come potenziale base del fallimento della<br />

terapia con ASA nel paziente <strong>di</strong>abetico<br />

09.50/10.10 Blan<strong>di</strong>zzi C (Pisa)<br />

Farmaci inibitori selettivi della COX-2 e meccanismi <strong>di</strong> protezione e riparazione della<br />

mucosa gastrointestinale<br />

10.10/11.00 Discussione<br />

60<br />

Realizzato con il contributo educazionale <strong>di</strong> Pfizer<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Farmacologia <strong>di</strong> Scienze<br />

SALA 2<br />

08.30-12.15<br />

Moderatori: Maura G (Genova) Pedata F (Firenze)<br />

Carmignani Marco 1 , Cesare P. 1 , Fanelli R. 2 , Valle G. 3 , Volpe A.R. 1<br />

1 Dipartimento <strong>di</strong> Biologia <strong>di</strong> Base ed Applicata, Sezione <strong>di</strong> Farmacologia e Tossicologia, Università <strong>di</strong><br />

L’Aquila; 2 IRCCS – Casa Sollievo della Sofferenza - Sezione <strong>di</strong> Car<strong>di</strong>ologia, S. Giovanni Rotondo (FG);<br />

3 IRCCS – Casa Sollievo della Sofferenza - Sezione <strong>di</strong> Me<strong>di</strong>cina Nucleare, S. Giovanni Rotondo (FG)<br />

Livelli critici <strong>di</strong> ipoperfusione splancnica: fattore critico <strong>di</strong> shock ipo<strong>di</strong>namico irreversibile da aumento<br />

<strong>di</strong> nitrossido plasmatico indotto da rilascio intestinale <strong>di</strong> encefalite.<br />

Giar<strong>di</strong>na Silvana, Marzani B., Marzatico F.<br />

Dipartimento <strong>di</strong> Scienze Fisiologiche e Farmacologiche Cellulari e Molecolari, Sez. Farmacologia e<br />

Biotecnologie Farmacologiche; Università <strong>di</strong> Pavia<br />

Valutazione “in vivo” <strong>degli</strong> enzimi antiossidanti e della perossidazione lipi<strong>di</strong>ca a <strong>di</strong>fferenti livelli dello<br />

strato corneo umano.<br />

Botti Francesca 1 , Ottolina A. 2 , Marcuzzo S. 1 , Mennini T. 3 , Parati E. 2 , Tonini M. 1 , Curti D. 1<br />

1 Dipartimento <strong>di</strong> Scienze Fisiologiche e Farmacologiche Celllari e Molecolari, Università <strong>di</strong> Pavia;<br />

2 Istituto Neurologico “C. Besta”, Milano; 3 Istituto Mario Negri, Milano<br />

Cellule staminali adulte come strumento per lo stu<strong>di</strong>o dei meccanismi responsabili del processo<br />

neurodegenerativo in topi con mutazione del gene per la proteina Vps54.<br />

pag_sx.indd 1 30/05/2007 2.36.18


Gessi Stefania 1 , Merighi S. 1 , Varani K. 1 , Fogli E. 1 , Sacchetto V. 1 , Benini A. 1 , Mirandola P. 2 ,<br />

Leung E. 3 , Mac Lennan S. 3 , Feo C. 4 , and Borea P.A. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Clinica e Sperimentale Sez. Farmacologia, Università <strong>di</strong> Ferrara; 2 Dip. <strong>di</strong><br />

Anatomia Umana, Farmacologia e Me<strong>di</strong>cina Forense, Ist. <strong>di</strong> Anatomia Umana, Osp. Maggiore,<br />

Università <strong>di</strong> Parma; 3 King Pharm. Res. and Dev., Inc., Cary, North Carolina, 4 Dipartimento <strong>di</strong><br />

Chirurgia, Anestesiologia e Ra<strong>di</strong>ologia, Università <strong>di</strong> Ferrara<br />

Recettori dell’adenosina in tessuti tumorali e in linee cellulari <strong>di</strong> colon: “focus” sul recettore A3.<br />

Quintieri Luigi 1 , Fantin M 1 , Rosato A 2,3 , Caruso M 4 , Geroni C 4 , Nassi A 1 , Floreani M 1<br />

1 Dipartimento <strong>di</strong> Farmacologia ed Anestesiologia, Università <strong>di</strong> Padova; 2 Dipartimento <strong>di</strong> Scienze<br />

Oncologiche e Chirurgiche, Università <strong>di</strong> Padova; 3 Istituto Oncologico Veneto, Padova; 4 Nerviano<br />

Me<strong>di</strong>cal Sciences S.r.l., Nerviano<br />

Confronto interspecie della biotrasformazione epatica dell’antitumorale nemorubicina nel suo<br />

metabolita attivo PNU-159682.<br />

Monti Elena, Molteni R., Marras E., Perletti G., Ravizza R., Garibol<strong>di</strong> M.B.<br />

Dipartimento Biologia Strutturale e Funzionale, Università dell’Insubria<br />

L’inibizione dell’espressione <strong>di</strong> hif-1 me<strong>di</strong>ante rna interference potenzia l’azione citotossica della<br />

doxorubicina in cellule <strong>di</strong> adenocarcinoma del colon umano.<br />

Intervallo 10.00/10.15<br />

Moderatori: Parolaro D (Varese) Sanna E (Cagliari)<br />

Capurro Valeria, Braida D., Zani A., Sala M.<br />

Dipartimento <strong>di</strong> Farmacologia, Chemioterapia e Tossicologia me<strong>di</strong>ca Università <strong>di</strong> Milano<br />

Coinvolgimento del sottotipo recettoriale CB1 nella risposta emozionale indotta dalla salvinorina a nel<br />

ratto.<br />

61<br />

Rubino Tiziana, Viganò D., Realini N. Guidali C., Parolaro D .<br />

DBSF e Centro <strong>di</strong> Neuroscienze, Università dell’Insubria<br />

Endocannabinoi<strong>di</strong> ed ansia: ruolo della corteccia prefrontale.<br />

Follesa Paolo 1,2 , Biggio F.1, Gorini G. 1 , Caria S., Mostallino M.C. 3 , Murru L. 1 , Sanna E. 1,2 ,<br />

Biggio G. 1,2,3<br />

1 Dipartimento <strong>di</strong> Biologia Sperimentale, Sezione <strong>di</strong> Neuroscienze, Università <strong>di</strong> Cagliari; 2 Centro <strong>di</strong><br />

Eccellenza per la Neurobiologia delle Dipendenze, 3 CNR Istituto <strong>di</strong> Neuroscienze, Unità <strong>di</strong><br />

Neuropsicofarmacologia, Cagliari<br />

Riduzione dell’espressione genica della subunità e della sensibilità del recettore GABA A<br />

all’allopregnanolone indotta dall’interruzione <strong>di</strong> un trattamento cronico con progesterone.<br />

Comelli Francesca 1 , Colleoni M. 2 , Giagnoni G. 1 , Costa B. 1<br />

1 Dipartimento <strong>di</strong> Biotecnologie Bioscienze, Università Milano-Bicocca; 2 Dipartimento <strong>di</strong><br />

Farmacologia, Università <strong>di</strong> Milano<br />

Effetto antiiperalgesico <strong>di</strong> un estratto <strong>di</strong> cannabis sativa in un modello <strong>di</strong> dolore neuropatico nel ratto:<br />

meccanismi implicati.<br />

Cipriani Sara 1 , Melani A. 1 , Gianfriddo M. 2 , Vannucchi M.G. 3 , Pedata F. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia Preclinica e Clinica M.A. Mancini, Università <strong>di</strong> Firenze; 2 Siena Biotech<br />

S.p.A., Siena; 3 Dipartimento <strong>di</strong> Anatomia, Istologia e Me<strong>di</strong>cina Forense, Università <strong>di</strong> Firenze<br />

Effetto dell’antagonismo selettivo del recettore adenosinico A 2A sul comportamento motorio e<br />

sull’espressione dell’ossido nitrico sintetasi neuronale nello striato <strong>di</strong> topi transgenici per la corea <strong>di</strong><br />

Huntington.<br />

pag_dx.indd 1 30/05/2007 2.38.07


Marcoli Manuela 1, Cervetto C. 1 , Paluzzi P. 1 , Guarnieri S. 1 , Maura G. 1,2<br />

1Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale, Sezione <strong>di</strong> Farmacologia e Tossicologia, Università <strong>di</strong><br />

Genova; 2Centro <strong>di</strong> Eccellenza per la Ricerca Biome<strong>di</strong>ca, Università <strong>di</strong> Genova<br />

Controllo da parte <strong>di</strong> cGMP dell’attivazione <strong>di</strong> recettori kainato nella corteccia cerebellare <strong>di</strong> ratto.<br />

Casale Federico, Ferretti C.<br />

Dipartimento <strong>di</strong> Anatomia, Farmacologia e Me<strong>di</strong>cina Legale, Università <strong>di</strong> <strong>Torino</strong><br />

Modulazione colinergica dell’espressione <strong>di</strong> Egr-1 in cellule <strong>di</strong> neuroblastoma umano SK-n-BE.<br />

Corsini Daniela 1 , Alboni S. 1 , Blom J.M.C. 2 , Benatti C. 1 , Caggia F. 1 , Barden N. 3 , Brunello N. 1 ,<br />

Tascedda F. 1<br />

1 Dipartimento Scienze Biome<strong>di</strong>che, Università <strong>di</strong> Modena e Reggio Emilia; 2 Dipartimento Pe<strong>di</strong>atria,<br />

Università <strong>di</strong> Modena e Reggio Emilia; 3 CHUL Research Center, Laval University, Quebec, Canada<br />

Regolazione dell’attività trascrizionale in ippocampo <strong>di</strong> topi transgenici per il recettore dei<br />

glucocorticoi<strong>di</strong> <strong>di</strong> tipo II: effetto dello stress da restraint.<br />

62<br />

Sessione ECM<br />

Simposio<br />

Terapia ormonale sostitutiva: se, quando, per quanto e perchè<br />

(<strong>SIF</strong> - AIGE)<br />

Moderatori: Genazzani AR (Pisa) Melis GB (Cagliari)<br />

SALA 3<br />

08.30-11.00<br />

08.30/08.50 Simoncini T (Pisa)<br />

Prevenzione car<strong>di</strong>ovascolare dopo la menopausa: quale ruolo per la terapia ormonale<br />

sostitutiva?<br />

08.50/09.10 Concas A (Cagliari)<br />

Neurosteroi<strong>di</strong>, plasticità neuronale e menopausa<br />

09.10/09.30 Genazzani AR (Pisa)<br />

Effetti centrali <strong>degli</strong> steroi<strong>di</strong>: dai sintomi alla prevenzione<br />

09.30/09.50 Nappi R (Pavia)<br />

Menopausa e sessualità: una terapia per la persona<br />

09.50/10.10 Paoletti A (Cagliari)<br />

L'ottimizzazione della dose e la personalizzazione del progestinico<br />

10.10/11.00 Discussione<br />

pag_sx.indd 1 30/05/2007 2.40.17


Simposio<br />

Aspetti cellulari e molecolari del precon<strong>di</strong>zionamento e<br />

postcon<strong>di</strong>zionamento ischemico: basi <strong>di</strong> intervento farmacologico<br />

SALA 5<br />

08.30-11.00<br />

Moderatori: Annunziato L (Napoli) Moroni F (Firenze)<br />

08.30/09.45 Pellegrini GD (Firenze)<br />

Modelli <strong>di</strong> precon<strong>di</strong>zionamento ischemico in fettine ippocampali: ruolo dei recettori al<br />

glutammato e della poli(ADP-ribosio) polimerasi<br />

09.45/10.00 Pizzi M (Brescia)<br />

Specificità dei complessi trascrizionali NF-kappaB nella regolazione della vulnerabilità<br />

all'ischemia cerebrale<br />

10.00/10.15 Scorziello A (Napoli)<br />

La neuroprotezione indotta dal Precon<strong>di</strong>zionamento anossico nei neuroni corticali è<br />

me<strong>di</strong>ata dall’NO e dalla Mn-SOD<br />

10.15/10.30 Pignataro G (Napoli)<br />

Postcon<strong>di</strong>tioning ischemico cerebrale, caratterizzazione molecolare <strong>di</strong> una nuova<br />

strategia neuroprotettiva<br />

Sessione ECM<br />

Simposio<br />

Basi farmacocinetiche/farmaco<strong>di</strong>namiche (PK/PD) per il corretto<br />

uso dei farmaci antimicrobici<br />

(<strong>SIF</strong> - SIC)<br />

Moderatori: Mazzei T (Firenze) Cricelli C (Firenze)<br />

08.30/09.00 Scaglione F (Milano)<br />

Basi (PK/PD) per il corretto uso dei farmaci antimicrobici<br />

09.00/09.30 Novelli A (Firenze)<br />

Variabili (PK/PD) in rapporto al paziente e agli organi<br />

09.30/10.00 Rossi A (Narni)<br />

Applicabilità dei criteri (PK/PD) nella pratica me<strong>di</strong>ca<br />

10.00/11.00 Discussione<br />

SALA 6<br />

08.30-11.00<br />

63<br />

pag_dx.indd 1 30/05/2007 2.41.38


64<br />

Sessione ECM<br />

Simposio<br />

Monossido <strong>di</strong> azoto (NO) ed infiammazione: prospettive<br />

terapeutiche<br />

Moderatori: Cantoni O (Urbino) Masini E (Firenze)<br />

SALA 7<br />

08.30-11.00<br />

08.30/08.50 Nisoli E (Milano)<br />

Ossido nitrico e mitocondriogenesi: rilevanza fisiopatologica nello sviluppo della<br />

sindrome metabolica<br />

08.50/09.10 Cantoni O (Urbino)<br />

La comprensione dei meccanismi <strong>di</strong> sopravvivenza delle cellule infiammatorie a<br />

NO/perossinitrito: un primo passo per lo sviluppo <strong>di</strong> nuove strategie farmacologiche<br />

per la terapia dell'infiammazione<br />

09.10/09.30 Clementi E (Milano)<br />

Ruolo del monossido <strong>di</strong> azoto e del controllo della infiammazione nella terapia delle<br />

<strong>di</strong>strofie muscolari<br />

09.30/09.50 Cirino G (Napoli)<br />

NOS endoteliale, sfingosina-1-fosfato ed infiammazione<br />

09.50/10.10 Madeddu P (Bristol)<br />

Statine che rilasciano ossido nitrico mostrano attività antinfiammatorie e riparative in<br />

modelli sperimentali <strong>di</strong> malattie car<strong>di</strong>ovascolari<br />

10.10/10.30 Masini E (Firenze)<br />

Monossido d'azoto e ceramide: un nuovo target per il controllo dell'infiammazione e<br />

dell'iperreattività bronchiale<br />

10.30/11.00 Discussione<br />

Sessione <strong>di</strong> Comunicazioni Orali<br />

Neurodegenerazione e neuroprotezione<br />

SALA 5<br />

11.00-13.00<br />

Moderatori: Memo M (Brescia) Parente L (Salerno)<br />

Marchetti Bianca 1,2 , Tirolo C. 1 , L’Episcopo F. 1 , Testa N. 1 , Caniglia S. 1 , Serra P.A. 2 , Rocchitta<br />

G. 2 , Giaquinta G. 1 , Morale M.C. 1 , Martino G. 3 , Plachino S. 3<br />

1 OASI Inst. (IRCCS) Troina (EN); 2 Dipartimento Farmacologia, Università <strong>di</strong> Sassari; 3 Unità <strong>di</strong><br />

Neuroimmunologia, Dipartimento <strong>di</strong> Neurologia e Fisiologia, San Raffaele, Milano<br />

Plasticità dei precursori neurali della regione subventricolare (SVZ) alla neurotossina MPTP:<br />

correlazione con la denervazione e reinnervazione nigrostriatale della SVZ.<br />

Serra Pier Andrea 1 , Migheli R. 1 , Rocchitta G. 1 , Bazzu G. 1 , Calia G. 1 , L‘Episcopo F. 3 ,<br />

Esposito G. 1 , Plachino S. 2 , Marchetti B. 1,3 , Miele E. 1<br />

1Dipartimento <strong>di</strong> Farmacologia, Ginecologia e Ostetricia, Sez. Farmacologia, Università <strong>di</strong> Sassari;<br />

2Dipartimento <strong>di</strong> Neuroscienze, Istituto scientifico San Raffaele, Milano; 3OASI (IRCCS) Istituto per la<br />

ricerca e la cura del ritardo mentale e dell’invecchiamento celebrale, Sez. Neurofarmacologia, Troina<br />

(EN)<br />

Il ciclo dell’acido ascorbico/acido deidroascorbico nelle cellule staminali provenienti dalla regione<br />

subventricolare del topo.<br />

pag_sx.indd 1 30/05/2007 2.43.27


Balduini Walter, Carloni S.<br />

Istituto <strong>di</strong> Farmacologia e Farmacognosia, Università <strong>di</strong> Urbino “Carlo Bo”<br />

Prolungato ruolo della morte cellulare <strong>di</strong> tipo necrotico dopo neurodegenerazione indotta da ipossiaischemia<br />

nel ratto neonato.<br />

Ferraro Luca 1 , Tomasini M.C. 1 , Fournier J. 2 , Mazza R. 1 , Manganelli S. 1 , Mazzoni E. 1 , Fuxe K. 3 ,<br />

Antonelli T. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Clinica e Sperimentale, Sezione <strong>di</strong> Farmacologia, Università <strong>di</strong><br />

Ferrara; 2 Sanofi-Aventis Recherche, Tolosa, Francia; 3 Dipartimento <strong>di</strong> Neuroscienze, Karolinska<br />

Institut, Stoccolma, Svezia<br />

Possibile ruolo dei recettori neurotensinergici nell’aumento dei livelli <strong>di</strong> glutammato e<br />

nell’apoptosi in seguito a deprivazione <strong>di</strong> ossigeno e glucosio in colture <strong>di</strong> neuroni corticali <strong>di</strong><br />

ratto.<br />

Gardoni Fabrizio, Marcello E., Epis R., Polli F., Malinverno M., Cattabeni F., Di Luca M.<br />

Dipartimento Scienze Farmacologiche – Università <strong>di</strong> Milano<br />

Nuovi targets <strong>di</strong> intervento farmacologico nella sinapsi eccitatoria glutammatergica.<br />

Moderatori: Nicoletti F (Roma) Tonon G (Cagliari)<br />

Battaglia Giuseppe 1 , Molinaro G. 1 , Riozzi B. 1 , Spinsanti P. 2 , Traficante A. 1 , Belluardo N. 3 ,<br />

Corti C. 4 , Nicoletti F. 1,2 , Bruno V. 1,2<br />

1 INM Neuromed, Pozzilli; 2 Dipartimento <strong>di</strong> Fisiologia Umana e Farmacologia, Università “La Sapienza”,<br />

Roma; 3 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Sperimentale, Università <strong>di</strong> Palermo; 4 Dipartimento <strong>di</strong> Biologia,<br />

GlaxoSmithKline, Verona<br />

La neuroprotezione me<strong>di</strong>ata dagli agonisti dei recettori metabotropici per il glutammato del II gruppo<br />

richiede la presenza dei recettori mGlu3 ed è me<strong>di</strong>ata dalla produzione <strong>di</strong> fattori neurotrofici.<br />

65<br />

Ferrari-Toninelli Giulia 1 , Bonini S.A. 1 , Uberti D. 1 , Zambrano N. 2 , Russo T. 2 , Memo M. 1<br />

1 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che e Biotecnologie, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Brescia; 2 CEINGE<br />

biotecnologie avanzate, Dipartimento <strong>di</strong> Biochimica e Biotecnologie Me<strong>di</strong>che, Università <strong>di</strong> Napoli<br />

Federico II<br />

La via del segnale <strong>di</strong> Notch come nuovo target farmacologico per la terapia delle neuropatie<br />

periferiche.<br />

Morrone Luigi A. 1 , Nucci C. 2,3 , Rombolà C. 1 , Cavaliere F. 1 , Cerulli A. 2 , Maccarrone M. 4 ,<br />

Corasaniti M.T. 3 , Bagetta G. 1<br />

1 Dipartimento Farmacobiologico, Università della Calabria; 2 Dipartimento <strong>di</strong> Biopatologia e Diagnostica<br />

per Immagini, Cattedra <strong>di</strong> Ottica Fisiopatologica, Università <strong>di</strong> Roma “Tor Vergata”; 3 IRCCS Istituto<br />

Neurologico Fondazione C. Mon<strong>di</strong>no, Centro <strong>di</strong> Neurofarmacologia Sperimentale Mon<strong>di</strong>no-Tor Vergata,<br />

Laboratorio <strong>di</strong> Neurochimica, Roma; 4 Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Università <strong>di</strong> Teramo;<br />

5 Dipartimento <strong>di</strong> Scienze Farmacobiologiche, Università “Magna Graecia” <strong>di</strong> Catanzaro<br />

Ruolo del sistema endocannabinoide nei meccanismi alla base del danno retinico in un modello<br />

sperimentale <strong>di</strong> ischemia da aumentata pressione intraoculare nel ratto.<br />

Maullu Carlo 1 , Cabras C.A. 1 , Salis B. 1 , Onali P. 2 , Dedoni S. 2 , Marongiu C. 1 , Taylor G. 1 , Tonon<br />

G. 1<br />

1 Bio-Ker S.r.l., Pula (CA)<br />

2 Dipartimento <strong>di</strong> Neuroscienze BB Bro<strong>di</strong>e, Università <strong>di</strong> Cagliari<br />

Produzione <strong>di</strong> Interferone- (IFN- ) da E. coli e strategie per migliorare la bio<strong>di</strong>sponibilità e il profilo<br />

farmacologico.<br />

pag_dx.indd 1 30/05/2007 2.45.02


Cuzzocrea Salvatore 1,2 , Genovese T. 1,2 , Mazzon E. 1,2 , Crisafulli C. 1 , Di Paola R. 1,2 , Muià C. 1,2 ,<br />

Esposito E. 2,3 , Bramanti P. 2 , Zhang J. 4 , Caputi A.P. 1,2 , Wang Z-Q. 5<br />

1 Dipartimento Clinico Sperimentale e Farmacologia, Università <strong>di</strong> Messina; 2 IRCCS Centro Neurolesi<br />

"Bonino-Pulejo" Messina; 3 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università Federico II Napoli;<br />

4 Guilford Pharmaceuticals Inc., Baltimore, USA; 5 International Agency for Research on Cancer, Lyon,<br />

France<br />

L’attività dell'enzima PARG me<strong>di</strong>a la risposta infiammatoria post-traumatica associata a trauma<br />

midollare.<br />

66<br />

Cre<strong>di</strong>ti ECM assegnati 4<br />

Corso <strong>di</strong> Aggiornamento<br />

Il trattamento a lungo termine della depressione: aspetti biologici<br />

e clinici<br />

Moderatori: Aguglia E (Trieste) Guazzelli M (Pisa)<br />

09.00/09.15 Aguglia E (Trieste)<br />

Apertura e introduzione<br />

09.15/10.00 Biggio G (Cagliari)<br />

Neurobiologia della remissione e reci<strong>di</strong>va dell'episo<strong>di</strong>o depressivo<br />

10.00/10.45 Torta R (<strong>Torino</strong>)<br />

La depressione fra psiche e soma: implicanze prognostiche e terapeutiche<br />

11.15/12.00 Mencacci C (Milano)<br />

Depressione: prevenzione delle ricorrenze<br />

12.00/12.30 Discussione<br />

SALA 4<br />

09.00-16.30<br />

12.30/13.00 Workshop<br />

Aguglia E (Trieste) Guazzelli M (Pisa) Mencacci C (Milano) Torta R (<strong>Torino</strong>)<br />

Presentazione dei casi clinici<br />

13.00/14.00 COLAZIONE DI LAVORO RISERVATA AI PARTECIPANTI<br />

14.00/16.00 Aguglia E (Trieste) Guazzelli M (Pisa) Mencacci C (Milano) Torta R (<strong>Torino</strong>)<br />

Elaborazione dei casi clinici<br />

16.00/16.30 Guazzelli M (Pisa)<br />

Conclusioni e questionario ECM<br />

Realizzato con il contributo educazionale <strong>di</strong> Wyeth<br />

Pausa caffè<br />

11.00-11.30<br />

pag_sx.indd 1 30/05/2007 2.55.01


Incontro con l'Esperto<br />

Update in <strong>di</strong>abetologia: gli inibitori del DPP-IV<br />

Moderatore: Carruba M (Milano)<br />

11.00/11.30 Mugelli A (Firenze)<br />

Il punto <strong>di</strong> vista del farmacologo<br />

11.30/12.00 Del Prato S (Pisa)<br />

Il punto <strong>di</strong> vista del <strong>di</strong>abetologo<br />

Sessione ECM<br />

SALA 3<br />

11.00-12.00<br />

Realizzato con il contributo educazionale <strong>di</strong> Novartis<br />

Compilazione Questionario ECM<br />

12.00-13.00<br />

Fine lavori del Congresso<br />

13.15<br />

67<br />

pag_dx.indd 1 30/05/2007 2.56.26


Senza titolo-3 1 28/05/2007 16.16.15


Au<strong>di</strong>torium Sala 1 Sala 2 Sala 3 Sala 4 Sala 5 Sala 6 Sala 7 Sala 8<br />

09.00/17.00 Corso <strong>di</strong><br />

Aggiornamento<br />

Il contributo della<br />

farmacologia al<br />

trattamento della<br />

depressione<br />

Mercoledì 6 giugno<br />

18.00/19.00 Cerimonia Inaugurale<br />

19.00/20.00 Lettura Inaugurale<br />

Three decades with three<br />

Swe<strong>di</strong>sh neuropeptides:<br />

focus on pain and<br />

depression<br />

20.00/22.00<br />

Cocktail <strong>di</strong> Benvenuto<br />

70<br />

pag_sx.indd 1 30/05/2007 3.35.00


Au<strong>di</strong>torium Sala 1 Sala 2 Sala 3 Sala 4 Sala 5 Sala 6 Sala 7 Sala 8<br />

Simposio<br />

Key research<br />

strategies in<br />

pharmacology:<br />

how to take<br />

water into dry<br />

pipe-lines<br />

Simposio<br />

Modulazione<br />

farmacologica<br />

dell'infiammazion<br />

e polmonare nella<br />

broncopneumopatia<br />

cronica<br />

ostruttiva<br />

Simposio<br />

Asma e patologie<br />

correlate<br />

Comunicazioni<br />

Orali<br />

Farmacologia<br />

delle sostanze<br />

d’abuso<br />

(08.30-11.30)<br />

Simposio<br />

Dalle scienze <strong>di</strong><br />

base alla scoperta<br />

<strong>di</strong> nuove terapie<br />

per l'epilessia<br />

Simposio<br />

<strong>SIF</strong> e informazione<br />

in<strong>di</strong>pendente sul<br />

farmaco<br />

Simposio<br />

Efficacia e sicurezza <strong>di</strong><br />

FANS tra<strong>di</strong>zionali e<br />

COXIB<br />

Simposio<br />

Modulazione<br />

farmacologica dei<br />

recettori P1<br />

08.30/11.00 Simposio<br />

Vecchi e nuovi<br />

antipsicotici a<br />

confronto<br />

11.00/11.30 Pausa caffè<br />

11.30/12.30 Lettura Plenaria<br />

Ruolo funzionale della<br />

neurogenesi nell'adulto<br />

12.30/13.30 Colazione <strong>di</strong> lavoro<br />

12.30/15.00 Sessione Poster<br />

Incontro con<br />

l'esperto<br />

Ricerca e sviluppo<br />

in antibioticoterapia:<br />

a che<br />

punto siamo?<br />

14.00/15.00 Incontro con<br />

l'esperto<br />

La vareniclina:<br />

nuove prospettive<br />

nella terapia del<br />

tabagismo<br />

Simposio<br />

Farmacoutilizzazione<br />

e<br />

appropriatezza<br />

d'uso dei farmaci<br />

Simposio<br />

La formazione<br />

specialistica in<br />

farmacologia<br />

Simposio<br />

<strong>Stu<strong>di</strong></strong> <strong>di</strong> sicurezza<br />

dei me<strong>di</strong>cinali<br />

biologici (anticorpi<br />

monoclonali)<br />

Tavola Rotonda<br />

Farmacologia <strong>di</strong><br />

genere: dal<br />

laboratorio alla<br />

società<br />

Simposio<br />

Infiammazioni e<br />

sindromi<br />

coronariche<br />

acute: stato<br />

dell'arte<br />

Simposio<br />

Nuove prospettive<br />

terapeutiche nel<br />

trattamento della<br />

depressione.<br />

L'approccio<br />

melatoninergico:<br />

dalla farmacologia<br />

all'evidenza clinica<br />

Comunicazioni Orali<br />

Giovani Farmacologi<br />

(15.00-20.00)<br />

Simposio<br />

Modulazione<br />

farmacologica dei<br />

recettori P2<br />

15.00/17.30 Simposio<br />

Nuove acquisizioni<br />

nella ricerca sui<br />

cannabinoi<strong>di</strong><br />

Simposio<br />

La malattia <strong>di</strong><br />

Parkinson: dalla<br />

biologia<br />

molecolare alla<br />

terapia<br />

Simposio<br />

Canali ionici<br />

come bersagli<br />

terapeutici per<br />

malattie<br />

genetiche e<br />

non-genetiche<br />

Simposio<br />

Meccanismi<br />

farmacologici che<br />

regolano la<br />

proliferazione e il<br />

<strong>di</strong>fferenziamento<br />

delle cellule<br />

staminali<br />

Simposio<br />

Targets cellulari e<br />

molecolari per lo<br />

sviluppo <strong>di</strong> nuove<br />

terapie in corso <strong>di</strong><br />

neuroAIDS<br />

Comunicazioni<br />

Orali<br />

Farmacologia del<br />

dolore e<br />

infiammazione<br />

Simposio<br />

Farmaci inibitori<br />

della pompa<br />

protonica e danno<br />

<strong>di</strong>gestivo indotto da<br />

FANS: aspetti<br />

farmacologici e<br />

clinici<br />

Simposio<br />

La neurobiologia e i<br />

trattamenti<br />

farmacologici del<br />

poliabuso<br />

17.30/19.30 Simposio<br />

Nuovi aspetti<br />

patogenetici e<br />

terapeutici della<br />

neurodegenerazione<br />

71<br />

Giovedì 7 giugno<br />

pag_dx.indd 1 27/05/2007 18.55.12


Au<strong>di</strong>torium Sala 1 Sala 2 Sala 3 Sala 4 Sala 5 Sala 6 Sala 7 Sala 8<br />

Simposio<br />

Farmacifarmacistifarmacie<br />

Simposio<br />

Meccanismi<br />

d'azione <strong>degli</strong><br />

antidepressivi:<br />

nuove acquisizioni<br />

Simposio<br />

I nuovi farmaci<br />

target-specifici in<br />

oncologia<br />

Simposio<br />

Sistema nervososistema<br />

immunitario tra<br />

interazione e<br />

integrazione:<br />

tempo per la<br />

neuro-immunofarmacologia?<br />

Simposio<br />

Nocicettina/<br />

orfanina FQ: dagli<br />

stu<strong>di</strong> <strong>di</strong> base alla<br />

clinica<br />

Comunicazioni<br />

Orali<br />

Farmacologia<br />

Car<strong>di</strong>ovascolare<br />

(08.30/11.30)<br />

Simposio<br />

Farmacologia dei<br />

recettori TRPV1<br />

(vanilloi<strong>di</strong>) nel sistema<br />

nervoso centrale e<br />

periferico<br />

Tavola Rotonda<br />

La prima del farmaco<br />

sull'uomo<br />

08.30/11.00 Simposio<br />

La cascata della via<br />

WNT come target delle<br />

patologie<br />

neurodegenerative<br />

Comunicazioni<br />

(09.50-11.00)<br />

11.00/13.00 Sessione Plenaria<br />

La ricerca clinica in<br />

Italia: attualità e<br />

prospettive<br />

12.30/17.30 Simposio<br />

Appropriatezza<br />

nella terapia<br />

farmacologica<br />

car<strong>di</strong>ovascolare<br />

Incontro con<br />

l'esperto<br />

Inibizione della<br />

corrente pacemaker<br />

IF:<br />

dall'elettrofisiologia<br />

alla pratica clinica<br />

Comunicazioni<br />

Orali<br />

Farmacologia<br />

car<strong>di</strong>ovascolare<br />

Venerdì 8 giugno<br />

13.00/14.00 Colazione <strong>di</strong> lavoro<br />

13.00/15.00 Sessione Poster<br />

Simposio<br />

I modelli animali<br />

nella ricerca<br />

biome<strong>di</strong>ca<br />

Comunicazioni<br />

Orali<br />

Farmaci<br />

antitumorali<br />

Comunicazioni<br />

Orali<br />

Nuove<br />

acquisizioni sulla<br />

Farmacologia <strong>di</strong><br />

Genere<br />

Simposio<br />

Atomoxetina,<br />

nuova alternativa<br />

terapeutica per il<br />

trattamento del<br />

<strong>di</strong>sturbo da deficit<br />

dell'attenzione e<br />

iperattività<br />

(ADHD)<br />

Simposio<br />

Lo stress nella<br />

patologia mentale:<br />

comportamento,<br />

neurobiologia e<br />

trattamento<br />

Simposio<br />

Angiogenesi tumorale<br />

e terapia<br />

antiangiogenica<br />

15.00/17.30 Simposio<br />

Glucocorticoi<strong>di</strong>,<br />

meccanismi molecolari<br />

ed efficacia<br />

antinfiammatoria ed<br />

immunosoppressiva<br />

17.30/19.30 Assemblea dei Soci<br />

72<br />

pag_sx.indd 1 27/05/2007 18.58.01


Au<strong>di</strong>torium Sala 1 Sala 2 Sala 3 Sala 4 Sala 5 Sala 6 Sala 7 Sala 8<br />

Simposio<br />

Monossido <strong>di</strong> azoto<br />

(NO) ed infiammazione:<br />

prospettive<br />

terapeutiche<br />

Simposio<br />

Basi<br />

farmacocinetiche/<br />

farmaco<strong>di</strong>namiche<br />

(PK/PD) per il<br />

corretto uso dei<br />

farmaci<br />

antimicrobici<br />

Simposio<br />

Aspetti cellulari e<br />

molecolari del<br />

precon<strong>di</strong>zionamento<br />

e<br />

postcon<strong>di</strong>zionamento<br />

ischemico: basi <strong>di</strong><br />

intervento<br />

farmacologico<br />

Simposio<br />

Terapia<br />

ormonale<br />

sostitutiva: se,<br />

quando, per<br />

quanto e<br />

perchè<br />

Comunicazioni Orali<br />

Farmacologia <strong>di</strong><br />

Scienze<br />

(08.30-12.15)<br />

08.30/11.00 Simposio<br />

Target molecolari<br />

del dolore cronico<br />

09.00/16.30 Corso <strong>di</strong><br />

Aggiornamento<br />

Il trattamento a<br />

lungo termine<br />

della<br />

depressione:<br />

aspetti biologici e<br />

clinici<br />

11.00/13.00 Comunicazioni<br />

Orali<br />

Neurodegenerazione<br />

e<br />

neuroprotezione<br />

11.00/11.30 Pausa caffè<br />

11.00/12.00 Lettura<br />

Plenaria<br />

Update in<br />

<strong>di</strong>abetologia:<br />

gli inibitori del<br />

DPP-IV<br />

73<br />

Sabato 9 giugno<br />

pag_dx.indd 1 30/05/2007 3.39.02


pag_sx.indd 1 28/05/2007 22.17.19


Sessione Poster<br />

Recettori e meccanismi <strong>di</strong> trasduzione del segnale<br />

Poster 1-20<br />

12.30-15.00<br />

1. Coupling of cannabinoid receptors to intracellular calcium mobilization in rat<br />

insulinoma B-cells<br />

Marini Pietro 1 , De Petrocellis L. 2 , Matias I. 2 , Schiano Moriello A. 2,3 , Starowicz K 3 , Cristino L. 2 ,<br />

Di Marzo V. 3<br />

1 Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”,<br />

Rome, Italy 2,3 Endocannabinoid Research Group, 2 Institute of Cybernetics and 3 Institute of<br />

Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, Comprensorio<br />

Olivetti, 80078, Pozzuoli, Naples, Italy<br />

2. Different striatal C-FOS expression following co-administration of delta-9-<br />

tetrahydrocannabinol with haloperidol or clozapine<br />

Casti Paola, a Marchese G. a , Sanna A. a , Casu G. a , Pinna Spada G. a , Pani L. a,b<br />

a Neuroscienze PharmaNess S.c.a r.l., c/o POLARIS, E<strong>di</strong>ficio 5, Loc.Piscinamanna, 09010 Pula<br />

(CA), Italy. b C.N.R. Istituto <strong>di</strong> Tecnologie Biome<strong>di</strong>che, Sezione <strong>di</strong> Cagliari, c/o Neuroscienze<br />

PharmaNess S.c.a r.l.<br />

76<br />

3. Altered endocannabinoid-me<strong>di</strong>ated synaptic plasticity in hippocampal neurons in<br />

obesity<br />

1 Massa Federico, 1,2 Mancini G., 2 Pagotto U., 1 Lutz Beat<br />

1 Department of Physiological Chemistry, Johannes Gutenberg University, Mainz, Germany.<br />

2 Endocrinology Unit, Department of Internal Me<strong>di</strong>cine and Gastroenterology, S. Orsola-<br />

Malpighi General Hospital, Alma Mater University of Bologna, Bologna, Italy<br />

4. Caveolae/lipid rafts control signaling of CB1 cannabinoid receptor in human breast<br />

cancer cells<br />

Grimal<strong>di</strong> Clau<strong>di</strong>a, Sarnataro D., Cavallo P., Capasso A., Bifulco M.<br />

Department of Pharmaceutical Sciences, University of Salerno, Fisciano, Italy<br />

5. Pharmacological characterization of single nucleotide polymorphisms for human CB2<br />

receptor<br />

Petrò Roberta, Beltramo M., Brusa R., Downey P., Jason S., Foglia C., Scandroglio P.,<br />

Reggiani A.<br />

Schering Plough Research Institute, Via Olgettina 58, 20132 Milano, Italy<br />

6. RITIRATO<br />

7. Lithium regulates neuronal excitability in rat hippocampus<br />

Murru Luca, Carta M., Pitzianti S., Corda G., Sanna E., Biggio G.<br />

Dept. Experimental Biology, Sect of Neuroscience, and Center of Excellence for the<br />

Neurobiology of Dependence. Cittadella Universitaria, SS 554 Km 4,500, 09042, Monserrato,<br />

Cagliari, Italy<br />

8. Thiocolchicoside inhibits the activity of various subtypes of recembinant GABA A<br />

receptors expressed in Xenoups Laevis oocyte<br />

Mascia Maria Paola a , Bachis E. b , Obili N. b , Maciocco E. a , Cocco G. A c , Sechi G.P. c , Biggio G. a,b<br />

a National Research Council, Institute of Neuroscience, Cagliari, Italy; b Department of<br />

Experimental Biology “B. Loddo”, University of Cagliari, Cagliari, Italy; c Neurological Clinic ,<br />

University of Sassari, Sassari, Italy<br />

pag_sx.indd 1 30/05/2007 3.45.04


9. Direct modulation of gabaergic transmission by thyroid hormones (THs) in<br />

hippocampus<br />

Losi Gabriele, Puia G.<br />

Dept. Biome<strong>di</strong>cal Science, University of Modena and Reggio Emilia, via Campi 287, Modena,<br />

ITALY<br />

10. Pregnancy and delivery change the gene expression of synaptic and extrasynaptic<br />

GABA A receptors in the rat hippocampus<br />

Mura Maria Luisa 1 , Mostallino M.C. 2 , Maciocco E. 2 , Biggio G. 1,2,3<br />

1 Departement of Experimental Biology, Section of Neuroscience, University of Cagliari,<br />

Monserrato (Cagliari), Italy; 2 CNR, Institute of Neuroscienze, Monserrato (Cagliari), Italy;<br />

3 Center of Excellence for the “Neurobiology of Drug Dependence”, University of Cagliari,<br />

Monserrato (Cagliari) Italy<br />

11. Plasticity of the gabaergic transmission in the rat hippocampus during pregnancy<br />

Murru Luca, Talani G., Serra V., Carta M., Sitzia F., Uras R., Sanna E., Biggio G.<br />

Dept. Experimental Biology, Sect of Neuroscience, and Center of Excellence for the<br />

Neurobiology of Dependence. Cittadella Universitaria, SS 554 Km 4,500, 09042, Monserrato,<br />

Cagliari, Italy<br />

12. Activation of group II metabotropic glutamate receptors prevents the <strong>di</strong>fferentiation<br />

of cultured neural progenitor cells isolated from the mouse subventricular zone into<br />

mature astrocytes<br />

Ciceroni Cinzia 1 , Mosillo P. 1 , Mastrantoni E. 1 , Magnotti M. C. 1 , Cappuccio I. 1,3 , Lupieri T. 1 ,<br />

Nicoletti F. 1,2 , Melchiorri D. 1<br />

1 Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”,<br />

Rome; 2 I.N.M. Neuromed, Pozzilli, Italy; 3 I.R.C.C.S. San Raffaele, Rome<br />

77<br />

13. In<strong>di</strong>vidual subtypes of metabotropic glutamate receptors regulates neural<br />

<strong>di</strong>fferentiation of cultured mouse embryonic stem cells<br />

Cappuccio Irene 1,2* , Sarichelou I. 1* , Costantino S. 1 , Ferranti F. 1 , Niccolini C. 1 , Nicoletti F. 1,3 ,<br />

Melchiorri D. 1<br />

1 Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”,<br />

Rome; 2 I.R.C.C.S. San Raffaele, Roma, 3 I.N.M. Neuromed, Pozzilli, Italy<br />

14. The human immunodeficiency virus-1 protein (TAT) modulates NMDA receptor<br />

function by acting at colocalized metabotropic glutamate receptor 1<br />

Musante Veronica 1 , Neri E. 1 , Severi P. 2 , Raiteri M. 1,3 , Pittaluga A. 1,3<br />

1 DI.ME.S, Pharmacology and Toxicology Section, Department of Experimental Me<strong>di</strong>cine,<br />

University of Genova, Italy, 2 Dision of Neurosurgery, Galliera Hospital, Genova, Italy, 3 Center<br />

of Excellence for Biome<strong>di</strong>cal Research, University of Genova, Italy<br />

15. Colocalization and functional interactions between presinaptic AMPA; NMDA and<br />

group I metabotropic glutamate receptors<br />

Neri Elisa, Musante V., Severi P., Pittaluga A., Raiteri M.<br />

1 DI.ME.S, Pharmacology and Toxicology Section, Department of Experimental Me<strong>di</strong>cine,<br />

University of Genova, Genova Italy; 2 Division of Neurosurgery, Galliera Hospital, Genova,<br />

Italy; 3 Center of Excellence for Biome<strong>di</strong>cal Research, University of Genova, Genova Italy<br />

16. Co-expression of metabotropic glutamate 1A (mGlu1A) receptor and cannabinoid 1<br />

(CB1) receptor immunoreactivity in the rat hippocampus<br />

Boscia Francesca, *Moroni F., Annunziato L. *Pellegrini-G. D.<br />

Dipartimento <strong>di</strong> Neuroscienze, Università <strong>di</strong> Napoli “Federico II”<br />

*Dipartimento <strong>di</strong> Farmacologia Preclinica e Clinica, Università <strong>di</strong> Firenze<br />

pag_dx.indd 1 30/05/2007 3.49.33


17. Biochemical and pharmacological evidences for (-)-epigallo catechin-3-gallate<br />

(EGCG) to link NMDA receptors in rat cortex<br />

Lograno Marco D., Romano M.R.<br />

Department of Pharmacobiology, University of Bari, Via E. Orabona, 4, 70125 Bari, Italy<br />

18. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist<br />

sb-612111: in vitro stu<strong>di</strong>es<br />

1 Fischetti Carmela, 1 Spagnolo B., 1 Carra’ G., 1 Fantin M., 2 Hebbes C., 2 McDonald J., 2 Barnes A.<br />

1 Rizzi A., 1 Marzola G., 3 Trapella C., 3 Fanton G., 1 Morari M., 2 Lambert D., 1 Regoli D., 1 Calo’ G.<br />

1 Dept. of Pharmacology and 3 Dept of Pharmaceutical Science, University of Ferrara, Italy.<br />

2 Dept. of Car<strong>di</strong>ovascular Sciences, University of Leicester, UK<br />

19. Activation of nociceptin/orphanin FQ and classical opioid receptors in CHO cells<br />

expressing the CHIMERIC Galpha qi5 protein promotes calcium mobilization<br />

Camarda Valeria 1 , Molinari P. 2 , Ambrosio C. 2 , Kostenis E. 3 , Regoli D. 1 , Guerrini R. 4 , Salvatori<br />

S. 4 , Calo’ G. 1<br />

1 Dept Exp and Clin Me<strong>di</strong>cine, Section of Pharmacology, University of Ferrara, Italy;<br />

2 Dept of Pharmacology, ISS, Rome, Italy; 3: Inst for Pharmaceutical Biology, Bonn, Germany;<br />

4: Dept of Pharmaceutical Sciences, University of Ferrara, Italy<br />

78<br />

20. Opposite effects on cell proliferation by wnt1 AND wNT7a proteins in cultured pc12<br />

cells<br />

De Vita Teresa 1 , Spinsanti P. 1 , Caruso A. 1 , Lisi I. 1 , Melchiorri D. 1 , Caricasole A. 2 , Nicoletti F. 1,3<br />

1 Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”;<br />

2 Sienabiotech S.p.A., Siena; and 3I.N.M. Neuromed, Pozzilli, Italy<br />

Controllo farmacologico dei processi <strong>di</strong> morte e proliferazione cellulare<br />

Poster 21 – 42<br />

21. Role of NO/Ca 2+ /CaM/MAPK signalling pathway in the mitogenic effect of IL-1 in<br />

C6 glioma cells<br />

Sticozzi Clau<strong>di</strong>a, Meini A., Palmi M.<br />

Dipartimento <strong>di</strong> Scienze Biome<strong>di</strong>che, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Siena, via Aldo Moro, 2 Siena<br />

22. Neurogenic response induced by fluoxetine chronic treatment in neural progenitor<br />

cells isolated from rat postnatal cerebellum<br />

Zusso Morena, Debetto P., Barbierato M., Guidolin D.*, Giusti P.<br />

Department of Pharmacology and Anestesiology, University of Padova, Italy<br />

*Department of Anatomy and Physiology, University of Padova, Italy<br />

23. Involvement of cannabinoid system in proliferation of cerebellar neural progenitor<br />

cells<br />

Soffia Silvia, Corso M., Barbierato M., Giusti P., Debetto P., Zusso M.<br />

Department of Pharmacology and Anesthesiology “E. Meneghetti”, University of Padova, Italy<br />

24. Effect of oxysterols on cell survival and proliferation pathways in human endothelial<br />

cells<br />

Agnoletto Laura, Poggiani C., Cusinato F., Trevisi L., Luciani S.<br />

Department of Pharmacology and Anaesthesiology, University of Padova<br />

pag_sx.indd 1 30/05/2007 3.50.45


25. Expression of CXCR4 and SDF1/CXCL12 in human normal pituitary and pituitary<br />

adenoma tissues: role in cell proliferation<br />

Florio Tullio, Barbieri F., Bajetto A., Porcile C., Pattarozzi A.,Gatti M., Corsaro A., Thellung S.,<br />

Villa V., Schettini G.<br />

Section of Pharmacology, Department of Oncology, Biology and Genetics, University of<br />

Genova, Italy<br />

26. Dopamine and L-DOPA increase in vitro proliferation of stem cells from the mouse<br />

subventricular zone<br />

Serra Pier Andrea a , Migheli R.,Rocchitta G., Calia G., Dedola S., Manca A. a , L‘Episcopo<br />

F. c , Pluchino S. b , Marchetti B. a,c , Desole M.S. a<br />

a Department of Pharmacology, University of Sassari, 07100 Sassari, Italy<br />

b Department of Neuroscience, S. Raffaele Scientific Institute, Milano,<br />

Italy<br />

c OASI Institute for Research and Care on Mental Retardation and Brain Aging<br />

(IRCCS), Neuropharmacology Section, Troina, Italy<br />

27. Antiproliferative effects of pyrazolo-pyrimi<strong>di</strong>ne -type inhibitors of SRC family<br />

tyrosine kinases derivates on human neuroblastoma cells<br />

Navarra Michele 1 , Celano M. 2 , Schenone S. 3 , Botta M. 4 , Bramanti P. 5 , Russo D. 2<br />

1 Pharmaco-Biological Department, University of Messina, 2 Department of Pharmacobiological<br />

Sciences, University "Magna Græcia" of Catanzaro, 2 Department of Pharmaceutical Sciences,<br />

University of Genova, 4 Department of Pure and Applied Me<strong>di</strong>cinal Chemistry, University of<br />

Siena, 5 IRCCS centro neurolesi “Bonino-Pulejo”<br />

28. Neuron-like cells derived from bone marrow stromal cells: expression and<br />

functioning of GABA B receptors<br />

Cervetto Chiara 1 , Paluzzi P. 1 , Guarnieri S. 1 , Marcoli M. 1 , Castagnola P. 2 , Tonachini L. 2 ,<br />

Mastrogiacomo M. 2 , Monticone M. 2 , Pestarino M. 3 , Can<strong>di</strong>ani S. 3 , Maura G. 1*<br />

1 Dep. Experimental Me<strong>di</strong>cine, 3 Dep. Biology, * Centre of Excellence for Biome<strong>di</strong>cal Research,<br />

University of Genova and 2 Ist Naz Ricerca sul Cancro, Genova, Italy<br />

79<br />

29. Influence of leptin on the early phases of bone formation during mouse skeleton<br />

organogenesis<br />

1 Rivasi Marianna, 1 Benelli A., 2 Ferretti M., 2 Benincasa M., 2 Bertoni L., 2 Cavani F., 2 Palumbo C.<br />

1 Dept. of Biome<strong>di</strong>cal Sciences, Section of Pharmacology; 2 Dept. of Anatomy and Istology,<br />

Section of Human Anatomy; University of Modena and Reggio Emilia, Modena, Italy<br />

30. Proliferation and invasiveness of human smooth muscle TSC2-/- cells. Effect of anti-<br />

EGFR and rapamycin<br />

Di Giulio Anna Maria, Isaia E., Grande V., Lesma E., Gorio A.<br />

Pharmacological Laboratories, Dept. of Me<strong>di</strong>cine, Surgery and Dentistry, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong><br />

<strong>di</strong> Milano<br />

31. Reversion of the phenotype of human TSC2 -/- smooth muscle cells. Novel insights for<br />

TSC and LAM therapy<br />

Lesma Elena, Grande V., Isaia E., Di Giulio A. M., Gorio A.<br />

Pharmacological Laboratories, Dept. of Me<strong>di</strong>cine, Surgery and Dentistry, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong><br />

<strong>di</strong> Milano<br />

32. Expression of Annexin A1 in mouse myoblast <strong>di</strong>fferentiation cell line<br />

Bizzarro Valentina, Festa M., Ercolino S.F., Franceschelli S., Solito E.*, Parente L., Putrella A.<br />

Department of Pharmaceutical Sciences, University of Salerno, Salerno, Italy<br />

*Department of Cellular and Molecular Neuroscience, Faculty of Me<strong>di</strong>cine, Imperial College,<br />

London, UK<br />

pag_dx.indd 1 30/05/2007 3.51.35


33. The glucocorticoid-induced leucine zipper (Gilz) inhibits skeletal myogenesis by<br />

counteracting myod activity<br />

Donato Valerio 1 , Velar<strong>di</strong> E. 1 , Bruscoli S. 1 , Bastianelli A. 1 , Donato R. 2 , Riccar<strong>di</strong> C. 1<br />

1 Dept. Clinical and Experimental Me<strong>di</strong>cine, Sect. Pharmacology, and 2 Dept. Experimental<br />

Me<strong>di</strong>cine and Biochemical Sciences, Sect. Anatomy, Perugia University Me<strong>di</strong>cal School,<br />

06122, Perugia, Italy<br />

34. Calixarene glycoconjugates inhibit c6 glioma cell proliferation and migration:<br />

interaction with growth factors<br />

Viola Santa 1 , Consoli Grazia M.L. 2 , Merlo S. 1 , Geraci C. 2 , Sortino M. A. 1<br />

1 Department of Experimental and Clinical Pharmacology, University of Catania and 2 Institute<br />

of Biomolecular Chemistry, CNR, Valverde, Catania<br />

35. Cannabinoids inhibit human colon cancer cell proliferation through CB 2 -receptor and<br />

ceramide pathway activation<br />

Mastroianni Rosanna a , Cianchi F. b , Magnelli L. c , Schiavone N. c , Perna F. b , Capaccioli S. c ,<br />

Manera C. d , Mannaioni P.F., Masini E. a<br />

a Department of Preclinical and Clinical Pharmacology, b Department of Critical Care Me<strong>di</strong>cine<br />

and c Department Pathology and Experimental Oncology, University of Florence, Florence,<br />

Italy; d Department of Pharmaceutical Sciences, University of Pisa, Pisa, Italy<br />

80<br />

36. Role of Lox pathway and endocannabinoid system in antitumor activity of<br />

Cannabi<strong>di</strong>ol, a non-psychoactive cannabinoid<br />

Valenti Marta 2 , Massi P. 1 , Gasperi M. 3 , Meli S. 2 , Maccarrone M. 3 Parolaro D. 2<br />

1 Department of Pharmacology, Chemotherapy and Toxicology, University of Milan, Via<br />

Vanvitelli 32, Milan, Italy<br />

2 Department of Structural and Functional Biology, Pharmacology Section, Center of<br />

Neuroscience, University of Insubria, Via A. da Giussano 10, Busto Arsizio (VA), Italy<br />

3 Department of Biome<strong>di</strong>cal Sciences, University of Teramo, 64100 Teramo, Italy<br />

37. Effects of the IL-6 receptor superantagonist SANT7 on TGF-B-induced cell<br />

proliferation and MAP kinase phosphorylation in primary cultures of fibrotic human<br />

lung fibroblasts<br />

Gallelli Luca, Falcone D., Renda T., Pelaia G.o, Maselli R., Savino R., De Sarro G.<br />

Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of Me<strong>di</strong>cine, University Magna<br />

Graecia of Catanzaro, Italy<br />

38. Effects of simvastatin and betamethasone on hydrogen peroxide induced MAPK<br />

activation, IL-8 production and cell proliferation in primary cultures of human<br />

squamous lung cancer cells<br />

Fratto Donatella 1 , Gallelli L. 1 , Renda T. 1 , Pelaia G. 2 , Maselli R. 2 , De Sarro G. 1<br />

1 Chair of Pharmacology, and 2 Chair of Respiratory Diseases, Department of Experimental and<br />

Clinical Me<strong>di</strong>cine, Faculty of Me<strong>di</strong>cine, University Magna Graecia of Catanzaro, Italy<br />

39. PKC isoenzyme is involved in growth and angiogenesis of prostate cancer<br />

Betti Niccolò 1 , Morbidelli L. 1 , Corti F. 2 , Mochly-Rosen D. 3 , Ziche M. 1<br />

1 Pharmacology section, Dept Molecular Biology, University of Siena. 2 Proteomic section, Dept<br />

Molecular Biology, University of Siena. 3 Molecular pharmacology, School of Me<strong>di</strong>cine,<br />

Stanford University<br />

pag_sx.indd 1 30/05/2007 3.52.27


40. Tumor necrosis factor related apoptosis inducing ligand inhibits angiogenesis<br />

stimulated by human glioblastoma cells<br />

Scuderi Mariagrazia Rita, Albini A. 1 , Lempereur L., Pennisi G. 2 , Bernar<strong>di</strong>ni R., Cantarella G.<br />

Department of Experimental and Clinical Pharmacology; and Department of Chemical<br />

Sciences; University of Catania, 95100 Catania, Italy; Laboratory of Molecular Oncology,<br />

Istituto Tumori, 16100 Genova, Italy<br />

41. Antiangiogenic and antitumour effects of metronomic irinotecan (CPT-11)<br />

Fioravanti Anna 1 , Orlan<strong>di</strong> P. 1 , Falcone A. 2 , Danesi R. 1 , Del Tacca M. 1 , Bocci G. 1<br />

1 Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa, 2 Oncology Unit; General Hospital, Livorno<br />

42. Natural and semisynthetic antraquinones, flavonoids and naphtoquinones effects on<br />

cell cycle in human ovarian cancer<br />

Montopoli M., Moro S.*, Cozza G.*, Zagotto G. *, Frol<strong>di</strong> G., Ragazzi E., Caparrotta L.<br />

Department of Pharmacology and Anaestesiology, University of Padova Largo E. Meneghetti 2,<br />

35131 Padova, Italy. * Department of Pharmaceutical Sciences, University of Padova, Via<br />

Marzolo 5, 35131 Padova, Italy<br />

Farmacologia della trasmissione sinaptica<br />

Poster 43 – 55<br />

43. SNAP-25 Phosphorylation on Serin 187 me<strong>di</strong>ates negative modulation of neuronal<br />

calcium dynamics<br />

Pozzi Davide 1 , Condliffe S. 1 , Grumelli C. 1 , Bozzi J. 2 , Caleo M. 2 , Proux-Gillardeaux V. 3 ,<br />

Takahashi M. 4 , Verderio C. 1 , Matteoli M. 1<br />

1 Department of Me<strong>di</strong>cal Pharmacology and CNR Institute of Neuroscience, Center of<br />

Excellence for Neurodegenerative Diseases, University of Milano, Via Vanvitelli 32, 20129<br />

Milano, Italy. 2 CNR- Institute of Neuroscience via G. Moruzzi 1, 56100 Pisa, Italy. 3 Institut<br />

Jacques Monod UMR7592 Tour 43 2ème étage 2, place Jussieu, F-75251 Paris Cedex 05,<br />

France. 4 Department of Biochemistry, Kitasato University School of Me<strong>di</strong>cine, Kitasato 1-15-1,<br />

Sagamihara-shi, Kanagawa 228-8555, Japan<br />

81<br />

44. Selective regulation of [ 3 H]D-aspartate release from hyppocampal nerve en<strong>di</strong>ngs by<br />

large-conductance Ca 2+ - and voltage-activated K + (BK) channels<br />

Martire Maria 1 , D’Amico M. 1 , Calciano S. 1 , Panza E. 2 , Iannotti F. 2,3 , Barrese V. 2 , Preziosi P. 1 ,<br />

Annunziato L. 2 , Tagliatatela M. 2,3<br />

1 Inst. of Pharmacology, Catholic University of S. Heart, Rome; 2 Division of Pharmacology,<br />

Dept. of Neuroscience, University of Naples Federico II, Naples; 3 Dept. of Health Science,<br />

University of Molise, Campobasso; Italy<br />

45. KCNQ channels regulate depolarization-induced changes in intracellular Ca 2+<br />

concentrations in rat cerebrocortical nerve en<strong>di</strong>ngs<br />

1 Luisi Rosa, 1 Panza E., 1 Secondo A., 2 Martire M., 1 Annunziato L., 1,3 Maurizio Taglialatela M.<br />

1 Div. of Pharmacology, Dept. of Neuroscience, School of Me<strong>di</strong>cine, Univ. “Federico II”, Naples;<br />

2 Insitute of Pharmacology, School of Me<strong>di</strong>cine, Catholic Univ. of Sacred Heart, Rome; 3 Dept.<br />

of Health Sciences, Univ. of Molise, Campobasso, Italy<br />

46. Adult astroglia is competent for Na + /Ca 2+ exchanger-operated exocytotic glutamate<br />

release triggered by mild depolarization<br />

1 Zappettini Simona, 2 Alloisio S., 1 Raiteri L., 1 Paluzzi S., 2 Nobile M., 1 Bonanno G.<br />

1 Department of Experimental Me<strong>di</strong>cine - Pharmacology and Toxicology Section and Center of<br />

Excellence for Biome<strong>di</strong>cal Research, University of Genoa, Italy. 2 Institute of Biophysics,<br />

National Research Council, Genoa, Italy<br />

pag_dx.indd 1 30/05/2007 3.53.40


47. Mechanisms of [ 3 H]glycine release from mouse spinal cord synaptosomes selectively<br />

labelled through glyt2 transporters<br />

Luccini Elisa, Raiteri L.<br />

Department of Experimental Me<strong>di</strong>cine, Pharmacology and Toxicology Section, University of<br />

Genoa<br />

48. Importance of protein kinase C epsilon for the allosteric modulation of GABA evoked<br />

currents in cortical culture at <strong>di</strong>fferent DIV<br />

Garzon Giorgio, Baral<strong>di</strong> M., Puja G.<br />

Dept. of BioMe<strong>di</strong>cal Sciences, University of Modena and Reggio Emilia, Via G. Campi 287,<br />

41100 Modena, Italy<br />

49. 7 nicotinic receptor present on mouse cortical astrocytes modulates endogenoous<br />

glutamate release<br />

Patti Laura 1 , Raiteri L. 1 , Grilli M. 1 , Robino F. 1 , Zappettini S. 1 , Bonanno G.B. 1,2 , Marchi M. 1,2<br />

1 Section of Pharmacology and Toxicology, Department of Experimental Me<strong>di</strong>cine, University of<br />

Genoa, Italy. 2 Center of Excellence for Biome<strong>di</strong>cal Research, University of Genoa, Italy<br />

50. The agonist of metabotropic glutamate 5 receptors CHPG inverts the effects of DHK<br />

(a blocker of glial glutamate uptake): an in vivo microdyalisis study<br />

Armida Monica, Pintor A., Pèzzola A., Popoli P.<br />

Department of Therapeutic Research and Me<strong>di</strong>cines Evaluation, Istituto Superiore <strong>di</strong> Sanità,<br />

Roma (Italy)<br />

82<br />

51. The metabotropic glutamate 5 (mGlu5Rs) and the adenosine A 2A receptors (A 2A Rs)<br />

oppositely modulate CB1-induced reduction of synaptic transmission in the rat<br />

striatum<br />

Martire Alberto, Tebano M.T., Domenici M.R., Popoli P.<br />

Department of Therapeutic Research and Me<strong>di</strong>cines Evaluation, Istituto Superiore <strong>di</strong> Sanità,<br />

Roma (Italy)<br />

52. Glutamate release induced by activation of GAT-1 transporters sited on glutamate<br />

releasing spinal cord gliosomes and its augmentation in a mouse model of<br />

amyotrophic lateral sclerosis<br />

1 Milanese Marco, Raiteri L., 1 Zappettini S., 2 Usai C., 1 Bonanno G.<br />

1 Department of Experimental Me<strong>di</strong>cine - Pharmacology and Toxicology Section and Center of<br />

Excellence for Biome<strong>di</strong>cal Research, University of Genoa, Italy. 2 Institute of Biophysics,<br />

National Research Council, Genoa, Italy<br />

53. Thyroid hormones modulate glutamatergic neurotransmission in hippocampus<br />

Puja Giulia, Losi G., Garzon G., Baral<strong>di</strong> M.<br />

Dept. of BioMe<strong>di</strong>cal Sciences, University of Modena and Reggio Emilia, Via G. Campi 287,<br />

41100 Modena, Italy<br />

54. Role of ionotropic glutamatergic receptors in the regulation of hippocampal<br />

norepinephrine ouput in vivo<br />

Matzeu Alessandra, Dazzi L., Biggio G.<br />

Department of Experimental Biology, Neuroscience section, University of Cagliari, Cagliari,<br />

Italy<br />

55. Alterations of glutamatergic transmission in a murine model of multiple sclerosis:<br />

preliminary results<br />

Pepicelli Olimpia a , Marte A. a , Uccelli A. c , Mancar<strong>di</strong> L. c , Raiteri M. a,b , Fedele E. a,b<br />

a Dept. of Experimental Me<strong>di</strong>cine, Pharmacology and Toxicology Section, University of Genoa;<br />

b Centre of Excellence for Biome<strong>di</strong>cal Research, University of Genoa; c Dept. of Neurosciences,<br />

Ophthalmology and Genetics, University of Genoa, Italy<br />

pag_sx.indd 1 30/05/2007 3.54.37


Farmacologia car<strong>di</strong>ovascolare<br />

Poster 56 – 70<br />

56. Mo<strong>di</strong>fication of pressure and placental protein expression in pregnant spontaneously<br />

hypertensive rats (SHR)<br />

1 Bianco Giuseppe, Iacono A., Esposito E., Mattace Raso G., 1 Autore G., Meli R.<br />

Department of Experimental Pharmacology, University of Naples “Federico II”, Naples,<br />

1 Department of Pharmaceutical Sciences, University of Salerno, Salerno, Italy<br />

57. Increased p22phox expression and reduced SOD activity are involved in early<br />

impairment of insulin-induced vaso<strong>di</strong>lation on resistance vessels of spontaneously<br />

hypertensive rats (SHR)<br />

Gagliar<strong>di</strong> Sara, Potenza M.A., Marasciulo F.L., Montagnani M.<br />

Department of Pharmacology and Human Physiology - Me<strong>di</strong>cal School - University of Bari,<br />

70124 Bari, Italy<br />

58. Vaso<strong>di</strong>lator activity of hydrogen sulfide (H 2 S) in human isolated mesenteric arteries<br />

Materazzi Serena 1 , Patacchini R. 2 , Nassini R. 1 , Zagli G. 1 , Giannelli M. 1 , Bechi P. 1 , Nicoletti P. 1 ,<br />

Geppetti P. 1, Harrison S. 1<br />

1 Department of Critical Care Me<strong>di</strong>cine & Surgery, University of Florence, Florence, Italy; and<br />

2 Department of Pharmacology, Chiesi Pharmaceuticals, Parma, Italy; Florence, Italy<br />

59. The vasorelaxant and anti-inflammatory action of raloxifene in rat aorta is partially<br />

me<strong>di</strong>ated by estrogen receptor alpha<br />

Pelosi Valeria 1,2 , Sancito P. 1,2 , Bolego C. 1 , Pinna C. 1 , Corsini A. 1 , Gaion R.M. 2 , Cignarella A. 1,2<br />

1 Department of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133 Milan;<br />

2 Department of Pharmacology and Anaesthesiology, University of Padova, Largo Meneghetti<br />

2, 35131 Padova, Italy<br />

83<br />

60. Inhibitors of cystathionine --lyase (CSE), propargylglycine and -cyanoalanine,<br />

modulate arterial vasorelaxation in rat aorta<br />

Vellecco Valentina, Di Lorenzo A., De Gruttola L., Brancaleone V., Roviezzo F., Bucci M., Cirino<br />

G.<br />

Department of Experimental Pharmacology, Faculty of Pharmacy, University of Naples<br />

“Federico II”<br />

61. Direct effects of ticlopi<strong>di</strong>ne and clopidogrel on resistance vessel in vitro<br />

Frol<strong>di</strong> Guglielmina, Montopoli M., Dorigo P., Caparrotta L.<br />

Department of Pharmacology and Anesthesiology -Pharmacology Division- Largo E.<br />

Meneghetti 2, University of Padova (Italy)<br />

62. Asymmetric <strong>di</strong>methylarginine (ADMA) induces vascular endothelium impairment and<br />

aggravates myocar<strong>di</strong>al ischemia-reperfusion injury in rats<br />

Bonomo Sara M. a , De Gennaro Colonna V. a , Manfre<strong>di</strong> B. a , Ferrario P. a ,.Bianchi M. a , Berti M. b ,<br />

Guazzi M. c , Berti F. a , Rossoni G. a<br />

a Department of Pharmacology, Chemoterapy and Me<strong>di</strong>cal Toxicology, University of Milano, Via<br />

Vanvitelli 32, Italy; b Institute of Car<strong>di</strong>ology, Monzino Car<strong>di</strong>ology Center, IRCCS, Milan, Italy;<br />

c Car<strong>di</strong>opulmonary Laboratory, Car<strong>di</strong>ology Division, University of Milano, San Paolo Hospital,<br />

Milano, Italy<br />

pag_dx.indd 1 30/05/2007 3.55.30


63. Anti-inflammatory and car<strong>di</strong>oprotective activities of synthetic HDL containing the<br />

37PA peptide<br />

Gomaraschi Monica*, Remaley A. # , Rossoni G. § , Franceschini G.*, Calabresi L.*<br />

*Center Enrica Grossi Paoletti, Department of Pharmacological Sciences, University of Milano,<br />

Italy, # Molecular Disease Section, National Heart, Lung, and Blood Institute, National<br />

Institutes of Health, Bethesda, MD, USA and § Department of Pharmacological Sciences,<br />

University of Milano, Italy<br />

64. Human pharmacology of naproxen so<strong>di</strong>um<br />

Capone Marta L., § † , Tacconelli S.,§ † Sciulli M.G. §† , Anzellotti P. §† , Di Francesco L. §† , Merciaro<br />

G. ‡ , Di Gregorio P. ‡ , Patrignani P. §†<br />

§ Department of Me<strong>di</strong>cine and Aging, School of Me<strong>di</strong>cine, “G.d’Annunzio” University; † “G.<br />

d’Annunzio” University Foundation, Ce.S.I.; and ‡ SS Annunziata Hospital, Chieti, Italy<br />

65. Doxorubicin car<strong>di</strong>otoxicity and apoptosis: variation of exposure times to the same<br />

cumulative dose<br />

Vitelli Maria Redenta, Piegari E., Rodolico G., Leone L., Marino L., Oliva P., Rossi F., Berrino L.<br />

Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology, Faculty of Me<strong>di</strong>cine and<br />

Surgery, Second University of Naples – Via Costantinopoli, 16 – 80138 Napoli<br />

84<br />

66. Apoptotic cell death in doxorubicin-induced car<strong>di</strong>omyopathy: role of peroxynitrite<br />

and LOX-1 receptor modulation<br />

Sculco Francesca 1 , Muscoli Ca. 1,2 , Palma E. 1 , Sacco I. 1 , Visalli V. 1 , Costa N. 1 , Rotiroti D. 1 ,<br />

Romeo F. 3 , Mollace V 1,2<br />

1 Faculty of Pharmacy, University “Magna Graecia” of Catanzaro, Italy; 2 San Raffaele Pisana<br />

IRCCS, Rome, Italy; 3 Chair of Car<strong>di</strong>ology, University of Rome “Tor Vergata”, Rome, Italy;<br />

4 Faculty of Pharmacy, University of Messina, Italy<br />

67. Ubiquitin-proteasome system contributes to the inflammatory injury of Experimental<br />

Acute <strong>di</strong>abetic myocar<strong>di</strong>al infarct<br />

D’Amico Michele 1,2 , Di Filippo C. 1,2 , Martella R. 3 , Rossi F. 1,2 ,<br />

1 Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology L. Donatelli, 2 ”Excellence<br />

Centre for Car<strong>di</strong>ovascular Disease”, and 3 Department of Geriatrics and Metabolic Diseases,<br />

2nd University of Naples, Italy<br />

68. Effects of oral essential amino acid supplementation in cachectic insuline resistance<br />

patients with chronic heart failure<br />

Boschi Federica * , Verri M. * , Dossena M. * , Opasich C.°, Aquilani R.^, Gualco A. ° , Pastoris O * .<br />

* Department of Physiological & Pharmacological Sciences, University of Pavia, Pavia, Italy;<br />

^IRCCS “S. Maugeri” Foundation, Montescano, Italy; °IRCCS “S. Maugeri” Foundation, Pavia<br />

69. Gender-<strong>di</strong>fferences in no and edhf modulation of vascular reactivity in rabbit<br />

mesenteric artery<br />

Fabi Fulvia, Coletta T., Lorenzini P., Del Basso Orsini P.<br />

Department of Drug Research and Evaluation, Istituto Superiore <strong>di</strong> Sanità, Roma, Italy<br />

70. Gender <strong>di</strong>fferences in nitric oxide production by inducible nitric oxide synthase in<br />

cytokine-stimulated rabbit carotid arteries<br />

Del Basso Orsini Paola, Calciano S., Fabi F.<br />

Department of Drug Research and Evaluation, Istituto Superiore <strong>di</strong> Sanità, Roma, Italy<br />

pag_sx.indd 1 30/05/2007 3.56.26


Farmacologia del sistema nervoso<br />

Poster 71 – 98<br />

71. Time-dependent and sequential modulation of signaling cascades, CREB activation<br />

and BDNF expression induced by antidepressants<br />

Tar<strong>di</strong>to Daniela 1 , Tiraboschi E. 1 , Barbiero V. S 1 , Moraschi S. 2 , Cattaneo A. 2 , Gennarelli M. 2 ,<br />

Racagni G. 1 , Popoli M. 1<br />

1 Center of Neuropharmacology, Dept of Pharmacological Sciences and Center of Excelence on<br />

Neurodegenerative Diseases, University of Milan, Italy. 2 Genetics Unit, I.R.C.C.S. “S. Giovanni<br />

<strong>di</strong> Dio”, Fatebenefratelli, Brescia, and Division of Biology and Genetics, Department of<br />

Biome<strong>di</strong>cal Sciences and Biotechnologies, University of Brescia, Brescia, Italy<br />

72. Chronic antidepressant treatments induces specific changes in BDNF expression and<br />

subcellular localization<br />

Maj Paola F. 1 , Calabrese F. 1 , Molteni R. 1 , Cattaneo A. 3 , Gennarelli M. 2,3 , Racagni G. 1 , Riva M.<br />

A. 1<br />

1 Center of Neuropharmacology, Pharmacol. Sciences Dept., University of Milan, Via Balzaretti<br />

9, 20133 Milan, Italy. 2 I.R.C.C.S. San Giovanni <strong>di</strong> Dio-Fatebenefratelli, Brescia, Italy. 3 Biol.<br />

and Gen. Div., Dept. Biome<strong>di</strong>cals and Biotechnology Sciences, University of Brescia<br />

73. Human astrocytes can be induced by imipramine to <strong>di</strong>fferentiate into cells with<br />

neuronal phenotype<br />

1 Cabras Stefano, 1 Reali C., 1 Scorciapino L., 1 Saba F., 1 Sirigu R., 2 Biggio G., 1 Sogos V.<br />

1 Department of Cytomorphology, University of Cagliari<br />

2 Department of Experimental Biology “Bernardo Loddo”, University of Cagliari<br />

74. Vagus nerve stimulation like antidepressant drugs enhances norepinephrine release<br />

and BDNF gene expression in the rat brain<br />

Gorini Giorgio 1,4 , Biggio F. 1 , Caria S. 1 , Follesa P. 1,2 , Marrosu F. 3 , Dazzi L. 1,2 , and Biggio G. 1,2<br />

University of Cagliari, Dept. of Experimental Biology, Section of Neuroscience 1 , Cntr. of<br />

Excellence for the Neurobiology of Dependence 2 , Dept. of Neurological and Car<strong>di</strong>ovascular<br />

Sciences 3 , 09123 Cagliari, Italy; University of Sassari, Dept. of Pharmacology, Gynecology<br />

and Obstetrics, Section of Pharmacology 4 , 07100 Sassari, Italy<br />

85<br />

75. Escitalopram alters BDNF, CREB and CaRF gene expression in <strong>di</strong>screte rat brain<br />

areas<br />

Benatti Cristina 1 , Alboni S. 1 , Capone G. 1 , Corsini D. 1 , Caggia F. 1 , Tascedda F. 1 , Blom Joan<br />

M.C. 2 , Brunello N. 1<br />

1 Department of Biome<strong>di</strong>cal Sciences, University of Modena and Reggio Emilia, Modena, Italy;<br />

2 Department of Pe<strong>di</strong>atrics, University of Modena and Reggio Emilia, Modena, Italy<br />

76. Acetyl salicylic acid increases the response of escitalopram in a rat model of<br />

depression<br />

Alboni Silvia 1 , Benatti C. 1 , Capone G. 1 , Caggia F. 1 , Corsini D. 1 , Tascedda F. 1 , Mendlewicz J. 2 ,<br />

Brunello N. 1<br />

1 Department of Biome<strong>di</strong>cal Sciences, University of Modena and Reggio Emilia, Modena, Italy;<br />

2 Department of Psychiatry, Erasme Hospital, Free University of Brussels, Belgium<br />

77. Synaptoproteomics of an animal model of depression combining genetic<br />

vulnerability and early-life stress<br />

Mallei Alessandra a , Tiraboschi E. a , Giambelli R. a , El Khoury A. b , Mathè A.A. b , Racagni G. a ,<br />

Popoli M. a<br />

a Center of Neuropharmacology-Department of Pharmacological Sciences, University of Milano<br />

(Italy). b NEUROTEC Department, Division of Psychiatry, Karolinska Institutet, Stockholm,<br />

(Sweden)<br />

pag_dx.indd 1 30/05/2007 3.57.25


78. Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the<br />

treatment of depression: a new strategy to shorten the latency of antidepressant<br />

me<strong>di</strong>cation?<br />

Matrisciano Francesco a,b , Panaccione I. a , Zusso M. d , Giusti P. d , Tatarelli R. b , Caruso A. a ,<br />

Iacovelli L. a , Scaccianoce S. a , Mathé A.A. c , Gruber S.H. c , Melchiorri D. a , Girar<strong>di</strong> P. b ,<br />

F. Nicoletti a,e<br />

a Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”,<br />

Piazzale Aldo Moro, 5, 00185 Rome, Italy. b Department of Psychiatry and Psychological<br />

Me<strong>di</strong>cine, Sant’Andrea Hospital, University of Rome “La Sapienza”; c Karolinska Institute,<br />

Department of Clinical Neuroscience - Psychiatry, Karolinska University Hospital Hud<strong>di</strong>nge,<br />

Stockholm, Sweden; d Department of Pharmacology and Anesthesiology, University of Padova,<br />

Italy; e I.N.M. Neuromed, Pozzilli, Italy<br />

79. Modulation of pre-synaptic and post-synaptic proteins after prolonged treatment<br />

with antipsychotic drugs<br />

Frasca Angelisa 1 , Fumagalli F. 1 , Racagni G. 1 , Riva M.A. 1<br />

1 Center of Neuropharmacology, Department of Pharmacological Sciences University of Milan,<br />

Via Balzaretti 9, 20133 Milan (Italy)<br />

86<br />

80. Effect of typical and atypical antipsychotics on in vivo dopamine transmission in<br />

<strong>di</strong>fferent brain areas<br />

Ullu Laura M., Valentini V., Tanda G., De Luca M.A., Di Chiara G.<br />

Department of Toxicology, Centre of Excellence “Neurobiology of Ad<strong>di</strong>ction", University of<br />

Cagliari, Italy<br />

81. Agonist activity of N-Desmethylclozapine, a major clozapine metabolite, at delta<br />

opioid receptors<br />

Olianas Maria C., Dedoni S., Garau L., Onali P.L.<br />

Section of Biochemical Pharmacology, Department of Neuroscience, University of Cagliari,<br />

Cagliari, Italy<br />

82. Haloperidol both prevents and reverses quinpirole-induced non regulatory water<br />

intake, a putative animal model of psychogenic poly<strong>di</strong>psia<br />

Amato Davide 1 , Stasi Maria Antonietta 2 , Borsini Franco 2 , Nencini Paolo 1<br />

1 Department of Human Phisiology and Pharmachology, University of Rome Sapienza,<br />

2 Research and Development Division, sigma-tau Industrie Farmaceutiche Riunite SpA,<br />

Pomezia<br />

83. Different role of NMDA receptors in the rostral and caudal part of thalamic reticular<br />

nucleus in a rat model of absence epilepsy, the WAG/Rij rat<br />

Citraro Rita 1 , Marra R 2 ., Scicchitano F 1 ., Russo E 1 ., Ferreri Ibbadu G 1 ., De Sarro<br />

G 1 .<br />

1 Section of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine and Surgery, University of Catanzaro, Italy, 2 ISBAF CNR, Department of<br />

Pharmacology, Faculty of Pharmacy, University of Catanzaro, Catanzaro, Italy<br />

84. Effects of adenosine receptor agonists and antagonists administration on spikewave<br />

<strong>di</strong>scharge in a genetic model of generalized absence epilepsy<br />

Citraro Rita 1 , Ferreri G. 1 , Russo E. 1 , D’Auro M. 2 , Ciccarelli R. 2 , De Sarro G. 1<br />

1 Chair of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine and Surgery, University of Catanzaro, 2 Chair of Pharmacology, Faculty of Me<strong>di</strong>cine<br />

and Surgery, University of Chieti, Italy<br />

pag_sx.indd 1 30/05/2007 3.58.24


85. Effects of the focal administration of MGLU2/3 receptor ligands in selected brain<br />

areas of WAG/RIJ rat, a genetic animal model of absence of epilepsy<br />

1 De Sarro Giovambattista, 1 Citraro R., 2 Ngomba R., 1 Russo E., 2 Battaglia G.,<br />

2,3 Nicoletti F.<br />

1 Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of Me<strong>di</strong>cine and Surgery,<br />

University of Catanzaro, Catanzaro, Italy,<br />

2 I.N.M. Neuromed, 86077 Pozzilli, Italy,<br />

3 Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”, Italy<br />

86. Homocysteine induced an increase of absence seizures in the electrocographic<br />

pattern of WAG/Rij rat<br />

Ferreri Ibbadu Guido 1 , Citraro R. 1 , Marra R. 2 , Siniscalchi A. 1,3 , Russo E. 1 , De<br />

Sarro G. 1<br />

1 Section of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine and Surgery, University of Catanzaro, Italy, 2 ISBAF CNR, Department of<br />

Pharmacology, Faculty of Pharmacy, University of Catanzaro, Catanzaro, 3 Depatment of<br />

Neuroscience, Annunziata Hospital, Cosenza, Italy<br />

87. Effects of non-competitive AMPA receptor antagonists injected into some brain areas<br />

of WAG/Rij rats, an animal model of generalized absence epilepsy<br />

1 Ferreri I. Guido, 2 Palma E., 2 Marra R., 1 Citraro R., 1 Russo E., 1 Curinga C., 3 Gitto R., 3 Chimirri<br />

A, 1 De Sarro G.<br />

1 Section of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine and Surgery, University of Catanzaro. 2 National council of research institute of<br />

neurological science, Catanzaro. 3 Department of Me<strong>di</strong>cinal Chemistry, Faculty of Pharmacy,<br />

University of Messina, Italy<br />

88. Selective activation of metabotropic glutamate receptors subtype 4 enhances<br />

spontaneous and evoked absence seizures<br />

Santolini Ines 1,4 , Ngomba R. 1 , Biagioni F. 1 , Citraro R. 2 , Radura A. 3 , Battaglia G. 1 , Bruno V. 1,4 ,<br />

Ferraguti F. 5 , Van Luijtelaar G. 3 , De Sarro G. 2 , Nicoletti F. 1,4<br />

1 I.N.M. Neuromed, Pozzilli, Italy; 2 Dept. of Exp. & Clin. Med., Univ. of Catanzaro, Italy; 3 Dept.<br />

of Biol. Psychol., Univ. of Nijmegen, The Netherlands; 4 Dept. of Hum. Physiol. & Pharm., Univ.<br />

“La Sapienza”, Rome, Italy; 5 Dept. of Pharm., Univ. of Innsbruck, Austria<br />

87<br />

89. Prenatal ethanol exposure effects on MAP-kinases pathway in a genetic model of<br />

absence epilepsy: the WAG/RIJ rat<br />

1 Arbitrio Mariamena, 3 Costa N., 1 Vecchio I., 1 Marra R., 1 Iannone M., 1 Strongoli M.C., 2 Cuda G.,<br />

2 Casadonte R., 2 De Sarro G., 1,3 Rotiroti D<br />

1 National Council of Research Institute of Neurological Science-Catanzaro. 2 Department of<br />

Experimental and Clinical Me<strong>di</strong>cine, Faculty of Me<strong>di</strong>cine and Surgery-Catanzaro. 3 Chair of<br />

Pharmacology, Faculty of Pharmacy-Catanzaro<br />

90. Topiramate dose-dependently mo<strong>di</strong>fies slow inhibitory post synaptic potentials<br />

evoked in rat olfactory cortical neurones in in vitro<br />

1 Russo Emilio, 1 De Sarro G., 2 Constanti A.<br />

1 Chair of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine and Surgery, University of Catanzaro, Catanzaro, Italy; 2 Pharmacology Department,<br />

School of Pharmacy, University of London, London, UK<br />

91. Zonisamide induces a slow dose-dependent hyperpolarization in rat olfactory<br />

cortical neurones in vitro<br />

1 Russo Emilio, 1 Scarfone S., 1 De Sarro G.<br />

1 Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of Me<strong>di</strong>cine and Surgery,<br />

University of Catanzaro, Catanzaro, Italy<br />

pag_dx.indd 1 30/05/2007 4.02.38


92. Effects of nitric oxide influence on experimentally-induced hyperexcitability of the<br />

hippocampus: in vivo and in vitro comparative electrophysiological study in the rat<br />

Rizzo Valerio 1 , Ferraro G. 1 , Sardo P. 1 , Carletti F. 1 , D’Agostino S. 1 , La Grutta V. 1 , Cannizzaro<br />

G. 2<br />

1 Dip. Me<strong>di</strong>cina Sperimentale, Sez. Fisiologia umana, Università <strong>di</strong> Palermo, Italy. 2 Dip. Scienze<br />

Farmacologiche, Università <strong>di</strong> Palermo, Italy<br />

93. Changes in neuroactive steroids levels, GABA A receptor plasticity and sensitivity to<br />

anxiolytic drugs induced by neonatal exposure to estrogen<br />

Calza Arianna, Sogliano C., Marra C.,Paganelli P.,Santoru F., Angioni M.M.,Biggio G.,Concas A.<br />

Department of Experimental Biology and Centre of Excellence for the “Neurobiology of Drug<br />

Dependence”, University of Cagliari, Italy<br />

94. Subchronic administration of statins reduces plasma and brain content of<br />

neuroactive steroids<br />

1 Dore Riccardo, 4 Pisu M.G., 2 Muntoni S., 134 Serra M., 134 Biggio G.<br />

1 Department of Experimental Biology; 2 Department of Toxicology, Unit of Oncology and<br />

Molecular Pathology; 3 Center of Excellence for the Neurobiology of Dependence; 4 CNR<br />

Institute of Neuroscience, Section of Cagliari, University of Cagliari<br />

88<br />

95. Flumazenil-sensitive dose-related physical dependence in planarians produced by<br />

two benzo<strong>di</strong>azepine and one non-benzo<strong>di</strong>azepine benzo<strong>di</strong>azepine receptor agonists<br />

Cavallo Federica b , Raffa R. B. a , Capasso A. b<br />

a Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia,<br />

PA, USA, b Department of Pharmaceutical Sciences, University of Salerno, Salerno, Italy<br />

96. GABAergic drugs become neurotoxic in cortical neurons pre-esposed to<br />

brain_derived neurotrophic factor<br />

Molinaro Gemma 1 , Battaglia G. 1 , Riozzi B. 1 , Storto M. 1 , Fucile S. 1,2 , Eusebi F. 1,2 , Nicoletti F. 1,2<br />

Bruno V. 1,2<br />

1 Istituto Neurologico Me<strong>di</strong>terraneo Neuromed, Pozzilli, Italy; 2 Department of Human<br />

Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy<br />

97. Expression patterns of promoters for NPY Y1 and Y5 receptors in Y5RITTA and<br />

Y1RVENUS bac transgenic mice<br />

Longo Angela, Oberto A., Acquadro E., Busb T., Sprengel R., Eva C.<br />

Dipartimento <strong>di</strong> Anatomia, Farmacologia e Me<strong>di</strong>cina Legale; Sezione <strong>di</strong> Farmacologia,<br />

Università <strong>degli</strong> stu<strong>di</strong> <strong>di</strong> <strong>Torino</strong>. Department of Molecular Neurobiology Max Planck Institute<br />

for Me<strong>di</strong>cal Research, 69120, Heidelberg, Germany<br />

98. Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by<br />

fluctuations in the brain content of neuroactive steroids during ethanol withdrawal<br />

in mice<br />

Bertocchi Ilaria, Eva C., Mele P., Collura D., Pisu M.P., Serra M., Biggio G.<br />

Dip.Anatomia, Farmacologia e Med Leg, Sez. Farmacologia, Università <strong>di</strong> <strong>Torino</strong>, Italy; Dip<br />

Biol Sperimentale, Sez Neuroscienze, Università <strong>di</strong> Cagliari, Italy; Centro Ecc. Neurobiol.<br />

Dipendenza, Università <strong>di</strong> Cagliari, Italy; C.N.R. Ist. Neurosci, Neuropsicofarmac., Cagliari<br />

Farmacologia dei processi degenerativi<br />

Poster 99 – 124<br />

99. Sulforaphane inhibits 6-hydroxydopamine-induced apoptosis by upregulation of<br />

MEK/ERK and PI3K/AKT in human neuronal cells<br />

Tarozzi Andrea 1 , Morroni F. 1 , Merlicco A. 1 , Angeloni C. 2 , Hrelia S. 2 , Cantelli-Forti G. 1 , Hrelia P. 1<br />

1 Department of Pharmacology, 2 Department of Biochemistry "G. Moruzzi", Alma Mater<br />

<strong>Stu<strong>di</strong></strong>orum - University of Bologna, via Irnerio 48, 40126 Bologna<br />

pag_sx.indd 1 30/05/2007 4.05.37


100. Characterization of the antiparkinsonian effects of the new adenosine A 2A receptor<br />

antagonist ST1535: acute and subchronic stu<strong>di</strong>es in rats<br />

Tronci Elisabetta (1) , Simola N. (1) , Borsini F. (4) , Schintu N. (1) , Frau L. (1) , Carminati P. (4) , Morelli<br />

M. (1,2,3)<br />

(1) Department of Toxicology, (2) Centre of Excellence for Neurobiology of Dependence, (3) CNR<br />

Institute of Neuroscience, University of Cagliari, Italy, (4) Sigma-Tau Industrie Farmaceutiche<br />

Riunite S.p.A., Pomezia (Rome), Italy<br />

101. Evaluation of the neuroprotective effect of THE A 2A receptor antagonist SCH58261<br />

on the MPTP mouse model of Parkinson’s <strong>di</strong>sease<br />

Schintu Nicoletta, Carta A.R., Morelli M.<br />

Department of Toxicology, University of Cagliari, Italy<br />

102. Mitochondrial factors involved in Parkinson's <strong>di</strong>sease by MPTP toxycity in Macaca<br />

Fascicularis and drug effect<br />

Brera Francesca, Gorini A., Villa R.F.<br />

Dipartimento <strong>di</strong> Scienze Fisiologiche-Farmacologiche Cellulari-Molecolari Sezione <strong>di</strong><br />

Farmacologia e Biotecnologie Farmacologiche Piazza Botta, 11 - 27100 Pavia, Università <strong>degli</strong><br />

<strong>Stu<strong>di</strong></strong> <strong>di</strong> Pavia<br />

103. CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity<br />

Sgadò Paola, Viaggi C., Vaglini F., Par<strong>di</strong>ni C., Caramelli A., Corsini G.U.<br />

Department of Neuroscience, Section of Pharmacology, University of Pisa and Center of<br />

Excellence ‘AMBISEN’ for the study of Environmental Toxins and CNS Diseases, Pisa, Italy<br />

104. Behavioural characterization of engrailed mutant mice as model of Parkinson’s<br />

<strong>di</strong>sease<br />

Pontis Silvia 1 , Pinna A. 2 , Sgadò P. 3 , Corsini G.U. 3 , Morelli M. 1,2<br />

1 Department of Toxicology, University of Cagliari, Italy. 2 CNR Institute for Neuroscience,<br />

Cagliari, Italy. 3 Department of Neuroscience, Pisa, Italy<br />

89<br />

105. Low and high dyskinetic treatments induce <strong>di</strong>fferent motor responses and mRNA<br />

changes in Caudate-Putamen in the 6-OHDA rat model of Parkinson’ s <strong>di</strong>sease<br />

Frau Lucia 1 , Carta A. R. 1 , Pinna A. 2 , Pontis S. 1 , Morelli M. 1,2 .<br />

1 Department of Toxicology, University of Cagliari. 2 CNR, Institute of Neuroscience, Cagliari<br />

106. Blockade of pallidal adenosine A 2A receptors potentiates contralateral rotational<br />

behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats<br />

Simola Nicola a , Fenu S. a , Baral<strong>di</strong> P.G. b , Tabrizi M. A. b , Morelli M. a<br />

a Department of Toxicology and Centre of Excellence for Neurobiology of Dependence,<br />

University of Cagliari, Cagliari, Italy; b Department of Pharmaceutical Sciences, University of<br />

Ferrara, Ferrara, Italy<br />

107. Analysys of the MPP + uptake in mesencephalic cell cultures from CYP 2E1 Knock-out<br />

mice<br />

Caramelli Andrea, Par<strong>di</strong>ni C., Viaggi C., Vaglini F., Sgadò P., Corsini G.U.<br />

Dip. <strong>di</strong> Neuroscienze Sez. Farmacol. Università <strong>di</strong> Pisa<br />

108. Effects of <strong>di</strong>rect and in<strong>di</strong>rect cannabinoid receptor agonists on levodopa-induced<br />

dyskinesias ina rat model of Parkinson's <strong>di</strong>sease<br />

Morgese Maria Grazia 1,3 , Cassano T. 1 , Trabace L. 1 , Cuomo V. 2 , Giuffrida A. 3<br />

1 Department of Biome<strong>di</strong>cal Sciences, University of Foggia, Italy;<br />

2 Department of<br />

Pharmacology and General Physiology, University of Rome, ‘La Sapienza’, Italy; 3 Department<br />

of Pharmacology, University of Texas Health Science Center at San Antonio, Texas, U.S.A<br />

pag_dx.indd 1 30/05/2007 4.09.03


109. The nitric oxide-leleasing derivative of furbiprofen HCT1026 decreases vulnerability<br />

of nigrostriatal dopaminergic neurons to MPTP via a switch of glia proinflammatory<br />

phenotype: implications for treatment of Parkinson's <strong>di</strong>sease<br />

L’Episcopo Francesca 1 , Testa N. 1 , Caniglia S. 1 , Tirolo C. 1 , Giaquinta G. 1 , Arcieri P. 1 , Serra<br />

P.A. 2 , Bazzu G. 2 , Morale M. C. 1 , Impagnatiello F. 3 , Marchetti B. 1,2<br />

1 Neuropharmacology, OASI Institute Researc and Care (IRCCS) Troina (EN), Italy and<br />

2 Department of Pharmacology, University of Sassari, Me<strong>di</strong>cal School, Sassari, Italy, and<br />

3 Nicox Research Institute, Bresso, Milano, Italy<br />

110. Neuroinflammatory response in the acute MPTP rodent model of Parkinson's<br />

<strong>di</strong>sease: time-dependent correlation with histopathological, neurochemical and<br />

behavioral response to nigrostriatal injury and repair<br />

L’Episcopo Francesca 1 , Salani G. 2 , Serra P.A. 3 , Caniglia S. 1 , Tirolo C. 1 ,Giaquinta G. 1 , Testa<br />

N. 1 , Rocchitta G. 3 , Calia G. 3 , Manca A. 3 , Morale M.C. 1 , Pluchino S. 2 , Martino G. 3 , Marchetti<br />

B. 1,2<br />

1 Neuropharmacology, OASI Institute for Research and Care (IRCCS) Troina (EN), Italy<br />

2 Neuroimmunology Unit, Department of Neurology and Physiology, San Raffaele Scientific<br />

Institute, Milano, and 3 Dept. Pharmacology, University of Sassari Me<strong>di</strong>cal School, Sassari,<br />

Italy<br />

90<br />

111. S100B protein promoted tau protein hyperphosphorilation through DKK-1 protein<br />

up-regulation and relative WNT pathway <strong>di</strong>sruption in cultured human neurons<br />

Esposito Giuseppe 1 , Scuderi C. 1, 4 , De Filippis D. 2 , Iuvone T. 2 , Savani C. 1, 5 , Lu Jie 3 , Sheen<br />

Volney 3 , Steardo L. 1<br />

1 Department of Human Physiology and Pharmacology “Vittorio Erspamer”, University of Rome<br />

“La Sapienza” - 2 Department of Experimental Pharmacology, University of Naples Federico<br />

II.<br />

3 Department of Neurology, Beth Israel Deaconess Me<strong>di</strong>cal Center, Harvard Me<strong>di</strong>cal School,<br />

Boston<br />

4 Department of Pharmacological Sciences, University of Palermo. 5 Department of Human<br />

Physiology and Pharmacology, University of Bari<br />

112. Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor Grb2 and<br />

Modulate ERK1,2 Signaling<br />

Clau<strong>di</strong>o Russo 5 , Nizzari M., Venezia V. 1 , Repetto E. 1 , Corsi V. 2 , Magrassi R. 2 , Gagliani M.C. 3 ,<br />

Florio T. 1 , Schettini G. 1 , Tacchetti C. 3 , Russo T. 4 , Diaspro A. 2<br />

1 Dip. Oncologia, Biologia e Genetica, Università <strong>di</strong> Genova, 2 Dip. Fisica, Università <strong>di</strong> Genova,<br />

3 Dip.Me<strong>di</strong>cina Sperimentale, Università <strong>di</strong> Genova, 4 Dip.Biochimica, Università <strong>di</strong> Napoli<br />

Federico II, 5 Dip. Scienze per la Salute, Università del Molise<br />

113. Nitric oxyde and dopaminergic system: neurochemical interactions in -amyloid<br />

injected rats<br />

Schiavone Stefania (a) , Lanni C. (b) , Cuomo V. (c) , Trabace L. (a) , Govoni S. (b)<br />

(a) Dept. Biome<strong>di</strong>cal Sciences, University of Foggia, Foggia, Italy; (b) Dept. of Experimental<br />

and Applied Pharmacology, University of Pavia, Pavia, Italy; (c) Dept. of Human Physiology<br />

and Pharmacology, Vittorio Espamer, University of Rome La Sapienza, Rome, Italy<br />

114. Alterations of tau protein and effect of lithium salts treatment on TgCRND8 mice<br />

Rosi Maria Cristina, Grossi C., Fiorentini A., Luccarini I., Casamenti F.<br />

Department of Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy<br />

pag_sx.indd 1 30/05/2007 4.18.41


115. Long-term treatment with CHF5074, a novel gamma-secretase modulator, markedly<br />

reduces brain beta-amyloid in a transgenic mouse model of Alzheimer's <strong>di</strong>sease<br />

Imbimbo Bruno P. 1 , Del Giu<strong>di</strong>ce E. 2 , Miccichè F. 2 , Colavito D. 2 , D'Arrigo A. 2 , Dalle Carbonare<br />

M. 2 , Villetti G. 1 , Facchinetti F. 1 , Volta R. 1 , Pietrini V., 3 Baroc M. F. 3 , Leon A. 2<br />

1 Research & Development, Chiesi Farmaceutici, Via Palermo 26/A, 43100 Parma; 2 Research &<br />

Innovation, Via Svizzera 16, 35127 Padua; 3 Department of Neurosciences, Neurology Section,<br />

University of Parma, 43100 Parma<br />

116. Angiogenesis in neurodegenerative processes: loss of regulatory A function<br />

contributes to endothelial degeneration<br />

Donnini Sandra, Cantara S., Giachetti A., Ziche M.<br />

Pharmacology Section, Dept. Molecular Biology, University of Siena, Italy<br />

117. The BH4 domain of Bcl-xl counteracts beta amyloid peptide toxicity on capillary<br />

endothelium<br />

Solito Raffaella, Donnini S., Cantara S., Giochetti A., Ziche M.<br />

Section of Pharmacology, Department of Molecular Biology, University of Siena<br />

118. Mitochondrial dysfunctions in a transgenic murine model of Alzheimer's <strong>di</strong>sease<br />

1 Cassano Tommaso, 2 Servid<strong>di</strong>o G., 2 Bellanti F., 2 Tamborra R., 1 Macheda T., 1 Morgese M.G.,<br />

1 Trabace L., 3 Oddo S., 3 LaFerla F.M., 4 Cuomo V., 2 Vendemiale G.<br />

1 Dept. of Biochemical Sciences Univ. of Foggia, Italy; 2 Dept. of Me<strong>di</strong>cal and Occupational<br />

Sciences, Univ. of Foggia, Italy; 3 Dept. of Neurobiology and Behavior, Univ. of California,<br />

Irvine, U.S.; 4 Dept. of Human Physiology and Pharmacology, Univ. of Rome “La Sapienza”,<br />

Italy<br />

119. Glia me<strong>di</strong>ates neuroprotection by estrogen against ß-amyloid toxicity: effect<br />

amplified by estrogen receptor overexpression<br />

Carbonaro Viviana 1 , Frasca G. 1 , Merlo S. 1 , Caraci F. 2 , Copani A. 2 , Sortino M.A. 2<br />

Departments of 1 Experimental and Clinical Pharmacology and 2 Pharmaceutical Sciences,<br />

University of Catania<br />

91<br />

120. Cannabi<strong>di</strong>ol in vivo suppresses A induced reactive gliosis<br />

Scuderi Caterina 1,2 , Esposito G. 1 , Savani C. 1,4 , De Filippis D. 2 , Iuvone T. 2 , Steardo L. 1<br />

1 Department of Human Physiology and Pharmacology “Vittorio Erspamer”, University of Rome<br />

“La Sapienza” -<br />

2 Department of Pharmacological Sciences, University of Palermo.<br />

3 Department of Experimental Pharmacology, University of Naples Federico II. 4 Department of<br />

Human Physiology and Pharmacology, University of Bari<br />

121. In vivo characterization of DKK-1 expression in transgenic animal models of<br />

Alzheimer's <strong>di</strong>sease<br />

Fiorentini Anna, Rosi M. C., Luccarini I., Grossi C., Casamenti F.<br />

Department of Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy<br />

122. in vivo effect of Clioquinol treatment in a mouse model of Alzheimer’s <strong>di</strong>sease<br />

Grossi Cristina, Rosi M. C., Fiorentini A., Luccarini I. , Casamenti F.<br />

Department of Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy<br />

123. Long-term treatment with a new anti-oligomeric beta-amyloid vaccine markedly<br />

reduces brain beta-amyloid load in a transgenic mouse model of Alzheimer's <strong>di</strong>sease<br />

Imbimbo Bruno P. 1 , Pietrini V., 2 Baroc M.F. 2 , Del Giu<strong>di</strong>ce E. 3 , Miccichè F. 3 , Colavito D. 3 ,<br />

D'Arrigo A. 3 , Dalle Carbonare M. 3 , Leon A. 3 , Villetti G. 1 , Facchinetti F. 1 , Moretto N. 4 , Ottonello<br />

S. 4<br />

1 Chiesi Farmaceutici, Via Palermo 26/A, Parma; 2 Department of Neurosciences, University of<br />

Parma, Parma; 3 Research & Innovation, Via Svizzera 16, Padua; 4 Department of Biochemistry<br />

and Molecular Biology, University of Parma, Viale G.P. Usberti 23/A, Parma<br />

pag_dx.indd 1 30/05/2007 4.20.22


124. Discovery of a series of molecules acting as potent alpha7 nAChR agonists with procognitive<br />

and neuroprotective properties<br />

Scali Carla 1 , Gianfriddo M. 1 , Bothmann H. 1 , Diodato E. 1 , Zanelli U. 1 , Caricasole A. 1 ,<br />

Gaviraghi G. 1 , Dunlop J. 2 , Roncarati R. 1 , Terstappen G.C. 1<br />

1 Siena Biotech SpA, Siena, ITALY, 2 Wyeth Research, Princeton, NJ, USA<br />

Farmacologia del dolore<br />

Poster 125 – 135<br />

125. Periaqueductal grey metabotropic glutamate receptor subtype 7 and 8 show<br />

opposite actions on amino acid release, nociceptive behaviour and rostral<br />

ventrome<strong>di</strong>al medulla ON and OFF cell activity<br />

Marabese Ida, Rossi F., Palazzo E., Vita D., Scafuro M.A., De Novellis V., Maione S.<br />

Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology “L. Donatelli”, The Second<br />

University of Naples, via Costantinopoli 16, 80138 Naples<br />

126. Role of the type 2 and 3 inositol 1,4,5-trisphosphate receptor in muscarinic<br />

antinociception in mice<br />

Vivoli Elisa, Galeotti N., Norcini M., Ghelar<strong>di</strong>ni C., Bartolini A.<br />

Department of Pharmacology – Viale G. Pieraccini, 6, 50139 – Florence<br />

92<br />

127. Involvment of type 1 and 3 ryano<strong>di</strong>ne receptor in mouse muscarinic antinociception<br />

Norcini Monica, Galeotti N., Vivoli E., Ghelar<strong>di</strong>ni, C., Bartolini A.<br />

Department of Pharmacology – Viale G. Pieraccini, 6, 50139 – Florence<br />

128. Detection and quantification of endogenous N/OFQ in the rat cerebrospinal fluid,<br />

under basal and stimulated con<strong>di</strong>tions<br />

Lopetuso Giuseppe, Romual<strong>di</strong> P., Candeletti S.<br />

Dip. Farmacologia - Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Bologna<br />

129. Impaired nociception in mice lacking the prokineticin receptor 2 (PKR2)<br />

Lattanzi Roberta, Giannini E., Melchiorri P., Negri L.<br />

Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”, Italy<br />

130. The central antinociceptive effect of N-arachidonoyl-phenolamine (AM404):<br />

implication of opioidergic and serotonergic systems<br />

Ruggieri Valentina a , Vitale G. a , Pini L. A. b , Sandrini M. a<br />

a Sect. of Pharmacology, Dept. of Biome<strong>di</strong>cal Sciences, University of Modena and Reggio E. b<br />

Clinical Pharmacology Unit, University of Modena and Reggio E<br />

131. 2-chloro-2’-C-methyl-N 6 -cyclopentyladenosine, a highly selective adenosine A1<br />

receptor agonist, has antinociceptive activity in the rat<br />

Gatta Luisa, Palazzo E., De Novellis V., Rossi F., Vita D., Maione S.<br />

Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology “L. Donatelli”, The Second<br />

University of Naples, via Costantinopoli 16, 80138 Naples<br />

132. 2-chloro-2’-C-methyl-N 6 -cyclopentyladenosine, a highly selective adenosine A1<br />

receptor agonist, modulates the ongoing and tail flick -related activity of RVM on<br />

and off cells<br />

Guida Francesca, Rossi F., Vita D., Marabese I., De Novellis V., Maione S.<br />

Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology “L. Donatelli”, The Second<br />

University of Naples, via Costantinopoli 16, 80138 Naples<br />

pag_sx.indd 1 30/05/2007 4.21.22


133. NGF-induced neurite outgrowth inhibition and pain control<br />

Restivo Alessandra, Salvati P., Caccia C.,<br />

Discovery, Newron Pharmaceuticals SpA, Bresso (MI), Italy<br />

134. Analgesic effects of new piridazione derivatives<br />

Pieretti Stefano 1 , Colucci M. 1 , Di Giannuario A. 1 , Maione F. 1,2 , Giovannoni M.P. 3 , Biancalani C. 3<br />

Dal Piaz V. 3<br />

1 Department of Drug Research and Evaluation, Italian National Institute of Health, Rome;<br />

2 Department of Experimental Pharmacology, University of Naples, “Federico II”; 3 Department<br />

of Pharmaceutical Sciences, University of Florence<br />

135. The protective effect of Olive oil phenols hydroxytyrosol and oleuropein on<br />

morphine tolerance<br />

Muscoli Carolina 1,2 , Procopio A. 1 , Vetrice D. 1 , Oliverio M. 1 , Arbitrio M. 3 , Rizzo M. 1 , Costa N. 1 ,<br />

Arcone R. 1 , Giovanni S. 4 , Rotiroti D. 1 , Nistico’ G. 5 , Salvemini D. 6 , Mollace V. 1<br />

1 Dept. of Pharmacobiol. Sciences, University of Catanzaro Magna Graecia, Italy; 2 San Raffaele<br />

Pisana IRCCS, Rome, Italy; 3 ISN-CNR; 4 Dept. of Chemistry, University of Calabria, Italy;<br />

5 Dept. of Biology, Univerity of “Tor Vergata”, Italy; 6 Dept. of Int. Med, Division of Pulmonary,<br />

Critical Care and Sleep Me<strong>di</strong>cine, Saint Louis University, St Louis, USA<br />

Farmacologia e tossicologia del comportamento<br />

Poster 136 – 150<br />

136. Neuropeptide S stimulates locomotor activity and wakefulness and evokes<br />

anxiolytic-like effects in mice<br />

1 Vergura Raffaella, 1 Rizzi A., 1 Marzola G., 2 Guerrini R., 2 Salvadori S., 1 Regoli D. 1 Calo’ G.<br />

1 Dept. of Pharmacology and 2 Dept of Pharmaceutical Science, University of Ferrara, Italy<br />

93<br />

137. Repeated restraint stress and anxiolytic drugs <strong>di</strong>fferentially modulate latent<br />

inhibition in C57BL6 mice<br />

Marcello Stefania a , Mongeau R. b , Andersen J. S. c , Pani L. d,a<br />

a Neuroscienze Pharmaness S.c.a.r.l., Cagliari.<br />

b NeuroPsychoPharmacologie, Faculté de<br />

Médecine Pitié-Salpêtrière, Paris, France. c Tofla Teld, Copenhagen, Denmark. d Istitute of<br />

Biome<strong>di</strong>cal Technologies, C.N.R., Milano<br />

138. Central administration of neuropeptide S (NPS) inhibits palatable food intake in the<br />

rat<br />

Fedeli Amalia, Economidou D., Braconi S., Cippitelli A., Massi M., Ciccocioppo R.<br />

Department of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, Italy<br />

139. Quinpirole-induced compulsive drinking in rats is influenced by manipulation of<br />

behavioral cost<br />

Milella Michele S., Amato D., Ba<strong>di</strong>ani A., Nencini P.<br />

Department of Human Phisiology and Pharmachology, University of Rome Sapienza<br />

140. Disturbances of eating behavior during workplace suffering<br />

Milano Walter, Petrella C., Capasso A.*.<br />

Mental Health Operations Unit District 44 ASL Napoli 1 and *Department of Pharmaceutical<br />

Sciences, University of Salerno, Italy<br />

pag_dx.indd 1 30/05/2007 4.22.34


141. Effects of systemic MPTP administration on behavior and dopamine changes in<br />

<strong>di</strong>alysate from the striatum of freely moving mice<br />

Manca Antonio a , Bazzu G. a , Calia G. a , Puggioni G. a , Rocchitta G. a , Dedola S. a , Migheli R. a ,<br />

Serra P.A. a<br />

a Department of Pharmacology, Me<strong>di</strong>cal School, University of Sassari, Viale S. Pietro 43/b,<br />

07100, Sassari, Italy<br />

142. Role of dopamine D2-like receptors in the microstructure of licking for water and<br />

so<strong>di</strong>um chloride solutions in water deprived rats<br />

D'Aquila Paolo S., Carta D., Casula M.G., Dore B., Murgia E., Serra G.<br />

Department of Drug Sciences, University of Sassari, Sassari, Italy<br />

143. Single, intense prenatal stress can <strong>di</strong>fferently affect emotional behavioUr accor<strong>di</strong>ng<br />

to the nature of the task. Influence of metyrapone<br />

Noto Giovanna, Plescia F., Cannizzaro E., Gagliano M., Provenzano G.M., Cannizzaro C.<br />

Department of Pharmacological Sciences, University of Palermo, Italy<br />

144. Manipulations of glucocorticoid induced stress response may <strong>di</strong>fferently affect the<br />

acquisition of a reward-facilitated spatial/visual learning task<br />

Barrile Vita, Plescia F., Cannizzaro G., La Barbera M., Mantia G. , Cannizzaro C.<br />

Department of Pharmacological Sciences, University of Palermo<br />

94<br />

145. Behavioural effects induced by chronic treatment with Epigallocatechin gallate<br />

(EGCG), the major catechin of green tea, in spontaneously hypertensive rat (SHR)<br />

Lemoli Mariangela, Montagnani M. , De Salvia M. A.<br />

Dept. Pharmacology and Human Physiology, Me<strong>di</strong>cal School, University of Bari, Piazza G.<br />

Cesare, 70124 Bari, Italy<br />

146. Impact of antipsychotic treatments of behavioral alterations induced by paradoxical<br />

sleep deprivation<br />

Frau Roberto 1 , Orrù M. 1 , Mereu G. 3 , Gessa G. L.i 1 , Marrosu F. 2 Bortolato M. 2<br />

1 Dept. of Neuroscience “Bernard B. Bro<strong>di</strong>e”. University of Cagliari, Cagliari, Italy<br />

2 Dept. of Car<strong>di</strong>ovascular and Neurological Science. University of Cagliari, Cagliari, Italy<br />

3 Dept. of Experimental Biology “B. Loddo”. University of Cagliari, Cagliari, Italy<br />

147. Role of GABAB receptors in the balance of epileptic and psychotic-like phenomena in<br />

DBA/2J mice<br />

Bortolato Marco 1 , Frau R. 2 , Orrù M. 2 , Piras A. P. 2 , Gessa G. L.i 2 , Castelli M.P. 2 , Mereu G. 3 ,<br />

Marrosu F. 1<br />

1 Dept. of Car<strong>di</strong>ovascular and Neurological Science. University of Cagliari, Cagliari, Italy<br />

2 Dept. of Neuroscience “Bernard B. Bro<strong>di</strong>e”. University of Cagliari, Cagliari, Italy<br />

3 Dept. of Experimental Biology “B.Loddo”. University of Cagliari, Cagliari, Italy<br />

148. Training-associated emotional arousal <strong>di</strong>fferentially modulates cannabinoid effects<br />

on object recognition memory<br />

Campolongo Patrizia 1-2 , Scaccianoce S. 1 , Modafferi A. 1 , Trezza V. 1 , Roozendaal B. 3 , Schelling<br />

G. 4 , McGaugh J.L. 3 , Cuomo V. 1<br />

1 Dept. of Human Physiology and Pharmacology, Univ. of Rome “La Sapienza”, Rome, Italy;<br />

2 Dept. of Biochemical Sciences, Univ. of Foggia, Foggia, Italy; 3 Center for the Neurobiology of<br />

Learning and Memory, Univ. of California, Irvine, USA; 4 Dept. of Anaesthesiology, Ludwig-<br />

Maximilians-University, Munich, Germany<br />

pag_sx.indd 1 30/05/2007 4.23.55


149. Gender-related effects of PREGS on emotionality, learning and memory performance<br />

in adult rats<br />

Diliberto Irene, Plescia F., Cannizzaro G., Mantia G., Provenzano G. M., Cannizzaro C.<br />

Department of Pharmacological Sciences, University of Palermo<br />

150. Use of Energy drinks in association with alcoholic beverages in a cohort of students<br />

of the School of Me<strong>di</strong>cine of the University of Messina<br />

Oteri Alessandro, Salvo F., Caputi A.P., Calapai G.<br />

Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina<br />

Sostanze d'abuso<br />

Poster 151 – 173<br />

151. Gamma hydroxybutirate (GHB) modulates NPY-Y1 receptor signalling in the<br />

amygdala of transgenic mice through GABA B receptor in a neurosteroids<br />

independent manner<br />

Mele P. a , Serra M. b,c,d , Pisu M.G. b,d , Eva C. a , Biggio G b,c,d .<br />

a Dep. Of Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine, Section of Pharmacology, University<br />

of Turin, Italy. b Dep. of Experimental Biology, Sec. of Neuroscience, University of Cagliari,<br />

Cagliari, Italy. c Center of Excellence for the Neurobiology of Dependence, University of<br />

Cagliari, Cagliari, Italy. d C.N.R. Institute of Neuroscience, Cagliari, Italy<br />

152. Mapping brain activity following gamma-hydroxybutyric acid administration using<br />

functional magnetic resonance imaging in rats<br />

Muntoni Anna Lisa 1 , Lu Hanbing 2 , Scholl C. A. 2 , Pistis M. 3 , Stein E.A. 2<br />

1 CNR Institute of Neuroscience and 3 Department of Neuroscience, University of Cagliari, Italy<br />

2 Neuroimaging Research Branch, National Institute on Drug Abuse, NIH, Baltimore, USA<br />

95<br />

153. Endocannabinoid system and nicotine withdrawal signs in mice<br />

Mannucci Carmen a , Pieratti A. a , Russo G. a , Caputi A. P. a , Calapai G. a<br />

a Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Section of<br />

Pharmacology, School of Me<strong>di</strong>cine, University of Messina, Italy<br />

154. Smoking cessation after the introduction of the law banning smoking in public<br />

places in Italy: a one-year follow-up study<br />

Grassi Maria Caterina*, Enea D.**, Nencini P.*<br />

*Department of Human Physiology and Pharmacology “V. Erspamer”. **Centro Policlinico<br />

Senza Fumo, “Sapienza” University of Rome, Italy<br />

155. Smoking cessation and body weight<br />

Grassi Maria Caterina*, Enea D.**, Marchetti R.**, Temperilli F.***, Villarosa F.***,<br />

Nencini P.*, Cuzzolaro M.***<br />

*Department of Human Physiology “V.Erspamer”, **Centro Policlinico Senza Fumo,<br />

***Department of Clinical Me<strong>di</strong>cine, “Sapienza” University of Rome, Italy<br />

156. Preliminary results in pivotal study on biomarkers related to smoking habits<br />

Calapai Gioacchino a , Moran<strong>di</strong> S. b , Mannucci C. a , Nunziata A. b , Caputi A. a , Bassi A. b<br />

a Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina -<br />

b BAT Italia S.p.A. R&D Via Amsterdam147, Rome<br />

157. Altered expression of metabotropic glutamate receptors in the nucleus accumbens<br />

during opiate dependence and withdrawal in the rat<br />

Modafferi Antonella M.E 1 ., Diana M. 2 , Scaccianoce S. 1<br />

1 Dept. of Human Physiology and Pharmacology - University of Rome La Sapienza; 2 Dept. of<br />

Drug Sciences - University of Sassari<br />

pag_dx.indd 1 30/05/2007 4.25.15


158. Time-dependent morphological and biochemical changes during morphine<br />

withdrawal in the rat nucleus accumbens<br />

Vinci Stefania 1 , Marinelli A. 2 , Olla A. 2 , Ibba F. 1 , Diana M. 3 , Spiga S. 2 , Acquas E. 1,4<br />

1 Department of Toxicology and 4 Centre of Excellence on Neurobiology of Ad<strong>di</strong>ction, University<br />

of Cagliari; 2 Department of Animal Biology and Ecology, University of Cagliari; 3 Department of<br />

Drug Sciences , University of Sassari<br />

159. Reciprocal effects of response contingent and non-contingent intravenous heroin on<br />

in vivo nucleus accumbens shell versus core dopamine: a repeated sampling<br />

micro<strong>di</strong>alysis study<br />

Cacciapaglia Fabio 1 , Lecca D. 1,2 , Valentini V. 1,2 , Di Chiara G. 1,2,3<br />

1 Department of Toxicology, 2 Centre of Excellence for <strong>Stu<strong>di</strong></strong>es on Ad<strong>di</strong>ctions and 3 Institute of<br />

Neuroscience, Consiglio Nazionale delle Ricerche (CNR), University of Cagliari, Italy<br />

160. Role of dopamine D 1 receptor in morphine- and lithium-induced con<strong>di</strong>tioned<br />

saccharin avoidance<br />

Simola Nicola, Fenu S., Rivas E., Di Chiara G.<br />

Department of Toxicology and Centre of Excellence for Neurobiology of Dependence,<br />

University of Cagliari, Cagliari, Italy<br />

96<br />

161. Dissociation in the modulatory effects of environment on heroin-induced<br />

psychomotor sensitization vs. heroin self-administration<br />

Celentano Michele, Caprioli D., Nencini P., Ba<strong>di</strong>ani A.<br />

Department of Human Physiology and Pharmacology, University of Rome Sapienza<br />

162. Methadone and buprenorphine maintenance effects on immune system function:<br />

comparison with untreated heroin ad<strong>di</strong>ctcs<br />

Somaini Lorenzo 1 , Franchi S. 2 , Leccese V. 1 , Gerra G. 3 , Panerai A. E 2 , Sacerdote P. 2<br />

1 Ad<strong>di</strong>ction Treatment Centre, Health Local Unit ASL 12 Biella. 2 Department of Pharmacology,<br />

via Vanvitelli 32, 20129 Milano. 3 Health Local Unit AUSL Parma<br />

163. The role of liver cytochrome isoforms on buprenorphine metabolism and it’s clinical<br />

relevance<br />

Somaini Lorenzo 1 , Gola M. 2<br />

1 2<br />

Ad<strong>di</strong>ction Treatment Centre, Health Local Unit ASL 12 Biella. Laboratory of<br />

Pharmacogenetics Lugano (CH)<br />

164. Anabolic androgenic steroids influence the expression of brain nerve growth factor<br />

in the rat<br />

Carretta Maria Teresa*, D’Amico D.*, Pace S., Modafferi A. M.E., Salemi M., Togna G.I.,<br />

Scaccianoce S.<br />

Dept. of Human Physiology and Pharmacology - University of Rome La Sapienza<br />

165. Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic<br />

neuronal death in mixed mouse cortical cultures<br />

Orlando Rosamaria 1* , Caruso A. 1* , Molinaro G. 2 , Motolese M. 1 , Matrisciano F. 1 , Togna G. 1 ,<br />

Melchiorri D. 1 , Nicoletti F. 1,2 , Bruno V. 1,2<br />

1 Istituto Neurologico Me<strong>di</strong>terraneo Neuromed, Pozzilli, Italy; 2 Department of Human<br />

Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy<br />

166. Effect of nandrolone and stanozolol on pro-inflammatory cytokine production by<br />

human macrophages<br />

Trefiletti Giuliana*, Togna A.R.*, Pacifici R.**, Bacosi A.**, Di Carlo S.** Togna G.I.*<br />

* Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”<br />

**Department of Therapeutic Research and Me<strong>di</strong>cines Evaluation, Istituto Superiore <strong>di</strong> Sanità,<br />

Rome<br />

pag_sx.indd 1 30/05/2007 4.27.01


167. The K-Opioid receptor agonist U-69593 prevents cocaine-induced DARPP-32<br />

phosphorylation at THR34 in the rat brain<br />

D´Addario Clau<strong>di</strong>o, Di Benedetto M., Candeletti S., Romual<strong>di</strong> P.<br />

Dept of Pharmacology - University of Bologna - via Irnerio 48, 40126 BOLOGNA<br />

168. Facilitation of con<strong>di</strong>tioned reinstatement of cocaine-seeking following central<br />

administration of neuropeptide S<br />

Kallupi Marsida, Economidou D., Cannella N., Stopponi S., Ciccocioppo R.<br />

Department of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, Italy<br />

169. Environmental modulation of cocaine and amphetamine seld administration<br />

Caprioli Daniele, Celentano M., Nencini P., Ba<strong>di</strong>ani A.<br />

Department of Human Physiology and Pharmacology, University of Rome La Sapienza<br />

170. Increased toxicity of cocaine adulterated with atropine: efficacy of <strong>di</strong>azepam<br />

Zani Alessia, Braida D., Rossoni G., Gori E. a , Capurro V., Sala M.<br />

Department of Pharmacology, Chemotherapy and Me<strong>di</strong>cal Toxicology, and a Behavioural<br />

Pharmacology and Drug Dependence Center, University of Milan, Via Vanvitelli 32, 20129,<br />

Milan, Italy<br />

171. Role of CREB in the prodynorphin gene expression regulation by MDMA<br />

Di Benedetto Manuela, Porticella E, D´Addario C, Candeletti S, Romual<strong>di</strong> P<br />

Dept of Pharmacology - University of Bologna - via Irnerio 48, 40126 BOLOGNA<br />

172. 3,4-methylen<strong>di</strong>oxymethamphetamine (ecstasy) induces formation of reactive<br />

oxygen species and tau protein phosphorilation in the hippocampus<br />

Busceti Carla L. 1 , Biagioni F. 1 , Riozzi B. 1 , Storto M. 1 , Battaglia G. 1 , Fornai F. 1,3 Bruno V. 1,5 ,<br />

Nicoletti F. 1,5<br />

1 I.N.M. Neuromed, Pozzilli, Italy; 2 Dept. of Neuropathol., Univ. of Amsterdam, The<br />

Netherland; 3 Dept. of Hum. Morphol. and Applied Biol., Univ. of Pisa, Italy; 4 SienaBiotech,<br />

Siena, Italy; 5 Dept. of Hum. Physiol. and Pharmacol., Univ. “La Sapienza”, Rome, Italy<br />

97<br />

173. Pharmacological and toxicological properties of Smart Drugs<br />

Oteri A. a , Calapai G. a , Pichini S. b , Zuccaro P. b , Palmi I. b , Caputi A.P. a,c<br />

a Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina<br />

b Istituto Superiore <strong>di</strong> Sanità, Rome. c IRCCS Centro Neurolesi ‘‘Bonino-Pulejo’’, Messina, Italy<br />

Faramacologia dell'apparato <strong>di</strong>gerente<br />

Poster 174 – 186<br />

174. Inhibitory modulation of the non-adrenergic non-cholinergic relaxation of the rat<br />

gastric fundus by nociceptin/orphanin FQ and related peptides<br />

Currò Diego, De Marco T., Martucci D., Preziosi P.<br />

Institute of Pharmacology, School of Me<strong>di</strong>cine, Catholic University of the Sacred Heart, Rome,<br />

Italy<br />

175. Nociceptin/orphanin FQ prevents gastric damage induced by acute stress in the rat<br />

by acting in the periphery<br />

Morini Giuseppina a , Gran<strong>di</strong> D. a , Solinghi E. a , Guerrini R. b , Polidori C. c , Massi M. c<br />

a Department of Human Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine, University of Parma,<br />

PARMA; b Department of Pharmaceutical Sciences and Biotechnology Center, University of<br />

Ferrara, Ferrara; c Department of Experimental Me<strong>di</strong>cine and Public Health, University of<br />

Camerino, Camerino, Italy<br />

pag_dx.indd 1 30/05/2007 4.27.57


176. Gastroprotective effects of the selective histamine H 3 receptor agonists methimepip<br />

and immethri<strong>di</strong>ne<br />

1 Adami Maristella, 1 Guaita E., 2 De Esch I.J.P., 2 Leurs R., 3 Stark H., 1 Coruzzi G.<br />

1 Department of Human Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine, University of Parma,<br />

Italy; 2 LACDR, Department of Me<strong>di</strong>cinal Chemistry, Vrije Universiteit Amsterdam, The<br />

Netherlands; 3 Institut für Pharmazeutische Chemie, J W Goethe-Universität, Frankfurt,<br />

Germany<br />

177. The gastric effect of UFP 112, a new NOP receptor agonist, in physiologiacl and<br />

pathological con<strong>di</strong>tions<br />

Petrella Carla a , Agostini S. a , Broccardo M. a , Guerrini R. b , Improta G. a , Morini G. c<br />

a Dept. Human Physiology and Pharmacology University of Rome “La Sapienza”, b Dept.<br />

Pharmaceutical Sciences and Biotechnology Center, University of Ferrara, c Dept. of Human<br />

Anatomy, Pharmacology and Forensis Me<strong>di</strong>cine, University of Parma –ITALY<br />

178. Effects of cyclooxygenase inhibitors on molecular mechanisms implicatd in gastric<br />

ulcer healing<br />

Colucci Rocchina 1 , Ghisu N. 1 , Antonioli L. 1 , Fornai M. 1 , Bernar<strong>di</strong>ni N. 2 , Ippolito C. 2 , Natale G. 2 ,<br />

Del Tacca M. 1 , Blan<strong>di</strong>zzi C. 1<br />

1 Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, 2 Department<br />

of Human Morphology and Applied Biology, University of Pisa, Italy<br />

98<br />

179. Dual effects of ticlopi<strong>di</strong>ne during formation and healing of ethanol-induced gastric<br />

lesions in the rat: comparison with aspirin<br />

Rapetti D. 1 , Guidobono F. 2 , Soglian A. 3 , Locatelli V. 1 , De Luca V. 2 , Sibilia V. 2<br />

1 Department of Experimental Me<strong>di</strong>cine, University of Milano- Bicocca, Monza, Italy<br />

2 Department of Pharmacology, Chemotherapy and Me<strong>di</strong>cal Tossicology, University of Milan,<br />

Italy<br />

3 Me<strong>di</strong>cal Department, Pharmaceutical Division, Bayer HealthCare, Milan, Italy<br />

180. Involvement of PKC in the adaptive changes of opioid receptos in the myenteric<br />

plexus after chronic sympathetic denervation<br />

1 Zanetti Elena, 1 Oldrini R., 2 Pascale A., 1 Canciani L., 1 Giuliani D., 2 Ama<strong>di</strong>o M., 3 Chiaravalli A.,<br />

1 Giaroni C., 1 Lecchini S., 1 Frigo G.<br />

1 Clinical and Applied Pharmacology Interuniversity Centre, University of Insubria and<br />

University of Pavia; 2 Experimental and Applied Pharmacology Dept, University of Pavia; 3 Dept.<br />

of Surgical Pathology Ospedale <strong>di</strong> Circolo of Varese<br />

181. Altered expression and phosphorylation of NMDA NR1 subunits in the myenteric<br />

plexus during hypoxia-hypoglicaemia<br />

1 Giaroni Cristina, 1 Zanetti E., 1 Giuliani D., 1 Oldrini R., 1 Bianchi F., 1 Moro E., 2 Trinchera M.,<br />

1 Crema F., 1 Lecchini S., 1 Frigo G.<br />

1 Clinical and Applied Pharmacology Interuniversity Centre, Universities of Insubria and Pavia,<br />

2 Department of Experimental and Clinical Biome<strong>di</strong>cal Sciences, University of Insubria<br />

182. Melatonin reverses LPS-induced gastro-intestinal motility <strong>di</strong>sturbances through the<br />

inhibition of oxidative stress<br />

De Filippis Daniele 1 , Esposito G. 3 , D’Amico A. 1 , De Man J.G. 2 , De Winter B.Y. 2 , Steardo L. 3 ,<br />

Iuvone T. 1<br />

1<br />

Department of Experimental Pharmacology, Faculty of Pharmacy, University of Naples<br />

Federico II, Via D. Montesano 49, 80131 Naples, Italy. 2 Division of Gastroenterology, Faculty<br />

of Me<strong>di</strong>cine, University of Antwerp, Universiteitsplein 1, B-2610 Antwerp, Belgium.<br />

3 Department of Human Physiology and Pharmacology “Vittorio Erspamer”Faculty of Pharmacy<br />

University of Rome “La Sapienza” Piazza A. Moro 5, 00151 Roma (Italy)<br />

pag_sx.indd 1 30/05/2007 4.29.17


183. The cannabinoid WIN 55212 inhibits pancreatic amylase secretion via cholinergic<br />

suppression<br />

Agostini Simona, Broccardo M., Improta G., Petrella C., Linari G.<br />

Dept. of Human Physiology and Pharmacology. University “La Sapienza”, Rome<br />

184. Sera of celiac patients with neurological <strong>di</strong>sorders evoke a mitochondrial-dependent<br />

apoptosis in human SH-Sy5Y neuroblastoma cells<br />

Cervio Elisabetta*, Volta U.°, Verri M.*, Boschi F.*, Pastoris O.*, Granito A.°, De Giorgio R.^,<br />

Tonini M.*<br />

*Dept of Phys & Pharm Sci, Univ Pavia; Dept of °Int Med, Car<strong>di</strong>oangiol, Hepatol & ^Int Med &<br />

Gastroenterol, Univ of Bologna, Italy<br />

185. Expression and function of the bradykinin B1 receptor in normal and inflamed<br />

human gallbladder<br />

Andre Eunice 1 , Gazzieri D. 1 , Bardella E. 1 , Ferreira J. 3 , Mori M.A. 4 , Bader M. 4 , João B.C. 5 , De<br />

Giorgio R. 6 , Corinaldesi R. 6 , Geppetti P. 1 , Trevisani M. 1<br />

1 Pharmacology Unit, University of Ferrara, 3 Dep. of Chemistry, Universidade Federal de Santa<br />

Maria, 4 Max Delbrück Center for Molecular Me<strong>di</strong>cine, Berlin-Buch, 5 Dep. of Pharmacology,<br />

Universidade Federal de Santa Catarina, Florianópolis, 6 Dep. Int. Med. and Gastroent.,<br />

University of Bologna<br />

186. A community pharmacies survey on prevalence of constipation and risk factors for<br />

laxative use in the local health <strong>di</strong>stricts of Verbania and Messina<br />

Morreale Ilaria (1) , Salvo F. (1) , Polimeni G. (1) , Vighi E. (2) , Poggi L. (2) , Dossi G. (2) , Rossitto<br />

A. (3) , De Sarro A. (1) , Calapai G. (1) , Caputi A.P. (1)<br />

(1) Dep. Clin Experim Med and Pharmacol, University of Messina, Italy. (2) Local Health District<br />

N. 14 (Verbano/Cusino/Ossola), Verbania, Italy<br />

99<br />

Farmacologia del metabolismo e del sistema endocrino<br />

Poster 187 – 195<br />

187. Exenatide achieved equivalent glycemic control to insulin glargine with weight<br />

reduction, independently from baseline BMI, in metformin and sulfonylurea-treated<br />

type-2 <strong>di</strong>abetes<br />

Gentilella Raffaella 4 ; Heine R.J. 1 ; Van Gaal L.F. 2 ; Johns D. 3 ; Mihm .J. 3 ; Widel M.H. 3 ; Brodows<br />

R.G. 3<br />

1 Diabetes Center, Department of Endocrinology, VU University Me<strong>di</strong>cal Center, Amsterdam,<br />

The Netherlands; 2 Department of Diabetology, Metabolism and Clinical Nutrition, Faculty of<br />

Me<strong>di</strong>cine, University Hospital Antwerp, Belgium; 3 Lilly Research Laboratories, Eli Lilly and<br />

Company, In<strong>di</strong>anapolis, IN, USA; 4 Eli Lilly Italy, Florence, Italy<br />

188. Effects of exenatide compared with twice-daily biphasic insulin aspart in patients<br />

with type 2 <strong>di</strong>abetes using metformin and a sulphonylurea<br />

Gentilella Raffaella 5 , Nauck M.A. 1 , Duran Garcia S. 2 , Kim D. 3 , Johns D. 4 , Festa A. 4 , Trautmann<br />

M. 4<br />

1 Clinical Diabetology, Diabeteszentrum Bad Lauterberg, Germany, 2 Cátedra de Endocrinología,<br />

Hospital de Valme, Seville, Spain, 3 Amylin Pharmaceuticals, Inc., San Diego, United States,<br />

4 Lilly Research Laboratories, Eli Lilly and Company, In<strong>di</strong>anapolis, United States; 5 Eli Lilly Italy,<br />

Florence, Italy<br />

pag_dx.indd 1 30/05/2007 4.30.39


189. A comparison of exenatide and insulin glargine in patients using a single oral<br />

anti<strong>di</strong>abetic agent<br />

Gentilella Raffaella 5 ,Barnett A.H. 1 , Trautmann M. 2 , Burger J. 3 , Johns D. 3 , Kim D. 4 , Brodows<br />

R. 3 , Festa A. 2 , Roberts A. 2<br />

1 Department of Diabetes/Endocrinology, Birmingham Heartlands Hospital, United Kingdom,<br />

2 Eli Lilly and Company, Hamburg, Germany, 3 Eli Lilly and Company, In<strong>di</strong>anapolis, United<br />

States, 4 Amylin Pharmaceuticals, Inc., San Diego, United States; 5 Eli Lilly Italy, Florence, Italy<br />

190. Safety and efficacy of exenatide over 16 weeks in patients with type 2 <strong>di</strong>abetes<br />

mellitus using a thiazoli<strong>di</strong>ne<strong>di</strong>one with or without metformin<br />

Gentilella Raffaella 6 , Zinman B. 1 , Hoogwerf B. 2 , Duran Garcia S. 3 , Milton D. 4 , Giaconia J. 4 , Kim<br />

D. 5 , Trautmann M. 7 , Brodows R. 4<br />

1 Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada, 2 Department of<br />

Endocrinology, Cleveland Clinic Foundation, Cleveland, USA, 3 Cátedra de Endocrinología,<br />

Hospital de Valme, Sevilla, Spain, 4 Eli Lilly and Company, In<strong>di</strong>anapolis, USA, 5 Amylin<br />

Pharmaceuticals, Inc., San Diego, USA, 6 Eli Lilly Italy, Florence, Italy, 7 Eli Lilly and Company,<br />

Hamburg, Germany<br />

191. Beta-cell function is markedly reduced in women with previous gestational <strong>di</strong>abetes<br />

Canu Silvia 1 , Franconi F. 1 , Tesi F. 2 , Seghieri G. 2<br />

1 Dpt. of Pharmacology, University of Sassari, Italy. 2 Dpt. of Internal Me<strong>di</strong>cine, Spedali Riuniti,<br />

Pistoia<br />

100<br />

192. Concentration of brain natriuretic peptide in women with gestational <strong>di</strong>abetes<br />

2 Campesi Ilaria,<br />

1 Tesi F., 1 Gironi A. 2 Canu S., 2 De Bellis A., 1 Anichini R., 1 Seghieri G.,<br />

2 Franconi F.<br />

1 Dpt. of Internal Me<strong>di</strong>cine, Spedali Riuniti, Pistoia, 2 Dpt. of Pharmacology, University of<br />

Sassari, Italy<br />

193. Biochemical mechanisms underlying endocannabinoid dysregulation in the pancreas<br />

and a<strong>di</strong>pose tissue of high fat <strong>di</strong>et-fed mice<br />

Matias Isabelle 1 , Starowicz K. 1 , Cristino L. 2 , Racioppi A. 1 , Di Marzo V. 1<br />

1,2 Endocannabinoid Research Group, 1 Institute of Biomolecular Chemistry and 2 Institute of<br />

Cybernetics, Consiglio Nazionale delle Ricerche, Pozzuoli (NA), Italy<br />

194. Ghrelin and des-acyl ghrelin inhibit isoproterenol-induced lipolysis in rat a<strong>di</strong>pocytes<br />

through activation of phospho<strong>di</strong>esterase 3B<br />

Baragli Alessandra, Ghè C., Arnoletti E., Muccioli G.<br />

Division of Pharmacology, Department of Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine,<br />

University of Turin, Turin, Italy<br />

195. Pharmacological modulation of metabolic, hormonal, and inflammatory alterations<br />

in an experimental model of hepatic steatosis<br />

1 Iacono Anna, 1,4 Esposito E., 1 Mattace Raso G., 2 Bianco G., 3,4 Cuzzocrea S., 1 Meli R.<br />

1 Department of Experimental Pharmacology, University of Naples “Federico II”, Naples;<br />

2 Department of Pharmaceutical Sciences, University of Salerno; 3 Department of Clinical and<br />

Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine, University of Messina, Messina;<br />

4 IRCCS Centro Neurolesi "Bonino-Pulejo," Messina, Italy<br />

pag_sx.indd 1 30/05/2007 4.34.12


Farmacologia della <strong>di</strong>sfunzione erettile<br />

Poster 196 – 201<br />

196. Involvement of mitogen-activated protein kinases (MAPKS) during testicular<br />

ischemia-reperfusion injury in nuclear factor-kB knock-out mice<br />

Minutoli Letteria 1 , Bitto A. 1 , Polito F. 1 , Fiumara T. 1 , Squadrito F. 1 , Mioni C. 2 , Antonuccio P. 3 ,<br />

Romeo C. 3 , Marini H. 4 , Guarini S. 2 Caputi A. P. 1 , Altavilla D. 1 .<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Univ of Messina 2 Dept<br />

of of Biomed Sci, Univ of Modena and Reggio Emilia, 3 Department of Med and Surg Pe<strong>di</strong>atric<br />

Sci, 4 Dept of Biochem, Physiol and Nutr Sci, University of Messina, Italy<br />

197. Stimulation of dopamine receptors in the paraventricular nucleus of the<br />

hypothalamus of male rats induces penile erection and increases extra-cellular<br />

dopamine in the nucleus accumbens: involvement of central oxytocin<br />

Succu Salvatora, Sanna F., Melis T., Argiolas A., Melis M.R.<br />

Bernard B. Bro<strong>di</strong>e Department of Neuroscience, University of Cagliari, Italy<br />

198. Influence of a cannabinoid CB 1 receptor antagonist, SR141716, on sexual behavior<br />

of male rats<br />

Zanoli Paola, Zavatti M., Montanari C., Rivasi M., Poggioli R., Benelli A.<br />

Department of Biome<strong>di</strong>cal Sciences, Section of Pharmacology, University of Modena and<br />

Reggio Emilia, Modena, Italy<br />

199. Hydrogen sulfide (H 2 S) relaxes human and rabbit corpus cavernosum in vitro<br />

Romina Nassini 1 , Patacchini R. 2 , Materazzi S. 1 , Mondaini N. 1 , Natali A. 1 , Geppetti P. 1 ,<br />

Harrison S. 1<br />

1 Department of Critical Care Me<strong>di</strong>cine & Surgery, University of Florence, Florence, Italy; and<br />

2 Department of Pharmacology, Chiesi Pharmaceuticals, Parma, Italy; Florence, Italy<br />

101<br />

200. Eurycoma longifolia improves copulatory activity of sexually sluggish rats<br />

Montanari Caterina, Zavatti M., Zanoli P., Baral<strong>di</strong> M.<br />

Dept. of Biome<strong>di</strong>cal Sciences, Section of Pharmacology and National InterUniversity<br />

Consortium for the Study of Natural Active Principles (CINSPAN), University of Modena and<br />

Reggio Emilia, Modena, Italy<br />

201. The tight-skin mice as a genetic model of Peyronie's-like <strong>di</strong>sease<br />

1,2 d’Emmanuele <strong>di</strong> Villa Bianca Roberta, 1,2 Sorrentino R., 3 Lungarella G., 1 Longo N., 1 Imbimbo<br />

C. 1 Mirone V. 1,2 Cirino G.<br />

1 Center for Preclinical and Clinical Research in Sexual Me<strong>di</strong>cine (CIRMS), 2 Department of<br />

Experimental Pharmacology, University of Naples Federico II,<br />

3 Departement of<br />

Physiopathology, Experimental Me<strong>di</strong>cine and Public Health, University of Siena<br />

Farmacologia dell'infiammazione<br />

Poster 202 – 213<br />

202. Pharmacological activity of selective COX-1 and COX-2 inhibitors in endothelial cells<br />

Sala Angelo, Bolego C., Buccellati C., Folco G.,<br />

Department of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133 Milan<br />

Italy<br />

203. Role of FGFR1 in the angiogenic response induced by PGE2<br />

Finetti Federica, Ziche M., Donnini S.<br />

Pharmacology section, Department of Molecular Biology, University of Siena<br />

pag_dx.indd 1 30/05/2007 4.36.33


204. Time course of brain PGE 2 level and synthesis pathway in LPS- fevered rats<br />

Di Matteo Anna, Bartella C., Mangano G., Apicella C., Mancini F., Coletta I., Guglielmotti A.,<br />

Polenzani L.<br />

Angelini Farmaceutici – ACRAF S.p.A Piazzale della Stazione S.Palomba-Pomezia Italy<br />

205. Brain Prostanoids profile in control and LPS-treated rats<br />

Bartella Cristina, Garrone B.e, Basta F., De Santi S., Vitiello M., Coletta I., Guglielmotti A.,<br />

Polenzani L.<br />

Angelini Farmaceutici – ACRAF S.P.A Piazzale della Stazione S.Palomba-Pomezia Italy<br />

206. Cysteinyl leukotrienes in human endothelial cells: synthesis and activities<br />

Sala Angelo , Carnini C., Accomazzo M.R., Borroni E., Vitellaro-Zuccarelli L., Folco G., Rovati<br />

G.<br />

Department of Pharmacological Sciences, Department of Biomolecular Sciences and<br />

Biotechnology, and Center for Car<strong>di</strong>opulmonary Pharmacology, University of Milan, 20133<br />

Milan, Italy<br />

207. Nitric-oxide scavenging properties of novel organic compounds containing cobalt<br />

(II) and ruthenium (III)<br />

1 Cantore Miriam, 2 Valtancoli B., 3 Cinci L., 2 Bencini A., 1 Ciuffi M., 1 Failli P.<br />

Depts. of: 1 Preclinical & Clinical Pharmacology,<br />

2 Chemistry and 3 Anatomy, Histology &<br />

Forensic Me<strong>di</strong>cine, University of Florence, Italy<br />

102<br />

208. Inhibition of nitric oxide pathway by an acetonic extract from Feijoa sellowiana<br />

berg. fruits<br />

Rossi Antonietta 1,2 , Pergola C. 1 , Formisano C. 3 , Guerriere L. 3 , Sautebin L. 1<br />

1 Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy;<br />

2 IRCCS Centro Neurolesi “Bonino-Pulejo”, University of Messina, Messina, Italy; 3 Department<br />

of Chemistry of Natural Products, University of Naples Federico II, Naples, Italy<br />

209. NCX 2057, a nitric oxide-derivative of ferulic acid, exerts anti-inflammatory activity<br />

in in-vitro and in-vivo models<br />

Ronchetti Daniela, Borghi V., Bion<strong>di</strong> S., Impagnatiello F.<br />

Nicox Research Institute, Bresso, Milan, Italy<br />

210. NCX 4040, a nitric oxide-donating aspirin derivative with improved antiinflammatory<br />

properties<br />

Anzellotti Paola, Di Francesco L., Tacconelli S., Patrignani P.<br />

Department of Me<strong>di</strong>cine and Center of Excellence on Aging, School of Me<strong>di</strong>cine, “G.<br />

d’Annunzio” University; †“G. d’Annunzio” University Foundation, Ce.S.I<br />

211. Evidence of cytokines levels modulation in rat serum exerted by Iacvita, a new<br />

antioxidant compound<br />

Ricchi Lucia, Corsi L., Geminiani E., Baral<strong>di</strong> M.<br />

Dip. Scienze Biome<strong>di</strong>che Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Modena e Reggio Emilia<br />

CINSPAN Consorzio Interuniversitario Nazionale per lo <strong>Stu<strong>di</strong></strong>o dei Principi Attivi Naturali<br />

212. Rapid release of annexin A1 following heat-shock response in LPS-stimulated<br />

macrophages<br />

Festa Michela, Parente L., Flower R. J. * , Perretti M. * , D’Acquisto F. * , Ercolino S.F.<br />

Department of Pharmaceutical Sciences, University of Salerno, Salerno, Italy. * William Harvey<br />

Research Institute, Dept. of Biochemical Pharmacology, Charterhouse Square, London,<br />

England<br />

pag_sx.indd 1 30/05/2007 4.38.13


213. Estrogen receptor antagonist ICI 182,780 inhibits the anti-inflammatory effect of<br />

glucocorticoids<br />

1,2 Salvatore Cuzzocrea, 3 Bruscoli S., 1 Crisafulli C., 1,2 Mazzon E., 3 Agostini M., 1 Muià C.,<br />

2,4 Esposito E.,<br />

3 Di Virgilio R.,<br />

4 Meli R.,<br />

5 Vegeto E.,<br />

5 Maggi A.,<br />

3 Riccar<strong>di</strong> C.<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina,<br />

Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy; 3 Department of Cinical and<br />

Experimental Me<strong>di</strong>cine, Pharmacology, University of Perugia, Italy;<br />

4 Department of<br />

Experimental Pharmacology, University of Naples “Federico II”, Naples Italy; 5 Department of<br />

Pharmacological Sciences, University of Milan, Italy<br />

Chemioterapia antibatterica, antivirale e antineoplastica<br />

Poster 214 – 228<br />

214. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and ZD6474 in<br />

bladder cancer cell lines<br />

Mey Valentina, Elisa G., Nannizzi S., Ricciar<strong>di</strong> S., Danesi R., Del Tacca M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine,<br />

University of Pisa<br />

215. Synergistic cytotoxycity, inhibition of AKT and C-KIT phosphorylation, modulation of<br />

gene expression by sorafenib and gemcitabine in human pancreatic cancer cells<br />

Ricciar<strong>di</strong> Simona, Giovannetti E. , Nannizzi S., Mey V., Pasqualetti G., Danesi R., Del Tacca<br />

M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa<br />

216. Inhibition of STAT 3 increases doxorubicin sensitivity in a human metastatic breast<br />

cancer cell line<br />

Roberta Molteni, Ravizza R., Garibol<strong>di</strong> M.B., Monti E.<br />

Dept. of Structural and Functional Biology, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> dell’Insubria<br />

103<br />

217. In vitro study of the interaction between gemcitabine and sorafeniv in non small<br />

cell lung cancer (NSCLC) A549 cell line<br />

Pasqualetti Giuseppe, Ricciar<strong>di</strong> S., Nannizzi S., Mey V., Elisa G., Danesi R., Del Tacca M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine - University of<br />

Pisa<br />

218. In vitro and in vivo antineoplastic effects of a novel platinum bioconjugate using a<br />

biocompatible polymeric matrix<br />

Garibol<strong>di</strong> Marzia Bruna, Gabano E. 1 , Sparnacci K. 1 , Laus M. 1 , Osella D. 1 , Ravizza R., Molteni<br />

R., Monti E.<br />

DBSF – Pharmacology Section, University of Insubria, Busto Arsizio (VA). 1 Dipartimento <strong>di</strong><br />

Scienze dell’Ambiente e della Vita, Università del Piemonte Orientale “A. Avogadro”,<br />

Alessandria<br />

219. Toxicological evaluation of mepacrine and interferon alfa-2A on U87-MG and Vero<br />

cell colture<br />

Coppi Andrea, Baggio G., Bruni E. Rossi T.<br />

University of Modena and Reggio Emilia- Italy: Departmentof Biome<strong>di</strong>cal Sciences-<br />

Section of Pharmacology; 287 G. Campi st 41100 Modena Italy<br />

pag_dx.indd 1 30/05/2007 4.39.14


220. Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the<br />

HA22T/VGH model of Overt hepatocellular carcinoma<br />

Carina Valeria, Labbozzetta M., Poma P., Alaimo A., Maurici A., Inguglia L., Notarbartolo M.,<br />

D’Alessandro N.<br />

Dipartimento <strong>di</strong> Scienze Farmacologiche, Università <strong>di</strong> Palermo<br />

221. HDAC inhibitors restore the p53 pathway in neuroblastoma cells<br />

Gnemmi Ilaria, Condorelli F., Genazzani A.A., Canonico P.L.<br />

DiSCAFF&DFB Center, Università del Piemonte Orientale, Novara, Italy<br />

222. Temperature influence on cellular uptake, DNA platination and antiproliferative<br />

activity of platinum(II) drugs<br />

Colangelo Donato a , Gabano E. b , Osella D. b , Viano I. a<br />

a Dept. Me<strong>di</strong>cal Sciences, Via Solaroli 17 I-28100 Novara, b Dept. of Ambiental and Life<br />

Sciences, via Bellini 25/G, I-15100 Alessandria, Università del Piemonte Orientale “A.<br />

Avogadro”, Italy<br />

223. Inhibition of P-GP/ATPASE activity of rat small intestine membrane vesicles by the<br />

novel, <strong>di</strong>hydropyri<strong>di</strong>ne MDR REVERTER DP7<br />

Alderighi Daniela, Sgaragli T., Dragoni S., Frosini M., Valoti M., Saponara S., Fusi F., Shah A.,<br />

Kawasae M., Motohashi N., Molnar J., Sgaragli G.<br />

Dipartimento <strong>di</strong> scienze biome<strong>di</strong>che, Università Degli <strong>Stu<strong>di</strong></strong> <strong>di</strong> Siena via A. Moro 2, 53100<br />

Siena<br />

104<br />

224. High energy shock waves increase paclitaxel efficacy in a syngenic model of breast<br />

cancer<br />

Canaparo Roberto 1,2 , Serpe L. 2 , Ean<strong>di</strong> M. 2 , Zara G.P. 2 , Berta L. 1 , Frairia R. 1<br />

1 Department of Clinical Pathophysiology, University of <strong>Torino</strong>, <strong>Torino</strong>, Italy. 2 Department of<br />

Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine, University of <strong>Torino</strong>, <strong>Torino</strong>, Italy<br />

225. Evaluation of synthetic "tubulysin U" induced cytotoxycity in HL60, C6, PC12 and<br />

ECV304 cell lines<br />

Manca Ilaria a , Sani M. b,c , Sanna A. a , Fossati G. b , Lazzari P. a , Huguenot F. b , Pani L. a,d , Zanda<br />

M. b<br />

a Neuroscienze PharmaNess S.c.a r.l., c/o POLARIS, E<strong>di</strong>ficio 5, Loc.Piscinamanna, 09010 Pula<br />

(CA), Italy. b C.N.R. Istituto <strong>di</strong> Chimica del Riconoscimento Molecolare, Via Mancinelli 7,<br />

20131 Milano, Italy. c KemoTech srl, Unità Operativa <strong>di</strong> Milano, Via Mancinelli 7, 20131 Milano,<br />

Italy. d C.N.R. Istituto <strong>di</strong> Tecnologie Biome<strong>di</strong>che, Sezione <strong>di</strong> Cagliari, c/o Neuroscienze<br />

PharmaNess S.c.a r.l.<br />

226. Anthocyani<strong>di</strong>ns modulate the cytotoxicity of irinotecan and oxaliplatin in human<br />

colon adenocarcinoma cells<br />

Cvorovic Jovana, Candussio L., Maestro A., Bartoli F., Decorti G.<br />

Department of Biome<strong>di</strong>cal Sciences, University of Trieste, Via Giorgieri 7, Trieste<br />

227. Preliminary results on antiproliferative effect of new deacetilase inhibitors on<br />

human leukemia cell lines<br />

Vitali Federica a , Turriziani M. b , D’Alfonso R. b , Lombardo M. b , Valenti S. c , Mai A. c , Tita B. a<br />

a Department of Human Physiology and Pharmacology, University of Rome “Sapienza”.<br />

b Department of Internal Me<strong>di</strong>cine, University of Rome “Tor Vergata”. c Department of<br />

Pharmaceutical <strong>Stu<strong>di</strong></strong>es, University of Rome “Sapienza”<br />

228. Topical administration of resveratrol as pre- and antineoplastic agent<br />

Berta Giovanni N., Mognetti B., Barberis A., Marinos L., Di Carlo F.<br />

Department of Clinical and Biological Sciences, University of Turin, I-10043 Orbassano, Italy<br />

pag_sx.indd 1 30/05/2007 4.41.01


Farmacologia clinica e sperimentazione clinica dei farmaci<br />

Poster 229 – 239<br />

229. Effect of topiramate treatment in a patient affected ny symptomatic trigeminal<br />

neuralgia<br />

Gallelli Luca 1 , Siniscalchi A. 2 , Borner Perrone I. 1 , Davoli A. 1 , De Sarro G. 1<br />

1 Chair of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine, University Magna Graecia of Catanzaro, Italy.<br />

2 Department of Neuroscience, Neurology Division, “Annunziata” Hospital, Cosenza, Italy<br />

230. Pharmacokinetics of tramadol and of ITS metabolite N-desmethyltramadol in<br />

fasting and fed horses, after single oral administration<br />

Buti Deanna, Saccomanni G.*, Sgorbini M., Mengozzi G., Manera C.* Giorgi M.<br />

Departments of Veterinary Clinics V.le delle Piagge 2 56124 Pisa, Italy. *Pharmaceutical<br />

Science Via Bonanno 6 56126 Pisa, Italy<br />

231. Administration of oral sustained-release tablet formulation of tramadol in horses:<br />

pharmacokinetics of the parental drug and of n-desmethyltramadol<br />

Magnani Francesca, Saccomanni G.*, Casini L.**, Soldani G., Manera C.*, Giorgi M.<br />

Departments of Vetrinary Clinics V.le delle Piagge 2 56124 Pisa, *Pharmaceutical Science V.<br />

Bonanno 6 56126 Pisa and **Animal Productions, S. Piero a Grado, 56010 Pisa, Italy<br />

232. High homocysteine plasma levels in patients treated with antiepileptic drugs<br />

Gallelli Luca 2 , Liotti A. 2 , Siniscalchi A. 1 , Davoli A. 2 , Marigliano N.M. 2 , De Sarro G. 2<br />

1 Department of Neuroscience, Neurology Division, “Annunziata” Hospital, Cosenza, Italy<br />

2 Chair of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine, University Magna Graecia of Catanzaro, Italy<br />

105<br />

233. Pharmakinetics of indomethacian in chronic migraine patients after withdrawal of<br />

the overused combination of indomethacin, prochlorperazine, and caffeine<br />

Ferrari Anna, Gallesi D., Sances G.*, Pinetti D., Bertolini A., Sternieri E.<br />

Toxicology and Clinical Pharmacology Section, Headache Centre, University Centre for<br />

Adaptive Disorders and Headache, Section Modena II. University of Modena and Reggio<br />

Emilia, Italy<br />

*Headache Unit, IRCCS C. Mon<strong>di</strong>no, University of Pavia, Italy<br />

234. Variability of oral sumatriptan pharmacokinetics in migraine patients<br />

Coccia Ciro, Pinetti D., Bertolini A., Sternieri E., Ferrari A.<br />

Toxicology and Clinical Pharmacology Section, Headache Centre, University Centre for<br />

Adaptive Disorders and Headache, Section Modena II. University of Modena and Reggio<br />

Emilia, Italy<br />

235. Hormonal index of well-being in women affected by me<strong>di</strong>cation overuse headache<br />

(MOH)<br />

Monnazzi Paola, Simeoni S., Martelletti P.* , Patacchioli F.<br />

Romana.<br />

Dept Human Physiology and Pharmacology “V. Erspamer”, *Internal Me<strong>di</strong>cine, 2 nd School of<br />

Me<strong>di</strong>cine, University of Rome La Sapienza, Italy<br />

pag_dx.indd 1 30/05/2007 4.47.44


236. Long-term efficacy of antihypertensive therapy in old-age patients with essential<br />

hypertension<br />

Sigala Sandra 1,2 , Alicandri C. 1 , Parini F. 1,2 , Valenti L. P. 1 , Parrinello G. 3 , Spano P.F. 2<br />

1 Division of Me<strong>di</strong>cine, Istituto Clinico Città <strong>di</strong> Brescia, Brescia, Italy; 2 Section of Pharmacology,<br />

Dept of Biomed Sci and Biotec, University of Brescia Me<strong>di</strong>cal School, Brescia, Italy; 3 Me<strong>di</strong>cal<br />

Statistic Unit, Dept of Biomed Sci and Biotec, University of Brescia Me<strong>di</strong>cal School, Brescia,<br />

Italy<br />

237. The role of CYP3A5 in methadone methabolism: a case report<br />

De Fazio Salvatore 1 , Scordo M.G. 2 , Gallelli L. 1 , Marigliano N.M. 1 , Ferreri Ibbadu G. 1 , Rende P. 1 ,<br />

De Sarro G. 1<br />

1 Chair of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine, University of Catanzaro, Via T. Campanella 115, 88100 Catanzaro, Italy<br />

2 Department of Me<strong>di</strong>cal Sciences, Clinical Pharmacology; Uppsala University, Akademiska<br />

sjukhuset, Ing. 61, 75185 Uppsala, Sweden<br />

238. Management of lithium therapy during pregnancy<br />

Lampus Simona, Serio S., Chillotti C., Del Zompo M., Ardau R.<br />

Clinical Psychopharmacology Center, Section of Clinical Pharmacology, Department of<br />

Neurosciences "B. B. Bro<strong>di</strong>e", University of Cagliari<br />

106<br />

239. A new apomorphine formulation for oral administration<br />

Zara Gian Paolo 1 , Cattaldo S. 4 , Cavalli R. 2 , Calderoni S. 4 , Muntoni E. 1 , Gasco M.R. 5 , Mauro<br />

A. 3-4 , Ean<strong>di</strong> M. 1<br />

1 Dipartimento Anatomia Farmacologia e Me<strong>di</strong>cina Legale, 2 Dipartimento <strong>di</strong> Scienze e<br />

Tecnologia del Farmaco, 3 Dipartimento <strong>di</strong> Neuroscienze, Università <strong>di</strong> <strong>Torino</strong> Italy - 4 IRRCS<br />

Istituto Auxologico Italiano, Piancavallo Italy – 5 Nanovector s.r.l. <strong>Torino</strong> Italy<br />

Farmacovigilanza, farmacoepidemiologia e farmacoeconomia<br />

Poster 240 – 251<br />

240. Investigation on the opportunity in initiating treatment for hepatitis C virus (HCV)<br />

infection among drug users<br />

Mattioli Francesca, Montinaro E.*, Ducci E.*, Martelli A.<br />

Department of Internal Me<strong>di</strong>cine, Pharmacology Unit, University of Genoa, I-16132 Genoa,<br />

Italy<br />

*Valbisagno Drug Dependence Service (SerT) of Genoa<br />

241. Reports of adverse reactions to antibiotics in the Tuscan Pharmaresearch Database<br />

Tuccori Marco 1 , Montagnani S. 1 , Giustini Saffi E. 2 , Salvetti A. 2 , Blan<strong>di</strong>zzi C. 1 , Del Tacca M. 1<br />

1 Tuscan Regional Center for Pharmacovigilance - Division of Pharmacology and<br />

Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of Pisa – Pisa, Italy<br />

2 Italian Society of General Me<strong>di</strong>cine (SIMG) – Florence, Italy<br />

242. Retrospective evaluation of antidepressants side effects<br />

De Fazio Salvatore, Gareri P., Palleria C., Gallelli L., De Sarro G.<br />

Chair of Pharmacology, School of Me<strong>di</strong>cine, University “Magna Graecia” of Catanzaro, “Mater<br />

Domini” University Hospital, Via T. Campanella 115, 88100 Catanzaro, Italy<br />

243. Guidelines on the clinical use of clozapine<br />

Ligas Franca, Ardau R., Chillotti C., Del Zompo M.<br />

Clinical Psychopharmacology Centre, Section of Clinical Pharmacology, Department of<br />

Neurosciences “B.B. Bro<strong>di</strong>e”, University of Cagliari<br />

pag_sx.indd 1 30/05/2007 4.51.03


244. Observational study comparing the safety of typical and atypical antipsychotic drugs<br />

in patients affected by dementia with behavioural and psychological symptoms of<br />

dementia (BPSD)<br />

Capuano Annalisa, Potenza S., Ferrante L., Gallo M., Rinal<strong>di</strong> B., Filippelli A., Rossi F.<br />

Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology “Leonardo Donatelli”. Center<br />

of Pharmacosurveillance and Pharmacoepidemiology, Faculty of Me<strong>di</strong>cine and Surgery, Second<br />

University of Naples, Italy<br />

245. Prescribing pattern of Anti-Parkinson drugs in Southern Italy: cross-sectional<br />

analysis in the years 2003-5<br />

Trifirò Gianluca 1,5 , Savica R. 2 , Morgante L. 2 , Tari M. 3 , Moretti S. 3 , Vanacore N. 4 , Spina E. 1,5 ,<br />

Arcoraci V. 1 , Caputi A.C. 1,5<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Pharmacology Unit,<br />

University of Messina, Italy; 2 Department of Neuroscience, Psychiatry and Anaesthesiology,<br />

University of Messina, Italy; 3 Caserta-1 Local Health Service, Caserta – Italy; 4 National<br />

Centre for Epidemiology Surveillance and Health Promotion. National Institute of Health,<br />

Rome, Italy; 5 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy<br />

246. Use of herbal products in children: risks and benefits<br />

Loizzo Stefano 1,2 , Loizzo A.L. 3 , Capasso A. 4 , Loizzo A. 1<br />

1 Dept of Drug Research and Evaluation and 2 Dept of Cell Biology and Neurosciences, Istituto<br />

Superiore <strong>di</strong> Sanita’, Roma, Italy; 3 Dept of Pae<strong>di</strong>atric Neuropsychiatry, University of Roma Tor<br />

Vergata, Roma, Italy, 4 Dept of Pharmacology, University of Salerno, Salerno, Italy<br />

247. Knowledge and use of herbal drugs in pregnancy<br />

1 Micheli Lucia, 1 Nencini C., 1 Franchi G.G., 2 Urso R. 1, 2 , Giorgi G.<br />

1 Department of Pharmacology “Giorgio Segre”, University of Siena. 2 Centro Regionale <strong>di</strong><br />

Farmacovigilanza, Area Vasta Sud- Est (Siena), Regione Toscana<br />

107<br />

248. Drugs and herbal products in hospital practice: use and potential interactions<br />

Stocco Andrea 1 , Gallo U. 2 , Bano F. 2 , Bin A. 1 , Grion A. M. 2 , Ori C. 1 , Gaion R. M. 1 , Giron M.C. 1<br />

1 Department of Pharmacology and Anesthesiology, University of Padova. 2 Department of<br />

Pharmaceutical Care, ULSS 16 – Padova<br />

249. Knowledges about herbal products among subjects on warfarin therapy and<br />

patient-physician relationship<br />

Benoni Giuseppina 1 , Cuzzolin L. 1 , Francini-Pesenti F. 2 , Zaffani S. 1 , Brocadello F. 2 , Pengo V.<br />

3 , Bassi A. 4<br />

1 Department of Me<strong>di</strong>cine & Public Health-Section of Pharmacology, University of Verona,<br />

Italy; 2 Clinical Nutrition Unit, Hospital of Padua, Italy; 3 Clinical Car<strong>di</strong>ology-Thrombosis Centre,<br />

University of Padua, Italy; 4 Department of Clinical and Experimental Me<strong>di</strong>cine, University of<br />

Verona, Italy<br />

250. Attitudes, knowledge and use of herbal products among pregnant women: a pilot<br />

survey in Tuscany<br />

Vannacci Alfredo, Lapi F., Morsuillo M., Meschini M., Cipollini F. c , Di Pirro M., Cecchi E. a ,<br />

Banchelli G., Firenzuoli F., Mugelli A.<br />

Department of Preclinical and Clinical Pharmacology, University of Florence, Italy a Emergency<br />

Department, Prato Hospital, ASL 4, Italy; b Centre of Natural Me<strong>di</strong>cine, ASL 11, Empoli, Italy;<br />

c Department of Statistical Sciences, University of Florence, Italy<br />

251. Surveillance and information on herbal me<strong>di</strong>cines use of in pregnancy in the Sicily<br />

Region<br />

Pieratti Antonella¹, Calapai G.¹, Corsello S.², Mirabile M.², Fava G.¹, Caputi A. P.¹<br />

1)<br />

Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina.<br />

2) U.O.C. of Ginecology and Obstetrics, Hospital S.S. Salvatore, Paternò, Catania<br />

pag_dx.indd 1 30/05/2007 4.52.45


Tossicologia sperimentale e clinica<br />

Poster 252 – 265<br />

252. Neurochemical modulation and behavioural change after neonatal administration of<br />

pyrethroids in animal model<br />

Nasuti Cinzia Carla 1 , Gabbianelli R. 2 , Di Stefano A. 3 , Cantalamessa F. 1<br />

1 Department of Experimental Me<strong>di</strong>cine and Public, University of Camerino, 62032 Camerino<br />

(MC).<br />

2 Department of Biology M.C.A., University of Camerino, 62032 Camerino (MC).<br />

3 Department of Drug Science, University of “G. D’Annunzio”, 66100 Chieti (CH)<br />

253. Role of brain renin angiotensin system in the acute hypertensive response to<br />

intracerebroventricular cadmium<br />

Varoni M.Vittoria, Palomba D., Anania V., Demontis M.P.<br />

D.B.A - Division of Pharmacology, Faculty of Veterinary Me<strong>di</strong>cine – University of Sassari<br />

254. Cancer chemoprevention: manipulation of xenobiotic metabolizing enzymes by<br />

glucoraphasatin and glucoraphasatin and glucoraphenin found in Brassicaceae<br />

Bonamassa Barbara 1 , Barillari J. 2 , Canistro D. 1 , Pozzetti L. 1 , Sapone A. 1 , Iori R. 2 , Biagi G.L. 1<br />

, Paolini M. 1<br />

1 Department of Pharmacology, Molecular Toxicology Unit, Alma Mater <strong>Stu<strong>di</strong></strong>orum - University<br />

of Bologna, Via Irnerio 48 - 40126 Bologna, Italy. 2 Agricultural Research Council - Research<br />

Institute for Industrial Crops (CRA-ISCI), via Corticella 133, Bologna, Italy<br />

108<br />

255. Effects of PCB101, PCB118, PCB138 and PCB153 alone and in mixture in MCF-7<br />

breast cancer cells: possible mechanism of action<br />

Chiesara Enzo, Marabini L., Ra<strong>di</strong>ce S.<br />

Department of Pharmacology, Chemoterapy and Me<strong>di</strong>cal Toxicology “E. Trabucchi”, University<br />

of Milan, Via Vanvitelli 32, 20129, Milan<br />

256. Does acetylsalycilic acid interfere with liver <strong>di</strong>methylbenzanthracene (DMBA)-<br />

metabolism? Study in a rat model of DMBA-induced mammary carcinogenesis<br />

Racca Silvia 1 , Spaccamiglio A. 1 , Dacasto M. 2 , Carletti M. 2 , Nebbia C. 2 , Abbadessa G. 1 , Di Carlo<br />

F. 1<br />

1 Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO);<br />

2 Department of Animal Pathology, Division of Pharmacology and Toxicology, University of<br />

Turin, Grugliasco (TO)<br />

257. Effect of isothiazolinones on redox omeostasis of rat erythrocytes<br />

* Frosali Simona, * Priora R., * Margaritis A., § Di Stefano A., * Di Giuseppe D., * Summa D., * Di<br />

Simplicio P.<br />

* Department of Neuroscience, Pharmacology Unit, University of Siena. § Department of<br />

Molecular Biology, University of Siena<br />

258. Verminoside and verbascoside from Kigelia Africana: cytotoxic and genotoxic effects<br />

in human lymphocytes<br />

Autore Giuseppina, Santoro A., Bianco G., Picerno P., Aquino R.P., Marzocco S., Gazzerro P.,<br />

Lioi M.B. 1 , Bifulco M.<br />

Dipartimento <strong>di</strong> Scienze Farmaceutiche, Università <strong>di</strong> Salerno, Fisciano Italy. 1 Dipartimento <strong>di</strong><br />

Scienze delle Produzioni Animali, Università della Basilicata, Potenza Italy<br />

259. DNA fragmentation in peripheral blood lymphocytes of patients with liver cirrhosis<br />

related to alcohol abuse or to hepatitis B or C viruses<br />

Grossi Sarah, Mattioli F., Manfre<strong>di</strong> V., Sumberaz A. * , Testino G. * , Martelli A.<br />

Department of internal Me<strong>di</strong>cine, Pharmacology Unit, University of Genoa, I-16132 Genoa,<br />

Italy. * Gastreoenterology Unit – St. Martino Hospital – Genoa<br />

pag_sx.indd 1 30/05/2007 4.58.11


260. Effects of DP7 on human and rat liver CYP-dependent activities: a kinetic study<br />

D’Elia Paolo, Dragoni S., De Matteis F., Valoti M., Kawase M., Shah A., Motohashi N., Molnar<br />

J., Sgaragli G.<br />

Dipartimento Scienze Biome<strong>di</strong>che, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Siena, via A. Moro 2, 53100 Siena<br />

261. Formation of DNA-damaging N-nitroso compounds from the interaction of calciumchannel<br />

blockers with nitrite<br />

Robbiano Luigi, Gosmar M., Martelli A.<br />

Department of Internal Me<strong>di</strong>cine, Pharmacology Unit, University of Genoa, I-16132 Genoa,<br />

Italy<br />

262. Low-level lead, cadmium and vana<strong>di</strong>um: "in vitro" evaluation of their genotoxic<br />

potential as influenced by copper, zinc or selenium<br />

Carmignani Marco, Volpe A.R., Cesare P., Aimola P.<br />

Section of Pharmacology and Toxicology, Department of Basic and Applied Biology, University<br />

of L’Aquila, Via Vetoio 2, 67010 Coppito (L’Aquila), Italy<br />

263. Inhibitory enzymatic activity of semicarbazide<br />

Mastrangelo Sabina 1 , Evandri M.G. 2 , Maranghi F. 3 , Mantovani A. 3 , Bolle P. 1<br />

1 Department of Human Physiology and Pharmacology, “Sapienza” University of Rome; 2 Italian<br />

Me<strong>di</strong>cines Agency, Rome; 3 Department of Food Safety and Veterinary Public Health, Italian<br />

National Health Institute, Rome<br />

264. In vitro effects of two over-the-counter bleaching poducts on gingival epithelium<br />

and dental restorative material<br />

Cimino F., Tomaino A., Speciale A., Cristiani M., Trombetta D., Saija A.<br />

1 Dept. Farmaco-Biologico, School of Pharmacy, University of Messina, Italy<br />

109<br />

265. Human umbilical cord-derived hematopoietic stem cells in cyto- and geno-toxicity<br />

stu<strong>di</strong>es: results with cadmium and chromium compounds<br />

Carmignani Marco, Aimola P., Cesare P., Orsini F., Volpe A.R.<br />

Section of Pharmacology and Toxicology, Department of Basic and Applied Biology, University<br />

of L’Aquila, Via Vetoio 2, 67010 Coppito (L’Aquila), Italy<br />

Farmacogenetica, farmacogenomica e terapia genica<br />

Poster 266 – 273<br />

266. Serotonin transporter 5HTTLPR polymorphism, clinical variants and symptom<br />

severity in patients with irritable bowel syndrome<br />

Ghisu Narcisa 1 , Colucci R. 1 , Bellini M. 2 , Rossi G. 3 , Blan<strong>di</strong>zzi C. 1 , Gori G.i 1 , Marchi S. 2 , Tonini<br />

M. 4 , Del Tacca M. 1<br />

1 Division of Pharmacology and Chemotherapy and 2 Gastrointestinal Unit, Department of<br />

Internal Me<strong>di</strong>cine, University of Pisa, Italy; 3 Institute of Clinical Physiology-C.N.R., Italy;<br />

4 Department of Physiological and Pharmacological Sciences, University of Pavia, Italy<br />

267. Adverse effects of azathioprine in pe<strong>di</strong>atric patients with inflammatory bowel<br />

<strong>di</strong>sease and multilocus genotypes of enzymes involved in the metabolism of<br />

thiopurines<br />

Stocco Gabriele 1,2 , Martelossi S. 1 , Barabino A. 3 , Decorti G. 2 , Bartoli F. 1 , Ventura A. 1<br />

1) University of Trieste, Department of Sciences of Reproduction and Development and<br />

I.R.C.C.S. “Burlo Garofolo” Trieste, Pe<strong>di</strong>atric Clinic – 2) University of Trieste, Department of<br />

Biome<strong>di</strong>cal Sciences – 3) I.R.C.C.S. “G. Gaslini”, Genova<br />

pag_dx.indd 1 30/05/2007 4.56.07


268. Corticosensitivity in inflammatory bowel <strong>di</strong>sease: role of glucocorticoid receptor<br />

polymorphisms<br />

De Iu<strong>di</strong>cibus S. 1, 2 , Stocco G. 1, 2 , Drigo I. 1, 2 , Norbedo S. 2 , Bartoli F. 1 , Decorti G. 1, 2 , Martelossi<br />

S. 2 , Ventura A. 2<br />

1 Department of Biome<strong>di</strong>cal Sciences, University of Trieste. 2 Department of Pae<strong>di</strong>atrics,<br />

I.R.C.C.S. Burlo Garofolo Trieste<br />

269. Evidence of an increase of the active metabolites of thiopurines induced by<br />

aminosalicylates in inflammatory bowel <strong>di</strong>sease<br />

Marino S. 1, 2 , Stocco G. 1, 2 , Pozzi E. 3 , Martelossi S. 2 , Lionetti P. 3 , Malusà N. 4 , Decorti G. 1, 2<br />

Bartoli F. 1 , Ventura A. 2<br />

1 Department of Biome<strong>di</strong>cal Sciences, University of Trieste. 2 Department of Pae<strong>di</strong>atrics,<br />

I.R.C.C.S. Burlo Garofolo Trieste. 3 Research Children’s Hospital ‘Meyer’, Florence.<br />

4 Department of Prevention, Azienda Sanitaria 1, Trieste<br />

270. Influence of thiopurine methyltransferase genotype and phenotype on adverse<br />

events and efficacy of azathioprine in rheumatologic and gastroenterologic patients<br />

Gori Giovanni 1 , Colucci R. 1 , Ghisu N. 1 , Fornai M. 1 , Tani C. 2 , Mosca M. 2 , Ceccarelli L. 3 , Blan<strong>di</strong>zzi<br />

C. 1 , Costa F. 3 , Marchi S. 3 , Bombar<strong>di</strong>eri S. 2 , Del Tacca M. 1<br />

1 Division of Pharmacology and Chemotherapy, 2 Gastroenterology Unit, and 3 Rheumatology<br />

Unit, Department of Internal Me<strong>di</strong>cine, University of Pisa, Pisa, Italy<br />

110<br />

271. Identification of mutations in HERG and KCNE2 genes associated with arrhythmia in<br />

patients treated with macrolides<br />

Pannacci Marilou 1 , Sullo N. 2 , Caronno A. 1 , Lucini V. 1 , Grosso S. 1 , Scaglione F. 1<br />

1 Department of Pharmacology, University of Milan, Milan, Italy. 2 Department of Experimental<br />

Me<strong>di</strong>cine- Section of Pharmacology, 2 nd University of Naples, Naples, Italy<br />

272. An allenic variant of Na+/Ca++ exchanger promoter region, A2689C, plays a role in<br />

<strong>di</strong>astolic blood pressure response to beta-blockers and <strong>di</strong>hydropyri<strong>di</strong>ne Ca ++<br />

antagonists treatment in hypertensive patients<br />

Trimarco Valentina*, Bellis A.**, Marino M.**, Gigante B.**, De Luca N.**, Trimarco B.**,<br />

Annunziato L.*, Di Renzo G.*<br />

*Division of Pharmacology, Dept. of Neuroscience, Federico II University of Naples, Naples,<br />

Italy. **Dept. of Car<strong>di</strong>ovascular and Immunological Sciences, Federico II University of<br />

Naples, Naples, Italy<br />

273. Distribution of CYP3A5 and MDR-1 single nucleotide polymorphisms in Caucasian<br />

liver transplant patients<br />

Provenzani Alessio 1 , Poma P. 2 , Labbozzetta M. 2 , Notarbartolo M. 2 , Di Stefano R. 1 , Triolo F. 3 ,<br />

Vizzini G. 4 , Gridelli B. 5 , D’Alessandro N. 2<br />

1 Department of Clinical Pharmacy - ISMETT, 2 Department of Pharmacological Sciences -<br />

Università <strong>di</strong> Palermo, 3 Regenerative Me<strong>di</strong>cine and Cell Therapy Unit - ISMETT, 4 Department<br />

of Me<strong>di</strong>cine - ISMETT, 5 Department of Abdominal Surgery and Transplantation - ISMETT<br />

Farmaci innovativi <strong>di</strong> origine biotecnologica<br />

Poster 274 – 282<br />

274. Prolonging the action of recombinant human growth hormone by monopegylation of<br />

muteins<br />

Caboi Francesca*, Bossi M.*, Crobu D.*, Cabras A.*, Scaramuzza S.*, Taylor G.*<br />

*Bio-Ker s.r.l. c/o Scientific and technologic Park of Sar<strong>di</strong>nia Polaris, Loc. Piscinamanna Pula<br />

(Cagliari)<br />

pag_sx.indd 1 30/05/2007 4.57.32


275. Novel G-CSF mutant for conjugation<br />

Salis Barbara, Caboi F., Pitzalis S., Maullu C., Sergi M., Sollai L., Taylor G.<br />

Bio-Ker s.r.l. c/o Scientific and technologic Park of Sar<strong>di</strong>nia Polaris, Loc. Piscinamanna Pula<br />

(Ca)<br />

276. New long lasting PEGylated-hGH<br />

Selis Fabio*, Scaramazza S.*, Contis M.*, Pasut G. + , Veronese F. + , Schrepfer R.*<br />

*Bioker S.r.l. c\o Polaris-Loc Piscinamanna, Pula (CA). + Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Padova,<br />

Dipartimento <strong>di</strong> Scienze Farmaceutiche<br />

277. Silica Microparticles for the controlled release of human growth hormone<br />

Sergi Mauro*, Morpurgo M. + , Selis F.*, Parisi L. + , Concas D.*, Marongiu C.*, Schrepfer R.*,<br />

Tonon G.*<br />

* Bioker S.r.l. c\o Polaris-Loc Piscinamanna, Pula (CA)<br />

+ Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Padova, Dipartimento <strong>di</strong> Scienze Farmaceutiche<br />

278. Inhibition of NF-kB activation by decoy ODN released from liposomes in activated<br />

macrophages<br />

De Stefano Daniela 1 , Maiuri M.C 1 ., Simeon V. 1 , De Rosa G. 2 , LaGuar<strong>di</strong>a V. 2 , Carnuccio R. 1<br />

1 Department of Experimental Pharmacology; 2 Department of Pharmaceutical Sciences;<br />

University of Naples “Federico II”, Via D. Montesano n 49, 80131 Naples, Italy<br />

279. Osteogenic <strong>di</strong>fferentiation of human a<strong>di</strong>pose-derived stem cells (hASC)<br />

De Girolamo L. 1;2 , Sartori M. 1 , Bastoni S. 3 , Brini A.T. 1<br />

1 Me<strong>di</strong>cal Pharmacology Department, Faculty of Me<strong>di</strong>cine, University of Milan.<br />

2 IRCCS Galeazzi Orthope<strong>di</strong>c Institute, Milan. 3 Orthope<strong>di</strong>c and Traumatological Institute,<br />

Faculty of Me<strong>di</strong>cine, University of Milan<br />

111<br />

280. In vitro effects of anti-inflammatory drugs incorporated in solid lipid nanoparticles<br />

on human peripheral mononuclear blood cells from IBD patients<br />

Serpe Loredana 1 , Canaparo R. 2 , Daperno M. 3 , Ean<strong>di</strong> M. 1 , Gasco M.R. 4 , Zara G.P. 1<br />

1 Department of Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine, University of <strong>Torino</strong>, <strong>Torino</strong>,<br />

2 Department of Clinical Pathophysiology, University of <strong>Torino</strong>, <strong>Torino</strong>, 3 Department of<br />

Gastroenterology, Mauriziano Hospital, <strong>Torino</strong>, 4 Nanovector s.r.l, <strong>Torino</strong><br />

281. PEGylation of Recombinant Human Granulocyte Colony-Stimulating Factor (r-h-G-<br />

CSF) produced in Escherichia coli: a new drug to overcome neutropenia<br />

Bonatesta Rosa Rita*, Caboi F.*, Sergi M.*, Sollai L.*, Onali P. + , Schrepfer R.* Tonon G.*<br />

*Bioker S.r.l. c\o Polaris-Loc Piscinamanna, Pula (CA). + Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Cagliari,<br />

Dipartimento <strong>di</strong> Neuroscienze<br />

282. EMEA and emerging therapies and technologies: activity of the Innovation Task<br />

Force<br />

De Lisa Roberto, Ranzani D., Brassart L., Moulon I., Papaluca Amati M.<br />

EMEA European Me<strong>di</strong>cines’ Agency<br />

Appropriatezza della prescrizione dei farmaci<br />

Poster 283<br />

283. In<strong>di</strong>pendent drug information and prescibing appropriateness: a chance for health<br />

professionals and patients<br />

Luppino Maria R. 1,3 , Alacqua M. 1,3 , Catania M.A. 1,3 , Fava G. 1,3 , Gentile M. 1,3 , Oteri A. 1,3 ,<br />

Polimeni G. 1,2,3 , Russo A. 1,3 , Aliferopulos H. 3 , Genovese R. 3 , Sgroi C. 3 , Silvestro A. 3 , Zangla<br />

A. 3 , Caputi A. P. 1,2,3<br />

1 University of Messina -<br />

2 IRCSS “Bonino-Pulejo”, Messina -<br />

3 Messina Provincial Drug<br />

Information Center<br />

pag_dx.indd 1 30/05/2007 4.59.24


Sessione Poster<br />

Recettori e meccanismi <strong>di</strong> trasduzione del segnale<br />

Poster 1-20<br />

13.00-15.00<br />

1. Pharmacological characterization of adenosine receptors in bovine chondrocytes<br />

Tosi A. 1 , Varani K. 1 , Vincenzi F. 1 , Gessi S. 1 , Merighi S. 1 , Fogli E. 1 , Sacchetto V. 1 , Simioni C. 1 ,<br />

De Mattei M. 2 , Caruso A. 2 , Borea P.A. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine, Pharmacology Section; 2 Department of<br />

Morphology and Hystology, University of Ferrara, Italy<br />

2. Bin<strong>di</strong>ng thermodynamics at the human A 2B adenosine receptor<br />

Fogli Eleonora 1 , Gessi S. 1 , Varani K. 1 , Merighi S. 1 , Sacchetto V. 1 , Simioni C. 1 , Leung E. 2 ,<br />

Mac Lennan S. 2 , Borea P.A. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine, Pharmacology Unit and Inter<strong>di</strong>sciplinary<br />

Center for the Study of Inflammation, University of Ferrara, Italy; 2 King Pharm. Research and<br />

Development, Inc., Cary, North Carolina.<br />

112<br />

3. Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible<br />

factor-1 in human glioblastoma cells<br />

Sacchetto Valeria 1 , Merighi S. 1 , Benini A. 1 , Mirandola P. 2 , Gessi S. 1 , Varani K. 1 , Simioni C.1,<br />

Fogli E.1, Leung E. 3 , Mac Lennan S. 3 , Borea P.A. 1 .<br />

1 Dpt of Clin. and Exp. Med., Pharmacol. Unit and Inter<strong>di</strong>sciplinary Center for the Study of<br />

Inflammation, Univ. of Ferrara, Italy; 2 Dpt of Human Anat., Pharmacol. and For. Med., Univ.<br />

of Parma, Italy; 3 King Pharm. Research and Development, Inc., Cary, North Carolina.<br />

4. Activated presynaptic P2x 7 receptors function as calcium channels linked to<br />

exocytotic glutamate release<br />

Guarnieri Stefania 1 , Paluzzi P. 1 , Cervetto C. 1 , Alloisio S. 2 , Nobile M. 2 , Marcoli M.1, Maura G. 1 *<br />

1 Dep. Experimental Me<strong>di</strong>cine, Pharmcology and Toxicology Section; * Center of Exellence for<br />

Biome<strong>di</strong>cal Research, University of Genoa, Genoa, Italy; 2 CNR, Biophysic Intitute, Genoa, Italy<br />

5. Activated P2x 7 receptors allow calcium entry and glutamate exit: investigation on<br />

transfected HEK 293 cells<br />

Paluzzi Paola 1 , Cervetto C. 1 , Guarnieri S. 1 , Alloisio S. 2 , Nobile M. 2 , Marcoli M. 1 , Maura G. 1*<br />

1 Dep. Experimental Me<strong>di</strong>cine, Pharmcology and Toxicology Section; * Center of Exellence for<br />

Biome<strong>di</strong>cal Research, University of Genoa, Genoa, Italy; 2 CNR, Biophysic Intitute, Genoa,<br />

Italy<br />

6. Extracellular Mg 2+ modulates C-terminal tail dependent P2x 7 receptor functional<br />

properties<br />

Alloisio Susanna, Barbieri R., Bozzo L., Nobile M.<br />

Institute of Biophysics, CNR, Via De Marini, 6 – 16149 Genoa, Italy<br />

7. Arachidonic acid potentiates native and recombinant P2x 7 -me<strong>di</strong>ated ERK1/2, but<br />

not JNK and p38 phosphorylation in cultured cortical astrocytes and human<br />

embryonic kidney 293 cells<br />

Barbieri Raffaella 1 , Alloisio S. 1 , Ferroni S. 2 , Nobile M. 1<br />

1 Institute of Biophysics, CNR, 16149 Genoa, Italy; 2 Dept. of Human and General Physiology,<br />

University of Bologna, 40127 Bologna, Italy<br />

pag_sx.indd 1 30/05/2007 5.04.34


8. Purinergic facilitation of parasympathetic activity in isolated pig detrusor:<br />

involvement of prejunctional P2X 3 receptors<br />

D’Agostino G., Con<strong>di</strong>no A.M., Barbieri A., Tonini M*<br />

Department of Experimental and Applied Pharmacology, School of Pharmacy, University of<br />

Pavia, Via Taramelli 14, and * Department of Physiological and Pharmacological Sciences, P.za<br />

Botta 10, I-27100 Pavia, Italy<br />

9. Role of P2 purinergic receptors on ca1 neurotransmission of rat hippocampal slices<br />

Traini Chiara , Coppi E., Pugliese A. M., Pedata F.<br />

Department of Preclinical and Clinical Pharmacology, University of Florence,<br />

Viale Pieraccini 6, 50139 Florence, Italy<br />

10. Role of PKA in EGFR transactivation induced by PGE2 in A431 cells<br />

Terzuoli Erika, Finetti F., Ziche M.<br />

Laboratory of angiogenesis, Department of Molecular Biology, University of Sien<br />

11. Insulin-like growth factor i (IGF-I) induces human mu opioid receptor (MOR)<br />

expression in <strong>di</strong>fferentiated neurons: role of transcription factors rest and STAT3<br />

Be<strong>di</strong>ni Andrea, Di Toro R. , Spampinato S.<br />

Department of Pharmacology and Toxicology – University of Bologna Irnerio 48 – 40126<br />

Bologna – Italy<br />

12. Resistin induces vascular insulin resistance through an impairment of AKT/eNOS<br />

phosphorylations<br />

Di Pardo Alba°, Gentile M.T.°, Vecchione C.°, Marino G.°, Antenucci G.°, Maffei A.°,<br />

Lembo G.° #<br />

°Department of Angio-Car<strong>di</strong>o-Neurology, Neuromed Institute, Pozzilli (IS), and # Department<br />

of Experimental Me<strong>di</strong>cine, “La Sapienza” University of Rome<br />

113<br />

13. Interaction between Wnt pathway and orphan nuclear receptors<br />

Motolese Marta 1 , Orlando R. 1 , Caricasole A. 3 , Terstappen G. C. 3 , Melchiorri D. 1 , Nicoletti F.<br />

1,2 , Caruso A. 1<br />

1 Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”;<br />

2 I.N.M. Neuromed , Pozzilli; Italy; 3 Sienabiotech s.p.a. Siena<br />

14. Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated<br />

human neutrophils<br />

Falzarano Sofia 1 , Franceschetti L. 1 , Spisani S. 2 , Selvatici R. 1<br />

1 Department of Experimental and Diagnostic Me<strong>di</strong>cine, Section of Me<strong>di</strong>cal Genetics, University<br />

of Ferrara; 2 Department of Molecolar Biochemistry and Biology, University of Ferrara<br />

15. The thyroid <strong>di</strong>sruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be<br />

an uncompetitive inverse agonist for the thyrotropin receptor<br />

Rossi Mario, Donati E., Dimida A., Ferrarini E., Agretti P., Giorgi F., Corsini G.U., Pinchera<br />

A., Vitti P., Tonacchera M., Maggio R.<br />

Department of Neuroscience (M.R., E.D., F.G., G.U.C.) and Department of Endocrinology,<br />

Centre of Excellence for the Study of Damage to the Nervous and Endocrine Systems<br />

Produced by Environmental, Alimentary, and Pharmacological Agents, AmbiSEN (A.D., E.F.,<br />

P.A., A.P., P.V., M.T.), University of Pisa, Pisa, Department of Experimental Me<strong>di</strong>cine,<br />

University of L’Aquila, Italy<br />

pag_dx.indd 1 30/05/2007 5.05.19


16. Pharmacological characterisation of the urotensin-ii receptor ligands urantide and<br />

UFP-803 in CHO hUT cells<br />

Batuwangala Madura 1,3 , Camarda V. 1 , Marzola E. 2 , McDonald J. 3 , Lambert D. G. 3 , Ng L. 3 ,<br />

Guerrini R. 2 , Regoli D. 1 , Calo’ G. 1<br />

1 Dept. of Pharmacology and 2 Dept. of Pharmaceutical Sciences, University of Ferrara, 44100<br />

Ferrara, Italy. 3 Dept. of Car<strong>di</strong>ovascular Sciences, Division of Anaesthesia, Pharmacology and<br />

Therapeutics, University of Leicester, Leicester, LE2 7LX, UK<br />

17. Stimulation of ephrin B induces mo<strong>di</strong>fications of hippocampal synaptic plasticity in<br />

neonatal and adult rats<br />

Piccinin Sonia 1 , Cinque C. 1 , Calo’ L. 1 , Patanè M. 1 , Melchiorri D. 1 , Bashir Z. 3 , Eusebi F. 1,2. ,<br />

Nicoletti F. 1,2<br />

1 Department of Human Physiology and Pharmacology, University La Sapienza of Rome, Italy;<br />

2 I.N.M. Neuromed, Pozzilli, Italy; 3 MRC Centre for synaptic plasticity, Department of Anatomy,<br />

University of Bristol, UK<br />

18. PGE2 promotes egfr transactivation and squamous cell carcinoma growth by the<br />

NOS and ERK1/2 pathways<br />

Solito Raffaella, Ziche M., Morbidelli L.<br />

Section of Pharmacology, Department of Molecular Biology, University of Siena<br />

114<br />

19. Selective H3 receptor isoforms activate Akt/GSK axis and ERK in rat cortical<br />

neurons<br />

Mariottini Chiara 1 , Bongers G. 3 , Leurs R. 3 , Fossati S. 2 , Chiarugi A. 2 , Blan<strong>di</strong>na P. 2 , Passani<br />

M.B. 2<br />

1 Dipartimento <strong>di</strong> Fisiologia, V.le Morgagni 65, Firenze, Italy; 2 Dipartimento <strong>di</strong> Farmacologia<br />

Preclinica e Clinica, V.le Pieraccini 6, Firenze, Italy; 3 Department of Me<strong>di</strong>cinal Chemistry, Vrije<br />

Universiteit, Amsterdam, The Netherlands<br />

20. Nitric oxide/cGMP signaling pathway exerts tonic control on intraocular pressure<br />

(IOP) homeostasis in rabbits<br />

Bastia Elena, Guzzetta M., Bion<strong>di</strong> S., Impagnatiello F.<br />

Nicox Research Institute, Bresso, Milano, Italy<br />

I canali ionici ed i meccanismi <strong>di</strong> trasporto<br />

Poster 21 – 30<br />

21. The effects of acetazolamide on calcium activated k+ channels in skeletal muscle<br />

are me<strong>di</strong>ated by interaction with the alpha subunit<br />

Mele Antonietta 1 , Tricarico D. 1 , Latorre R. 2 , Torres Y. 2 , Conte Camerino D. 1<br />

1 Dept. of Pharmacobiology, Fac of Pharmacy,University of Bari, Bari Italy; 2 Centro de Estu<strong>di</strong>os<br />

Cientificos, Val<strong>di</strong>via, Chile<br />

22. Fluvastatin may induce a chronic reduction of the store operated calcium entry in<br />

striated fibres: an other brick in the wall of the hypolipedemic drugs' myotoxicity?<br />

Rolland Jean-Francois, Liantonio A., Conte Camerino D.<br />

Department Pharmaco-Biology, Faculty of Pharmacy, University of Bar<br />

23. Hydrophobicity of phenylalanine 1586 within the pore of the human Nav1.4 so<strong>di</strong>um<br />

channel is a determinant of local anesthetic bin<strong>di</strong>ng<br />

Desaphy Jean-François 1 , Dipalma A. 1 , Catalano A. 2 , Lentini G. 2 , Franchini C. 2 , Tortorella<br />

V. 2 , Conte Camerino D. 1<br />

1 Section of Pharmacology, Department of Pharmacobiology, Faculty of Pharmacy, University<br />

of Bari, Via Orabona 4 – campus, 70125 Bari, Italy; 2 Department of Me<strong>di</strong>cinal Chemistry,<br />

Faculty of Pharmacy, University of Bari<br />

pag_sx.indd 1 30/05/2007 5.06.32


24. Structural requirements of n-benzyl tocainide analogs for stereoselective and potent<br />

block of skeletal muscle so<strong>di</strong>um channels<br />

1 De Bellis Michela, 1 De Luca A., 2 Corbo F., 2 Muraglia M., 2 Franchini C., 2 Tortorella P., 1 Conte<br />

Camerino D.<br />

1 Unit of Pharmacology, Department of Pharmacobiology, Faculty of Pharmacy, University of<br />

Bari and 2 Department of Me<strong>di</strong>cal Chemistry, Faculty of Pharmacy University of Bari, Italy<br />

25. Cellular and subcellular localization of Na + -Ca 2+ exchanger (NCX) 1, 2 and 3 in<br />

central nervous system (CNS)<br />

Magi Simona 1 , Castaldo P. 1 , Salucci S. 3 , Gobbi P. 3 , Minelli A. 2 , Amoroso S. 1<br />

1 Section of Pharmacology, Department of Neuroscience, University “Politecnica delle Marche”,<br />

Ancona and Institute of 2 Physiological and 3 Morphological Sciences, University of Urbino “Carlo<br />

Bo”<br />

26. Transport of pyri<strong>di</strong>ne nucleotides across the plasma membrane in mammalian cells<br />

Ercolano Emanuela, Billington R. A, Condorelli F., Canonico P.L., Genazzani A.A.<br />

DiSCAFF, Università del Piemonte Orientale, Novara<br />

27. So<strong>di</strong>um calcium exchanger and so<strong>di</strong>um dependent glutamate transporters<br />

involvement in energy production, in rat heart<br />

1 Castaldo Pasqualina, 2 Rodolico G., 2 Piegari E., 1 Magi S., 1 Corcione E., 2 Berrino L., 1 Amoroso<br />

S.<br />

1 Section of Pharmacology, Department of Neuroscience, Università “Politecnica delle Marche”,<br />

Ancona; 2 Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology, Second University<br />

of Naples<br />

28. Taurine prevents the <strong>di</strong>suse-associated alteration of soleus muscle calcium<br />

homeostasis in the hindlimb-unloaded rats<br />

Giannuzzi Viviana, Liantonio A., Desaphy Jean-François, Pierno S., Conte Camerino D.<br />

Section of Pharmacology, Dept. of Pharmacobiology, University of Bari, Italy<br />

115<br />

29. Evaluation of the effects of a combined chronic treatment with atorvastatin and<br />

fenofibrate on rat skeletal muscle: an ex vivo electrophysiological and<br />

cytofluorimetric study<br />

Cippone Valentina, Giannuzzi V., Pierno S., Liantonio A., Conte Camerino D.<br />

Dept. of Pharmacobiology, Section of Pharmacology, Faculty of Pharmacy, University of Bari,<br />

Italy<br />

30. Pharmacological targeting of renal clc-k chloride channels: ligands structural<br />

requirements and therapeutic potential<br />

Liantonio Antonella 1 , Picollo A. 2 , Babini E. 2 , De Bellis M. 1 , Fracchiolla G. 3 , Carbonara G. 3 ,<br />

Tortorella P. 3 , Pusch M.l 2 , Conte Camerino D. 1<br />

1 Section of Pharmacology, Dept. of Pharmacobiology, University of Bari, Italy; 2 Institute of<br />

Biophysic-CNR, Genova, Italy; 3 Dept. of Me<strong>di</strong>cinal Chemistry, University of Bari, Italy<br />

Controllo farmacologico dei processi <strong>di</strong> morte e proliferazione cellulare<br />

Poster 31 – 45<br />

31. Endocannabinoids contribute to the neuroprotective effects of mGlu1 receptor<br />

antagonists against post-ischemic neuronal death<br />

Landucci Elisa, Scartabelli T., Cozzi A., Mannaioni G., Moroni F., Pellegrini G.D.<br />

Dipartimento <strong>di</strong> Farmacologia Preclinica e Clinica, Università <strong>di</strong> Firenze, Viale Pieraccini 6,<br />

50139 Firenze<br />

pag_dx.indd 1 30/05/2007 5.07.23


32. Transforming growth factor-1 protects rat cortical neurons against early and late -<br />

amyloid toxicity<br />

Caraci Filippo 1 , Copani A. 1 , Battaglia G. 2 , Nicoletti F. 2,3 , Sortino M.A. 4<br />

1 Dept. of Pharmaceutical Sciences, University of Catania ; 2 I.N.M. Neuromed, Pozzilli, Italy,<br />

3 Dept. of Human Physiology and Pharmacology, University of Rome ‘‘La Sapienza’’; 4 Dept. of<br />

Experimental and Clinical Pharmacology, University of Catania<br />

33. -Amyloid effects in <strong>di</strong>fferentiation and death of neural progenitor cell-derived<br />

neurons<br />

Calafiore Marco 1 , Giuffrida M.L. 1 , Sortino M.A. 2 , Copani A 1<br />

1 Department of Pharmaceutical Sciences,<br />

2 Department of Experimental and Clinical<br />

Pharmacology, University of Catania, Catania.<br />

34. Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of<br />

ischemic tolerance<br />

Scartabelli Tania, Landucci E., Moroni F., Pellegrini G.D.<br />

Dipartimento <strong>di</strong> Farmacologia Preclinica e Clinica, Università <strong>di</strong> Firenze, Viale Pieraccini 6,<br />

50139 Firenze.<br />

116<br />

35. Regulation of autophagy by the inositol trisphosphate receptor<br />

Maiuri Maria Chiara 1,2 , Criollo A. 2 , Tasdemir E. 2 , Carnuccio R. 1 , Kroemer G. 2<br />

1 Department of Experimental Pharmacology, Faculty of Biotechnological Sciences, University<br />

of Naples “Federico II”, Via D. Montesano 49, 80135 Napoli, Italy; 2 INSERM U848, University<br />

“Paris Sud”, Institut G. Roussy, 39 rue C. Desmoulins, F-94805 Villejuif, France<br />

36. Peripheral neuropathies: apoptosis-preventing activity of Acetyl-L-Carnitine<br />

Di Cesare Mannelli Lorenzo*, Ghelar<strong>di</strong>ni C.*, Vivoli E.*, Toscano A. § , Bartolini A.*<br />

* University of Florence, Dept. of Preclinical and Clinical Pharmacology, Viale Pieraccini 6,<br />

50139, Florence, Italy; § University of Florence, Dept. of Anatomy Hystology and Forensic<br />

Me<strong>di</strong>cine, Viale Morgagni 85, 50139, Florence, Italy<br />

37. Effects of combination treatment with azidothymi<strong>di</strong>ne and pharmacological<br />

inhibitors of NF-kB on apoptotic cell death in uninfected or virus-infected<br />

transformed cell lines<br />

3,5 Macchi Beatrice, 1 Minutolo A. 2 Matteucci C. , 1 , Balestrieri E. 3 Ascolani A. 4 Mastino A.<br />

1 Department of Experimental Me<strong>di</strong>cine and Biochemical Science, University of Rome “Tor<br />

Vergata”, Rome;<br />

2 Institute of Neurobiology and Molecular Me<strong>di</strong>cine, C.N.R., Rome;<br />

3 Department of Neuroscience, University of Rome “Tor Vergata”, Rome; 4 Department of<br />

Microbiological, Genetic and Molecular Sciences, University of Messina, Messina. 5 IRCCS Santa<br />

Lucia Rome, Italy<br />

38. Modulation of Bcl-2 expression by gemcitabine and nimesulide in human pancreatic<br />

tumor cell lines<br />

Longoni Biancamaria, Giovannetti A,, Bertacca L, Navarra T. , Mosca F.<br />

Department of Oncology, Transplantation and Advanced Technologies in Me<strong>di</strong>cine, University<br />

of Pisa<br />

39. Protective effect of levetiracetam versus oxygen stress -induced cell death in PC12<br />

and in SH-SY5Y cell lines<br />

1 Ascolani Arianna, 2 Matteucci C., 2 Balestrieri E, 3 Caltagirone C., 1,3 Macchi B.<br />

1 Department of Neuroscience, University of Rome “Tor Vergata”, Rome, Italy. 2 Department of<br />

Experimental Me<strong>di</strong>cine and Biochemical Science, University of Rome “Tor Vergata”, Rome,<br />

Italy. 3 IRCCS S. Lucia Rome, Italy<br />

pag_sx.indd 1 30/05/2007 5.08.31


40. Role of reactive oxygen species (ROS) in the antiapoptotic effect of oxysterols on<br />

human umbilical vein endothelial cells (HUVEC)<br />

Poggiani Chiara, Agnoletto L., Cusinato F., Trevisi L., Luciani S.<br />

Department of Pharmacology and Anaestesiology, University of Padova<br />

41. Hydrogen peroxide-dependent ERK1/2 dephosphorylation me<strong>di</strong>ates toxicity via<br />

upstream inhibition of the survival signalling in U937 cells exposed to peroxynitrite<br />

Cerioni Liana, Cantoni O.<br />

Institute of Pharmacology and Pharmacognosy, University of Urbino “Carlo Bo”<br />

42. Subnormothermic machine perfusion reduces necrosis and apoptosis and improves<br />

energy status during preservation of steatotic rat livers: implications for<br />

transplantation<br />

1 Ferrigno Andrea, 2 Rizzo V., 3 Carlucci F., 3 Tabucchi A., 4 Boncompagni E., 1 Richelmi P., 5 Cillo U,<br />

4 Freitas I., 1 Vairetti M.<br />

1 Dept. Int. Med. and Therapeutics and 2 Dept. of Biochemistry, IRCCS San Matteo, Univ. of<br />

Pavia; 3 Dept. Int. Med., Univ. of Siena, 4 Dept. of Animal Biology and IGM-CNR, Univ. of Pavia,<br />

5 Dept. General Surgery, Univ. of Padua<br />

43. A pathogenetic hypothesis of Unverricht-Lundborg <strong>di</strong>sease onset and progression<br />

Buzzi Andrea b , Franceschetti S. a , Sancini G. a , Zucchini S. b , Para<strong>di</strong>so B. b , Magnaghi G. a ,<br />

Frassoni C. a , Chikhladze M. a , Avanzini G. a , Simonato M. b<br />

a Neurological Institute “C. Besta”, Milan, Italy; b University of Ferrara, Italy<br />

44. Antiapoptotic effects of green tea polyphenol epigallocatechin-3-gallate (EGCG) on<br />

ischemic injury of the rat retina<br />

Tamburella Alessandra, Leggio G.M., Drago F.<br />

Department of Experimental and Clinical Pharmacology, University of Catania, Catania, Italy<br />

117<br />

45. Melanocortins improve wound healing in experimental burn injury<br />

Bazzani Carla 1 , Giuliani D. 1 , Mioni C. 1 , Galantucci M. 1 , Zaffe D. 2 , Minutoli L. 3 , Bitto A. 3 ,<br />

Botticelli A. R. 4 , Altavilla D. 3 , Squadrito F. 3 , Guarini S. 1<br />

1 Dept. Biome<strong>di</strong>cal Sciences, Sect. Pharmacology, and 2 Dept. Anatomy and Histology,<br />

University of Modena and Reggio Emilia; 3 Dept. Clinical Exp. Me<strong>di</strong>cine and Pharmacology,<br />

Sect. Pharmacology, University of Messina; 4 Dept. Human Pathology, University of Pavia<br />

Farmacologia della trasmissione sinaptica<br />

Poster 46 – 53<br />

46. Muscarinic control of parasympathetic activity in isolated porcine airways:<br />

involvement of M1/M2 muscarinic autoreceptors<br />

Con<strong>di</strong>no A.M., Barbieri A., Zonta F., D’Agostino G.<br />

Department of Experimental and Applied Pharmacology, School of Pharmacy, University of<br />

Pavia, Via Taramelli 14, I-27100 Pavia, Italy<br />

47. Hierarchical control of dopamine neuron-firing patterns by neuronal nicotinic<br />

receptors<br />

Mameli-Engvall Monica 1,2,3 , Evrard A. 2 , Pons S. 2 , Maskos U. 2 , Svensson H.T. 1 , Changeux J-P. 2 ,<br />

Faure P. 2<br />

1 Karolinska Institute, Dept. Physiology and Pharmacology, S-17177 Stockholm, Sweden;<br />

2 Institut Pasteur, Unité Récepteurs et Cognition, URA CNRS 2182, Paris Cedex 15, France ;<br />

3 EDX Diagnostics SPA, Sardegna Ricerche, Localita’ Piscinamanna, Ed.3, 09010 Pula, Italy<br />

pag_dx.indd 1 30/05/2007 5.09.24


48. The release of endocannabinoids in the CA1 hippocampal area is modulated by<br />

mGlu1 receptors: a patch clamp study<br />

Mannaioni Guido, Baccini G., Landucci E., Moroni F., Pellegrini G.D.<br />

Dipartimento <strong>di</strong> Farmacologia Preclinica e Clinica, Università <strong>di</strong> Firenze, Viale Pieraccini 6,<br />

50139 Firenze<br />

49. Evidence for a possible interaction between cannabinoid and serotonergic systems<br />

in modulating inhibitory synaptic transmission in basolateral amygdala<br />

Domenici M.R. 1 , Marsicano G. 2 , Azad S.C. 3 , Lutz B. 4 , Popoli P. 1 , Zieglgänsberger W. 3 , Rammes<br />

G. 3<br />

1 Dep. Drug Res and Evaluation, Istituto Superiore <strong>di</strong> Sanità, Rome, Italy ; 2 Centre de<br />

Recherche INSERM François Magen<strong>di</strong>e, Bordeaux, France; 3 Max-Planck Institut for Psychiatry,<br />

Munich, Germany; 4 Dep of Physiological Chemistry,Johannes Gutenberg University, Mainz,<br />

Germany<br />

50. Pharmacological characterization of a new non-imidazole histamine H 3 antagonist<br />

Flammini Lisa, Bertoni S., Saccani F., Ballabeni V., Impicciatore M., Barocelli E.<br />

Department of Applied Pharmacological, Biological and Chemical Sciences, University of<br />

Parma, V.le GP Usberti 27/a, Parma<br />

118<br />

51. Serotonin efflux from rat dorsal raphe nucleus slices: modulation by corticotropin<br />

releasing factor<br />

Marino Silvia, Nazzaro C., Siniscalchi A.<br />

Department of Clinical and Experimental Me<strong>di</strong>cine University of Ferrara Via Fossato <strong>di</strong><br />

Mortara, 17-19 44100 Ferrara<br />

52. Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following<br />

noradrenaline depletion<br />

Macheda Teresa 1 , Cassano T. 1 , Morgese M.G. 1 , Trabace L. 1 , Cuomo V. 2 , Gobbi G. 3<br />

1 Department of Biome<strong>di</strong>cal Sciences, University of Foggia, Italy;<br />

2 Department of<br />

Pharmacology and General Physiology, University of Rome, ‘La Sapienza’, Italy; 3 Dept. of<br />

Psychiatry, McGill University, Montréal, Qc, Canada<br />

53. Functional proteomics of neuroplasticity-related signaling in a rat model of<br />

depression with gene-enviroment interaction<br />

Musazzi Laura 1 , Giambelli R. 1,2 , Tar<strong>di</strong>to D. 1 , Caffino L. 1 , El Khoury A. 3 , Mathé A. 3 , Racagni<br />

G. 1 , Popoli M. 1<br />

1 Center of Neuropharmacology-Department of Pharmacological Sciences, University of Milano,<br />

Italy; 2 Department of Experimental and Clinical Pharmacology, School of Me<strong>di</strong>cine, University<br />

of Catania, Catania (Italy); 3 Karolinska Institutet, Inst. of Clinical Neuroscience, Karolinska<br />

Hospital Hud<strong>di</strong>nge, Stockholm (Sweden)<br />

Farmacologia car<strong>di</strong>ovascolare<br />

Poster 54 – 72<br />

54. Endothelial cells response to polyethylene terephthalate surfaces activated by<br />

irra<strong>di</strong>ation<br />

Pezzatini Silvia 1 , Satriano C. 2 , Morbidelli L. 1 , Ziche M. 1<br />

1 Pharmacology section, Dept Molecular Biology, University of Siena, Via A. Moro 2, 53100<br />

Siena, Italy; 2 Laboratory for Molecular Surfaces and Nanotechnologies and CSGI, Dept. of<br />

Chemical Sciences, University of Catania, viale A. Doria 6, 95025 Catania, Italy<br />

55. Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 (TIMP-4)<br />

favouring coronary endothelial cell motility<br />

Monti Martina, Donnini S., Morbidelli L., Ziche M.<br />

Laboratory of Angiogenesis, Department of Molecular Biology, University of Siena<br />

pag_sx.indd 1 30/05/2007 5.10.44


56. Ace inhibitor-induced angiogenesis in coronary endothelium is me<strong>di</strong>ated by<br />

Fibroblast growth factor-2<br />

Donnini Sandra, Giachetti A., Ziche M., Morbidelli L.<br />

Laboratory of Angiogenesis, Dept. Molecular Biology, University of Siena, Siena, Ital<br />

57. Membrane proteins involved in flavonoid transport in endothelial cells<br />

Maestro Alessandra , Terdoslavich M. , Petris G. , Passamonti S. , Decorti G. <br />

Department of Biome<strong>di</strong>cal Sciences and Department of Biochemistry, Biophysics and<br />

Chemistry of Macromolecules, University of Trieste, Trieste<br />

58. A nitric oxide releasing pravastatin derivative, NCX 6550, improves vascular<br />

response in human and hypertensive rat vessels<br />

Presotto C., Miglietta D., Olivieri R., Uzzo M., Vago T.*, Gelpi G. # , Monopoli A.<br />

Nicox Research Institute, Bresso, Milan, Italy; * Department of Endocrinology, University<br />

Hospital “L.Sacco”, Milan; # Division of Car<strong>di</strong>ovascular Surgery, “L.Sacco” Hospital, Milan<br />

59. Nebivolol induces nitric oxide productione in the heart<br />

Maffei A. 1 , Poulet R. 1 , Di Pardo A. 1 , Carangi R. 1 , Carullo P. 1 , Gentile M.T. 1 , Lembo G. 1,2<br />

1 IRCCS Neuromed, Pozzili (IS); 2 La Sapienza University, Rome<br />

60. Role of protein kinase C and Rho kinase in the rat-selective vasoconstrictor effect of<br />

normormide<br />

1 Cavalli Maurizio, 2 Papparella I., 2 Ceolotto G., 1 Bova S.<br />

1 Department of Pharmacology and Anesthesiology, University of Padova; 2 Department of<br />

Clinical and Experimental Me<strong>di</strong>cine, University of Padova<br />

61. Hydrogen sulphide involvement in vascular tone in <strong>di</strong>abetic rats<br />

D’Emmanuele <strong>di</strong> Villa Bianca Roberta, Sorrentino R., Miti<strong>di</strong>eri E., Sorrentino R.<br />

Department of Experimental Pharmacology, University of Naples Federico II<br />

119<br />

62. Hyperglycemia-me<strong>di</strong>ated overexpression of cyclooxygenase-2 (COX-2) participates<br />

in vascular hyporeactivity of streptozotocin-induced type I <strong>di</strong>abetes<br />

Tarquinio Mariela, Nacci C., De Bene<strong>di</strong>ctis L., Montagnani M.<br />

Department of Pharmacology and Human Physiology - Me<strong>di</strong>cal School - University of Bari,<br />

70124 Bari, ITALY<br />

63. Neutrophil-dependent cerebral oedema in normal and <strong>di</strong>abetic rat: role of<br />

transcellular synthesis of cysteinil leukotrienes<br />

Brivio Ivan, Buccellati C., Di Gennaro A., Folco G., Sala A.<br />

Center for Car<strong>di</strong>opulmonary Pharmacology, Dep. of Pharmacological Sciences, University of<br />

Milan<br />

64. Angiotensin ii involvement in remodelling of carotids subjected to pressure overload<br />

Bianco Giuseppe 1 , Miti<strong>di</strong>eri E. 2 , D’Emmanuele <strong>di</strong> Villa Bianca R. 2 , Pinto A. 1 , Autore G. 1 ,<br />

Sorrentino R. 2<br />

1 Dipartimento <strong>di</strong> Scienze Farmaceutiche, Università <strong>di</strong> Salerno, Salerno; 2 Dipartimento <strong>di</strong><br />

Farmacologia Sperimentale, Università <strong>di</strong> Napoli, Federico II<br />

65. Evaluation of the effect of two <strong>di</strong>fferent doses of aspirin in patients undergoing<br />

coronary artery bypass graft (CABG)<br />

Brambilla Marta 1 , Centenaro C. 2 , Tremoli E. 1,2 , Parolari A. 2 , Camera M. 1,2<br />

1 Dept. Pharmacological Sciences, University of Milan; 2 Centro Car<strong>di</strong>ologico Monzino IRCCS,<br />

Milan, Italy<br />

pag_dx.indd 1 30/05/2007 5.11.54


66. Polydeoxyribonucleotide (PDRN) increases vegf production and blood flow in an<br />

experimental model of hind limb ischemia in rats<br />

Fiumara Tiziana 1 , Polito F. 1 , Bitto A. 1 , Minutoli L. 1 , Di Stefano V. 1 , Altavilla D. 1 , Cattarini G. 2 ,<br />

Caputi A.P 1 , Squadrito F. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina<br />

and 2 Mastelli srl, Sanremo, Italy<br />

67. Hydrogen sulfide (H 2 S) inhibits aggregation of human platelets<br />

Zagli Giovanni 1 , Patacchini R. 2 , Trevisani M. 1 , Abbate R. 1 , Cinotti S. 1 , Gensini GF. 1 , Masotti<br />

G. 1 , Geppetti P. 1<br />

1 Department of Critical Care Me<strong>di</strong>cine & Surgery, University of Florence, Florence, Italy;<br />

2 Department of Pharmacology, Chiesi Pharmaceuticals, Parma, Italy<br />

68. SERCA2 pump expression and phosphorilated phospholamban in mechanicalinduced<br />

ventricular hypertrophy in rats<br />

Popolo Ada, Morello S., 1 D’Emmanuele <strong>di</strong> Villa Bianca R., Marzocco S., 1 Sorrentino R., Autore<br />

G., Pinto A.<br />

Department of Pharmaceutical Sciences, University of Salerno; 1 Department of Experimental<br />

Pharmacology, University of Napoli “Federico II”<br />

120<br />

69. Nitric oxide donors: anti-aggregating effects and mechanisms of inhibition of<br />

platelet aggregation<br />

Priora Raffaella, Margaritis A., Frosali S., Summa D., Di Giuseppe D., Di Simplicio P.<br />

Department of Neuroscience, Pharmacology Unit, University of Siena<br />

70. Effects of hyperbaric oxygen therapy on thrombocytopenia and platelet aggregation<br />

during an experimental model of multiple organ failure syndrome<br />

Donniacuo Maria 1 , Rinal<strong>di</strong> B. 2 , Capuano A. 2 , Liguori G. 2 , Imperatore F. 2 , Cuzzocrea S. 3 ,<br />

Filippelli A. 2 , Rossi F. 2<br />

1 Doctorate in Pharmacological Sciences and Respiratory Physiopathology, Second University of<br />

Naples, Italy; 2 Department of Experimental Me<strong>di</strong>cine and Excellence Center of Car<strong>di</strong>ovascular<br />

Disease, Second University of Naples, Italy; 3 Department of Clinical and Experimental<br />

Me<strong>di</strong>cine and Pharmacology, University of Messina, Italy<br />

71. Proximal and <strong>di</strong>stal effects of arteriotomy in rat carotids: an extensive microarray<br />

analysis of gene expression<br />

1 Finicelli Mauro, 1 Forte A., 4 De Luca P., 2 Santè P., 2 Quarto C., 3 Onorati F., 3 Renzulli A.,<br />

1 Galderisi U., 2 Cotrufo M., 1 Cipollaro M., 1 Cascino A., 1 Rossi F., 1 Berrino L.<br />

Dept. of 1 Exp. Me<strong>di</strong>cine and 2 Car<strong>di</strong>othoracic Sciences, Second University of Naples; 3 Unit of<br />

Car<strong>di</strong>ac Surgery, University Magna Graecia, Catanzaro; 4 BIOGEM S.c.a.r.l., Ariano Irpino<br />

72. Effect of carbon nanotubes on human platelets<br />

Russier Julie § , Togna A. R. § , Togna G. I § , Serafino A.*, Almairac R.**, Fiorito S. <br />

§ Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”;<br />

*Institute of Neurobiology and Molecular Me<strong>di</strong>cine, CNR, Rome; **Laboratoire des Colloides,<br />

Verres, et Nanomateriaux,CNRS - University of Montpellier II; Department of Experimental<br />

Me<strong>di</strong>cine University of Rome “La Sapienza” - CNR<br />

pag_sx.indd 1 01/06/2007 15.29.05


Farmaci per la riduzione del rischio car<strong>di</strong>ovascolare<br />

Poster 73 – 80<br />

73. Antiatherosclerotic properties of everolimus: in vitro and in vivo stu<strong>di</strong>es<br />

Corsini A., Bellosta S., Baetta R., Ferri N., Arnabol<strong>di</strong> L., Canavesi M., Pfister P.*,Granata A.,<br />

Dorent R.*<br />

Department of Pharmacological Sciences, University of Milan, Milan, Italy; *Novartis Pharma<br />

AG, Basel, Switzerland<br />

74. Infection and atherosclerosis: simvastatin lowers the risk of developing<br />

atherosclerosis by limiting coxsackievirus B infection and the expression of proinflammatory<br />

markers in human vascular endothelial cells<br />

Ferioli Elena*, Bottelli A.*, Armocida G.*, Conal<strong>di</strong> P.G.°<br />

*Department of Me<strong>di</strong>cine and Public Health, University of Insubria, Varese, Italy; °ISMETT,<br />

Palermo, Italy<br />

75. In vivo stimulation of LXR increases the efflux potential of sera and promotes the<br />

reverse cholesterol transport<br />

Zanotti Ilaria, Potì F., Pedrelli M., Favari E., Calabresi L.*, Moleri E.*, Bernini F.<br />

Dept. of Pharmacological and Biological Sciences and Applied Chemistries, University of<br />

Parma, Parma, and *Center E. Grossi Paoletti, Dept. of Pharmacological Sciences, University<br />

of Milan, Milan<br />

76. Role of mesna to reduce homocysteine levels through SH/SS exchange reaction:<br />

possible therapeutical applications in hyperhomocysteinemic patients<br />

Di Giuseppe Daniele, Frosali S., Priora R., Margaritis A., Summa D., Di Simplicio P.<br />

Department of Neuroscience, Pharmacology Unit, University of Siena<br />

121<br />

77. Protein-thiol substitution or protein dethiolation by SH/SS echange reactions: the<br />

albumin model<br />

Di Simplicio Paolo, Summa D., Ottavia S., Priora R., Frosali S., Margaritis A., Di Giuseppe D.,<br />

Niccolai N.<br />

Department of Neuroscience, Pharmacology Unit, and Dept of Molecular Biology, University of<br />

Siena, 53100 Siena, Italy; *Department of Molecular Biology, University of Siena, 53100<br />

Siena, Italy<br />

78. Flaxseed oil supplementation increases plasma and tissue concentrations of ( -3)<br />

fatty acids in rats<br />

Notarangelo Francesca § , Avallone R. § , Rustichelli C. # , Campioli E. § , Braghiroli D. # , Baral<strong>di</strong> M. §°<br />

§ Department of Biome<strong>di</strong>cal Sciences, # Department of Pharmaceutical Sciences, Via Campi<br />

287, 41100 Modena, Italy, Pharmacology, °National InterUniversity Consortium for the Study<br />

of Natural Active Principles (CINSPAN)<br />

79. Synthesis and preliminary biological evaluation of new partially fluorinated thiol<br />

dual inhibitors of neutral endopeptidase 24.11 and angiotensin converting enzyme<br />

Tambaro Simone a , Olimpieri F. b , Lazzari P. a , Volonterio A. b , Pittau B. a , Pani L. a,c , Zanda M b<br />

a Neuroscienze PharmaNess S.c.a r.l., c/o POLARIS, E<strong>di</strong>ficio 5, Loc.Piscinamanna, 09010 Pula<br />

(CA), Italy; b C.N.R. Istituto <strong>di</strong> Chimica del Riconoscimento Molecolare, Via Mancinelli 7,<br />

20131 Milano, Italy; d C.N.R. Istituto <strong>di</strong> Tecnologie Biome<strong>di</strong>che, Sezione <strong>di</strong> Cagliari, c/o<br />

Neuroscienze PharmaNess S.c.a r.l.<br />

80. Car<strong>di</strong>oprotective activity of sidenafil in rats with chronic nitric oxide synthase<br />

inhibition<br />

Manfre<strong>di</strong> Barbara, De Gennaro Colonna V., Berti F., Rossoni G.<br />

Department of Pharmacology, Chemotherapy and Me<strong>di</strong>cal Toxicology, University of Milan,<br />

Italy<br />

pag_dx.indd 1 30/05/2007 5.15.49


Farmacologia del sistema nervoso<br />

Poster 81 – 110<br />

81. Nociceptin/Orphanin FQ-induced inhibition of electrical activity in dorsal raphe<br />

nucleus slices from normal and stressed rats<br />

Siniscalchi Anna, Barbieri M., Nazzaro C., Beani L.<br />

Department of Clinical and Experimental Me<strong>di</strong>cine University of Ferrara, Via Fossato <strong>di</strong><br />

Mortara, 17-19; 44100 Ferrara<br />

82. Pharmacological characterization of the Nociceptin/Orphaninn FQ receptor<br />

antagonist SB-612111: in vivo stu<strong>di</strong>es<br />

1 Rizzi Anna, 1 Gavioli E., 1 Marzola G., 1 Spagnolo B., 1 Zucchini S., 2 Ciccocioppo R., 3 Trapella C.,<br />

1 Regoli D., 1 Calo’ G.<br />

1 Dept. of Pharmacology and 3 Dept of Pharmaceutical Science, University of Ferrara, Italy;<br />

2 Dept. of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, Italy<br />

83. Functional antagonism between Nociceptin/Orphanin FQ (N/OFQ) and CRF in the<br />

rat brain: evidence for involvement of the bed nucleus of the stria terminalis<br />

Ro<strong>di</strong> Donata (1) , Zucchini S. (1) , Simonato M. (1) , Cifani C. (2) , Massi M. (2) , Polidori C. (2)<br />

1)<br />

Department of Clinical and Experimental Me<strong>di</strong>cine, Pharmacology Section, and Neuroscience<br />

Centre, University of Ferrara; 2) Department of Experimental Me<strong>di</strong>cine and Publich Health,<br />

University of Camerino<br />

122<br />

84. Anticonvulsant effects of orphanin FQ on seizures induced by pentylenetetrazole<br />

Di Giannuario Amalia 1 , Colucci M. 1 , Maione F. 1,2 , Mascolo N. 2 , Pieretti S. 1<br />

1 Department of Drug Research and Evaluation, Istituto Superiore <strong>di</strong> Sanità, V.le Regina Elena<br />

299 - 00161 Rome. 2 Department of Experimental Pharmacology, University of Naples Federico<br />

II, Via Domenico Montesano 49 - 80131 Naples<br />

85. Effect of novel Nociceptin/Orphanin FQ-NOP receptor ligands on food intake in<br />

wistar rats<br />

Cifani Carlo a , Polidori C. a , Calò G. b , Massi M. a<br />

a Department of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, I-62032,<br />

Camerino, Italy; b Department of Experimental and Clinical Me<strong>di</strong>cine, Section of Pharmacology<br />

and Neuroscience Center, University of Ferrara, I-44100 Ferrara, Italy<br />

86. Chronic i.c.v. Treatment with [Nphe 1 , Arg 14 , Lys 15 ] N/OFQ-NH 2 (UFP-101), a potent<br />

nop receptor antagonist, reverses behavioural and biochemical effects of chronic<br />

mild stress in rats<br />

Vitale Giovanni a , Ruggieri V. a , Frigeri C. a , Filaferro M. a , Guerrini R. b , Massi M. c<br />

a Department of Biome<strong>di</strong>cal Sciences, Section of Pharmacology, University of Modena and<br />

Reggio Emilia; b Department of Pharmaceutical Sciences , University of Ferrara; c Department<br />

of Pharmacological Sciences and Experimental Me<strong>di</strong>cine, University of Camerino<br />

87. Nociceptin/Orphanin FQ and food intake in <strong>di</strong>sease-prone WOKW and <strong>di</strong>seaseresistant<br />

DA rats<br />

a Cifani Carlo, a Filippetti R., b Kloting I., a Massi M., a Polidori C.<br />

a Department of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, I-62032<br />

Camerino, Italy - b Department of Laboratory Animal Science, Me<strong>di</strong>cal Faculty, University of<br />

Greifswald, D-17495 Karlsburg, Germany<br />

pag_sx.indd 1 30/05/2007 5.36.18


88. The neuro<strong>di</strong>fferentiative effect of estrogen involves nuclear receptors and is<br />

me<strong>di</strong>ated by TGF-<br />

Merlo Sara 1,2 , Canonico P.L. 2 , Copani A. 3 , Sortino M.A. 1<br />

Departments of 1 Experimental and Clinical Pharmacology and 3 Pharmaceutical Sciences,<br />

University of Catania, and 2 DISCAFF, University of Piemonte Orientale, Novara<br />

89. Erythropoietin inhibts the release, but not synthesis, of corticotropin-releasing<br />

hormone from rat hypothalamic explants in vitro<br />

Tringali Giuseppe, Lisi L., Pozzoli G., Navarra P.<br />

Institute of Pharmacology, Catholic University Me<strong>di</strong>cal School, Rome, Italy<br />

90. Neurochemical effects of post-weaning social isolation in adult rat brain<br />

Colaianna Marilena (a) , De Giorgi A. (a) , Cuomo V. (b) , Trabace L. (a)<br />

(a) Dept. Biome<strong>di</strong>cal Sciences, University of Foggia, Foggia, Italy; (b) Dept. of Human Physiology<br />

and Pharmacology, Vittorio Espamer, University of Rome La Sapienza, Rome, Italy<br />

91. Strain-dependent levels of biogenic amine in post-weaning socially-isolated rats<br />

Castrignanò Silvia (a) , Zotti M. (a) , Cuomo V. (b) , Trabace L. (a)<br />

(a) Dept. of Biome<strong>di</strong>cal Sciences, University of Foggia; (b) Dept. of Human Physiology and<br />

Pharmacology, Vittorio Espamer, University of Rome La Sapienza, Rome, Italy<br />

92. Selective volume reduction of anterior cingulate cortex in young adult rats after<br />

neonatal excitotoxic lesion of ventral hippocampus<br />

Casu Gianluca * , Marchese G. * , Casti P. * , Pinna Spada G. * , Pani L. *<br />

§* Neuroscienze PharmaNess S.c.a r.l., c/o POLARIS, E<strong>di</strong>ficio 5, Loc.Piscinamanna, 09010 Pula<br />

(CA), Italy; § C.N.R. Istituto <strong>di</strong> Tecnologie Biome<strong>di</strong>che, Sezione <strong>di</strong> Cagliari, c/o Neuroscienze<br />

PharmaNess S.c.a r.l.<br />

123<br />

93. Acute but not chronic treatment with olanzapine reduces experimental anxiety in<br />

rats: possible mechanisms<br />

Locchi Federica, Rimon<strong>di</strong>ni R., Dall’Olio R., Gandolfi O.<br />

Department of Pharmacology, University of Bologna, 40128 Bologna, Italy<br />

94. Gender <strong>di</strong>fferences on long term effects of rat prenatal stress on dorsal and ventral<br />

hippocampal metabotropic glutamate receptors and anxiety behaviour<br />

Zuena Anna Rita 1,2 , Casolini P. 1 , Mairesse J. 1,2 , Cinque C. 1 , Matteucci P. 1 , Alemà G.S. 1 , Morley-<br />

Fletcher S. 2 , Catalani A. 1 , Nicoletti F. 1,3 , Maccari S. 2<br />

1 Dept of Human Physiology and Pharmacology, Univesity of Rome “La Sapienza”, Italy; 2 Lab<br />

of Perinatal Stress, University of Lille 1, France; 3 INM Neuromed, Pozzilli, Italy<br />

95. Post-natal repeated mild stress induces changes in brain NAD(P)H recycling in adult<br />

male mice: role of the opioid system<br />

Loizzo Stefano, Guarino I., Galietta G., Fortuna A., Loizzo A., Spampinato S., Campana G.,<br />

Capasso A., Franconi F.<br />

Section of Drugs and Health for the Child and the Woman, Dept of Drug Research and<br />

Evaluation, and National Centre for Rare Diseases, Istituto Superiore <strong>di</strong> Sanita’, Roma, Dept<br />

of Pharmacology, University of Bologna, Dept of Pharmacology, University of Salerno, Dept of<br />

Pharmacology and Centre of Excellence for Biotechnology and Bio<strong>di</strong>versity University of<br />

Sassari, and GIOIA Foundation<br />

96. Changes in hippocampal gene expression profile following acute and chronic stress<br />

in the mouse<br />

Ubal<strong>di</strong> Massimo 1 , Lourdusamy A. 1 , Soverchia L. 1 , Cippitelli A. 1 , Ruggeri B. 1 , Har<strong>di</strong>man G. 2 ,<br />

Ciccocioppo R. 1<br />

1 Department of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino Italy;<br />

2 Department of Me<strong>di</strong>cine, University of California San Diego, CA, USA<br />

pag_dx.indd 1 30/05/2007 5.33.54


97. Treatment of premenstrual syndrome with continuous low dosage sertralin<br />

Tammaro Emanuela*, Milano W., Milano L., Rundle-Smith S., Petrella C., Capasso A.*<br />

Mental Health Operations Unit District 44 ASL Napoli 1 and *Department of Pharmaceutical<br />

Sciences, University of Salerno, Italy<br />

98. Novel therapeutic opportunities in unipolar depression<br />

Corsi Mauro, W.P.<br />

Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithkline S.p.A., Verona, Italy<br />

99. Lifestyle interventions on bodyweight gain olanzapine-induced: result from a<br />

randomized-controlled trial<br />

Cammarano Michela*, Milano W., Comazzi M.°, Milano L., Petrella C., Capasso A.*<br />

Unità Operativa Salute Mentale Distretto 44 ASL Napoli1; * Department of Pharmaceutical<br />

Sciences, University of Salerno, Italy; ° Unità <strong>di</strong> Psichiatria Azienda Ospedaliera <strong>di</strong> Melegnano<br />

Milano<br />

124<br />

100. Tolerability of antipsychotics in children and adolescents: a prospective study<br />

Alacqua Marianna 1 , Trifirò G. 1,4 , Arcoraci V. 1 , Germanò E. 2 , Gagliano A. 2 , Siracusano M. 2 , Di<br />

Vita G. 3 , Gagliano C. 3 , Spina E. 1, 4<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Pharmacology Unit,<br />

University of Messina, Italy - 2 Division of Child Neurology and Psychiatry, University of<br />

Messina, Italy - 3 Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS),<br />

Troina, Italy; 4 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy<br />

101. Plasma concentrations of quetiapine during coadministration with antiepileptic<br />

drugs in psychiatric patients<br />

D’Arrigo Concetta 1 , Migliar<strong>di</strong> G. 1 , Santoro V. 2 , Muscatello M.R. 3 , Zoccali R. 3 , Spina E 1,2<br />

1 Section of Pharmacology, Department of Clinical and Experimental Me<strong>di</strong>cine and<br />

Pharmacology, 2 IRCCS Centro Neurolesi “Bonino-Pulejo” and 3 Department of Neurosciences,<br />

Psychiatric and Anesthesiological Sciences, University of Messina, Messina, Italy<br />

102. Potential application of testosterone metabolites in the treatment of<br />

adrenoleukodystrophy<br />

Carissimi Romina 1 , Blasevich M. 1 , Cappa M. 2 , Uziel G. 3, Petroni A. 1<br />

1 Depart. of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133 Milan, Italy;<br />

2 Depart. of Pe<strong>di</strong>atrics Me<strong>di</strong>cine, Children’s Hospital “Bambino Gesù”, IRCCS, Rome, Italy;<br />

3 Child Neurology Dep., Istituto Neurologico “C. Besta”, Milan, Italy<br />

103. Development of specific biomarkers for als clinical progression: validation and<br />

potential roles in pathogenesis<br />

Bonini Sara A. 1 , Zhao Z. 2 , Lange D. J 3 ., Ho L. 2 , Yemul S. 2 , Wang J. 2 , Salton S. 4 , Memo M. 1 ,<br />

Pasinetti G.M. 2<br />

1 Department of Biome<strong>di</strong>cal Sciences and Biotechnologies, University of Brescia, Brescia, Italy;<br />

2 Department of Psychiatry, 3 Department of Neurology, 4 Department of Neuroscience, Mount<br />

Sinai School of Me<strong>di</strong>cine, New York, New York, USA<br />

pag_sx.indd 1 30/05/2007 5.37.18


104. Functional heterogeneity of histaminergic neurons suggest interesting applications<br />

of GSK189254, a novel H 3 receptor antagonist<br />

Giannoni Patrizia 1 , Passani M.B. 1 , Nosi D. 2 , Medhurst A.D. 3 , Chazot P. 4 , Shenton F. 4 ,<br />

Blan<strong>di</strong>na P. 1<br />

1 Dipartimento <strong>di</strong> Farmacologia Preclinica and Clinica, 2 Dipartimento <strong>di</strong> Anatomy Universita’ <strong>di</strong><br />

Firenze Italy, 3 Neurology Centre of Excellence for Drug Discovery,GlaxoSmithKline,Essex<br />

CM19 5AW, UK, 4 Centre for Integrative Neuroscience, School of Biological and Biome<strong>di</strong>cal<br />

Sciences, Durham University, UK<br />

105. Improvements in long-term memory retention by inhibition of fatty acid amide<br />

hydrolase (FAAH) are me<strong>di</strong>ated by -type peroxisone proliferator-activated<br />

receptors (PPAR) And not by cannabinoid CB 1 receptors<br />

Mazzola C 1 , Medalie J. 1 , Panlilio L.V. 1 , Solinas M. 2 , Drago F. 3 , Goldberg S.R. 1 , Yasar S. 4<br />

1 Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch, Intramural<br />

Research Program, NIDA, NIH, DHHS, Baltimore, MD, 21224, USA. 2 Department Laboratoire<br />

de Biologie et Physiologie Cellulaires, CNRS-6187, Université de Poitiers, 86022, Poitiers,<br />

France. 3 Department of Experimental and Clinical Pharmacology, Me<strong>di</strong>cal School, University of<br />

Catania, Italy. 4 Division of Geriatric Me<strong>di</strong>cine, Johns Hopkins Me<strong>di</strong>cal School, Baltimore, MD,<br />

21224, USA<br />

106. Tricyclic pyrazoles. Synthesis and biological evaluation of novel 4,5-<strong>di</strong>hydro-1H-6-<br />

oxa-cyclohepta[1,2-c]pyrazole-based analogues of cannabinoid antagonist NESS<br />

0327<br />

Dessì Christian ‡ , Murineddu G. † , Ruiu S. ‡ , Loriga G. † , Manca I. † , Lazzari P. ‡ , Pau A. † ,<br />

Reali R. ‡ , Pinna G.A. † , Pani L. ‡,§<br />

‡ Neuroscienze PharmaNess S.c.a r.l., c/o POLARIS, E<strong>di</strong>ficio 5, Loc.Piscinamanna, 09010 Pula<br />

(CA), Italy; † Dipartimento Farmaco Chimico Tossicologico, Università <strong>di</strong> Sassari, Via F. Muroni<br />

23/A, 07100 Sassari, Italy; § C.N.R. Istituto <strong>di</strong> Tecnologie Biome<strong>di</strong>che, Sezione <strong>di</strong> Cagliari, c/o<br />

Neuroscienze PharmaNess S.c.a r.l.<br />

125<br />

107. Early and late post-mortem neural stem cells grow and <strong>di</strong>fferentiate in vitro. A novel<br />

source for cellular therapy<br />

Madaschi Laura 1* , Marfia G. 1* , Cigognini D. 1 , Bottai D. 1,2 , Di Giulio A.M. 1 , Gorio A. 1,2<br />

1) Dept. of Me<strong>di</strong>cine, Surgery and Dentistry, Faculty of Me<strong>di</strong>cine, University of Milan, Italy;<br />

2) Clinical Pharmacology IRCCS Humanitas, Milan, Italy; *These two authors equally<br />

contributed at this work<br />

108. Calcineurin primes GnRH-secreting neurons for migration<br />

Zaninetti Roberta, Tacchi S., Erriquez J., Distasi C., Maggi R.*, Canonico P.L., Genazzani A.A.<br />

Dipartimento <strong>di</strong> Scienze Chimiche, Alimentari, Farmaceutiche Farmacologiche, Drug and Food<br />

Biotechnology Center, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> del Piemonte Orientale “A. Avogadro”, Novara<br />

*Laboratorio <strong>di</strong> Neuroendocrinologia dello Sviluppo, Istituto <strong>di</strong> Endocrinologia, CEND,<br />

Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Milano<br />

109. Peptide-derivatized nanoparticles as carriers of drugs into the central nervous<br />

system<br />

Tacchi Raffaella 1 , Vergoni A.V. 3 , Tosi G. 4 , Costantino L. 4 , Rivasi F. 2 , Bertolini A. 1 , Ruozi B. 4 ,<br />

Forni F. 4 , Vandelli M.A. 4<br />

Departments of: Diagnostic and Laboratory Services, Section of Clinical Pharmacology 1 and<br />

Section of Pathological Anatomy 2 ; Biome<strong>di</strong>cal Sciences, Section of Pharmacology 3 ;<br />

Pharmaceutical Sciences 4 ; University of Modena and Reggio Emilia<br />

110. Standar<strong>di</strong>zed analysis of c-fos mRNA expression pattern in rat brain<br />

autora<strong>di</strong>ography using freeware imaging software<br />

Dipasquale Pasqua, Celentano M., Righetti L., Lucchino I., Gaetani S., Cuomo V.<br />

Department of Human Physiology and Pharmacology, University of Rome “La Sapienza”<br />

pag_dx.indd 1 30/05/2007 5.42.56


Farmacologia dei processi degenerativi<br />

Poster 111 – 132<br />

111. GPR17: a new dual receptor for both extracellular nucleotides and cysteinylleucotrienes<br />

involved in brain ischemia<br />

Gelosa Paolo 1 , Sironi L.i 1 , Guerrini U. 1 , Tremoli E. 1,2 , Enrico R. 1 , Patrizia Rosa 3 , Lecca D. 1 ,<br />

Pignieri A. 1 , Abbracchio M. P 1* , Cimino M. 4*<br />

1 Department of Pharmacological Sciences, University of Milan, Italy - 2 Monzino Car<strong>di</strong>ologic<br />

Centre IRCCS, Milan, Italy - 3 CNR Institute of Neuroscience, Cellular and Molecular<br />

Pharmacology, Milan, Italy - 4 Institute of Pharmacology and Pharmacognosy, University of<br />

Urbino, Italy; *equally contributed to the present work<br />

112. Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus<br />

Russo E. 1 , Donato G. 1 , De Fazio S. 1 , De Fazio P. 1 , Perrotta I. 2 , De Sarro G. 1<br />

1 Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of Me<strong>di</strong>cine and Surgery,<br />

University of Catanzaro, Catanzaro, Italy; 2 Ecology Department, University of Calabria,<br />

Cosenza, Italy.<br />

126<br />

113. Blunted HPA axis activity during ischemia protects adult rats neonatally exposed to<br />

glucocorticoids against brain damage<br />

Cinque Carlo 1 , Mairesse J. 3 , Casolini P. 1 , Domenici M. R. 2 , Galluzzo M. 2 , Musumeci M. 2 , Alemà<br />

G. S. 1 , Zuena A. R. 1 , Matteucci P. 1 , Maccari S. 3 , Nicoletti F. 1,4 , Catalani A. 1<br />

1. Dep. of Human Physiol & Pharmacol, University “Sapienza”, Rome, Italy; 2. Dep. of<br />

Pharmacol, Istituto Superiore <strong>di</strong> Sanità, Rome, Italy; 3. Lab. Perinatal Stress, JE2365.<br />

University of Lille 1, 59655 Villeneuve d’Ascq, France; 4. INM Neuromed, Pozzilli, Italy<br />

114. Knocking-down and knocking-out of NCKX2 gene expression exacerbate the brain<br />

insult induced by focal ischemia<br />

Cuomo Ornella, Pignataro G., Gala R., Boscia F., Tortiglione A., Valsecchi V., Di Renzo GF.,<br />

Lytton J.* , Annunziato L.<br />

Division of Pharmacology, Department of Neuroscience, School of Me<strong>di</strong>cine, , Federico II<br />

University of Naples, Via S. Pansini 5, 80131 Naples, Italy. *Department of Biochemistry and<br />

Molecular Biology University of Calgary, Calgary, Alberta, Canada<br />

115. Neuroprotective effect of melanocortins in focal cerebral ischemia<br />

Giuliani Daniela 1 , Ottani A. 1 , Mioni C. 1 , Galantucci M. 1 , Bazzani C. 1 , Zaffe D. 2 , Bitto A. 3 ,<br />

Minutoli L. 3 , Botticelli A. R. 4 , Altavilla D. 3 , Squadrito F. 3 , Guarini S. 1<br />

1 Dept. Biome<strong>di</strong>cal Sci., Sect. Pharmacology, and 2 Dept. Anatomy and Histology, University of<br />

Modena and Reggio Emilia; 3 Dept. Clin. Exp. Med. Pharmacol., Sect. Pharmacology, University<br />

of Messina; 4 Dept. Human Pathology, University of Pavia<br />

116. Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration<br />

related to temporal lobe epilepsy<br />

Biagioni Francesca 1 , Busceti C.L. 1 , Aronica E. 2* , Storto M. 1 , Battaglia G. 1 , Giorni F.S. 3 , Fornai<br />

F. 1,3 , Gra<strong>di</strong>ni R. 4 , Caricasole A. 5 , Nicoletti F. 1,6 , Bruno V. 1,6<br />

1 I.N.M. Neuromed, Pozzilli, Italy; 2 Dept. of Neuropathol., Univ. of Amsterdam, The<br />

Netherland; 3 Dept. of Hum. Morphol., Univ. of Pisa, Italy; 5 SienaBiotech, Siena, Italy; 5 Dept.<br />

of Exp. Med. and 6 Hum. Physiol. And Pharmacol. , Univ. “La Sapienza”, Rome, Italy<br />

117. Stimulation of proteinase-activated receptors 1 and 2 induces neurodegeneration in<br />

the rat olfactory system<br />

Dedoni Simona, Olianas M.C., Garau L., Onali P.<br />

Section of Biochemical Pharmacology, Department of Neuroscience, University of Cagliari,<br />

Cagliari, Italy.<br />

pag_sx.indd 1 30/05/2007 5.44.38


118. Histone deacetylase (HDAC) inhibitors reduce the in vitro and in vivo<br />

neuroinflammatory response in mice<br />

Faraco Giuseppe, Fossati S., Formentini L., *Mascagni P., *Fossati G., *Leoni F., Moroni F.,<br />

Chiarugi A.<br />

Dipartimento <strong>di</strong> Farmacologia Clinica e Preclinica, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Firenze<br />

*Italfarmaco S.p.a., Milan, Italy<br />

119. Neuroprotection by 17-estra<strong>di</strong>ol in whole rat urinary bladder subjected to<br />

ischaemia/reperfusion injury<br />

Valeri Aurora, Pessina F., Sgaragli G.<br />

Dip. Scienze Biome<strong>di</strong>che, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Siena, Via Aldo Moro 2 , 53100 Siena<br />

120. Heme oxygenase activity in immortalized hypothalamic neurons GT1-7<br />

Mores Na<strong>di</strong>a, Mancuso C., Errico S., Barone E., Preziosi P.<br />

Istituto <strong>di</strong> Farmacologia – Facoltà <strong>di</strong> Me<strong>di</strong>cina e Chirurgia<br />

Università Cattolica del Sacro Cuore - Roma<br />

121. Spinal cord injury and neural precursors. Homing, fate and recovery of function<br />

Bottai Daniele 1,2 , Maraschi L. 1 , Di Giulio A. M. 1 , Gorio A. 1,2 .<br />

1) Department of Me<strong>di</strong>cine, Surgery and Dentistry, University of Milan, Via A. <strong>di</strong> Ru<strong>di</strong>nì 8,<br />

20142 Milano, Italy; 2) Clinical Pharmacology IRCCS Humanitas Via Manzoni 56, 20089<br />

Rozzano, Milano, Italy.<br />

122. Melatonin protects from the long-term morphological and functional consequences<br />

of a neonatal hypoxic-ischemic brain injury in rats<br />

Carloni Silvia, Buonocore G. 1 , Perrone S. 1 , Longini M. 1 , Proietti F. 1 , Balduini W.<br />

Istituto <strong>di</strong> Farmacologia e Farmacognosia, Università <strong>degli</strong> <strong>Stu<strong>di</strong></strong> <strong>di</strong> Urbino “Carlo Bo”, Via S.<br />

Chiara 27, Urbino; 1 Dipartimento <strong>di</strong> Pe<strong>di</strong>atria, Ostetricia e Me<strong>di</strong>cina della Riproduzione,<br />

Sezione <strong>di</strong> Neonatologia Università <strong>di</strong> Siena, Policlinico Le Scotte Via M. Bracci, Siena<br />

127<br />

123. Pentoxifylline ameliorates calcium homeostasis and improves regeneration in<br />

skeletal muscle of dystrophic mdx mice: a comparison with the effects of a<br />

combined treatment prednisolone-taurine<br />

Bur<strong>di</strong> Rosa 1 , Rolland J.-F. 1 , Cozzoli A. 1 , Giannuzzi V. 1 , Liantonio A. 1 , Camerino G. M. 1 ,<br />

Andretta F. 2 , Confalonieri P. 2 , Mangieri D. 3 , Nico B. 3 , De Luca A. 1<br />

1 Unit of Pharmacology, Department of Pharmacobiology, Faculty of Pharmacy, University of<br />

Bari, Italy; 2 Muscular Pathology Unit, National Neurological Institute Carlo Besta, Milan, Italy,<br />

3 Department of Human Anatomy and Histology, University of Bari, Italy<br />

124. Effect of a chronic treatment with gentamicin on in vivo and ex vivo markers of<br />

dystrophic progression in mdx mouse<br />

Cozzoli Anna 1 , Bur<strong>di</strong> R. 1 , Cippone V. 1 , Nicchia G. P. 2 , Frigeri A. 2 , Camerino G.M. 2 , Mangieri<br />

D. 3 , Nico B. 3 , De Luca A. 1<br />

1 Dept. of Pharmacobiology, Faculty Pharmacy and 2 Dept. of General and Environmental<br />

Physiology, 3 Department of Human Anatomy and Histology, University of Bari, Italy<br />

125. VEGF overexpression via adeno-associated virus gene transfer promotes skeletal<br />

muscle regeneration and enhances muscle function in mdx mice<br />

Di Stefano Vincenzo 1 , Bitto A. 1 , Minutoli L. 1 , Altavilla D. 1 , Messina S. 2 , Vita G. 2 , Giacca M. 3 ,<br />

Caputi A.P. 1 , Squadrito F. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, University of Messina,<br />

2 Dept of Neurosci, Psych and Anaesthesiol, University of Messina, 3 Mol Med Lab, International<br />

Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy<br />

pag_dx.indd 1 30/05/2007 5.45.36


126. Possible antioxidant effect of sulphur mud- bath therapy in treatment of<br />

osteoarthrosis<br />

1,2 Costantino Maria, 2 Lampa E., 3 Giuberti G., 3 Caraglia M., 3 Abbruzzese A., 2 Filippelli A.<br />

1 CE.RI.S.T. (Center of Thermal Researches and <strong>Stu<strong>di</strong></strong>es srl), Naples, Italy; 2 Department of<br />

Experimental Me<strong>di</strong>cine–Pharmacological Division, II University of Naples-Italy; 3 Department of<br />

Biochemistry and Biophysics “F. Cedrangolo” – II University of Naples, Naples, Italy<br />

127. Bilirubin modulates neurotrophin redox signaling<br />

Mancuso Cesare 1 , Eboli M.L. 2 , Calabrese V. 3 , Preziosi P. 1 , Galeotti T. 2 , Pani G. 2<br />

From the Institutes of 1 Pharmacology and 2 General Pathology, Catholic University School of<br />

Me<strong>di</strong>cine, Largo F. Vito, 1 - 00168 Roma, Italy; 3 Dept. of Chemistry, Biochemistry and Mol.<br />

Biology Section, Faculty of Me<strong>di</strong>cine, University of Catania, 95100, Catania, Italy<br />

128. A study on biological activities of cyani<strong>di</strong>n-3-O-glucoside related to its antioxidant<br />

properties<br />

1 Speciale A., 1 Cimino F., 1 Chirafisi J., 1 Cristani M., 2 Ermito S., 1 Spinzia C., 1 Saija A.<br />

1 Dept. Farmaco-Biologico, School of Pharmacy, University of Messina - Vill. SS. Annunziata<br />

98168 Messina, Italy. 2 Institute of Gynecology and Obstetrics, University of Messina, Italy<br />

128<br />

129. Protective effect of Mn(III) tetrakis (4-benzoic acid) porphyrin on the inactivation<br />

of primary antioxidant enzymes in keratinocytes by photodynamically generated<br />

free ra<strong>di</strong>cals<br />

Muscoli Carolina 1 , Nistico’ S. 2 , Arcone R. 1 , Colica C. 1 , Visalli V. 1 , Vetrice D. 1 , Casale F. 1 , Del<br />

Vecchio I. 3 , Strangoli M.C. 3 , Mollace V. 1 , Rotiroti D. 3<br />

1 Dept of Pharmacobiol. Sciences, University of Catanzaro Magna Graecia, Italy; 2 School of<br />

Me<strong>di</strong>cine, Univesity of Rome “Tor Vergata”; 3 ISN-CNR<br />

130. Anticataractogenic property of -glutamylcysteine ethyl ester in an animal model of<br />

cataract<br />

Pannini Simone, Barberi L., Leone R. L, Casini P.<br />

Department of Farmacology “G. Segre”, University of Siena<br />

131. Assessment of blood and salivary antioxidant system in subjects with periodontitis<br />

and peri-implantitis<br />

Fiaschi Anna Ida, *Ruggero G., De Vuono G., Cerretani D., *Cozzolino A.<br />

Department of Pharmacology “G. Segre”, * Department of Odontostomatologic Science,<br />

Maxillo-Facial Surgery Division, University of Siena<br />

132. Status of lipid peroxidation in patients with osteoarthritis underwent a tammef<br />

system<br />

Fiaschi Anna Ida, *Battisti E., *Albanese A., Cerretani D., Runci F.<br />

Department of Pharmacology “G. Segre”, * Centre TAMMEF, University of Siena<br />

Farmacologia del dolore<br />

Poster 133 – 144<br />

133. Repeated treatment with AM404 reduces mechanical allodynia and thermal<br />

hyperalgesia in a model of neuropathic pain without central effects<br />

Sasso Oscar, La Rana G., Russo R., D’Agostino G., Iacono A., Meli R., Calignano A.<br />

Dep Experimental Pharmacology, Faculty of Pharmacy, via D. Montesano 49-Naples<br />

pag_sx.indd 1 30/05/2007 5.46.40


134. Antihyperalgesic and antiallodynic effect of purinergic antagonists in a mouse<br />

model of mononeuropathy: neuroinflammatory involved mechanisms<br />

Trovato Anna Elisa 1 , Franchi S. 1 , Magnaghi V. 2 , Panerai A. E. 1 , Procacci P. 4 , Rodella L. F. 3 ,<br />

Sacerdote P. 1 , Valsecchi A. E. 1 , Colleoni M. 1<br />

1 Dep. Pharmacol. Chem. Med. Toxicol, Univ. of Milan, 2 Dep. Endocrinol, Center Excell.<br />

Neurodegen. Dis., Univ. of Milan, 3 Divis. Anat., Dep. Biome<strong>di</strong>c. Sci. Biotechnol., Univ. of<br />

Brescia, 4 Inst. Histol. Embriol. Neurocytol., Univ. of Milan<br />

135. Phytoestrogen genistein reduces nociceptive hypersensitivity in the mouse chronic<br />

constriction injury model<br />

Valsecchi Anna E., Franchi S., Panerai A. E., Sacerdote P., Trovato A. E. , Colleoni M.<br />

Departement of Pharmacology, Chemoterapy and Me<strong>di</strong>cal Toxicology, University of Milan<br />

136. Blockade of the TRPV1 receptor and of the fatty acid amide hydrolase enzyme in a<br />

mouse model of neuropathic pain prevents pain-like behaviour and caspases<br />

activation<br />

Giordano Catia, Siniscalco D., Migliozzi A., Rossi F., Di Marzo V.°, Maione S.<br />

Istituto <strong>di</strong> Chimica Biomolecolare, CNR, Pozzuoli (NA), Italy; Department of Experimental<br />

Me<strong>di</strong>cine, section of Pharmacology, Second University of Naples, Via S. Maria <strong>di</strong> Costantinopoli<br />

16 – 80138 Naples, Italy<br />

137. The fatty-acid amide hydrolase inhibitor URB597 reduces neuropathic pain after oral<br />

administration in mice<br />

Russo Roberto, La Rana G., D’Agostino G., Sasso O., LoVerme J., Piomelli D., Malignano A.<br />

Department of Experimental Pharmacology, University of Naples, Italy.; Department of<br />

Pharmacology and the Center for Drug Discovery, University of California, Irvine<br />

138. N-arachidonoyl-serotonin: a fatty acid amide hydrolase inhibitor with antagonistic<br />

activity at TRPV1 receptors and analgesic properties in vivo<br />

Palazzo Enza 1 , De Petrocellis L. 2 , Petrosino S. 2 , Gatta L. 1 , Guida F. 1 , Ortar G. 3 , Rossi F. 1 ,<br />

Maione S. 1 , Di Marzo V. 2<br />

1 Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology “L. Donatelli”, Second<br />

University of Naples, via Costantinopoli 16, 80138 Naples. 2 Endocannabinoid Research Group,<br />

Institutes of Cybernetics and of Biomolecular Chemistry, CNR, Pozzuoli (Naples). 3 Dipartimento<br />

<strong>di</strong> <strong>Stu<strong>di</strong></strong> Farmaceutici, Università <strong>di</strong> Roma 'La Sapienza”, Roma<br />

129<br />

139. A novel pharmacological approach for the treatment of neuropathic pain: toll-like<br />

receptor 4 antagonists as modulators of activated microglia<br />

Costa Barbara, Comelli F., Peri F., Granucci F., Bettoni I., Rossini C., Giagnoni G.<br />

Department of Biotechnology and Bioscience, University of Milano-Bicocca<br />

140. Ethanol causes neurogenic vaso<strong>di</strong>latation by TRPV1 activation and CGRP release in<br />

the trigeminovascular system of the guinea pig<br />

Benemei S. 1 , Nicoletti P. 1 , Trevisani M. 2 , Manconi M. 3 , De Siena G. 1 , Zagli G. 1 , Capone J.A. 2 ,<br />

Geppetti P. 1 , Pini L.A. 4<br />

1 Clinical Pharmacology Unit, Department of Critical care Me<strong>di</strong>cine and Surgery, University of<br />

Florence, 2 Center of Excellence for the Study of Inflammation and Headache Center,<br />

University of Ferrara, Ferrara, 4 Department of Laboratory Me<strong>di</strong>cine and Forensic Me<strong>di</strong>cine,<br />

University of Modena and Reggio Emilia, Italy<br />

141. Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene in<br />

migraine patients<br />

Bisogno Angelina (3) , Pizza V. (1) , Volpe G. (1) , Infante F. (2) , Schiavo G. (2) , Lamaida E. (1) ,<br />

Agresta A. (1) , Bianchi A. (3) , Capasso A. (3)<br />

1) Neurophysiopatology 2) Molecular Biology, S. Luca Hospital, Vallo della Lucania (SA),<br />

3) University of Salerno, Italy<br />

pag_dx.indd 1 30/05/2007 5.47.33


142. Genetic polymorphisms and migraine<br />

Longobar<strong>di</strong> Francesca (3) , Pizza V. (1) , Volpe G. (1), Infante F. (2) , Lamaida E. (1) , Agresta A. (1) ,<br />

Bisogno A. (3) , Bianchi A. (3) , Capasso A. (3)<br />

(1) Neurophysiopatology Service; (2) Molecular Biology Service, S. Luca Hospital, Vallo della<br />

Lucania (SA), ASL SA/3; (3) Department of Pharmaceutical Sciences, University of Salerno,<br />

Italy.<br />

143. Long-term intrathecal morphine in patients with chronic non-cancer pain upregulates<br />

mu opiod receptor gene expression in lymphocytes<br />

Campana Gabriele 1 , Raffaeli W. 2 , Sarti D. 2 , Spampinato S. 1<br />

1 Dept. Of Pharmacology - University of Bologna-Irnerio 48 - 40126 – Bologna; 2 Pain and<br />

Palliative Care Unit, Infermi Hospital, Rimini -Via Ovi<strong>di</strong>o - 47900 - Rimini<br />

144. Comparative production of the active tramadol metabolite o-desmethyl-tramadol<br />

(m1) in domestic animal species<br />

Zonca Annalisa*, Cagnar<strong>di</strong> P.*, Villa R.*, Ravasio G. # , Vettorato E. $ , Isola M. $ , Montesissa C. §<br />

*Dipartimento <strong>di</strong> Scienze e Tecnologie Veterinarie per la Sicurezza Alimentare, Milano;<br />

§ Dipartimento <strong>di</strong> Sanità Pubblica Patologia Comparata ed Igiene Veterinaria, Padova;<br />

# Dipartimento <strong>di</strong> Scienze Cliniche Veterinarie, Milano; $ Dipartimento <strong>di</strong> Scienze Cliniche<br />

Veterinarie, Padova<br />

Sostanze <strong>di</strong> abuso<br />

Poster 145 – 161<br />

130<br />

145. Effect of uncontingent and subchronic administration of ad<strong>di</strong>ctive drugs on neuronal<br />

plasticity in the rat nucleus accumbens<br />

Ibba Federico 1 , Vinci S. 1 , Spiga S. 2 , Acquas E. 1, 3 , Di Chiara G. 1, 3<br />

1 Department of Toxicology and 3 Centre of Excellence on Neurobiology of Ad<strong>di</strong>ction, University<br />

of Cagliari; 2 Department of Animal Biology and Ecology, University of Cagliari<br />

146. Trend of drugs of abuse detection in the urine of patients of the university hospital<br />

of modena, during the period 1997-2006<br />

Coccia Ciro, Ferrari A., Castellana C. N., Poppi B., Pisa S., Bertolini A., Sternieri E.<br />

Toxicology and Clinical Pharmacology Section. Department of Laboratory Services University<br />

of Modena and Reggio Emilia, Italy<br />

147. Difference in the degree of nicotine dependence and development of depression<br />

between cannabis users and polidrug users<br />

Russo Giuseppina A. 1 , Garuana A. 2 , Mannucci C. 1 , Tedesco M. 1 ,<br />

Calapai G. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Section of<br />

Pharmacology, School of Me<strong>di</strong>cine, University of Messina, Italy; 2 Territorial Service for<br />

Ad<strong>di</strong>ction (Ser.T.) of the District of Ribera – Local Sanitary Unit USL n°1, Agrigento (Italy)<br />

148. The cannabinoid antagonist SR 141716A reduces the increase of extra-cellular<br />

dopamine release in the rat nucleus accumbens induced by a novel high palatable<br />

food<br />

Melis Tiziana, Sanna F., Succu S., Argiolas A., Melis M.R.<br />

Beranrd B. Bro<strong>di</strong>e Department of Neurosciences, University of Cagliari, Italy<br />

149. Cannabinoid self-administration in the rat: gender <strong>di</strong>fferences and effect of<br />

ovariectomy<br />

Spano M. Sabrina 1,3 , Fattore L. 2,3 , Altea S. 1 , Angius F. 1 , Fadda P. 1,3 1, 2,3<br />

, Fratta W. 1 Department of Neuroscience, University of Cagliari ; 2 Institute of Neuroscience CNR, Section<br />

of Cagliari; 3 Centre of Excellence "Neurobiology of Dependence", University of Cagliari<br />

pag_sx.indd 1 30/05/2007 5.48.33


150. Psychosis onset: use of cannabis x COMT genotype interaction. A case-only design<br />

analysis in a first-episode psychosis sample<br />

La Cascia Caterina 1,2 , Di Forti M. 2 , Murray R.M. 2 , La Barbera D. 1 , Butt A. 2 , Mondelli V. 2 ,<br />

Eyeson J. 2 , Navari S. 2 , Aas M. 2 , Clifford D. 2 , Dazzan P. 2 , Pariante C. 2 , Morgan C. 2 , Freeman<br />

B. 2 , Luzi S. 2 , Dempster D. 2 , Rivera M. 2 , Collier D. 2 , Powell J. 2 , Cannizzaro G. 3<br />

1 Dept. of Clinical Neurosciences, University of Palermo, 2 Institute of Psychiatry, King’s College<br />

London, UK, 3 Dept. of Pharmacological Sciences, University of Palermo<br />

151. Flumazenil selectively prevents the increase in 4 subunit gene expression and an<br />

associated change in GABA A receptor function induced by ethanol withdrawal<br />

Caria Stefania 1 , Biggio F. 1 , Gorini G. 1 , Murru L. 1 , Sanna E. 1,2 , Follesa P. 1,2 ,Biggio G. 1,2<br />

University of Cagliari, Department of Experimental Biology, Section of Neuroscience 1 ; Center<br />

of Excellence for the Neurobiology of Dependence 2 , 09123 Cagliari, Italy<br />

152. Pregnenolone sulfate enhancement of GABA release in the developing rat<br />

cerebellum is me<strong>di</strong>ated by presynaptic nmdars and is modulated by ethanol<br />

Carta Mario, Murru L., Vir<strong>di</strong>s F., Brockmann M.D., Marras R., Sanna E., Biggio G.<br />

Dept. Experimental Biology, Sect of Neuroscience, and Center of Excellence for the<br />

Neurobiology of Dependence. Cittadella Universitaria, SS 554 Km 4,500, 09042, Monserrato,<br />

Cagliari, Italy<br />

153. Neurosteroid-me<strong>di</strong>ated increase of GABAergic tonic inhibition in rat dentate gyrus<br />

granule cells by ethanol<br />

Sanna Enrico,Talani G., Zucca S., Biggio G.<br />

Dept. Experimental Biology, Sect. of Neuroscience, and Center of Excellence for the<br />

Neurobiology of Drug Dependence, University of Cagliari, Cittadella Universitaria, Monserrato,<br />

Cagliari, Italy<br />

131<br />

154. Activation of transient receptor potential vanilloid type 1 (TRPV1) by ethanol: role<br />

of endogenous lipid me<strong>di</strong>ators<br />

Campi B., Gatti R., Andre E., Geppetti P., Trevisani M.<br />

Inter<strong>di</strong>sciplinary Centre of Excellence for the Study of Inflammation (ICSI), University of<br />

Ferrara, Ferrara, Italy<br />

155. Transient receptor potential vanilloid 1, substance P & reactive oxygen species<br />

me<strong>di</strong>ate ethanol-induced gastric injury<br />

Trevisani M. 1 , Gazzieri D. 1 , Harrison S. 2 , Cottrell G.S. 5 , Andre E. 1 , Massi D. 3 , Zecchi S. 4 ,<br />

Lungarella G. 6 , Bunnett N.W. 5 , Geppetti P. 1,2<br />

1 Center of Excellence for the Study of Inflammation, University of Ferrara; Departments of<br />

2 Critical Care Me<strong>di</strong>cine and Surgery, 3 Human Pathology and Oncology, and 4 Anatomy,<br />

University of Florence; 5 Departments of Surgery and Physiology, University of San Francisco,<br />

6 Department of Physiopathology, University of Siena<br />

156. Ethanol induced dopamine release in the rat mesolimbic system. Role of<br />

acethaldehyde<br />

Sirca Donatella 1 , Mereu M. 1 , Golosio A. 1 , Enrico Paolo 2 , Diana M. 1<br />

1) “G. Minar<strong>di</strong>” Laboratory of Cognitive Neuroscience, Department of Drug Sciences;<br />

2) Department of Biome<strong>di</strong>cal Sciences. University of Sassari, 07100 Sassari, Italy<br />

157. RITIRATO<br />

pag_dx.indd 1 30/05/2007 5.49.12


158. Intermittent intoxication with ethanol vapor induces a long-lasting hypnotic<br />

tolerance and behavioral sensitivity in rat<br />

Rimon<strong>di</strong>ni R. † , Sommer W.*, Heilig M.*, Dall’Olio R. † , Locchi F. † , Gandolfi O †<br />

*Laboratory of Clinical and Translational <strong>Stu<strong>di</strong></strong>es, National Institute on Alcohol Abuse and<br />

Alcoholism, National Institutes of Health, Bethesda, MD 20892;<br />

† Department of<br />

Pharmacology, University of Bologna, 40128 Bologna, Italy<br />

159. Reduction of ethanol drinking following chronic administration of the antiepileptic<br />

levetiracetam in genetically selected alcohol preferring rats<br />

Stopponi Serena, Postolache Cristita, Nazzareno C., Economidou D., Fedeli A., Massi M.,<br />

Ciccocioppo R.<br />

University of Camerino, Italy<br />

160. Effect of the selective fatty acid amide hydrolase inhibitor URB597 on ethanol abuse<br />

related behaviours in the rat<br />

Braconi Simone, Piomelli D.*, Duranti A. § , Tonini A. § , Tarzia G. § , Cannella N., Massi M.,<br />

Ciccocioppo R., Cippitelli A.<br />

Department of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, Italy;<br />

*Gillespie Neuroscience Facility, University of California, Irvine, USA; § Institute of Me<strong>di</strong>cinal<br />

Chemistry, University of Urbino “ Carlo Bò”, Italy<br />

132<br />

161. Neuropeptide S: a new neurotrasmitter system involved in relapse to alcoholseeking<br />

behaviour<br />

1 Cannella Nazzareno, 1 Economidou D., 1 Kallupi M., 2 Guerrini R., 3 Calò G., 1 Ciccocioppo R.<br />

1 Dept. of Experimental Me<strong>di</strong>cine and Public Health, University of Camerino, Italy; 2 Dept of<br />

Pharmaceutical Science and, 2 Dept. of Pharmacology, University of Ferrara, Italy<br />

Farmacologia della funzione respiratoria<br />

Poster 162 – 172<br />

162. Role of TGF- on MAP kinase phosphorylation and cell proliferation in primary<br />

cultures of human lung fibroblast<br />

Sullo Nikol, Gallelli L., De Nardo M., Orlotti D., Russo M., Marrocco G., D’Agostino B., De Sarro<br />

GB., Rossi F.<br />

Department of Experimental Me<strong>di</strong>cine, Sect. of Pharmacology, Faculty of Me<strong>di</strong>cine and<br />

Surgery, 2nd University of Naples, via Constantinopoli 16, 80138 Naples, Italy.<br />

163. Ethanol sensitises TRPV1-me<strong>di</strong>ated cough in guinea pigs by a protein kinase C-<br />

dependent pathway<br />

Gatti Raffaele 1 , Andre E. 1 , Campi B. 1 , Geppetti P. 1, 2 Trevisani M. 1<br />

1 Inter<strong>di</strong>sciplinary Centre of Excellence for the Study of Inflammation (ICSI), University of<br />

Ferrara, Ferrara, Italy; 2 Department of Critical Care Me<strong>di</strong>cine and Surgery, University of<br />

Florence, Florence, Italy<br />

164. The role of ceramide pathway in asthma<br />

Giannini Lucia a , Bani D. b , Uliva C. a , Marzocca C. a , Comhair Suzy A.A. c , Erzurum Serpil C. c , Li<br />

D. d , Ndengele Michael d , Salvemini D. d , Masini E. a<br />

a Department of Preclinical and Clinical Pharmacology, and b Anatomy, Histology and Forensic<br />

Science, Section of Histology, University of Florence, Italy; c Pulmonary, Critical Care Me<strong>di</strong>cine<br />

and Cancer Biology, The Lerner Research Institute, The Cleveland Clinic Foundation,<br />

Cleveland, USA; d Internal Me<strong>di</strong>cine, Division of Pulmonary, Critical Care and Sleep Me<strong>di</strong>cine,<br />

St Louis University, St Louis, USA<br />

pag_sx.indd 1 30/05/2007 5.50.01


165. Role of nociceptin and its receptor in animal model of asthma<br />

Orlotti Donatella, De Nardo M., Russo M., Sullo N., Marrocco G., Rossi F., D’Agostino B.<br />

Department of Experimental Me<strong>di</strong>cine, Sect. of Pharmacology, Faculty of Me<strong>di</strong>cine and<br />

Surgery, 2nd University of Naples, via Constantinopoli 16, 80138 Naples, Italy<br />

166. Activation of protease-activated receptor-2 reduces airways inflammation in<br />

experimental allergic asthma<br />

Russo Mariangela, Orlotti D., De Nardo M., Marrocco G., Sullo N., Guastafierro MG., Rossi F.,<br />

D’Agostino B.<br />

Department of Experimental Me<strong>di</strong>cine, Sect. of Pharmacology, Faculty of Me<strong>di</strong>cine and<br />

Surgery, 2nd University of Naples, via Constantinopoli 16, 80138 Naples, Italy<br />

167. M 3 muscarinic receptors in peripheral lung parenchima of patients with chronic<br />

obstructive pulmonary <strong>di</strong>sease<br />

Vincenzi F. 1 , Varani K. 1 , Caramori G. 2 , Tosi A. 1 , Gessi S. 1 , Merighi S. 1 , Fogli E. 1 , Sacchetto V.<br />

1 , Simioni C. 1 , Papi A. 2 , Borea P.A. 1<br />

Department of Clinical and Experimental Me<strong>di</strong>cine, Pharmacology Section 1 and Respiratory<br />

Disease Section 2 , University of Ferrara, Italy<br />

168. Glycogen synthase kinase-3 inhibition attenuates the development of bleomycininduced<br />

lung injury<br />

1,2 Cuzzocrea S., 1,2 Genovese T., 1,2 Mazzon E., 3 Esposito E., 1 Muià C., 4 Abdelrahman M., 1,2 Di<br />

Paola R., 2 Bramanti P., 4 Thiemermann C.<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine,<br />

University of Messina, Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy;<br />

3 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università <strong>di</strong> Napoli “Federico II”, Italy; 4 The<br />

William Harvey Research Institute, Centre for Experimental Me<strong>di</strong>cine, Nephrology and Critical<br />

Care, St Bartholomew’s and The Royal London School of Me<strong>di</strong>cine and Dentistry, London, UK<br />

133<br />

169. Modulation of the non-adrenergic, non-cholinergic inhibitory system by adenosine<br />

A 1 and A 3 receptors in the guinea-pig isolated trachea<br />

Dellabianca Antonio*, De Amici E.*, Tonini S.*, De Angelis S.**, Faniglione M.**, Candura S.<br />

M*, Tonini M.**<br />

*Dept. Preventive Occupational and Community Me<strong>di</strong>cine, University of Pavia; **Dept. of<br />

Physiological and Pharmacological Sciences, University of Pavia<br />

170. New roles for cysteinyl leukotriene in asthma: from airway remodelling to 2 -<br />

Adrenoreceptor dysfunction<br />

Rovati G. Enrico 1 , 2 Baroffio M. 1 Citro S., 1 Capra V., 2 Crimi C., 2 Brusisco V.<br />

1 Laboratory of Molecular Pharmacology, Section of Eicosanoid Pharmacology, Dept. of<br />

Pharmacological Sciences, University of Milan; and 2 Respiratory Pathophysiology Unit, Dept.<br />

of Internal Me<strong>di</strong>cine, University of Genoa<br />

171. Sphingosine-1-phosphate/Sphingosine kinase pathway is involved in mouse airway<br />

hyper-responsiveness<br />

Roviezzo Fiorentina, Di Lorenzo A., Bucci M., Brancaleone V., De Gruttola L., Vellecco V.,<br />

Rossi F., D’Agostino B., Cirino G.<br />

Department of Experimental Pharmacology, Faculty of Pharmacy, University of Naples-<br />

Federico II-; Department of Experimental Me<strong>di</strong>cine-Section of Pharmacology, Faculty of<br />

Me<strong>di</strong>cine and Surgery, 2nd University of Naples<br />

pag_dx.indd 1 30/05/2007 5.50.41


172. Evidence for a role of adenosine A1 receptor in bronchial hyperreactivity of<br />

sensitized wistar rats<br />

Alfieri Alessio, Cicala C.<br />

Department of Experimental Pharmacology, University of Naples “Federico II”, Naples<br />

Farmacologia dell'apparato <strong>di</strong>gerente<br />

Poster 173 – 184<br />

173. APP, a novel selective adenosine deaminase inhibitor, is effective against<br />

experimental colitis<br />

Antonioli Luca 1 , Fornai M. 1 , Colucci R. 1 , Ghisu N. 1 , Da Settimo F. 2 , Natale G. 3 , Vir<strong>di</strong>s A. 4 ,<br />

Breschi M.C. 5 , Del Tacca M. 1 , Blan<strong>di</strong>zzi C. 1<br />

1 Division of Pharmacology and Chemotherapy,<br />

1,4 Department of Internal Me<strong>di</strong>cine,<br />

2 Department of Pharmaceutical Sciences, 3 Department of Human Morphology and Applied<br />

Biology, and 5 Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology,<br />

University of Pisa, Pisa, Italy<br />

174. Effects of the non-peptidyl low molecular weight ra<strong>di</strong>cal scavenger IAC in DNBSinduced<br />

colitis in rats<br />

Vasina Valentina * , Broccoli M. * , Ursino M. G. * , Soleti A. # , Paolini M. * , De Ponti F. *<br />

* Department of Pharmacology, Alma Mater <strong>Stu<strong>di</strong></strong>orum - University of Bologna, Italy;<br />

# Medestea Research, <strong>Torino</strong>, Italy<br />

134<br />

175. The NK 1 receptor antagonist SSR140333 ameliorates experimental colitis in rats<br />

Ursino Maria Grazia, Vasina V., Croci Tiziano*, De Ponti F.<br />

Dept. of Pharmacology, University of Bologna, Bologna, Italy *Sanofi-Aventis Research<br />

Centre, Milan, Italy<br />

176. Responsiveness of longitu<strong>di</strong>nal and circular muscle to relaxing me<strong>di</strong>ators is<br />

<strong>di</strong>fferentially affected in rat hypertrophied ileum<br />

Bertoni Simona, Ghizzar<strong>di</strong> P., Tognolini M., Ballabeni V., Impicciatore M., Barocelli E.<br />

Dipartimento <strong>di</strong> Scienze Farmacologiche, Biologiche e Chimiche Applicate. Università <strong>degli</strong><br />

<strong>Stu<strong>di</strong></strong> <strong>di</strong> Parma. Viale Usberti 27/a, 43100 Parma, Italy<br />

177. In rat ileum adenosine deaminase is not only an ecto- but also an exo-enzyme<br />

Calligaro Giulia, Bin A., Giron M. C., Gaion R.M.<br />

Department of Pharmacology and Anesthesiology, University of Padova<br />

178. Herpes simplex virus-1 infection alters the carbachol- and KCl-induced contractions<br />

in rat small intestine<br />

Zoppellaro Chiara 1 , Brun P. 2 , Giron M. C. 1 , Bin A. 1 , Gaion R.M. 1 , Castagliuolo I. 2<br />

1 Department of Pharmacology and Anesthesiology, University of Padova; 2 Department of<br />

Histology, Microbiology & Me<strong>di</strong>cal Biotechnologies, University of Padova<br />

179. Adenosine receptors and metabolism in the intestinal tract<br />

Bin Anna 1 , Giron M.C. 1 , Calligaro G. 1 , Castagliuolo I. 2 , Gaion R.M. 1<br />

1 Department of Pharmacology and Anesthesiology, University of Padova<br />

2 Department of Histology, Microbiology and Me<strong>di</strong>cal Biotechnology, University of Padova<br />

180. Role of A 2A adenosine receptors in the regulation of human colon motility<br />

Fornai Matteo 1 , Antonioli L. 1 , Colucci R. 1 , Ghisu N. 1 , Buccianti P. 2 , Chiarugi M. 2 , Blan<strong>di</strong>zzi C. 1 ,<br />

Del Tacca M. 1<br />

1 Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, and<br />

2 Department of Surgery, University of Pisa, Pisa, Italy<br />

pag_sx.indd 1 30/05/2007 5.51.59


181. Gender-related role of nitric oxide in electrically evoked contractions in human<br />

colonic circular muscle<br />

Maselli M.A., Trisolini P., Pezzolla F., Demma I., De Ponti F.°<br />

Scientific Institute of Gastroenterology “S. de Bellis”, Castellana Grotte, Bari; °Department of<br />

Pharmacology, University of Bologna, Bologna, Italy<br />

182. Role of 5-HT receptors in modulating propulsive activity and accommodation in the<br />

guinea pig <strong>di</strong>stal colon<br />

Balestra Barbara*, Cervio E.*, Sternini C.**, De Giorgio R. # , Tonini M.*<br />

*Dept. of Physiological & Pharmacological Sciences, University of Pavia, **Dept. of Me<strong>di</strong>cine<br />

and Neurobiology, David Geffen School of Me<strong>di</strong>cine, University of California, Los Angeles,<br />

# Dept. of Internal Me<strong>di</strong>cine & Gastroenterology, University of Bologna, Italy<br />

183. The effects of UFP112, a novel nociceptin/orphanin FQ-NOP receptor ligand, on<br />

colonic propulsion and defecation in physiological and pathological con<strong>di</strong>tions<br />

Broccardo M. a , Agostini S. a , Guerrini R. b , Improta G. a , Linari G. a , Petrella C. a<br />

a Dept. Human Physiology and Pharmacology, University of Rome “Sapienza”, b Dept.<br />

Pharmaceutical Sciences and Biotechnology Center, University of Ferrara, Italy<br />

184. Effect of modeled microgravity con<strong>di</strong>tions on rat intestinal transit<br />

Peana Alessandra T. 1 ., Marzocco S. 2 , Pulighe E. 1 , Bianco G. 2 , Proto Pippia 1 , Pinto A. 2 ,<br />

Autore G. 2<br />

1 Department of Drug Science, University of Sassari, via Muroni 23/a, 07100, Sassari;<br />

2 Department of Pharmaceutical Science, University of Salerno, via Ponte don Melillo, 84084,<br />

Fisciano, Salerno<br />

Farmacologia del metabolismo e del sistema endocrino<br />

Poster 185 – 193<br />

135<br />

185. Menopausal transition: a possible risk factor for neurodegenerative events<br />

Rigamonti Antonello E. 1 , Bonomo S. M. 1 , Giunta M. 1 , Galimberti D. 2 , Guaita A. 3 , Gagliano M.<br />

G. 4 , Müller E. E. 1 , Cella S.G. 1<br />

1 Department of Me<strong>di</strong>cal Pharmacology and 2 Department of Neurological Sciences, Fondazione<br />

IRCCS Ospedale Maggiore Policlinico, Milan, Italy; 3 Geriatric Institute “Camillo Golgi”,<br />

Abbiategrasso, Italy; 4 Department of Transfusion Me<strong>di</strong>cine, “San Carlo Borromeo” Hospital,<br />

Milan, and CEND, University of Milan<br />

186. Effects of the phytoestrogen genistein on some pre<strong>di</strong>ctors of car<strong>di</strong>ovascular risk in<br />

osteopenic, postmenopausal women: a randomized, double-blind, placebocontrolled<br />

study<br />

Marini Herbert 1 , Minutoli L. 2 , Polito F. 2 , Bitto A. 2 , Altavilla D. 2 , Frisina N. 3 , D’Anna R. 4 , Lubrano<br />

C. 5 , Adamo E. B 1 , Caputi A. P. 2 ,Squadrito F. 2<br />

1 Dept. of Bioch., Phys. and Nutr. Sci., 2 Dept. of Clin. and Exp. Med. and Pharm., 3 Dept. of Int.<br />

Med., 4 Dept. of Obst. and Gyn. Sci., Messina; 5 Dept. of Med. Physiop., “La Sapienza” Univ.,<br />

Rome, Italy<br />

187. In vitro and in vivo anti-inflammatory activities of pseudomorelin, a ghrelin-mimetic<br />

pseudotetrapeptide<br />

Ghè Corrado, Baragli A., Arnoletti E., Deghenghi R., Muccioli G.<br />

Division of Pharmacology, Department of Anatomy, Pharmacology and Forensic Me<strong>di</strong>cine,<br />

University of Turin, Turin, Italy<br />

pag_dx.indd 1 30/05/2007 5.52.47


188. Ghrelin and des-acyl ghrelin induce murine C2C12 myoblasts <strong>di</strong>fferentiation and<br />

fusion into myotubes<br />

Arnoletti Elisa § , Filigheddu N.*, Ghè C. § , Ponzetto C. ‡ , Crepal<strong>di</strong> T. ‡ , Graziani A.*, Muccioli G. §<br />

§ Division of Pharmacology and ‡ Anatomy, Department of Anatomy, Pharmacology and<br />

Forensic Me<strong>di</strong>cine, University of Turin, Turin, Italy; *Department of Me<strong>di</strong>cal Sciences,<br />

University of Piemonte Orientale “Amedeo Avogadro”, Novara, Italy<br />

189. Endocrine and extraendocrine effects of ghrelin and novel synthetic analogs<br />

Bulgarelli Ilaria a , Bresciani E. a , Tamiazzo L. a , Rapetti D. a , Perrissoud D. b , Torsello A. a,c ,<br />

Locatelli V. a,c<br />

a Department of Experimental Me<strong>di</strong>cine, University of Milan Bicocca, Monza, Italy; b Zentaris<br />

GmbH, Frankfurt, Germany; c Interdepartmental Center for Bioinformatics and Proteomics,<br />

University of Milano-Bicocca, Monza, Italy<br />

190. Efects of irbesartan on the myocar<strong>di</strong>al ischemia/reperfusion injury in ZDF rats with<br />

metabolic syndrome<br />

Di Filippo Clara 1,2 , Lampa E. 1,2 , Martella R. 3 , Vargiu G. 4 , Paizis G. 4 , D’Amico M. 1,2<br />

1 Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology L. Donatelli, 2 ”Excellence<br />

Centre for Car<strong>di</strong>ovascular Disease”, and 3 Department of Geriatrics and Metabolic Diseases,<br />

2nd University of Naples, Italy. 4 Sanofi-Aventis, Milano<br />

136<br />

191. Effects of liposome-encapsulated pyrazolo-pyrimi<strong>di</strong>ne derivate on the growth of<br />

human thyroid cancer cells<br />

1 Celano Marilena, 1 Cosco D., 2 Navarra M., 1 Alcaro S., 3 Schenone S., 1 Procopio S., 1 Varano E.,<br />

4 Botta M., 1 Fresta M., 1 Russo D.<br />

1 Dip. <strong>di</strong> Scienze Farmacobiologiche Univ. Catanzaro, 2 Dip. Farmacobiologico, Univ. Messina,<br />

3 Dip. Scienze Farmaceutiche, Univ. Genova, e 4 Dip. Farmaco Chim. Tecnol., Univ. Siena<br />

192. Effect of testosterone on p70S6k phosphorylation in skeletal muscle cell coltures<br />

1 Dattolo Maria G., 1 Saviano R., 1 La Rana G., 1 Calignano A., 2 Miniaci M. , 1 Scotto P.<br />

1 Dept.of Experimental Pharmacology, University of Napoli “Federico II”; 2 Dept.of Experimental<br />

and Clinical Me<strong>di</strong>cine, University of Catanzaro, Italy<br />

193. Endogenous benzo<strong>di</strong>azepines and intestinal bacterial flora in normal and<br />

pathological con<strong>di</strong>tions<br />

Campioli Enrico § , Avallone R. § , Ferrieri A. § , Baral<strong>di</strong> M. §°<br />

§ Department of Biome<strong>di</strong>cal Sciences, Via Campi 287, 41100 Modena, Italy, °National<br />

InterUniversity Consortium for the Study of Natural Active Principles (CINSPAN),<br />

Farmacologia dell'infiammazione<br />

Poster 194 – 204<br />

194. Effects of a methanolic extract of sedum telephium in LPS-activated rat<br />

macrophages<br />

Polito Francesca 1 , Bitto A. 1 , Minutoli L. 1 , Fiumara T. 1 , Giachetti D. 2 , Miral<strong>di</strong> E. 2 , Biagi M. 2<br />

Squadrito F. 1 , Caputi A. P. 1 , Altavilla D. 1<br />

1 Dept of Exp and Clinical Me<strong>di</strong>cine and Pharmacology and 2 Dept of Environmental Sci, Section<br />

of Pharm Biol, University of Siena, Italy<br />

195. Different phenotypes of microglia activation<br />

Dello Russo Cinzia, Tringali G., Navarra P.<br />

Istituto <strong>di</strong> Farmacologia, Università Cattolica del S Cuore, Largo F Vito 1 - Roma<br />

pag_sx.indd 1 30/05/2007 5.53.35


196. Mapping of the human promoter of GNB2L1 gene enco<strong>di</strong>ng the RACK1 protein and<br />

its regulatory role in the immunosenescence<br />

Del Vecchio Igor 1 , Zuccotti A. 1 , Corsini E. 2 , Racchi M. 1 , Lucchelli A. 1 , Govoni S. 1<br />

1 Department of Experimental and Applied Pharmacology, University of Pavia, Viale Taramelli<br />

14, 27100 Pavia, Italy; 2 Department of Pharmacological Sciences, University of Milano, Via<br />

Balzaretti 9, 20133 Milan, Italy<br />

197. Antinflammatory activity and gastroprotective effect of the antioxidant compound<br />

iacvita in rats<br />

Zavatti Manuela, Zanoli P., Montanari C., Vezzalini F. , Baral<strong>di</strong> M.<br />

Department of Biome<strong>di</strong>cal Sciences, Section of Pharmacology and National InterUniversity<br />

Consortium for the Study of Natural Active Principles (CINSPAN), University of Modena and<br />

Reggio Emilia, Modena, Italy<br />

198. The glucocorticoid-induced leucine zipper (GILZ) protects against DNBS-induced<br />

colitis development<br />

Velar<strong>di</strong> Enrico 1 , Donato V. 1 , Bruscoli S. 1 , Mazzon E. 2 , Cannarile L. 1 , Cuzzocrea S. 2 , Riccar<strong>di</strong><br />

C. 1<br />

1 Dept. Clinical and Experimental Me<strong>di</strong>cine, Sect. Pharmacology, Perugia University Me<strong>di</strong>cal<br />

School, 06122, Perugia, and 2 Dept Clinical and Experimental Me<strong>di</strong>cine and Pharmacology,<br />

Messina University Me<strong>di</strong>cine School, Torre Biologica, Policlinico Universitario, 98123, Italy<br />

199. Mucin depleted foci (MDF) are useful biomarkers to study inflammation-induced<br />

colon carcinogenesis in rodents<br />

Caderni Giovanna, Femia A.P., Dolara P., Tarquini E., Salvadori M.<br />

Department of Pharmacology University of Florence, Florence, Italy<br />

137<br />

200. Local administration of palmitoylethanolamide reduces chronic granulomaassociated<br />

angiogenesis in rat<br />

D’Amico Alessandra, De Filippis D., Iuvone T.<br />

1 Department of Experimental Pharmacology, Faculty of Pharmacy, University of Naples<br />

Federico II, Via D. Montesano 49, 80131 Naples, Italy<br />

201. Contribution of 4 1 integrin to the antiallergic effect of levocabastine in<br />

experimental conjunctivitis<br />

Spartà Antonino M., Qasem Ahmed R., Bucolo C., Baiula M., Govoni P., Fascì D., Spampinato<br />

S.<br />

Department of Pharmacology, University of Bologna<br />

202. Protection against UVB-induced damage in rabbit eye by 4-coumaric acid<br />

Lodovici Maura 1 , Morbidelli L. 2 , Akpan V. 1 , Ziche M. 2 , Dolara P. 1<br />

1 Department of Pharmacology, University of Florence, Viale Pieraccini 6, 50139, Florence<br />

(Italy); 2 Department of Molecular Biology, University of Siena, Via A. Moro 2, 53100 Siena<br />

(Italy)<br />

203. CT327, a novel therapeutic agent for topical treatment of psoriasis<br />

Barone Domenico, Bertarione Rava Rossa L., Traversa S., Mainero V., Oderda C., Pincelli C.*,<br />

Marconi A.*, Fumero S.<br />

Creabilis therapeutics SpA, Via Ribes, 5 – 10010 Colleretto Giacosa (TO), Italy; *University of<br />

Modena e Reggio Emilia, Via del Pozzo, 71 – 41100 Modena, Italy<br />

pag_dx.indd 1 30/05/2007 5.54.15


204. Role of peroxisome proliferators activated receptors alpha (PPAR-) in acute<br />

pancreatitis induced by cerulean<br />

1 De Sarro Angelina, 1,2 Mazzon E., 1,2 Genovese T., 1,2 Di Paola R., 1 Muià C., 1 Malleo G.,<br />

3‡ Esposito E., Caputi A.P. 1,2 ., Cuzzocrea S. 1,2<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine,<br />

University of Messina, Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy;<br />

3 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università <strong>di</strong> Napoli “Federico II”, Napoli, Italy<br />

Chemioterapia antibatterica, antivirale e antineoplastica<br />

Poster 21 – 30<br />

205. Analysis of the thymidylate synthase gene structure in colorectal cancer patients,<br />

and its possible relation with the 5-fluorouracil drug response<br />

Sanguedolce Rosario 1 , Gulotta G. 2 , Cajozzo M. 3 , Agrusa A. 2 , Feo S. 4 , Sanguedolce G. 1 ,<br />

Calascibetta A. 1<br />

1 Dipartimento <strong>di</strong> Scienze Farmacologiche, 2 Chirurgia Generale e d’Urgenza, 3 Dipartimento <strong>di</strong><br />

Discipline Chirurgiche ed Oncologiche, 4 DOSAC. University of <strong>Stu<strong>di</strong></strong>es of Palermo<br />

138<br />

206. Irinotecan metronomic chemotherapy in metastatic colorectal cancer patients: a<br />

pharmacokinetic and pharmacodynamic study<br />

Bocci Guido 1 , Allegrini G. 2 , Fioravanti A. 1 , Orlan<strong>di</strong> P. 1 , Loupakis Fotios 2 , Barletta M. T. 2 , Di<br />

Paolo A. 1 , Falcone A. 2 , Danesi R. 1 , Del Tacca M. 1<br />

1 Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa, Pisa; 2 Division of Me<strong>di</strong>cal Oncology, General Hospital, Livorno<br />

207. Adenosine receptor A3: role and expression in human thyroid cancer<br />

Pinto A., Morello S., Petrella A., Festa M., Popolo A., Parente L., Chiappetta G.*<br />

Department of Pharmaceutical Sciences, University of Salerno, Italy; *Tumor Institute,<br />

Fondazione Senatore G. Pascale, Naples, Italy<br />

208. Antimetastatic effect of a novel non competitive CXCR1/CXCR2 inhibitor in human<br />

melanoma<br />

*Bruno Annalisa, *Mosca M., *Buanne P., °Del Bufalo D., °Desideri M., °Giorgini S., § Ruco L.,<br />

*Allegretti M., *Gloaguen I., *Bizzarri C., * Melillo G., *Bertini R., °Zupi G.<br />

*Dompé pha.r.ma s.p.a., via Campo <strong>di</strong> Pile, 67100 L’AQUILA, ITALY; °Regina Elena Cancer<br />

Institute, via delle Messi d’Oro 156, 00158 ROME, ITALY; § S.Andrea Hospital, University La<br />

Sapienza, via <strong>di</strong> Grottarossa 1035, 00189 ROME, ITALY<br />

209. Pharmacokinetics of cisplatin during intraperitoneal hyperthermic chemotherapy<br />

perfusion (IHCP) in patients with peritoneal carcinomatosis<br />

*Cerretani Daniela, *Ferraro M. T., *Fiaschi A. I., *Miceli G. B.,**Cioppa T., **Marrelli<br />

D.,**Corso G.,**Pedrazzani C.,**Roviello F.<br />

*Department of Pharmacology “G. Segre”, University of Siena; **Department of Human<br />

Patology and Oncology, Unit of Surgical Oncolgy, University of Siena<br />

210. Effects of zoledronic acid on cathepsin K circulating levels in patients with bone<br />

metastasis<br />

Leto Gaetano¹, Tumminello F.M¹., Badalamenti G.², Incorvaia L.², Fulfaro F.², Crescimanno<br />

M.¹, Flan<strong>di</strong>na C.¹, Gebbia N.²<br />

¹Lab. Chemioter. Sperimentale and ²U.O. <strong>di</strong> Oncologia Me<strong>di</strong>ca, Dipartimento <strong>di</strong> Discipline<br />

Chirurgiche ed Oncologiche; Policlinico Universitario P. Giaccone, 90127 Palermo, Italy<br />

pag_sx.indd 1 30/05/2007 5.55.11


211. Therapeutic drug monitoring of antiretroviral agents: determination of plasma<br />

concentrations by means of a high-pressure liquid chromatographic technique<br />

Pinetti Diego i , Motta A. ii , Gallesi D. i , Guaral<strong>di</strong> G. ii<br />

i Toxicology and Clinical Pharmacology, Department of Laboratory Services, University of<br />

Modena and Reggio Emilia; ii Department of Me<strong>di</strong>cine and Me<strong>di</strong>cine Specialities, University of<br />

Modena and Reggio Emilia<br />

212. H 2 S and no affect intracellular killing of can<strong>di</strong>da albicans modulating GSH levels<br />

Grosso Silvia 1 , Caronno A. 1 , Lucini V. 1 , Pannacci M. 1 , Sullo N. 2 , Scaglione F. 1<br />

1 Department of Pharmacology, University of Milan, Milan, Italy; 2 Depatment of Experimental<br />

Me<strong>di</strong>cine- Section of Pharmacology, II University of Naples, Naples, Italy<br />

213. Pharmacokinetic/pharmacodynamic of macrolides in an in vivo model of Chlamy<strong>di</strong>a<br />

pneumoniae's pneumonia<br />

Caronno Alessia, Lucini V., Grosso S., Pannacci M., Scaglione F.<br />

Department of Pharmacology, University of Milan, Milan, Italy<br />

214. Bioavailability improvement of polymyxin B by calcium alginate/chitosan<br />

microparticles<br />

Rossi Tiziana°, Baggio G.°, Coppi A.°, Bruni E.°, Ruberto A.°, Iannuccelli V.* Coppi G.*<br />

University of Modena and Reggio Emilia- Italy: °Department of Biome<strong>di</strong>cal Sciences- Section<br />

of Pharmacology; * Department of Pharmaceutical Sciences, 287 G. Campi st 41100 Modena<br />

Italy<br />

Immunofarmacologia<br />

Poster 215 – 224<br />

139<br />

215. Atorvastatin treatment influences polymorphonuclear leukocyte function: a<br />

longitu<strong>di</strong>nal study<br />

Loraschi Anna, Schembri L., Maio R.C., Marino F., Cosentino M., Guasti L., Rasini E., Legnaro<br />

M., Colombo C., Cereda E., Cimpanelli M., Castiglioni L., Tozzi M.*, Castelli P.*, Venco A.,<br />

Lecchini S.<br />

Department of Clinical Me<strong>di</strong>cine, Section of Experimental and Clinical Pharmacology and<br />

*Department of Surgical Surgical Science, University of Insubria, Varese, Italy<br />

216. Treatment with simvastatin mo<strong>di</strong>fies AT 1 R expression and function in<br />

polymorphonuclear leukocyte of high car<strong>di</strong>ovascular risk subjects: a longitu<strong>di</strong>nal<br />

study<br />

Maio Ramona Consuelo, Marino F., Guasti L., Cosentino M., Rasini E., Ferrari M., Cimpanelli<br />

M.G., Loraschi A., Legnaro M., Cereda E., Crespi C., Venco A., Lecchini S.<br />

Department of Clinical Me<strong>di</strong>cine, Section of Experimental and Clinical Pharmacology,<br />

University of Insubria, Varese<br />

217. Effects of atorvastatin treatment on the modulation of leukocyte function in patients<br />

undergoing peripheral vascular intervention: a longitu<strong>di</strong>nal study<br />

Schembri Laura, Loraschi A., Maio R.C., Marino F., Cosentino M., Guasti L., Rasini E., Legnaro<br />

M., Colombo C., Cereda E., Cimpanelli M., Castiglioni L., Tozzi M. 1 , Castelli P. 1 , Venco A.,<br />

Lecchini S.<br />

Department of Clinical Me<strong>di</strong>cine, Section of Experimental and Clinical Pharmacology and<br />

1 Department of Surgical Sciences, University of Insubria, Varese, Italy<br />

pag_dx.indd 1 30/05/2007 5.55.49


218. Atorvastatin and minocycline, effective combination in experimental autoimmune<br />

encephalomyelitis<br />

Luccarini Ilaria a , Biagioli T. b , Ballerini C. b , Biamonte F. c , Bellucci A. d , Fiorentini A. a , Casamenti<br />

F. a<br />

a Dept of Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. b Dept<br />

of Neurology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy. c Dept of<br />

Neuroscience, University Campus Bio-Me<strong>di</strong>co of Rome, Italy. d Dept Biomed. and Biotechnol.<br />

Sci., University of Brescia, Viale Europa 11, 25123 Brescia, Italy.<br />

219. IL-2 induces an altered CD4/CD8 ratio of splenic T lymphocytes from transgenic<br />

mice overexpressing the glucocorticoid-induced protein GILZ<br />

Pozzesi Nicola, Riccar<strong>di</strong> C., Delfino D.V.<br />

Section of Pharmacology, Toxicology and Chemotherapy, Department of Clinical and<br />

Experimental Me<strong>di</strong>cine, University of Perugia Me<strong>di</strong>cal School, Perugia, Italy<br />

220. Out of frame BCR-ABL fusion peptides as targets of the immunotherapy in chronic<br />

myelogenous leukemia<br />

Casnici Clau<strong>di</strong>a, Crotta K., Lattuada D., Mastrotto C., Volpe G. * , Panuzzo C.*, Kuka M.*,<br />

Saglio G.*, Marelli O.<br />

Department of Pharmacology, School of Me<strong>di</strong>cine, University of Milan, Milan, Italy;<br />

*Department of Clinical and Biological Science, University of Turin, Turin, Italy<br />

140<br />

221. Expression of the ang II type 1 receptor on human CD4 + CD25 +hi regulatory T cells<br />

Rasini Emanuela, Marino F., Guasti L., Ferrari M., Legnaro M. Schembri L., Venco A., Lecchini<br />

S., Cosentino M.<br />

Department of Clinical Me<strong>di</strong>cine, University of Insubria, Varese, Italy<br />

222. Effect of <strong>di</strong>fferent mentha piperita varieties on proliferation and cytokine production<br />

in human peripheral blood mononuclear cells<br />

Carcano Elena, Cosentino M., Bombelli R., Luini A., Marino F., * Colombo M. L., # Conti A.,<br />

Lecchini S.<br />

Dept. Clinical Me<strong>di</strong>cine, Sect. Clin. Exp. Pharmacology, University of Insubria, Varese, I,<br />

* Dept. Pharm. Sci. Technol., University of Turin, I, and # Alpine Foundation for Life Sciences,<br />

Olivone, CH<br />

223. Mo<strong>di</strong>fied -galactosyl ceramide analogs for stimulating iNKT cells: a<br />

pharmacological characterization<br />

Fallarini Silvia 1 , Panza L. 1 , Compostella F. 2 , Ronchetti F. 2 , De Libero G. 3 , Lombar<strong>di</strong> G. 1<br />

1 DISCAFF Department, University of “Piemonte Orientale”, Novara, Italy ; 2 Department of<br />

Chemistry, Biochemistry and Biotechnology for Me<strong>di</strong>cine, University of Milano, Milano, Italy;<br />

3 Experimental Immunology, Department of Research, University Hospital, Basel, Switzerland<br />

224. A tuscan olive oil extract inhibits Nuclear Factor-Kappa B activation in<br />

monocyte/macrophages from healthy donors<br />

Bardelli Clau<strong>di</strong>o 1 , Gunella G. 1 , Amoruso A. 1 , Brunelleschi S. 1 , Romani A. 2 , Ieri F. 2 , Coinu R. 3 ,<br />

Franconi F. 3<br />

1 Dept. Me<strong>di</strong>cal Sciences, University “A. Avogadro”, Novara (Italy); 2 Dept. Pharmacological<br />

Chemistry, University of Florence (Italy);<br />

3 Center of Excellence for Biotechnology<br />

Development and Bio<strong>di</strong>versity Research, University of Sassari (Italy)<br />

pag_sx.indd 1 30/05/2007 5.56.38


Farmacologia clinica e sperimentazione clinica dei farmaci<br />

Poster 225 – 240<br />

225. Quality of life of pe<strong>di</strong>atric patients with attention deficit hyperactivity <strong>di</strong>sorder and<br />

oppositive defiant <strong>di</strong>sorder: an italian double-blind placebo-controlled study with<br />

atomoxetine<br />

Dell’Agnello Grazia 2 , Curatolo P. 1 , Mancini F. 2<br />

1 Neuropsychiatria Infantile Clinica Sant’Alessandro, Rome, Italy; 2 Eli Lilly Italia<br />

226. Evening and early morning administration of atomozetine in ADHD children: a<br />

comparison<br />

Dell’Agnello Grazia 4 , Kelsey D. 1 , Sutton V. 1 , Lewis D. 2 , Schuh K. 1 ; Sumner C. 1 , Quintana H. 3 ,<br />

Fre<strong>di</strong>ani S. 4 , Rossi A. 4<br />

1 Lilly Research Laboratories,In<strong>di</strong>anapolis,IN;<br />

2 Monarch Me<strong>di</strong>cal Research,Norfolk,VA;<br />

3 Louisiana State University Health Science Center,New Orleans,LA; 4 Eli Lilly Italia<br />

227. Safety and tolerability of duloxetine in the treatment of major depressive <strong>di</strong>sorder:<br />

analysis of pooled data from eight placebo-controlled clinical trials<br />

Mancini Michele, Barraco A., Rossi A.<br />

Eli Lilly Italia S.p.A.<br />

228. The new antidepressant duloxetine: car<strong>di</strong>ovascular effects<br />

Mancini Michele, Barraco A., Rossi A.<br />

Eli Lilly Italia S.p.A.<br />

229. The management of bipolar mania: a national survey of baseline data from the<br />

emblem study<br />

Mancini Michele 2 , Bellantuono C. 1 , Rossi A. 2 , Barraco A. 2 , Goetz I. 3 , for the Italian EMBLEM<br />

study group<br />

1 Department of Me<strong>di</strong>cine and Public Health, Section of Psychiatry and Clinical Psychology,<br />

University of Verona, Italy; 2 Eli Lilly Italia S.p.A. for the Italian EMBLEM study group; 3 Eli Lilly<br />

and Company, Windlesham, UK<br />

141<br />

230. European mania in bipolar longitu<strong>di</strong>nal evaluation of me<strong>di</strong>cation (emblem) study:<br />

results of the acute 12-week phase in Italy by regional location (north, centre and<br />

south)<br />

Mancini Michele 1 , Rossi A. 1 , Barraco A.1, Goetz I. 2 , for the Italian EMBLEM study group<br />

1 Eli Lilly Italia S.p.A.; 2 Eli Lilly and Company, Windlesham, UK<br />

231. Effectiveness of antipsychotic treatment in outpatients with schizophrenia: 36-<br />

month results from the schizophrenia outpatients health outcomes (SOHO) study<br />

Scatigna Marco (3) , Novick Diego (1) , Haro Josè M. (2) , Brown James (1) , Suarez Diego (2) , Rossi<br />

Andrea (3) , Fre<strong>di</strong>ani Sonia (3) , Ratcliffe Mark C. (1) , and the SOHO Study Group (4)<br />

(1) Eli Lilly and Company, Windlesham, UK (2) Unità ricerca e sviluppo, San Joan de Deu-SSM,<br />

Sant Boi, Barcellona, Spagna (3) Eli illy Italia S.p.A. (4) Alonso J (SP), Gasquet I (FR), Haro JM<br />

(SP) Jones PB (UK), Knapp M (UK), Lepine JP (FR), Naber D (DE), Slooff CJ (NL)<br />

232. Tolerability of outpatient antipsychotic treatment: 36-month results from the<br />

european schizophrenia outpatients health outcomes (soho) study<br />

Scatigna Marco (5) , Novick D. (1) , Haro Josè M. (2) , Suarez D. (2) , Bushe C. (3) , Lepine A. (4) , Rossi<br />

A. (5) , Fre<strong>di</strong>ani S. (5) , the SOHO Study Group (6)<br />

(1) Eli Lilly and Company, Windlesham, UK (2) Unità ricerca e sviluppo, San Joan de Deu-SSM,<br />

Sant Boi, Barcellona, Spagna (3) Eli Lilly and Company, Basingstoke, UK; (4) Hôpital Fernand<br />

Widal Parigi Cedex 10 (5) Eli Lilly Italia S.p.A. (6) Alonso J (SP), Gasquet I (FR), Haro JM (SP)<br />

Jones PB (UK), Knapp M (UK), Lepine JP (FR), Naber D (DE), Slooff CJ (NL)<br />

pag_dx.indd 1 30/05/2007 5.57.26


233. Therapeutic monitoring of clozapine, ABCB1 genotyping and response to treatment<br />

in psychotic patients<br />

Lastella Marianna*, Consoli G.°, Amatori F.*, Catena M.°, Ciapparelli A.°, Ciofi L.*, Golia F.°,<br />

Carmassi C.°, Danesi R.*, Dell’Osso L.°, Del Tacca M.*, Di Paolo A.*<br />

*Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa; °Psychiatric Clinic, Department of Psychiatry, Neurobiology, Pharmacology and<br />

Biotechnology, University of Pisa, Pisa<br />

234. Essential tremor is responsive to combined topiramate and declorazepam treatment<br />

Gallelli Luca 2 , Siniscalchi A. 1 , Borner Perrone I. 2 , Davoli A. 2 , De Sarro G. 2<br />

1 Department of Neuroscience, Neurology Division, “Annunziata” Hospital, Cosenza, Italy;<br />

2 Chair of Pharmacology, Department of Experimental and Clinical Me<strong>di</strong>cine, Faculty of<br />

Me<strong>di</strong>cine, University Magna Graecia of Catanzaro, Catanzaro, Italy<br />

235. Therapeutic drug monitoring of gentamicin in newborns: our experience<br />

Martinelli Valentina, Serpi A.*, Carta P., Fanos V.*, Del Zompo M., Testa M.*<br />

Section of Clinical Pharmacology, Department of Neurosciences “B.B. Bro<strong>di</strong>e”, University of<br />

Cagliari; *Institute of Neonatal Pathology and Intensive Therapy, University of Cagliari<br />

142<br />

236. Phase II marker lesion study of 6-week intravesical gemcitabine instillation in<br />

patients with low-risk superficial bladder cancer<br />

Russo Francesca 6 , Brausi M. 1 , Giussani L. 2 , Altieri V. 3 , Rigatti P. 4 , Gontero P. 5 , Bertelli L. 6 ,<br />

Rossi A. 6 , Langer F. 7 , Bono A. 2<br />

1 Divisione <strong>di</strong> Urologia AUSL, Modena, 2 Divisione <strong>di</strong> Urologia Ospedale <strong>di</strong> Circolo e Fondazione<br />

Macchi, Varese, 3 Clinica Urologia Azienda Universitaria Policlinico Federico II , Napoli,<br />

4 Clinica Urologia Università Vita e Salute, Ospedale S. Raffaele, Milano, 5 Clinica <strong>di</strong> Urologia<br />

Ospedale Maggiore della Carità, Novara, 6 Eli Lilly Italia; 7 Eli Lilly EuMed<br />

237. Comparison between <strong>di</strong>fferent topical hypotensive drugs in two experimental<br />

models of glaucoma in the rabbit<br />

*Fabrizi Francesca, °Giambene B., °Galassi G., *Uliva C., § Ongini E., *Masini E.<br />

*Department of Preclinical and Clinical Pharmacology; University of Florence;°Department of<br />

Oto-neuro-ophthalmological Sciences, University of Florence and § NicOx Research Institute,<br />

Milan, Italy<br />

238. Plasma levels of arginine and lactate in rehabilitation patients with spinal cord<br />

injury and pressure ulcers<br />

Verri Manuela*, Aquilani R.^, Boschi F.*, Dossena M.*, Iadarola P.°, Viglio S.°, Pastoris O.*<br />

*Department of Physiological & Pharmacological Sciences; °Department of Biochemistry “A.<br />

Castellani”, University of Pavia, Pavia, Italy; ^IRCCS “S. Maugeri” Foundation, Montescano,<br />

Italy<br />

239. Sildenafil citrare versus Tadalafil for ED treatment: preference of italian patients<br />

and reasons of their choice<br />

Gentilella Raffaella 6 , Fusco F., Lembo A. 1 , Ludovico G.M. 2 , Pirozzi Farina F. 3 , Montorsi F. 4 ,<br />

Menchini Fabris F. 5 , Sicuteri R. 6 , Rossi A. 6 , Mirone V.<br />

Clinica Urologica, Università Federico II, Napoli; 1 Div. Urologia, Ospedali Riuniti <strong>di</strong> Bergamo;<br />

2 Unità <strong>di</strong> Urologia Operativa, Ospedale Civile, Monopoli, Bari; 3 Università Di Sassari, Clinica<br />

Urologica; 4 Reparto <strong>di</strong> Urologia, Ospedale S. Raffaele, Milano; 5 Unità <strong>di</strong> Andrologia, Università<br />

<strong>di</strong> Pisa, Pisa; 6 Eli Lilly Italia<br />

240. The magnitude of inhibitory drug interactions is dependent on liver functional status<br />

Pegoraro Paola 1 , De Martin S. 1 , Orlando R. 2 , Palatini P. 1<br />

1 Department of Pharmacology and Anaesthesiology, and of 2 Me<strong>di</strong>cal and Surgical Sciences<br />

University of Padova, Italy<br />

pag_sx.indd 1 30/05/2007 5.58.25


Farmacovigilanza, farmacoepidemiologia e farmacoeconomia<br />

Poster 241 – 253<br />

241. Gabapentin-induced rhabdomyolysis: a case report<br />

Tuccori Marco 1,2 , Lombardo G. 2 , Lapi F. 1,4 , Vannacci A. 1,4 , Blan<strong>di</strong>zzi C. 1,4 , Mugelli A. 1,4 , Del<br />

Tacca M. 1,2<br />

1 Tuscan Regional Center for Pharmacovigilance;<br />

2 Division of Pharmacology and<br />

Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of Pisa – Pisa, Italy; 3 Intensive<br />

Care Unit - Hospital of Empoli, Florence – Italy; 4 Department of Preclinical and Clinical<br />

Pharmacology - University of Florence, Florence – Italy<br />

242. Anticoagulants and drugs at interaction risk<br />

Alacqua Marianna 1 , Trifirò G. 1,4 , Moretti S. 3 , Tari M. 3 , Galdo M. 3 , Tari U. 3 , Caputi A.P. 1,4 ,<br />

UVEC group 3 , ArcoracI V. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, Pharmacology Unit,<br />

University of Messina, Italy - 2 Division of Child Neurology and Psychiatry, University of<br />

Messina, Italy - 3 “Caserta 1” Local Health Service, Caserta, Italy - 4 IRCCS Centro Neurolesi<br />

"Bonino-Pulejo", Messina, Italy<br />

243. Vigilance system for undesirable effects of cosmetic products (cosmetovigilance) in<br />

Europe<br />

Sportiello Liberata 1 , Sautebin L. 1,2<br />

1 Department of Experimental Pharmacology, 2 Pharmacoeconomic and Pharmacoutilization<br />

Research Centre, Faculty of Pharmacy, University of Naples Federico II, Naples, Italy<br />

244. Notification of undesirable effects of cosmetic products by pharmacists and<br />

dermatologists: a pilot project<br />

Sautebin Li<strong>di</strong>a<br />

Department of Experimental Pharmacology, Pharmacoeconomic and Pharmacoutilization<br />

Research Centre, Faculty of Pharmacy, University of Naples Federico II, Naples, Italy<br />

143<br />

245. Gender <strong>di</strong>fference in adverse drug reactions: analysis of spontaneous reports of an<br />

italian interregional database (GIF)<br />

Salvo F. (1) , Cutroneo P.M. (1) , Meneghelli I. (2) , Motola D. (3) , Del Tacca M. (4) , Ros B. (5) , Capuano<br />

A. (6) , Leoni O., Polimeri G. (1)<br />

(1) Dep. Clin Experim Med and Pharmacol, University of Messina, Italy - (2) Clinical<br />

Pharmacology Unit, University of Verona, Italy - (3) Interuniversity Research Centre for<br />

Pharmacoepidemiology, University of Bologna, Italy - (4) Division of Pharmacology and<br />

Chemotherapy, University of Pisa, Italy; (5) Pharmaceutical Service of Friuli Venezia Giulia<br />

Health Department, Trieste, Italy - (6) Department of Experimental Me<strong>di</strong>cine, Second University<br />

of Naples, Italy - (7) Lombardy Centre of Pharmacovigilance, Milan, Italy<br />

246. Gender and age-related drug prescription patterns in the varese local health<br />

authority<br />

Leoni Olivia 1 , Banfi F. 2 , Soma R. 1 , Manfre<strong>di</strong> L. 1 , Oria C. 1 , Roi C. 1<br />

1 PAC Department, Varese Local Health Authority, Italy; 2 Health Managed, Varese Local Health<br />

Authority, Italy<br />

247. The pharmacological consultation service as a valid tool for developing a correct<br />

drug approach: "the Poppers' case"<br />

Stochino M. Erminia, Asuni C., Carta P., Del Zompo M.<br />

Drug Information Centre, Section of Clinical Pharmacology, Department of Neurosciences<br />

“B.B. Bro<strong>di</strong>e”, University of Cagliari<br />

pag_dx.indd 1 30/05/2007 5.59.06


248. Adverse reactions to contrast me<strong>di</strong>a: an analysis from spontaneous reporting data<br />

Paola Cutroneo 1 , Polimeri G. 1,2 , Curcuruto R. 1 , Russo A. 1 , Calapai G. 1 , Caputi A.P. 1<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine,<br />

University of Messina, Italy; 2 Istituto <strong>di</strong> Ricovero e Cura a Carattere Scientifico (IRCCS)<br />

Centro Neurolesi "Bonino-Pulejo," Messina, Italy<br />

249. Regional surveillance of emergency department visits for outpatient adverse drug<br />

events<br />

Gallo Mariapina, Ferrante L., Illiano M.L., Russo F., Annibale R., Filippelli A., Rossi F.,<br />

Captano A.<br />

Department of Experimental Me<strong>di</strong>cine, Section of Pharmacology “Leonardo Donatelli”. Center<br />

of Pharmacosurveillance and Pharmacoepidemiology, Faculty of Me<strong>di</strong>cine and Surgery, Second<br />

University of Naples, Italy<br />

250. Pharmacovigilance teaching in the european faculties of pharmacy<br />

Rossi Antonietta 1 , Pergola C. 1 , Sautebin L. 1,2<br />

1 Department of Experimental Pharmacology, 2 Pharmacoeconomic and Pharmacoutilization<br />

Research Centre, Faculty of Pharmacy, University of Naples Federico II, Naples, Italy.<br />

144<br />

251. Promoting continuing education in pharmacovigilance: the experience of<br />

"Pharmasearch", a network of general practitioners reporting adverse drug<br />

reactions<br />

Catania Maria A. 1 , Salvo F. 1 , Oteri A. 1 , Polimeni G. 1,5 , Russo A. 1 , Giustini Saffi E. 2 , Sessa A. 2 ,<br />

Tuccori M. 3 , Martelli A. 4 , Del Tacca M. 3 , Caputi A. P. 1,5<br />

1 University of Messina; 2 Area Pharmasearch, SIMG;<br />

3 University of Pisa;<br />

4 University of<br />

Genova; 5 IRCCS Neurolesi “Bonino-Pulejo”, Messina<br />

252. The blink project: a new biome<strong>di</strong>cal researchers' database (www.doyoublink.net)<br />

Biggio Giovanni 3 , Busconi P. 1 , Ferranti S. 2 , Ceserani I. 3 , Pistotti V. 4 , Casale F. 3 , Caglioti L. 5 ,<br />

Garattini S. 4<br />

1 Promotore, Fondazione Schering, Italy – 2S Sviluppo tecnico database, New! S.a.s., Milano,<br />

Italy; 3 Società Italiana <strong>di</strong> Farmacologia, Milano, Italy - 4 Istituto <strong>di</strong> Ricerche Farmacologiche<br />

“Mario Negri”, Italy - 5 Università "La Sapienza", Roma, Italy<br />

253. On parenteral formulations and golden standards for quality and safety<br />

a Naccari C., b Giovinazzo C., a Saija A., a Tomaino A.<br />

a Dept. Farmaco-Biologico, Faculty of Pharmacy, University of Messina, Contrada Annunziata,<br />

98168 Messina, Italy; b Faculty of Pharmacy, University of Messina, Contrada Annunziata,<br />

98168 Italy<br />

Farmacognosia e fitoterapia: aspetti sperimentali e clinici<br />

Poster 254 – 265<br />

254. Central effects of a new secoisopimarane <strong>di</strong>terpenoid from aerial parts of Salvia<br />

cinnabarina<br />

Maione Francesco 1,2 , Colucci M. 2 , Bisio A. 3 , Romussi G. 3 , Pieretti S. 2 , Di Giannuario A. 2 , Maria<br />

C. Bonito M.C. 1,2 , Mascolo N. 1<br />

1 Department of Experimental Pharmacology, University of Naples “Federico II, Naples;<br />

2 Department of Drug Research and Evaluation, Italian National Institute of Health, Rome;<br />

3 Department of Chemistry and Pharmaceutical Technology and Alimentary, University of<br />

Genoa, Genoa<br />

255. In vitro antioxidant activity of aged extracts of some italian spontaneous Allium<br />

species<br />

Nencini Cristina, Micheli L., Giorgi G., Franchi G.G.<br />

Department of Pharmacology “Giorgio Segre”, University of Siena<br />

pag_sx.indd 1 30/05/2007 6.00.06


256. Effect of Allium neapolitanum on liver injury induced by ethanol in rats<br />

Nencini Cristina, Franchi G. G., Giorgi G., Micheli L.<br />

Department of Pharmacology “Giorgio Segre”, University of Siena<br />

257. Antioxidant properties of infusions from leaves and inflorescences of Achillea<br />

millefolium ssp. collina B. By use of chemical and biological assays<br />

Bombelli R. 1 , Luini A. 1 , Giorgi A. 2 , Licheri G. 2 , Carcano E. 1 , Marino F. 1 , Cosentino M. 1 ,<br />

Cocucci M. 2 , Lecchini S. 1<br />

1 Dipartimento <strong>di</strong> Me<strong>di</strong>cina Clinica, Sezione <strong>di</strong> Farmacologia Sperimentale e Clinica, Università<br />

<strong>degli</strong> <strong>Stu<strong>di</strong></strong> dell’Insubria, Varese and 2 Dipartimento <strong>di</strong> Produzione Vegetale, Università <strong>degli</strong><br />

<strong>Stu<strong>di</strong></strong> <strong>di</strong> Milano, Milano<br />

258. In vitro antioxidant, antimutagen and anti-inflammatory activity of extracts and<br />

stilbenes from Glycyrrhiza glabra leaves<br />

1 Cristani M., 1 Saija A., 1 D’arrigo M., 1 Naccari C., 2 Ruberto G., 2 Bion<strong>di</strong> D.D., 1 Trombetta D.<br />

1 Dept. Farmaco-Biologico, School of Pharmacy, University of Messina, Italy - 2 CNR Institute of<br />

Biomolecular Chemistry - Catania, Valverde, Catania, Italy<br />

259. Protective effect of Hypericum perforatum in zymosan-induced multiple organ<br />

dysfunction syndrome<br />

1 De Sarro Angelina, 1,2 Mazzon E., 1,2 Di Paola R., 1 Muià C., 1,2 Genovese T., 2 Bramanti P.,<br />

3 Esposito E., 4 Menegazzi M., 3 Meli R., 4 Suzuki H., 1,2 Cuzzocrea S.<br />

1 Department of Clinical and Experimental Me<strong>di</strong>cine and Pharmacology, School of Me<strong>di</strong>cine,<br />

University of Messina, Italy; 2 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy;<br />

3 Dipartimento <strong>di</strong> Farmacologia Sperimentale, Università <strong>di</strong> Napoli “Federico II”, Napoli, Italy;<br />

4 Department of Neuroscience and Vision, University of Verona, Verona, Italy<br />

145<br />

260. Inhibition of human cAMP phospho<strong>di</strong>esterases as a mechanism of the spasmolytic<br />

effect of Matricaria recutita L. water extract<br />

Dell’Agli Mario, Dal Cero E., Maschi O., Bosisio E.<br />

Department of Pharmacological Sciences, Faculty of Pharmacy, University of Milan, Italy<br />

261. Phenylpropanoid rich essential oils as potential antithrombotics endowed with<br />

gastroprotective effects<br />

Tognolini Massimiliano 1 , Barocelli E. 1 , Bertoni S. 1 , Impicciatore M. 1 , Bruni R. 2 , Ballabeni V. 1<br />

1 Dept of pharmacological, biological and applied chemical sciences. University of Parma. Viale<br />

Usberti 27/a, 43100 Parma, Italy; 2 Dept of evolutionary and functional biology. University of<br />

Parma. Viale Usberti 11/a, 43100 Parma, Italy<br />

262. Biological activity of bergamot peel extracts (Citrus bergamia Risso)<br />

Trombetta D., D’Arrigo M., Ginestra G., Arcoraci T., Mandalari G., Saija A., Cristani M.<br />

Dept. Farmaco-Biologico, School of Pharmacy, University of Messina - Vill. SS. Annunziata<br />

98168 Messina, Italy<br />

263. Evidence to implicate phospho-Akt (p-Akt) in the mechanisms underlying<br />

neuroprotection afforded by the essential oil of bergamot against excitotoxicity in<br />

vitro<br />

Maida Simona 1 , Fratto V., Navarra M. 1 , Bagetta G. 2 , Corasaniti M.T. 1<br />

1 Department of Pharmacobiological Sciences, University “Magna Graecia” of Catanzaro,<br />

Catanzaro, Italy; 2 Department of Pharmacobiology and University Centre of Adaptive<br />

Disorders and Headache (UCADH), section of Neuropharmacology of Normal and Pathological<br />

Neuronal Plasticity, University of Calabria, Rende (CS), Italy<br />

pag_dx.indd 1 30/05/2007 6.00.45


264. The protective effect of bergamot oil non volatile fraction on LOX-1 expression in<br />

balloon injury-related neointima formation<br />

Sacco Iolanda 1 , Palma E. 1 , Sculco F. 1 , Colica C. 1 , Visalli V. 1 , Muscoli S. 3 , Ragusa S. 1 ,<br />

Mondello L. 4 , Rotiroti D. 1 , Romeo F. 3 , Mollace V. 1,2<br />

1 Faculty of Pharmacy, University “Magna Graecia” of Catanzaro, Italy; 2 San Raffaele Pisana<br />

IRCCS, Rome, Italy; 3 Chair of Car<strong>di</strong>ology, University of Rome “Tor Vergata”, Rome, Italy;<br />

4 Faculty of Pharmacy, University of Messina, Italy<br />

265. Vascular activity of isolates from the Hyacinthaceae of south Africa<br />

Maida Simona 1 , Fratto V., Navarra M. 1 , Bagetta G. 2 , Corasaniti M.T. 1<br />

1 Department of Pharmacobiological Sciences, University “Magna Graecia” of Catanzaro,<br />

Catanzaro, Italy; 2 Department of Pharmacobiology and University Centre of Adaptive<br />

Disorders and Headache (UCADH), section of Neuropharmacology of Normal and Pathological<br />

Neuronal Plasticity, University of Calabria, Rende (CS), Italy<br />

Farmacogenetica, farmacogenomica e terapia genica<br />

Poster 266 – 280<br />

266. Olymorphisms of the ABCB1 gene pre<strong>di</strong>ct drug resistance in epileptic patients<br />

Lastella Marianna*, Danesi R.*, Cascio E.*, Jensen S. § , Iu<strong>di</strong>ce A. § , Murri L. § , Del Tacca M.*,<br />

Di Paolo A.*<br />

*Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine;<br />

§ Division of Neurology, Department of Neurosciences - University of Pisa<br />

146<br />

267. Herpes simplex vectors expressing FGF-2 and BDNF prompt neuronogenesis and<br />

exert <strong>di</strong>sease-mo<strong>di</strong>fying effects in a model of temporal lobe epilepsy<br />

Mazzuferi Manuela 1 , Para<strong>di</strong>so B. 1 , Marconi P. 1 , Zucchini S. 1 , Berto E. 1 , Binaschi A. 1 , Bozac A. 1 ,<br />

Buzzi A. 1 , Magri E. 1 , Navarro Mora G. 2 , Ro<strong>di</strong> D. 1 , Volpi I. 1 , Fabene P.F. 2 , Marzola A. 1 ,<br />

Manservigi R. 1 , Simonato M. 1<br />

1 University of Ferrara, 2 University of Verona, Italy<br />

268. Alzheimer's <strong>di</strong>sease: association study between response to cholinesterase<br />

inhibitors and can<strong>di</strong>date genes in a sar<strong>di</strong>nian sample<br />

Squassina Alessio 1 , Congiu D. 1 , Manconi F. 1 , Putzu P.F 2 , Chillotti C. 1 , Del Zompo M. 1 , Piccar<strong>di</strong><br />

M. 1<br />

1 Unit of Clinical Pharmacology, Department of Neurosciences ‘‘B. B. Bro<strong>di</strong>e’’, University of<br />

Cagliari, 2 Division of Geriatrics, Local Health Agency 8, Cagliari, Italy<br />

269. Impact of CYP3A4 and CYP3A5 polymorphisms on clinical outcome of donepezil in<br />

Alzheimer's <strong>di</strong>sease patients<br />

Paoletti T. 1 , Scordo M.G. 2 , Miglio G. 1 , Villa M.L. 3 , Dahl M.L. 2 , Lombar<strong>di</strong> G. 1<br />

1 DISCAFF Department, University of “Piemonte Orientale Amedeo Avogadro”, Novara, Italy;<br />

2 Department of Me<strong>di</strong>cal Sciences, Clinical Pharmacology, Uppsala University Hospital,<br />

Uppsala, Sweden; 3 Geriatric Clinical Unit, “ Ospedale Maggiore della Carità”, Novara, Italy<br />

270. Role of polymorphisms of the UGT1A9 gene in comt inhibitor-induced hepatotoxicity<br />

in parkinson's <strong>di</strong>sease: a clinical study<br />

1 Ferrari Marco, 1 Cosentino M., 1 Marino F., 1 Bono G., 2 Martignoni E., 3,4 Nappi G., 1 Lecchini S.<br />

1 Dept. Clin. Med., University of Insubria, Varese, 2 Dept. Med. Sci., University of Piemonte<br />

Orientale “Amedeo Avogadro”, Novara and Dept. Neurorehabil. Mov. Disord., “Salvatore<br />

Maugeri” Foundation, Scientific Institute of Veruno, NO, 3 Dept. of Neurol. Otorhinolaryngol.,<br />

University “La Sapienza”, Rome, and 4 I.R.C.C.S. C. Mon<strong>di</strong>no, Pavia, Italy<br />

pag_sx.indd 1 30/05/2007 6.01.35


271. Genetic polymorhisms of serotonin transporter and monoamine oxidase; and<br />

response to SSRI antidepressant drugs in terminal cancer patients<br />

Schillani Giulia, Capozzo M., Conte A.M., De Vanna M., Giral<strong>di</strong> T.<br />

Department of Biome<strong>di</strong>cal Sciences, University of Triest<br />

272. Lithium response: association study with can<strong>di</strong>date genes<br />

Manchia Mirko, Squassina A., Lampus S., Ardau R., Chillotti C., Del Zompo M., Severino G.<br />

Section of Clinical Pharmacology, Department of Neurosciences “B.B. Bro<strong>di</strong>e”, University of<br />

Cagliari<br />

273. Pharmacogenomics and triptans: a pilot study of association between clinical<br />

response to rizatriptan and some can<strong>di</strong>date genes<br />

Asuni Carlo, Stochino M.E., Congiu D., Cherchi A., Piccar<strong>di</strong> M. P., Del Zompo M.<br />

Headache Centre, Section of Clinical Pharmacology, Department of Neurosciences “B.B.<br />

Bro<strong>di</strong>e”, University of Cagliari<br />

274. Synergistic cytotoxicity of oxaliplatin and pemetrexed in colon cancer cells: cellular<br />

and molecular mechanisms<br />

Nannizzi Sara, Giovannetti E., Mey V., Ricciar<strong>di</strong> S., Del Tacca M., Danesi R.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa<br />

275. Molecular mechanisms underlying the synergistic interaction of the EGFR tyrosine<br />

kinase inhibitor erlotinib with the multitargeted antifolate pemetrexed in non-small<br />

cell lung cancer cells<br />

Giovannetti Elisa 1,2 , Smid K. 1 , Mey V. 2 , Tekle C. 1 , Nannizzi S. 2 , Rodriguez J.A 1 , Ricciar<strong>di</strong> S. 2 ,<br />

Del Tacca M. 2 , Giaccone G. 1 , Danesi R. 2 , Peters Godefridus J 1<br />

1 Dept. Me<strong>di</strong>cal Oncology, VU University Me<strong>di</strong>cal Center, Amsterdam, The Netherlands; 2 Dept.<br />

Internal Me<strong>di</strong>cine, Div. Pharmacology and Chemotherapy, University of Pisa, Italy<br />

147<br />

276. Pharmacogenetic evaluation of Aurora A kinase in colorectal cancers<br />

Amatori Federica Maria*, Boldrini L § , Di Paolo A*, Lastella M*, Fontanini G § , Del Tacca M*,<br />

Danesi R*.<br />

*Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine; § Division of<br />

Pathology, Department of General Surgery, University of Pisa<br />

277. Epigenetic mechanisms of sensitivity to irinotecan in colorectal cancer cell lines<br />

Crea Francesco, Giovannetti E., Mey V., Nannizzi S., Ricciar<strong>di</strong> S., Danesi R., Del Tacca M.<br />

Division of Pharmacology and Chemotherapy, Department of Internal Me<strong>di</strong>cine, University of<br />

Pisa, Pisa, Italy<br />

278. Genetic polymorphisms in DNA repair genes and their impact on susceptibility to<br />

multiple myeloma<br />

Angelini Sabrina 1 , Cantelli-Forti G. 1 , Terragna C. 2 , Renzulli M. 2 , Cavo M. 2 , Hrelia P. 1<br />

1 Department of Pharmacology, University of Bologna; 2 Institute of Haematology and Me<strong>di</strong>cal<br />

Oncology “Seragnoli”, University of Bologna<br />

279. Genetic polymorphism of bleomycin hydrolase: a new biomarker for human<br />

mutagen sensitivity<br />

Maffei Francesca 1 , Carbone F. 1 , Angelini S. 1 , Cantelli Forti G. 1 , Norppa Hannu 2 , Hrelia P. 1<br />

1 Department of Pharmacology, University of Bologna, Via Irnerio 48 40126 Bologna, Italy;<br />

2 Finnish Institute of Occupational Health, Topeliuksenkatu 41 aA, FI-00250 Helsinki, Finland<br />

pag_dx.indd 1 30/05/2007 6.02.14


280. DNA vaccine strategy against chronic B-cell lymphoma: anti-i<strong>di</strong>otypic CDR3<br />

vaccination<br />

Schirru Cristina 1 , Maullu C. 1 , Deidda F. 1 , Rinal<strong>di</strong> M. 3 , Signori E. 2,3 , Massi E. 2 , Chiarella P. 1,2 ,<br />

Marelli O. 4 , Tonon G. 1 , Fazio V.M. 2,3<br />

1 Bioker S.r.l. Polaris Loc.piscinamanna Pula (CA); 2 CIR, Section of Molecular Me<strong>di</strong>cine and<br />

Biotechnology, University "Campus Bio-Me<strong>di</strong>co", Rome, Italy; 3 Institute of Neurobiology and<br />

Molecular Me<strong>di</strong>cine, CNR Rome, Italy; 4 Dipartimento Di Farmacologia, Chemioterapia E<br />

Tossicologia Me<strong>di</strong>ca, Università <strong>di</strong> Milano<br />

148<br />

pag_sx.indd 1 30/05/2007 6.03.02


38<br />

pag_sx.indd 1 30/05/2007 7.14.27


Aas M 131<br />

Abbadessa G 108<br />

Abbate R 120<br />

Abbate M 43<br />

Abbracchio M 35, 126<br />

Abbruzzese A 128<br />

Abdelrahman M 133<br />

Accomazzo MR 102<br />

Acquadro E 88<br />

Acquas E 96, 130<br />

Adami M 98<br />

Adamo E 58, 135<br />

Adcock I<br />

Adornetto A<br />

Agnati LF 30<br />

Agnoletto L 78, 117<br />

Agostini M 103,<br />

Agostini S 98, 99, 135<br />

Agresta A 129, 130<br />

Agretti P 113<br />

Agrusa A 138<br />

Aguglia E 28, 38, 66<br />

Aiello A<br />

Aimola P 109<br />

Akpan V 137<br />

Alacqua M 111, 124, 143<br />

Alaimo A 104<br />

Albanese A 128<br />

Albini A 81<br />

Alboni S 62, 85<br />

Alcaro S 136<br />

Alderighi D 104<br />

Alemà GS 123, 126<br />

Alfieri A 134<br />

Alicandri C 106<br />

Aliferopulos H 111<br />

Allegretti M 138<br />

Allegrini G 138<br />

Alloisio S 81, 112<br />

Almairac R 120<br />

Altamura CA 28, 38<br />

Altavilla D 54, 58, 101, 117,<br />

126, 127 , 135, 136<br />

Altea S 130<br />

Altieri V 142<br />

Ama<strong>di</strong>o M 98<br />

Ama<strong>di</strong>o S<br />

Amantea D 43<br />

Amato D 86, 93<br />

Amatori FM 59, 142, 147<br />

Ambrosio C 78<br />

Amici A 59<br />

Amoroso S 31, 37, 115<br />

Amoruso A 35, 37, 140<br />

Anania V 108<br />

Andersen SJ 93<br />

Andre E 131, 132<br />

Andreassi MG<br />

Andretta F 127<br />

Angeli A 58<br />

Angelini S 147<br />

Angeloni C 88<br />

Angioni MM 88<br />

Angius F 130<br />

Anichini R 100<br />

Annibale R 144<br />

Annunziato L 35, 63, 77, 81, 110,<br />

126<br />

Antenucci G 113<br />

Antonelli T 31<br />

Antonioli L 98, 134<br />

Antonuccio P 101<br />

Anzellotti P 84, 102<br />

Apicella C 102<br />

Appen<strong>di</strong>no G 47<br />

Aquaro S<br />

Aquilani R 84<br />

Aquino RP 108<br />

Arbitrio M 87, 93<br />

Arcieri P 57, 90<br />

Arcone R 93, 128<br />

Arcoraci T 145<br />

Arcoraci V 107, 124, 143<br />

Ardau R 106, 147<br />

Argiolas A 101, 130<br />

Armida M 82<br />

Armocida G 121<br />

Arnabol<strong>di</strong> L 121<br />

Arnoletti E 100, 135, 136<br />

Aronica E 126<br />

Ascolani A 116<br />

Assaretti AR<br />

Asuni C 143, 147<br />

Autore G 83, 108, 119, 120<br />

Avallone R 121, 136<br />

Avanzini G 117<br />

Aviello G 58<br />

Ayrol<strong>di</strong> E 58<br />

Azad S 118<br />

Azzena G<br />

Babini E 115<br />

Baccini G 118<br />

Bachis E 76<br />

Bacosi E 96<br />

Badalamenti G 138<br />

Bader G 48<br />

Bader M 99<br />

Ba<strong>di</strong>ani A 93, 96, 97<br />

Badura A<br />

Baetta R 121<br />

Bagetta G 43, 44, 65, 145, 146<br />

Baggio G 103, 139<br />

Baigent C 29<br />

Baiula M 58, 137<br />

Bajetto A 79<br />

Balduini W 65, 127<br />

Balestra B 135<br />

Balestrieri E 28, 116<br />

Ballabeni V 118, 134, 145<br />

Ballerini P 35<br />

Ballerini C 140<br />

Banchelli G 107<br />

Banfi F 143<br />

Bani D 132<br />

Bano F 107<br />

Barabino A 109<br />

Barabino E 36<br />

Baragli A 100,135<br />

Baral<strong>di</strong> M 58, 82, 101, 102, 121,<br />

136, 137<br />

Baral<strong>di</strong> PG 28, 37, 89<br />

Barberi L 128<br />

Barberis A 59, 104<br />

Barbierato M 78<br />

Barbieri A 113, 117<br />

Barbieri F 79<br />

Barbieri R 112<br />

Barbieri M 122<br />

Barbieri S 54<br />

Barbiero V 85<br />

Bardella E 99<br />

Bardelli C 35, 37, 140<br />

Barden N 62<br />

Barillari J 108<br />

Barletta MT 138<br />

Barnes A 78<br />

Barnes P 32<br />

Barnett A 100<br />

Baroc MF 91<br />

Barocelli E 118, 134, 145<br />

Baroffio M 133<br />

Barone D 137<br />

Barone E 127<br />

Barraco A 141<br />

Barrese V 81<br />

Barrile V 94<br />

Bartella C 102<br />

Bartesaghi S<br />

Bartoli F 104, 109, 110<br />

Bartolini A 92, 116, 43<br />

Bassi A 95, 107<br />

Basta F 102<br />

Bastia E 80, 114<br />

Bastianelli A 58, 80<br />

Bastoni S 111<br />

Battaglia G 65, 87, 88, 7, 116,<br />

126,<br />

Battisti E 128<br />

Batuwangala M 114<br />

Bazzani C 53, 117, 126<br />

Bazzu G 36, 64, 90, 94<br />

Beani L 122<br />

Bechi P 83<br />

Be<strong>di</strong>ni A 113<br />

Belfiore D 36<br />

Bellanti F 91<br />

Bellantuono C 28, 39, 141<br />

Bellik L 48, 54, 59<br />

Bellini G 35<br />

Bellini M 109<br />

Bellis A 100, 110<br />

Bellosta S 121, 43<br />

Belluardo N 65<br />

Bellucci A 140<br />

Beltramo M 76<br />

Benatti C 62, 85<br />

Bencini A 102<br />

Benelli A 79, 101<br />

Benemei S 129<br />

Benincasa M 79<br />

Benini A 37, 61, 112<br />

Benoni G 107<br />

Bergersen L<br />

Bernar<strong>di</strong>ni N 98<br />

Bernar<strong>di</strong>ni R 43, 81<br />

Bernini F 121<br />

Berrino L 37, 38, 53, 84, 115,<br />

120<br />

Berta GN 59, 104<br />

Berta L 104<br />

Bertacca L 116<br />

Bertarione Rava Rossa L 137<br />

Bertelli L 142<br />

Berti F 48, 83, 121<br />

Berti M 83<br />

Bertini R 138<br />

Berto E 146<br />

Bertocchi I 88<br />

Bertolini A 30, 31, 53, 105, 125,<br />

130<br />

Bertoni S 79, 118, 134, 145<br />

Bertorelli R 50<br />

Bertossi F<br />

Betti N 80<br />

Bettiol E<br />

Bettoni I 129<br />

Bezzi P 44<br />

Biagi GL 108<br />

Biagi M 136<br />

152


Biagioli T 140<br />

Biagioni F 87, 97, 126<br />

Biamonte F 140<br />

Bianchi A 129, 130<br />

Bianchi F 98<br />

Bianchi M 83<br />

Bianco F<br />

Bianco G 83, 100, 108, 119, 135<br />

Biasin A<br />

Bifulco M 76, 108<br />

Biggio F 61, 85, 131<br />

Biggio G 26, 27, 30, 36, 38, 53,<br />

56, 61, 66, 76, 77, 82, 85, 88,<br />

95, 131, 144<br />

Billington RA 115<br />

Bin A 107, 134<br />

Binaschi A 146<br />

Bion<strong>di</strong> DM 145<br />

Bion<strong>di</strong> S 102, 114<br />

Bisio A 144<br />

Bisogno A 129, 130<br />

Bitto A 54, 58, 101, 117, 120,<br />

126, 127, 135, 136<br />

Bizzarri C 138<br />

Bizzarro V 79<br />

Blan<strong>di</strong>na P 114, 125<br />

Blan<strong>di</strong>zzi C 42, 59, 60, 98, 106,<br />

109, 110, 134, 143<br />

Blasevich M 124<br />

Blom JMC 62, 85<br />

Bocci G 59, 81, 138<br />

Boccuti S 37<br />

Boldrini L 147<br />

Bolego C 57, 83, 101<br />

Bolla M<br />

Bolle P 109<br />

Bombar<strong>di</strong>eri S 110<br />

Bombelli R 50, 140, 145<br />

Bonamassa B 108<br />

Bonanno G 81, 82, 105<br />

Bonatesta RR 111<br />

Boncompagni E 117<br />

Bongers G 114<br />

Bonini SA 65,124<br />

Bonito MC 144<br />

Bono A 142<br />

Bono G 146<br />

Bonomo SM 83, 135<br />

Bonuccelli U<br />

Borea PA 28, 37, 61, 112, 133<br />

Borghi V 102<br />

Borner Perrone I 105, 142<br />

Borracci P 36<br />

Borrelli F 58<br />

Borroni E 102<br />

Borsini F 51, 86, 89<br />

Bortolato M 94<br />

Boschi F 84, 99, 142<br />

Boscia F 77, 126<br />

Bosisio E 145<br />

Bossi M 110<br />

Bothmann H 92<br />

Botta M 79, 136<br />

Botta P 36<br />

Bottai D 125, 127<br />

Bottelli A 121<br />

Botti F 60<br />

Botticelli A 117, 126<br />

Bottinelli R<br />

Bova S 119<br />

Bozac A 146<br />

Bozzo L 112<br />

Braconi S 93, 132<br />

Braghiroli D 121<br />

Braida D 61, 97<br />

Bramanti P 38, 66, 79, 133, 145<br />

Brambilla M 54, 119<br />

Brancaleone V 54, 83, 133<br />

Brassart L 111<br />

Brausi M 142<br />

Breckenridge A 46<br />

Breghi L 54<br />

Brera F 89<br />

Breschi MC 134<br />

Bresciani E 136<br />

Bretoni L<br />

Brini AT 111<br />

Brivio I 119<br />

Brocadello F 107<br />

Broccardo M 98, 99, 135<br />

Broccoli M 134<br />

Brockmann MD 131<br />

Brodows D<br />

Brodows RG 99, 100<br />

Brogioni S<br />

Brown J 141<br />

Brucato L 58<br />

Brun P 134<br />

Brunelleschi S 35, 37, 140<br />

Brunelli S<br />

Brunello N 33, 62, 85<br />

Bruni E 103, 139<br />

Bruni R 145<br />

Bruno V 65, 87, 88, 96, 97, 126<br />

Bruno A 138<br />

Brusa R 76<br />

Bruscoli S 58, 80, 103, 137<br />

Brusoni B 54<br />

Buanne P 138<br />

Buccellati C 101, 119<br />

Bucci M 54, 83, 133<br />

Buccianti P 134<br />

Buckingham J 33<br />

Bucolo C 137<br />

Buiatti E<br />

Buitelaar JK<br />

Bulgarelli I 136<br />

Bunnett NW 131<br />

Buonocore G 127<br />

Bur<strong>di</strong> R 127<br />

Busceti C 97, 126<br />

Busconi P 144<br />

Bushe C 141<br />

Buti D 105<br />

Butt A 131<br />

Buzzi A 117, 146<br />

Bymaster B 56<br />

Caboi F 110, 111<br />

Cabras A 65, 110<br />

Cabras S 85<br />

Caccia C 93<br />

Caccia S<br />

Cacciapaglia F 96<br />

Caciagli F 28<br />

Caderni G 137<br />

Caffino L 118<br />

Caggia F 62, 85<br />

Cagliati L 144<br />

Cagnar<strong>di</strong> P 130<br />

Cajozzo M 138<br />

Calabrese F 85<br />

Calabrese V 128<br />

Calabresi L 54, 84, 121<br />

Calafiore M 116<br />

Calapai G 95, 97, 99, 107, 130,<br />

144<br />

Calascibetta A 138<br />

Calcagno E<br />

Calciano S 81, 84<br />

Calderoni S 106<br />

Calia G 64, 79, 90, 94<br />

Calignano A 42, 50, 128, 136<br />

Calixto J 99<br />

Calligaro G 134<br />

Calò G 49, 122, 132<br />

Calò L<br />

Caltagirone C 116<br />

Calza A 88<br />

Camarda V 78, 114<br />

Camera M 54, 119<br />

Camerino GM 47, 127<br />

Cammarano M 124<br />

Campana G 123, 130<br />

Campese A 50<br />

Campesi I 57, 100<br />

Campi B 131, 132<br />

Campioli E 121, 136<br />

Campolongo P 94<br />

Canapaio R 104, 111<br />

Canavesi M 121<br />

Canciani L 98<br />

Candeletti S 92, 97<br />

Can<strong>di</strong>ani S 79<br />

Caldura SM 133<br />

Candussio L 104<br />

Canetta A<br />

Caniglia S 57, 64, 90<br />

Canistro D 108<br />

Cannarile L 137<br />

Cannella N 97, 132<br />

Cannizzaro C 94, 95<br />

Cannizzaro E 94<br />

Cannizzaro G 94, 95, 88, 131<br />

Canonico PL 41, 60, 104, 115,<br />

123, 125<br />

Cantalamessa F 108<br />

Cantara S 91<br />

Cantarella G 81<br />

Cantelli Forti G 39, 58, 88, 147<br />

Cantoni O 64, 117<br />

Cantore M 102<br />

Canu S 57, 100<br />

Canzoniero LMT<br />

Corsi V 90<br />

Capaccioli S 80<br />

Caparrotta L 81, 83<br />

Capasso A 76, 88, 93, 107, 123,<br />

124, 129, 130<br />

Capasso F 58<br />

Papasso R 58<br />

Capecchi PL 28<br />

Capellino S 49<br />

Capone J 129<br />

Capone ML 47, 54, 84<br />

Capone G 85<br />

Capozzo M 147<br />

Cappa M 124<br />

Cappetta D 47<br />

Cappuccio I 77<br />

Capra V 133<br />

Caprioli D 96, 97<br />

Capuano A 47, 107, 120, 143<br />

Capurro V 61, 97<br />

Caputi AP 29, 38, 40, 53, 54, 58,<br />

66, 95, 97, 99, 101, 107, 111,<br />

120, 127, 135, 136, 138, 143,<br />

144<br />

Caraci F 91, 116<br />

Canaglia M 128<br />

153


Caramelli A 89<br />

Caramori G 133<br />

Carangi R 119<br />

Carbonara G 115<br />

Carbonaro V 91<br />

Carbone F 147<br />

Carcano E 50, 140, 145<br />

Caria S 61, 85, 131<br />

Caricasole A 46, 78, 92, 113, 126<br />

Carina V 104<br />

Carissimi R 124<br />

Carletti F 88<br />

Carletti M 108<br />

Carlin A 53<br />

Carloni S 65,127<br />

Carlucci F 117<br />

Carmassi C 142<br />

Carmignani M 60, 109<br />

Carminati P 89<br />

Carnini C 102<br />

Carnuccio R 43, 111, 116<br />

Carone C 30<br />

Caronno A 110, 139<br />

Carra’ G 78<br />

Carratù MR 36<br />

Carretta MT 96<br />

Carru C 57<br />

Carruba M 67<br />

Carta AR 89<br />

Carta D 94<br />

Carta M 36, 76, 77, 131<br />

Carta P 142, 143<br />

Carta S 57<br />

Carullo P 119<br />

Carusio N 37<br />

Caruso A 78, 86, 96, 112, 113<br />

Caruso M 61<br />

Casadonte R 89<br />

Casale F 62, 128, 144<br />

Casamenti F 46, 90, 91, 140<br />

Cascino A 120<br />

Cascio E 146<br />

Casini P 128<br />

Casini L 105<br />

Casnici C 140<br />

Casolari P 123, 126<br />

Cassano T 31, 89, 91, 118<br />

Castagliuolo I 134<br />

Castagnola P 79<br />

Castaldo P 31, 35, 115<br />

Castellana CR 130, 135<br />

Castelli MP 94<br />

Castelli P 139<br />

Casti P 76, 123<br />

Castiglioni L 139<br />

Castiglioni C<br />

Castrignanò S 57, 123<br />

Casu G 76, 123<br />

Casula MG 94<br />

Catalani A 123, 126<br />

Catalano A 114<br />

Catania MA 53, 107, 111, 116,<br />

117, 118, 123, 125, 128, 144,<br />

145<br />

Catania A 53, 107, 111, 116,<br />

117, 118, 123, 125, 128, 144,<br />

145<br />

Catena M 142<br />

Cathalà A<br />

Cattabeni F 65<br />

Cattaldo S 106<br />

Cattaneo A 85<br />

Cattaneo E<br />

Cattaneo MG 38, 57<br />

Cattarini G 120<br />

Cavaliere F 65<br />

Cavallesco G<br />

Cavalli M 119<br />

Cavalli R 106<br />

Cavallo F 59, 88<br />

Cavallo P 76<br />

Cavani F 79<br />

Cavo M 147<br />

Ceccarelli L 110<br />

Cecchi E 107<br />

Celano M 79, 136<br />

Celentano M 96, 97, 125<br />

Cella S 40, 135<br />

Centenaro C 119<br />

Ceolotto G 119<br />

Cerbai E 45, 47, 59<br />

Cereda E 139<br />

Cerioni L 117<br />

Cerretani D 128, 138<br />

Cerulli A 65<br />

Ceruti S 35<br />

Cervetto C 62, 79, 112<br />

Cervio E 99, 135<br />

Cervo L<br />

Cesare P 60, 94, 109, 116, 120,<br />

128<br />

Ceserani I 144<br />

Changeux JP 30, 117<br />

Chazot P 125<br />

Cherchi A 147<br />

Chiappetta G 138<br />

Chiaravalli A 98<br />

Chiarella P 148<br />

Chiarugi A 114, 127<br />

Chiarugi M 134<br />

Chiesa G 48<br />

Chiesara E 40, 48, 108<br />

Chikhladze M 117<br />

Chillotti C 106, 146, 147<br />

Chimirri A 87<br />

Chinellato A 40, 48<br />

Chini B 57<br />

Chirafisi J 128<br />

Chiroli S 40<br />

Christian H<br />

Ciampi O<br />

Cianchi F 80<br />

Ciapparelli A 142<br />

Cicala C 134<br />

Ciccarelli R 86<br />

Ciccocioppo R 41, 49, 93, 97,<br />

122, 123, 132<br />

Ciceroni C 77<br />

Cifani C 122<br />

Cifelli G<br />

Cignarella A 57, 83<br />

Cigognini D 125<br />

Cilio MR 35<br />

Cillo U 117<br />

Cimino F 109, 128<br />

Cimino M 126<br />

Cimpanelli MG 139<br />

Cinci L 102<br />

Cinotti S 120<br />

Cinque C 114, 123, 126<br />

Ciofi L 59, 142<br />

Cioppa T 138<br />

Cipollaro M 120<br />

Cipollini F 107<br />

Cipollone F 60<br />

Cippitelli A 93, 123, 132<br />

Cippone V 47, 115, 127<br />

Cipriani S 61<br />

Cirino G 32, 54, 55, 64, 83, 101,<br />

133<br />

Citraro R 86, 87<br />

Citro S 133<br />

Ciuffi M 102<br />

Clementi E 64<br />

Coccia C 105, 130<br />

Cocco GA 76<br />

Cocucci M 145<br />

Coinu R 57, 140<br />

Colaianna M 57, 123<br />

Colangelo D 104<br />

Colavito D 91<br />

Coletta I 102<br />

Coletta T 84<br />

Colica C 128, 146<br />

Colleoni M 61, 129<br />

Collier D 131<br />

Collino M 48, 58<br />

Collura D 88<br />

Colnago D 54<br />

Colombo A<br />

Colombo C 139<br />

Colombo G 53<br />

Colombo ML 140<br />

Colucci MA 42, 93, 122, 144<br />

Colucci R 98, 109, 110, 134<br />

Coluccia A 36<br />

Comazzi M 124<br />

Comelli F 61, 129<br />

Comhair S 132<br />

Comi G 50<br />

Compostella F 140<br />

Conal<strong>di</strong> G 121<br />

Concas A 35, 62, 88<br />

Concas D 111<br />

Con<strong>di</strong>no AM 113, 117<br />

Condorelli F 104, 115<br />

Confalonieri P 127<br />

Congiu D 146, 147<br />

Consoli D 36<br />

Consoli G 142<br />

Consoli GML 80<br />

Constanti A 87<br />

Conte AM 147<br />

Conte Camerino D 36, 45, 47,<br />

114, 115<br />

Conti A 140<br />

Conti S 50<br />

Conti V 37<br />

Conti L<br />

Contis M 111<br />

Conzen S<br />

Copani A 41, 91, 116, 123<br />

Coppi A 103, 139<br />

Coppi G 139<br />

Coppi E 113<br />

Corasaniti T 43, 65, 145, 146<br />

Corbi GM 37<br />

Corbo F 115<br />

Corcione E 31, 115<br />

Corda G 76<br />

Corinaldesi R 99<br />

Cornaglia G<br />

Cornelli L 48<br />

Corona C<br />

Corrao G 40<br />

Corsaro A 79<br />

Corsello S 107<br />

Corsi L 57, 58, 102<br />

Corsi M 124<br />

154


Corsini A 83, 121<br />

Corsini E 137<br />

Corsini G 113, 89<br />

Corsini D 62, 85<br />

Corso G 138<br />

Corso M 78<br />

Corti F 80<br />

Corti C 65<br />

Coruzzi G 98<br />

Cosco D 136<br />

Cosentino M 49, 50, 139, 140,<br />

145, 146<br />

Cossu G 30<br />

Costa B 61, 129<br />

Costa F 110<br />

Costa N 84, 87, 93<br />

Costantino L 31, 125<br />

Costantino M 128<br />

Costantino S 77<br />

Cotrufo M 120<br />

Cottrell G 131<br />

Covarello D<br />

Cozza G 81<br />

Cozzi A 115<br />

Cozzoli A 127<br />

Cozzolino A 128<br />

Crea F 147<br />

Crema F 98<br />

Crepal<strong>di</strong> T 136<br />

Crescimanno M 138<br />

Crespi C 139<br />

Cricelli C 39, 40, 52, 63<br />

Crimi E 133<br />

Criollo A 116<br />

Crisafulli C 66, 103<br />

Cristalli G<br />

Cristani MT 128, 145<br />

Cristante T<br />

Perrotta C<br />

Cristino L 76, 100<br />

Cristita P 132<br />

Crobu D 110<br />

Croci T 134<br />

Crotta K 140<br />

Crouch N<br />

Cuboni S<br />

Cuccurullo C<br />

Cuccurullo F<br />

Cuda G 87<br />

Cuomo O 126<br />

Cuomo V 30, 31, 34, 57, 89, 90,<br />

91, 94, 118, 123, 125<br />

Cupani C<br />

Curatolo P 141<br />

Curcuruto R 144<br />

Curinga C 87<br />

Currò D 97<br />

Curti D 60<br />

Cusinato F 78, 117<br />

Cutroneo P 144<br />

Cutroneo PM 143<br />

Cuzzocrea S 38, 50, 55, 66, 100,<br />

103, 120, 133, 137, 138, 145<br />

Cuzzolaro M 95<br />

Cuzzolin L 107<br />

Cvorovic J 104<br />

D’Addario C 97<br />

Da Settimo F 134<br />

Dacasto M 108<br />

D'Acquisto F 102<br />

D'Acunto CW 59<br />

Daffara F 58<br />

D'Agostino B 132, 133, 32, 49<br />

D'Agostino G 42, 50, 113, 117,<br />

128, 129<br />

D'Agostino S 88<br />

Daina Economidou 132<br />

Dal Ben D<br />

Dal Cero E 145<br />

Dal Piaz V 93<br />

D'Alessandro N 37, 104, 110<br />

D'Alfonso R 104<br />

D'Alimonte I<br />

Dalle Carbonare M 91<br />

Dall'Olio R 123, 132<br />

Damiano V 37<br />

D'Amico A 98, 137<br />

D'Amico M 81, 84, 136<br />

D’Amico Monia 81, 84, 136<br />

D'Amico D 96<br />

Danesi R 50, 59, 81, 103, 138,<br />

142, 146,147<br />

D'Anna R 58, 135<br />

D'Antona G<br />

Daperno M 111<br />

D'Aquila PS 94<br />

Darnaudery M<br />

D'Arrigo A 91<br />

D'Arrigo C 124<br />

D'Arrigo M 145<br />

Dattolo MG 136<br />

D'Auro M 86<br />

Dahl ML 146<br />

Davoli A 105, 142<br />

Dazzan P 131<br />

Dazzi L 56, 82, 85<br />

De Amici E 133<br />

De Angelis S 133<br />

De Angelis A 47<br />

De Bellis M 115<br />

De Bellis A 100<br />

De Bene<strong>di</strong>ctis L 119<br />

De Esch Iwan IP 98<br />

De Fazio P 126<br />

De Fazio S 106<br />

De Filippis D 43, 137, 90, 91, 98<br />

De Francia S 58<br />

De Gennaro Colonna V 83, 121<br />

De Giorgi A 123<br />

De Giorgio R 99, 135<br />

De Girolamo L 111<br />

De Gruttola L 83, 133<br />

De Iu<strong>di</strong>cibus S 110<br />

De Libero G 140<br />

De Lisa R<br />

De Luca A 47, 115, 127<br />

De Luca MA 86<br />

De Luca N 110<br />

De Luca P 120<br />

De Luca V 98<br />

De Man J 98<br />

De Marco T 97<br />

De Martin S 142<br />

De Martino F 58<br />

De Mattei M 112<br />

De Matteis F 109<br />

De Metrio M 54<br />

De Nardo M 132, 133<br />

De Novellis V 43, 47, 92<br />

De Petrocellis L 76, 129<br />

De Ponti F 42, 134, 135<br />

De Rosa G 111<br />

De Salvia MA 94<br />

De Santi S 102<br />

De Sarro A 35, 99, 138<br />

De Sarro G 40, 80, 86, 87, 105,<br />

106, 126, 132, 142<br />

De Siena G 129<br />

De Stefano D 43, 47, 111<br />

De Vanna M 147<br />

De Vita T 78<br />

De Winter B 98<br />

Deambrosis P 48<br />

Debutto P 78<br />

Decorti G 104, 109, 110, 119<br />

Dedola S 36, 79, 94<br />

Dedoni S 65, 86, 126<br />

Deghenghi R 135<br />

Deidda F 148<br />

Del Basso Orsini P 84<br />

Del Bufalo D 138<br />

Del Duca C<br />

Del Giu<strong>di</strong>ce E 91<br />

Del Soldato P 48<br />

Del Tacca M 103, 106, 109, 110,<br />

134, 138, 142, 143, 144, 416,<br />

147, 40, 42, 59, 81, 98<br />

Del Vecchio I 128, 137<br />

Del Zompo M 29, 106, 142, 143,<br />

146, 147<br />

Delfino D 140<br />

D'Elia P 109<br />

Della Bianca A 133<br />

Dell'Agli M 145<br />

Dell'Agnello G 56, 141<br />

Dell'Osso L 142<br />

Demma I 135<br />

D'Emmanuele Di Villa Bianca R<br />

101, 119, 120<br />

Demontis MP 51, 108<br />

Dempster D 39, 131<br />

Desaphy JF 36, 114, 115<br />

Desideri M 138<br />

Desole MS 47, 79<br />

Dessì C 125<br />

Devono G<br />

Di Benedetto M 97<br />

Di Carlo F 58, 59, 104, 108<br />

Di Carlo S 96<br />

Di Cesare Mannelli L 116<br />

Di Chiara G 51, 86, 96, 130<br />

Di Febbo C 54<br />

Di Filippo C 84, 136<br />

Di Forti M 131<br />

Di Francesco L 47, 102, 84<br />

Di Giannuario A 122, 144, 42, 93<br />

Di Giulio AM 79, 125, 127<br />

Di Giuseppe D 108, 120, 121<br />

Di Gregorio P 84<br />

Di Iorio P<br />

Di Lorenzo A 54, 83, 133<br />

Di Luca M 41, 65<br />

Di Marzo V 34, 43, 47, 76, 100,<br />

129<br />

Di Matteo A 102<br />

Di Paola R 66<br />

Di Paolo A 59, 138, 142, 146,<br />

147<br />

Di Pardo A 113, 119<br />

Di Pirro M 107<br />

Di Renzo G 110, 126<br />

Di Simplicio P 108, 120, 121<br />

Di Stefano A 108<br />

Di Stefano R 110<br />

Di Stefano V 54, 120, 127<br />

Di Toro R 113, 58<br />

Di Vita G 124<br />

Diana Estello M<br />

155


Diana M 131, 36, 41, 43, 51, 95,<br />

96<br />

Diani E 48<br />

Dianzani C 48, 58<br />

Diaspro A 90<br />

Di Giannuario A 42, 122, 144<br />

Diliberto I 95<br />

Dimida A 113<br />

Diodato E 92<br />

Di Palma A 114, 36<br />

Di Pasquale P 125<br />

Distasi C 125<br />

Dolora P 137<br />

Domenica MR 82, 118, 126<br />

Donati E 102, 113<br />

Donati V<br />

Donato G 126<br />

Donato V 137, 58<br />

Donniacuo M 47, 120<br />

Donnini S 91, 101, 118, 119<br />

Dore B 94<br />

Dore R 88, 36<br />

Dorent R 121<br />

Dorigo P 83<br />

Dossena M 84, 142<br />

Dossi G 99<br />

Dorent R 121<br />

Dorigo P 83<br />

Dossena M 84, 142<br />

Dossi G 99<br />

Douville K 54<br />

Downey P 76<br />

Drago F 125, 33, 36, 59, 117<br />

Dragoni S 104, 109<br />

Drigo I 110<br />

Ducci E 106<br />

Dunlop J 92<br />

Duran S 99, 100<br />

Duranti A 132<br />

Ean<strong>di</strong> M 104, 106, 111<br />

Eberini I 54<br />

Eboli ML 54<br />

Economidou D 93, 97, 132<br />

Edwards G 97<br />

El Khoury A 85, 118<br />

Emanueli C<br />

Enea D 95<br />

Enrico P 126, 131, 133, 136, 137<br />

Epis R 57, 64, 65, 66, 79, 90,<br />

131<br />

Ercolano E 115<br />

Ercolino SF 79, 102<br />

Ermito S 128<br />

Ernst E 58<br />

Errico S 127<br />

Erriquez J 125<br />

Erzurum S 132<br />

Esposito E 38, 50, 66, 83<br />

Esposito Giovanni 43, 64, 90,<br />

91, 98<br />

Esposito Giuseppe<br />

Etzi R<br />

Eusebi F 88, 114<br />

Eva C 57, 88, 95<br />

Evandri MG 109<br />

Evangelista V 47<br />

Evoli A 45<br />

Evrard A 117<br />

Eyeson J 131<br />

Francini-Pesenti F 107<br />

Fabbri L 32<br />

Fabene PF 146<br />

Fabi F 84<br />

Fabrizi F 142<br />

Facchi A<br />

Facchinetti F 91<br />

Fadda P 30, 130<br />

Failli P 102<br />

Falcone A 59, 80, 81, 138<br />

Falcone D 80<br />

Fallarini S 140<br />

Falzarano S 113<br />

Fanelli R 60<br />

Faniglione M 133<br />

Fanos V 142<br />

Fantin Marianna 61, 78<br />

Fantin Martina<br />

Fanton G 78<br />

Fantozzi R 48, 51, 58<br />

Faraco G 127<br />

Farina C 43<br />

Fascì D 137<br />

Fattore L 30, 31, 130<br />

Faure P 117<br />

Fava G 107, 111<br />

Favari E 121<br />

Fazia ML<br />

Fazio VM 148<br />

Fedele E 82<br />

Fedeli A 93<br />

Femia AP 137<br />

Fenu S 89, 96<br />

Feo C 61<br />

Feo S 138<br />

Ferioli E 121<br />

Ferraguti F 87<br />

Ferrante L 107, 144<br />

Ferranti F 77<br />

Ferranti S 144<br />

Ferrara A<br />

Ferrara N 37<br />

Ferrari A 105, 130<br />

Ferrari D 35<br />

Ferrari M 50, 139, 140, 146<br />

Ferrarini E 113<br />

Ferrario P 83<br />

Ferrari-Toninelli G 65<br />

Ferraro L 31, 65<br />

Ferraro MT 138<br />

Ferraro G 88<br />

Ferreira J 99<br />

Ferreri Ibbadu G 86, 87, 106<br />

Ferrero V 37<br />

Ferretti C 62<br />

Ferretti M 79<br />

Ferri N 121<br />

Ferrieri A 136<br />

Ferrigno A 117<br />

Ferroni S 112<br />

Festa A 99, 100<br />

Festa M 59, 79, 102, 138<br />

Festa R<br />

Fiaschi AI 128, 138<br />

Filaferro M 30, 122<br />

Filigheddu N 136<br />

Filippelli A 29, 37, 43, 47, 107,<br />

120, 128, 144<br />

Filippetti R 122<br />

Filippi S 54<br />

Filippi U 51<br />

Fimognari C 58<br />

Finetti F 101,113<br />

Finicelli M 120<br />

Finocchiaro G 44<br />

Finotti P 37<br />

Fioravanti A 81, 138<br />

Fiorentini A 90, 91, 140<br />

Fioretti MC 51, 55<br />

Fiorito S 120<br />

Fiorucci S 54<br />

Firenzuoli F 107<br />

Fischetti C 78<br />

Fiumara T 54, 101, 120, 136<br />

Flammini L 118<br />

Flan<strong>di</strong>na C 138<br />

Floreani M 61<br />

Florent H<br />

Florio T 79, 90<br />

Flower RJ 102<br />

Foffa I<br />

Fogli E 61, 112, 133<br />

Foglia C 76<br />

Folco G 32, 101, 102, 119<br />

Follesa P 61, 85, 131<br />

Fontaine B 45<br />

Fontanini G 50, 147<br />

Forlani A 50<br />

Formentini L 127<br />

Formisano C 102<br />

Fornai F 45, 97, 126<br />

Fornai M 98, 110, 134<br />

Forni F 31, 125<br />

Forni G 59<br />

Forte A 120<br />

Fortuna A 123<br />

Fossati Giacomo 104, 127<br />

Fossati Gianluca<br />

Fossati S 114, 127<br />

Fournier J 65<br />

Fracasso C<br />

Fracchiolla G 115<br />

Frairia R 104<br />

Franceschelli S 79<br />

Franceschetti S 117<br />

Franceschetti L 113<br />

Franceschi M<br />

Franceschini G 54, 84<br />

Franchi Gian Gabriele 107, 144,<br />

145, 43<br />

Franchi Gianfranco<br />

Franchi S 129, 42, 43, 96<br />

Franchini C 114, 115<br />

Franconi F 100, 123, 140, 39, 57<br />

Frasca A 86<br />

Frasca G 91<br />

Frasson M 37<br />

Frassoni C 117<br />

Fratta W 130, 30, 31, 33, 34,<br />

Fratto V 145, 146<br />

Fratto D 80<br />

Frau L 89<br />

Frau R 94<br />

Fredduzzi S 50<br />

Fre<strong>di</strong>ani S 141<br />

Freeman B 131<br />

Freitas I 117<br />

Fresta M 136<br />

Fresu LG 35<br />

Frigeri A 127<br />

Frigeri C 122<br />

Frigo G 40,98<br />

Frisina N 135, 98<br />

Frol<strong>di</strong> G 81, 83<br />

Frosali S 108, 120, 121<br />

Frosini M 104<br />

Fruttarolo F<br />

Fucile S 88<br />

Fumagalli F 86<br />

Fumagalli M<br />

156


Fumero S 137<br />

Furlanut M 40<br />

Fusco F 142<br />

Fusi F 104<br />

Fuxe K 30, 65<br />

Gabano E 103, 104<br />

Gabbianelli R 108<br />

Gaetani S 31, 125<br />

Gagliani MC 90<br />

Gagliano A 124<br />

Gagliano C 124<br />

Gagliano Maria G<br />

Gagliano M 94, 135<br />

Gagliar<strong>di</strong> S 83<br />

Gaion RM 83, 107, 134<br />

Gala R 126<br />

Galantucci M 117, 126<br />

Galassi G 142<br />

Galderisi U 120<br />

Galdo M 143<br />

Galeotti N 92<br />

Galeotti T 128<br />

Galletta G 123<br />

Galimberti D 135<br />

Gallelli L 80, 105, 106, 132, 142<br />

Gallesi D 105, 139<br />

Galli C<br />

Gallicchio M 48, 58<br />

Gallo M 144<br />

Gallo U 107<br />

Galluzzo M 126<br />

Galvez B<br />

Gandolfi O 123, 132<br />

Garattini S 144<br />

Garau L 86, 126<br />

Gardoni F 65<br />

Gareri P 106<br />

Garibol<strong>di</strong> MB 61, 103<br />

Garrone B 102<br />

Garuana A 130<br />

Garzon G 82<br />

Gasco MR 106, 111<br />

Gasperi V<br />

Gass P 56<br />

Gatta L 92, 129<br />

Gatti M 79<br />

Gatti R 131, 132<br />

Gavioli E 122<br />

Gaviraghi G 46, 92<br />

Gazzerro P 108<br />

Gazzieri D 99, 131<br />

Gebbia N 50, 138<br />

Gelosa P 43, 126<br />

Gelpi G 119<br />

Geminiani E 57, 58, 102<br />

Genazzani AA 62, 104, 115, 125<br />

Genedani S 30<br />

Gennarelli M 85<br />

Genovese R 111<br />

Genovese T 66<br />

Genuini GF 120<br />

Gentile MT 113, 119<br />

Gentile M 111<br />

Gentilella A<br />

Gentilella Raffaella 99, 100, 142<br />

Gentilella Robert<br />

George Alfred L Jr 47<br />

Geppetti P 32, 47, 83, 99, 101,<br />

120, 129, 131, 132<br />

Gerace E<br />

Geraci C 80<br />

Germini G 59<br />

Germanò E 124<br />

Geroni C 61<br />

Gerra G 96<br />

Gertow K 54<br />

Gessa GL 94<br />

Gessi S 37, 61, 112, 133<br />

Ghè C 100, 135, 136<br />

Ghelar<strong>di</strong>ni C 43, 92, 116<br />

Grezzi A<br />

Ghisu N 98, 109, 110, 134<br />

Ghizzar<strong>di</strong> P 134<br />

Giacca M 127<br />

Giaccone G 138, 147<br />

Giachetti A 91, 119<br />

Giachetti D 136<br />

Giaconia L 100<br />

Giagnoni G 61, 129<br />

Giambelli R 85, 118<br />

Giambene B 142<br />

Gianazza E 54<br />

Gianella A 43<br />

Gianfriddo M 61, 92<br />

Gianneli M<br />

Giannini E 50, 92<br />

Giannini L 132<br />

Giannoni P 125<br />

Giannuzzi V 115, 127<br />

Giaquinta G 57, 64, 90<br />

Giar<strong>di</strong>na S 60<br />

Gironi C 98<br />

Gigante B 110<br />

Gillies G<br />

Ginestra G 145<br />

Giordano C 43, 129<br />

Giorgi A 123, 145<br />

Giorgi Filippo<br />

Giorgi Franco 113<br />

Giorgi G 144, 145<br />

Giorgi M 105<br />

Giorgini S 138<br />

Giovannetti A 116<br />

Giovannetti E 103, 147<br />

Giovannini MG<br />

Giovannoni MP 93<br />

Giovinazzo C 144<br />

Giral<strong>di</strong> T 147<br />

Giral<strong>di</strong> P<br />

Giron MC 100, 107, 134<br />

Gironi A 100<br />

Gitto R 87<br />

Giuberti G 128<br />

Giuffrida A 89<br />

Giuffrida ML 116<br />

Giuliani D 53, 54, 98, 117, 126<br />

Giunta M 135<br />

Giuntini S<br />

Giussani L 142<br />

Giusti P 40, 48, 78, 86<br />

Giustini SE 106, 144<br />

Giustino A 36<br />

Gliozzi M 43<br />

Gloaguen I 138<br />

Gnemmi I 104<br />

Gobbi G 118<br />

Gobbi P 115<br />

Goetz I 141<br />

Goffredo D<br />

Gola M 96<br />

Goldberg SR 31, 125<br />

Golia F 142<br />

Golino P 38<br />

Gomaraschi M 54, 84<br />

Gontero P 142<br />

Gori E 97<br />

Gori G 109, 110<br />

Gorini A 89<br />

Gorini G 61, 85, 131<br />

Gorio A 44, 79, 125, 127<br />

Gosmar M 109<br />

Govoni P 137<br />

Govoni S 90, 137<br />

Granata A 121<br />

Grande V 79<br />

Gran<strong>di</strong> D 97<br />

Granito A 99<br />

Granucci F 129<br />

Grassi MC 33, 95<br />

Graziani A 136<br />

Gridelli B 110<br />

Grieco P 53<br />

Grilli M 36, 82<br />

Grimal<strong>di</strong> C 76<br />

Grion AM 107<br />

Grohmann U 55<br />

Grossi C 90, 91<br />

Grossi S 108<br />

Grosso S 110, 139<br />

Gruber S 86<br />

Guaita A 135<br />

Guaita E 98<br />

Gualco A 84<br />

Guaral<strong>di</strong> G 139<br />

Guarini S 37, 53, 54, 101, 117,<br />

126<br />

Guarino I 123<br />

Guarnieri S 62, 79, 112<br />

Guastaferro M<br />

Guasti L 139, 140<br />

Guazzi M 83<br />

Guerriere L 102<br />

Guerrini Remo<br />

Guerrini Renato 78, 93, 97, 98,<br />

114, 122, 132, 135<br />

Guerrini U 126<br />

Guglielmi MD 54<br />

Guglielmotti 102<br />

Guida F 92, 129<br />

Guidali C 31, 61<br />

Guidarelli A<br />

Guidobono F 98<br />

Guidolin D 30, 79<br />

Gulotta G 138<br />

Gunella G 35, 140<br />

Guzzetta M 114<br />

Guzzetti S<br />

Har<strong>di</strong>man G 123<br />

Haro J 141<br />

Harrison S 83, 101, 131<br />

Haycox A 40<br />

Hebbes C 78<br />

Heilig M 132<br />

Heine R 99<br />

Ho L 124<br />

Hoogwerf B 100<br />

Hoozemans J<br />

Hrelia P 58, 88, 147<br />

Hwa J 54<br />

Iacobelli M<br />

Iacono A 50, 83, 100, 128<br />

Iacovelli L 86<br />

Iadarola P 142<br />

Iannone M 87<br />

Iannotti F 81<br />

Iannuccelli V 139<br />

Ibba F 96<br />

Ieri F 140<br />

Iezzi A<br />

157


Iezzi M 59<br />

Illiano M 144<br />

Imbimbo B 91<br />

Imbimbo C 101<br />

Impagnatiello F 90, 102, 114<br />

Imperatore F 120<br />

Impicciatore M 118, 134, 145<br />

Improta G 49, 98, 99, 135<br />

Incorvaia L 138<br />

Infante F 129, 130<br />

Inguglia L 104<br />

Innocenzi A<br />

Invernizzi R 51<br />

Ionta MT<br />

Iori R 108<br />

Ippolito C 98<br />

Isaia E 79<br />

Isola M 130<br />

Iu<strong>di</strong>ce A 146<br />

Iuvone T 43, 90, 91,98 ,137<br />

Jaconi M<br />

Jason S 76<br />

Jensen S 146<br />

John C<br />

Johns Don 99, 100<br />

Johns Don J<br />

Johns J<br />

Juri B 81<br />

Kachare D<br />

Kallupi M 97, 132<br />

Kawase M 109,<br />

Kelsey D 141<br />

Kerbel R 55<br />

Kim Dennis 99, 100<br />

Kim Don<br />

Kim J<br />

Klinge I<br />

Kloting I 122<br />

Klugmann S 54<br />

Koorbanally C<br />

Kostenis E 78<br />

Krankel N<br />

Kroemer G 116<br />

Kuka M 140<br />

Kunic J 47<br />

La Barbera D 131<br />

La Barbera M 94<br />

La Cascia C 131<br />

La Ferla F<br />

La Grutta V 88<br />

La Rana G 42, 50, 128, 129, 136<br />

Labbozzetta M 37, 104, 110<br />

Laghi Pasini F<br />

Laguar<strong>di</strong>a V 111<br />

Lamaida E 129, 130<br />

Lambert DG 114<br />

Lambertucci C<br />

Lampa E 128, 136<br />

Lampus S 106, 147<br />

Lanas A 29<br />

Landucci E 115, 116, 118<br />

Lange DJ 124<br />

Langer F 142<br />

Lanni C 90<br />

Lapi F 107, 143<br />

Lastella M 59, 142, 146, 147<br />

Latorre R 114<br />

Lattanzi R 42, 50, 92<br />

Lattuada D 140<br />

Laus M 103<br />

Lazzari P 104, 121, 125<br />

Lazzeri M 49<br />

Le Fur G 34<br />

Lecca Daniele 96<br />

Lecca Davide 126<br />

Leccese V 96<br />

Lecchini S 50, 98, 139, 140, 145,<br />

146<br />

Ledda F 48, 54, 59<br />

Leggio GM 36, 117<br />

Legnaro M 139, 140<br />

Lembo A 142<br />

Lembo G 113, 119<br />

Lemoli M 94<br />

Lempereur L 81<br />

Lencioni M 59<br />

Lentini G 114<br />

Lenzi M 58<br />

Leon A 91<br />

Leonar<strong>di</strong> P 53<br />

Leone L 84<br />

Leone RL 128<br />

Leoni F 127<br />

Leoni O 143<br />

Leopar<strong>di</strong> G<br />

Lepine A 141<br />

L'Episcopo F 64, 79<br />

Lesma E 79<br />

Leto G 138<br />

Leung E 37, 61, 112<br />

Leurs R 98, 114<br />

Lewis D 141<br />

Li D 132<br />

Liantonio A 47, 114, 115, 127<br />

Licheri GL 147<br />

Ligas F 106<br />

Liguori G 120<br />

Linari G 99, 135<br />

Lintas A 36<br />

Lioi MB 108<br />

Lionetti P 110<br />

Liotti A 105<br />

Lisi I 78<br />

Lisi L 123<br />

Lo VJ<br />

Locatelli V 98, 136<br />

Locchi F 123, 132<br />

Lodovici M 137<br />

Logobar<strong>di</strong> F<br />

Lograno MD 78<br />

Loizzo Alberto 123, 107<br />

Loizzo Annalivia 57, 107<br />

Loizzo S 57, 107, 123<br />

Lombar<strong>di</strong> G 140, 146<br />

Lombardo G 143<br />

Lombardo M 104<br />

Lonati C 53<br />

Longini M 127<br />

Longo A 88<br />

Longo N 101<br />

Lopetuso G 92<br />

Loraschi A 139<br />

Lorenzini P 84<br />

Loriga G 125<br />

Losi G 77, 82<br />

Loupakis F 138<br />

Lourdusamy A 123<br />

Lovaglio S<br />

Lowry JP 36<br />

Lu H 95<br />

Lu J 90<br />

Lubrano C 58, 135<br />

Lucacchini A<br />

Luccarini I 90, 91, 140<br />

Lucchelli A 137<br />

Lucchino I 125<br />

Luccini E 82<br />

Luciani S 78, 117<br />

Lucini V 110, 139<br />

Lucioni C 40<br />

Ludovico GM 142<br />

Luini A 140, 145<br />

Luisi R 81<br />

Lungarella G 101, 131<br />

Luongo L 43<br />

Lupieri T 77<br />

Luppino MR 111<br />

Lutz B 76, 118<br />

Luzi S 131<br />

Lytton J 126<br />

Mac Lennan S 61, 112<br />

Maccari S 56, 123, 126<br />

Maccarrone M 65, 80<br />

Macchi B 116, 142<br />

Macheda T 91, 118<br />

Maciocco E 30, 76, 77<br />

Maclennan S 37<br />

Madaschi L 125<br />

Madeddu P 64<br />

Maestro A 104, 119<br />

Maffei A 113, 119<br />

Maffei F 147<br />

Maggi A 103<br />

Maggi R 125<br />

Maggio R 45, 113<br />

Magi S 31, 115<br />

Magnaghi G 117<br />

Magnaghi V 129<br />

Magnani F 105<br />

Magnelli L 80<br />

Magnotti MC 77<br />

Magrassi R 90<br />

Magri E 146<br />

Mai A 104<br />

Maida S 145, 146<br />

Mainero V 137<br />

Maio RC 139<br />

Maione F 42, 93, 122, 144<br />

Maione S 42, 43, 47, 60, 92, 129<br />

Mairesse J 123, 126<br />

Maiuri MC 111, 116<br />

Maj PF 85<br />

Malinverno M 65<br />

Mallei A 85<br />

Malleo G 138<br />

Malorni W 57<br />

Malusà N 110<br />

Mameli-Engvall M 117<br />

Manca A 79, 90, 94<br />

Manca I 104, 125<br />

Mancar<strong>di</strong> L 82<br />

Manchia M 147<br />

Mancini F 102, 141<br />

Mancini G 76<br />

Mancini M 141<br />

Manconi F 146<br />

Manconi M 129<br />

Mancuso C 127, 128<br />

Mandalari G 145<br />

Manera C 80, 105<br />

Manfre<strong>di</strong> B 48, 83, 121<br />

Manfre<strong>di</strong> L 143<br />

Manfre<strong>di</strong> V 108<br />

Mangano G 102<br />

Mangieri D 127<br />

Mannaioni G 115, 118<br />

Mannaioni PF 80<br />

Mannucci C 95, 130<br />

Manservigi R 146<br />

158


Mantia G 94, 95<br />

Mantovani A 50, 109<br />

Marabese I 92<br />

Marabini L 108<br />

Maranghi F 109<br />

Marasciulo FL 48, 83<br />

Marcellino D 30<br />

Marcello E 65<br />

Marcello S 93<br />

Marchese G 123, 76<br />

Marchesi M 48<br />

Marchetti B 57, 64, 79, 90<br />

Marchetti C 58<br />

Marchetti R 95<br />

Marchi M 36, 82<br />

Marchi S 109, 110<br />

Marcoli M 62, 79, 112<br />

Marconi A 137<br />

Marconi P 146<br />

Marcuzzo S 60<br />

Marelli O 140, 148<br />

Marenzi G 54<br />

Marfella R<br />

Marfia G 125<br />

Margaritis A 108, 120, 121<br />

Margheriti F<br />

Marigliano NM 105, 106<br />

Marilotti L 39<br />

Marinelli A 96<br />

Marini H 58, 101, 135<br />

Marini P 76<br />

Marino Franca 49, 50, 139, 140,<br />

145, 146<br />

Marino Gennaro 113<br />

Marino Laura 84<br />

Marino Marina 110<br />

Marino Sara<br />

Marino Silvia 110, 118<br />

Marinos LM 104<br />

Marinovich M 44<br />

Mariottini C 114<br />

Marongiu C 65, 111<br />

Marotto MF<br />

Marra C 88<br />

Marra R 86, 87, 131<br />

Marras E 61<br />

Marras R 131<br />

Marrelli D 138<br />

Marrocco G 132, 133<br />

Marrosu F 30, 85, 94<br />

Marsicano G 118<br />

Marte A 82<br />

Martelletti P 57, 105<br />

Martelli A 106, 108, 109, 144<br />

Martelossi S 109, 110<br />

Marti M 43, 49<br />

Martignoni E 146<br />

Martinelli M 43<br />

Martinelli V 142<br />

Martini C 43<br />

Martino G 64, 90<br />

Martire A 82<br />

Martire M 81<br />

Martorana A<br />

Martucci D 97<br />

Marzani B 60<br />

Marzatico F 60<br />

Marzocca C 132<br />

Marzocco S 108, 120, 135<br />

Marzola A 146<br />

Marzola E 144<br />

Marzola G 78, 122, 93<br />

Masami K<br />

Masami T 81<br />

Mascagni P 127<br />

Maschi O 145<br />

Mascia MP 76<br />

Mascolo N 122, 144<br />

Maselli MA 135<br />

Maselli R 80<br />

Masi G 56<br />

Masini E 132, 142, 64, 80<br />

Maskos U 30, 117<br />

Masotti G 120<br />

Massa F 76<br />

Massi D 131<br />

Massa E 148<br />

Massa M 49, 51, 122, 132, 93, 97<br />

Massa P 80<br />

Massidda B 50<br />

Mastino A 116<br />

Mastrangelo S 109<br />

Mastrantoni E 77<br />

Mastrogiacomo M 79<br />

Mastroiacovo F<br />

Mastroianni R 80<br />

Mastrotto C 140<br />

Matarrese P 57<br />

Materazzi S 83, 101<br />

Mathé A 86, 118<br />

Matias I 76, 100<br />

Matrisciano F 86, 96<br />

Mattace Raso G 83, 100<br />

Caleo M 81<br />

Matteoli M 81<br />

Matteucci P 123, 126<br />

Matteucci C 116<br />

Mattioli F 106, 108<br />

Matuschak G<br />

Matzeu A 82<br />

Maullu C 65, 111, 148<br />

Maura G 60, 62, 79, 112, 137<br />

Maurici A 37, 104<br />

Mauro A 106<br />

Mazza R 65<br />

Mazzaglia G 39, 40<br />

Mazzola C 36, 125<br />

Mazzon E 38, 65, 66, 103, 133,<br />

137, 138, 145<br />

Mazzoni E 65<br />

Mazzuferi M 146<br />

Mcdonald J 78, 114<br />

Mcgaugh LJ 94<br />

Meda C 57<br />

Medalie J 125<br />

Medhurst A 125<br />

Meini A 78<br />

Mela F<br />

Melani A 28, 61<br />

Melchiorri D 44, 77, 78, 86, 96,<br />

113, 114<br />

Melchiorri P 42, 43, 50, 92<br />

Mele A 114<br />

Mele P 88, 95<br />

Meli R 38, 50, 83, 100, 103, 128,<br />

145<br />

Meli S 80<br />

Melillo G 55, 135, 138<br />

Melis GB 62<br />

Melis MR 101, 130<br />

Melis M 31<br />

Melis T 130<br />

Memo M 41, 65, 124<br />

Mencacci C 28, 66<br />

Menchini Fabris F 142<br />

Mendlewicz J 85<br />

Menegazzi M 145<br />

Meneghelli I 143<br />

Meneguz A 39, 59<br />

Mengozzi G 105<br />

Menna PA 37<br />

Mennini T 60<br />

Merciaro G 84<br />

Mereu GP 94<br />

Mereu M. 131<br />

Merighi S 37, 61, 112, 133<br />

Merlicco A 88<br />

Merlo S 80, 91, 123<br />

Messina S 127<br />

Mey V 103, 147<br />

Mezzetti A<br />

Micale V 36<br />

Miccichè F 91<br />

Miceli F 35<br />

Miceli BG 138<br />

Micheli L 107, 144, 145<br />

Michellson D<br />

Miele E 64<br />

Migheli R 64, 79, 94<br />

Migliar<strong>di</strong> G 124<br />

Miglietta D 119<br />

Miglio GL 146<br />

Migliozzi A 129<br />

Mihm M 99<br />

Milanese M 82<br />

Milano L 124<br />

Milano W 124<br />

Milella M 93<br />

Milton D 100<br />

Minelli A 115<br />

Mini E 50, 55<br />

Miniaci M 55<br />

Minotti G 37<br />

Minutoli L 54, 58, 101, 117, 120,<br />

126, 127, 135, 136<br />

Minutolo A 116<br />

Mioni C 53, 101, 117, 126<br />

Mirabile M 107<br />

Miral<strong>di</strong> E 136<br />

Mirandola P 37, 61, 112<br />

Mirone V 101, 142<br />

Mishra R<br />

Miti<strong>di</strong>eri E 119<br />

Mocaer E<br />

Mochly-Rosen D 55, 80<br />

Modafferi A 94<br />

Modafferi AME 95, 96<br />

Mognetti B 59, 104<br />

Moison D<br />

Moleri E 121<br />

Molin Pradel N<br />

Molinari P 78<br />

Molinaro G 65, 88, 96<br />

Mollace V 44, 84, 93, 128, 146<br />

Molnar J 104, 109<br />

Molteni R 61, 85, 103<br />

Mombelli G 54<br />

Mondaini N 101<br />

Mondelli V 131<br />

Mondello L 146<br />

Mongeau R 93<br />

Monnazzi P 57, 105<br />

Monopoli A 37, 119<br />

Montagnani M 48, 83, 94, 119<br />

Montagnani S 106<br />

Montali M<br />

Montanari C 57, 101, 137<br />

Monteleone P 38<br />

Montesissa C 130<br />

159


Monti E 61, 103<br />

Monti M 118<br />

Monticone M 79<br />

Montinaro E 106<br />

Montopoli M 81, 83<br />

Montorsi F 142<br />

Montuschi P 32<br />

Moore P 48<br />

Moorman A<br />

Morale MC 64, 90<br />

Moran<strong>di</strong> S 95<br />

Morari M 43, 78<br />

Moraschi S 85<br />

Morbidelli L 80, 114, 118, 119,<br />

137<br />

Morelli M 45, 89<br />

Morello S 120, 138<br />

Mores N 127<br />

Moretti S 107, 143<br />

Moretti U 29<br />

Moretto N 91<br />

Morgan C 131<br />

Morgante L 107<br />

Morgese MG 89, 91, 118<br />

Mori M 99<br />

Morigi M 59<br />

Morini G 97, 98<br />

Morley-Fletcher S 123<br />

Moro E 98<br />

Moro S 81<br />

Moroni F 63, 115, 116, 118, 127<br />

Morpurgo M 111<br />

Morreale I 99<br />

Morris J<br />

Morrone LA 65<br />

Morroni F 88<br />

Morsuillo M 107<br />

Mosca F 116<br />

Mosca M 110, 138<br />

Moschini M 29<br />

Mosillo P 77<br />

Mostallino MC 30, 61, 77<br />

Motohashi N 104, 109<br />

Motola D 143<br />

Motolese M 96, 113<br />

Motta A 139<br />

Moulon I 111<br />

Muccioli G 100, 135, 136<br />

Mugelli A 29, 53, 67, 107, 143<br />

Muggironi G<br />

Muià C 38, 66, 103, 133, 138,<br />

145<br />

Mulholland D<br />

Muller C<br />

Muller E<br />

Muntoni AL 31, 95<br />

Muntoni E 106<br />

Muntoni S 88<br />

Mura ML 30, 77<br />

Muraglia M 115<br />

Murgia E 94<br />

Murineddu G 125<br />

Murray RM 131<br />

Murri L 146<br />

Murru L 30, 36, 61, 76, 77, 131<br />

MusanteV 77<br />

Musazzi L 118<br />

Muscatello MR 124<br />

Muscoli C 44, 84, 93, 128<br />

Muscoli S 146<br />

Musiani P 59<br />

Mussa MV 58<br />

Mussoni L 43<br />

Musumeci M 126<br />

Naccari C 144, 145<br />

Nacci C 119<br />

Nannizzi S 147, 103<br />

Nappi G 62, 146<br />

Nassi A 61<br />

Nassini R 83, 101<br />

Nasuti CC 108<br />

Natale G 98, 134<br />

Natale MR<br />

Natali A 101<br />

Nauck MA 99<br />

Nava F 41<br />

Navari S 131<br />

Navarra M 79, 136, 145, 146<br />

Navarra P 123, 136<br />

Navarra T 116<br />

Navarro Mora G 146<br />

Nazzaro C 118, 122<br />

Ndengele M 132<br />

Nebbia C 108<br />

Negri 42, 43, 50, 60, 92, 144<br />

Nencini C 107, 144, 145<br />

Nencini P 86, 93, 95, 96, 97<br />

Neri E 77<br />

Ngomba R 87<br />

Nicchia GP 127<br />

Niccolai N 121<br />

Niccolini C 77<br />

Nico B 127<br />

Nicoletti F 123, 126, 129, 46, 60,<br />

65, 77, 78, 86, 87, 88, 96, 97,<br />

113, 114, 116<br />

Nicoletti P 83, 129<br />

Nicolussi E 50<br />

Niro V<br />

Nisoli E 64<br />

Nisticò G 93<br />

Nisticò S 128<br />

Nistri A<br />

Nistri S<br />

Nizzari M 90<br />

Nobile M 81, 112<br />

Nobili E 43<br />

Norbedo S 110<br />

Norcini M 43, 92<br />

Norppa H 147<br />

Nosi D 125<br />

Notarangelo F 121<br />

Notarbartolo M 37, 104, 110<br />

Noto G 94<br />

Novelli A 63<br />

Novi F<br />

Novick D 141<br />

Nucci C 65<br />

Nunziata A 95<br />

Oberto A 88<br />

Obili N 76<br />

Oddo S 91<br />

Oderda C 137<br />

Oldrini R 98<br />

Olianas MC 86, 126<br />

Olimpieri F 121<br />

Oliva P 84<br />

Oliverio M 93<br />

Olivieri R 119<br />

Olivieri F<br />

Olla A 96<br />

Onali P 58, 65, 86, 111, 126<br />

O'Neill RD<br />

Ongini E 142<br />

Onor ML<br />

Onorati F 120<br />

Opasich F 84<br />

Ori C 107<br />

Oria C 143<br />

Orlan<strong>di</strong> P 81, 138<br />

Orlan<strong>di</strong>ni C 59<br />

Orlando Rocco<br />

Orlando Rosamaria 96, 113, 142<br />

Orlotti D 132, 133<br />

Orrù Marco<br />

Orrù Marisa 94<br />

Orsini F 109<br />

Osella D 103, 104<br />

Otar G<br />

Oteri A 95, 97, 111, 144<br />

Ottani A 126<br />

Pace S 96<br />

Pacifici R 96<br />

Paganelli P 88<br />

Pagetta A 37<br />

Pagotto U 76<br />

Paizis G 136<br />

Palatini P 142<br />

Palazzo E 92, 129<br />

Palleria C 106<br />

Palma E 84, 87,146<br />

Palmi I 97<br />

Palmi M 78<br />

Palomba D 108<br />

Palombo C<br />

Paluzzi P 62, 79, 112,<br />

Paluzzi S 81<br />

Panaccione I 86<br />

Panerai AE 129, 43, 96<br />

Pani G 128,<br />

Pani L 76, 93, 104, 121, 123, 125<br />

Panin F 36<br />

Panini S<br />

Panlilio LV 125<br />

Pannacci M 110, 139<br />

Pantalone D 59<br />

Panuzzo C 140<br />

Panza Elisa 81<br />

Panza L 140<br />

Paoletti T 146<br />

Paoletti AM 62<br />

Paolini M 108, 134<br />

Papaluca Amati M 111<br />

Papi A 133<br />

Papotti M 59<br />

Papparella I 119<br />

Para<strong>di</strong>so B 117, 146<br />

Parati E 60<br />

Par<strong>di</strong>ni C 89<br />

Parente L 55, 59, 64, 79, 102,<br />

138<br />

Parenti A 5, 48, 59<br />

Pariante C 131<br />

Parini F 106<br />

Parolari A 119<br />

Parolaro D 31, 34, 61, 80<br />

Parolini C<br />

Parrinello G 106<br />

Pascale A 98<br />

Pascotto A 35<br />

Pasinetti GM 124<br />

Pasqualetti G 103<br />

Passamonti S 119<br />

Passani MB 114, 125<br />

Pastoris O 84, 99, 142<br />

Pasut G 111<br />

Patacchini R 83, 101, 120<br />

Patacchioli FR 57, 105<br />

Patanè M 114<br />

160


Patrignani P 47, 54, 84, 102<br />

Patrono C 29, 40<br />

Pattarozzi A 79<br />

Patti L 36, 82<br />

Pau A 125<br />

Peana AT 135<br />

Pedata F 35, 60, 61, 113<br />

Peddes C<br />

Pedrazzani C 138<br />

Pedrelli M 121<br />

Pegoraro P 142<br />

Pelaia G 80<br />

Pellegrini-Giampietro D 63, 77,<br />

115, 116, 118<br />

Pelosi V 57, 83<br />

PengoV 107<br />

Pennisi G 81<br />

Pepicelli O 82<br />

Pepponi R<br />

Pergola C 102, 144<br />

Peri F 129<br />

Perletti G 61<br />

Perna F 80<br />

Perra S 31<br />

Perretti M 102<br />

Perrissoud D 136<br />

Perrone S 127<br />

Perrotta C<br />

Perrotta I 126<br />

Perseu MG<br />

Perucca E 30<br />

Perusin M 50<br />

Pessina F 127<br />

Pestarino M 79<br />

Peters GJ 147<br />

Petrella A 59, 138<br />

Petrella Carla 98<br />

Petrella Clau<strong>di</strong>o 124, 135, 93, 99<br />

Petrillo P 43<br />

Petris G 119<br />

Petrò R 76<br />

Petroni A 124<br />

Petroni S<br />

Pezzatini S 118<br />

Pèzzola A 82<br />

Pezzolla F 135<br />

Pfister P 121<br />

Picano E<br />

Piccar<strong>di</strong> MP 46, 147<br />

Piccinin S 114<br />

Piccione F 58<br />

Piccoli A 47<br />

Picerno P 108<br />

Pichini S 97<br />

Picollo A 115<br />

Piegari E 115, 37, 84<br />

Pieratti A 107, 95<br />

Pieretti S 122, 144, 42, 93<br />

Pierno S 115<br />

Pietrini V 91<br />

Pignataro G 126, 63<br />

Pigneri A<br />

Pillolla G 31<br />

Pilloni M<br />

Pilotto A 42<br />

Pincelli C 137<br />

Pinchera A 113<br />

Pinetti D 105, 139<br />

Pini L 129, 92<br />

Pinna A 89<br />

Pinna C 83<br />

Pinna GA 125<br />

Pinna Spada G 123, 76<br />

Pino R<br />

Pinto A 119, 138, 82<br />

Pintor A 82<br />

Piomelli D 129, 132, 34<br />

Pippia P 135<br />

Piras AP 94<br />

Pirozzi Farina F 142<br />

Pirro E 58<br />

Pisa S 130<br />

Pistis M 31, 95<br />

Pistotti V 144<br />

Pisu MG 36, 88, 95<br />

Pittaluga A 44, 77<br />

Pittau B 121<br />

Pitzalis S 111<br />

Pitzianti S 76<br />

Pizza V 129, 130<br />

Plescia F 94, 95<br />

Pluchino S 79, 90<br />

Poggi L 99<br />

Poggiani C 117, 78<br />

Poggioli R 101<br />

Polenzani L 102<br />

Polidori C 122, 97<br />

Polimeni G 111, 144, 29, 99<br />

Polito F 101, 120, 135, 136, 54,<br />

58<br />

Polli F 65<br />

Pollicita M<br />

Poma P 104, 110, 37<br />

Pomelli D<br />

Pompella G<br />

Pons S 117, 30<br />

Pontis S 89<br />

Ponzetto C 136<br />

Popoli P 118, 28, 46, 82<br />

Popolo A 120, 138<br />

Poppi B 130<br />

Porcile C 79<br />

Porcu E 30<br />

Porreca E 54<br />

Porticella E 97<br />

Potenza MA 48, 83<br />

Potenza RL<br />

Potenza S 107<br />

Potì F 121<br />

Poulet R 119<br />

Powell J 131<br />

Pozzesi N 140<br />

Pozzetti L 108<br />

Pozzi E 110<br />

Pozzoli G 123<br />

Presotto C 119<br />

Preti D<br />

Preziosi P 127, 128, 81, 97<br />

Priora R 108, 120, 121<br />

Procacci P 129<br />

Procopio S 136<br />

Proietti F 127<br />

Provenzani A 110<br />

Provenzano GM 94, 95<br />

Puccetti P<br />

Puddu I<br />

Puggioni G 36, 94<br />

Pugliese AM 113, 35<br />

Puia G 77<br />

Pulighe E 135<br />

Pusch M 115<br />

Putzu P 146, 26<br />

Qasem AR 137<br />

Quarto C 120<br />

Quintana H 141<br />

Quintieri L 61<br />

Quon MJ 48<br />

Racagni G 28, 38, 85, 86, 118<br />

Racca S 108<br />

Racchi M 137<br />

Racioppi A 100<br />

Ra<strong>di</strong>ce S 108<br />

Raffa R 88<br />

Raffaeli W 130<br />

Ragazzi E 81<br />

Ragusa S 146<br />

Raiteri L 81, 82<br />

Raiteri M 36, 77, 82<br />

Rammes G 118<br />

Ranzani D 111<br />

Rasini E 50, 139, 140<br />

Ratcliffe M 141<br />

Ravasio G 130<br />

Ravizza R 103, 61<br />

Reali C 85<br />

Reali R 125<br />

Realini N 61<br />

Reggiani A 50, 76<br />

Regoli D 49, 78, 93, 114, 122<br />

Reimondo G 58<br />

Reitano E 44<br />

Remaley A 84<br />

Renda T 80<br />

Rende P 106<br />

Renna G 36<br />

Renzulli A 120<br />

Renzulli M 147<br />

Repetto E 90<br />

Restivo A 93<br />

Ribichini F 37<br />

Riccar<strong>di</strong> C 39, 55, 58, 80, 103,<br />

137, 140<br />

Ricchi L 57, 58, 102<br />

Ricci S 59<br />

Ricciar<strong>di</strong> S 103, 147<br />

Richelmi P 117<br />

Rigamonti AE 135<br />

Rigamonti E 48<br />

Rigatti P 142<br />

Righetti L 125<br />

Rimon<strong>di</strong>ni R 123, 132<br />

Rinal<strong>di</strong> B 37, 47, 107, 120<br />

Rinal<strong>di</strong> M 148<br />

Riozzi B 65, 88, 97<br />

Riva MA 28, 56, 85, 86<br />

Rivas E 96<br />

Rivasi F 31, 125<br />

Rivasi M 79, 101<br />

Rivera M 131<br />

Rizzi A 78, 93, 122<br />

Rizzi M 37<br />

Rizzo G 54<br />

Rizzo M 93<br />

Rizzo V 88, 117<br />

Robbiano L 109<br />

Roberts A 100<br />

Roberts D 30<br />

Robino F 36, 82<br />

Rocca A<br />

Rocchitta G 36, 64, 79, 90, 94<br />

Rodella LF 129<br />

Ro<strong>di</strong> D 122, 146<br />

Ro<strong>di</strong>nò P<br />

Rodolico G 84, 115, 37<br />

Rodriguez J 147<br />

Rodriguez M 59<br />

Roi C 143<br />

Rolf Sprengel 88<br />

Rolland JF 114, 127<br />

161


Romagnino S<br />

Romagnoli P 47<br />

Romani A 140<br />

Romano MR 78<br />

Rombolà L 65<br />

Romeo C 101<br />

Romeo F 146<br />

Romual<strong>di</strong> P 92, 97<br />

Romussi G 144<br />

Roncarati R 92<br />

Ronchetti D 102<br />

Ronchetti F 140<br />

Roozendaal B 94<br />

Rosa AC 58<br />

Rosa P<br />

Rosato A 61<br />

Rosi MC 90<br />

Rossi A 63, 102, 141, 142, 144<br />

Rossi F 32, 37, 38, 43, 47, 52,<br />

84, 92, 120, 129, 132, 133, 144<br />

Rossi G 109<br />

Rossi M 113<br />

Rossi T 103, 139<br />

Rossini C 129<br />

Rossitto A 99<br />

Rossoni G 48, 83, 84, 97, 121<br />

Rotiroti D 84, 87, 93, 128, 146<br />

Rovati G 102, 133<br />

Roviello F 138<br />

Roviezzo F 54, 83, 133<br />

Ruberto A 139<br />

Ruberto G 145<br />

Rubino T 31, 61<br />

Ruco L 138<br />

Ruffilli MP 39, 46<br />

Ruggero G 128<br />

Ruggieri V 92, 122<br />

Ruiu S 125<br />

Runci F 128<br />

Rundle-Smith S 124<br />

Ruozi B 125<br />

Russier J 120<br />

Russo A 111, 144<br />

Russo D 79, 136<br />

Russo E 79, 86, 136<br />

Russo F 142, 144<br />

Russo G 95, 130<br />

Russo M 132, 133<br />

Russo R 42, 44, 50, 128, 129<br />

Russo T 65, 90<br />

Russo E 86, 87, 126<br />

Rustichelli C 121<br />

Saba F 85<br />

Saccani F 118<br />

Sacchetti G<br />

Sacchetto E<br />

Sacchetto V 61, 112, 133<br />

Sacco I 146<br />

Saccomanni G 105<br />

Sacerdote P 42, 43, 49, 96, 129<br />

Saglio G 140<br />

Saija A 128, 144, 145<br />

Sala A 101, 119<br />

Sala M 61, 97<br />

Salani G 90<br />

Salemi M 96<br />

Salis B 65, 111<br />

Salton S 124<br />

Salucci S 115<br />

Salvadori M 137<br />

Salvadori S 93<br />

Salvati P 93<br />

Salvatorelli E 37<br />

Salvemini D 93, 132<br />

Salvetti A 106<br />

Salvo F 95, 99, 143, 144<br />

Sances G 105<br />

Sancesario G<br />

Sancini G 117<br />

Sandrini M 92<br />

Sanguedolce G 138<br />

Sanguedolce R 138<br />

Sani M 104<br />

Sanna A 76, 104<br />

Sanna E 30, 36, 45, 61, 76, 77,<br />

131<br />

Sanna F 101, 130<br />

Santè P 120<br />

Santillo M<br />

Santolini I 87<br />

Santoro A 108<br />

Santoro V 124<br />

Santoru F 88<br />

Sanvito P<br />

Saponara S 104<br />

Sapone A 108<br />

Saporiti F 50<br />

Saramin C 48<br />

Sardo P 88<br />

Sarichelou I 77<br />

Sarnataro D 76<br />

Sarti D 130<br />

Sartiani L 44<br />

Sartori MF 111<br />

Sasso O 42, 50, 128, 129<br />

Satriano C 118<br />

Sautebin L 102, 143, 144<br />

Savani C 43, 90, 91<br />

Saviano R 136<br />

Savica R 107<br />

Savino R 80<br />

Scaccianoce S 86, 94, 95, 96<br />

Scafuro MA 92<br />

Scaglione F 32, 34, 110, 139<br />

Scaldaferri E 48<br />

Scali C 92<br />

Scandroglio P 76<br />

Scaramuzza S 110<br />

Scarcelli C<br />

Scarfone S 87<br />

Scartabelli T 115, 116<br />

Scatigna M 52, 141<br />

Schelling G 94<br />

Schembri L 139, 140<br />

Schenone S 79, 136<br />

Scherma M 31<br />

Schettini G 79, 90<br />

Schiano Moriello A 76<br />

Schiavo G 129<br />

Schiavone S 90<br />

Schiavone N 80<br />

Schillani G 147<br />

Schintu N 89<br />

Schirru C 39, 148<br />

Scholl CA 95<br />

Schrepfer R 111<br />

Schuh K 141<br />

Scicchitano F 86<br />

Sciorati C<br />

Sciulli MG 84<br />

Scorciapino L 85<br />

Scordo MG<br />

Scorziello A 63<br />

Scotto P 136<br />

Scuderi C 43, 90, 91<br />

Scuderi MR<br />

Sculco F 146<br />

Sebastiao AM<br />

Sechi GP<br />

Secondo A 81<br />

Seghieri G 100<br />

Selis F 111<br />

Selvatici R 113<br />

Serafino A 120<br />

Sergi M 111<br />

Serio S 106<br />

Seripa D<br />

Serpe L 104, 111<br />

Serpi A 142<br />

Serra G 57, 94<br />

Serra M 36, 56, 88, 95<br />

Serra 36, 64<br />

Serra V 77<br />

Servid<strong>di</strong>o G 91<br />

Sessa E<br />

Severi P 77<br />

Severino G 147<br />

Sgadò P 89<br />

Sgaragli G 104, 109, 127<br />

Sgaragli T 104<br />

Sgorbini M 105<br />

Sgroi C 111<br />

Sgura A 44<br />

Shah A 104, 109<br />

Shanton F<br />

Shapiro MS 35<br />

Sheen V 90<br />

Sibilia V 98<br />

Sicuteri R 142<br />

Sigala S 106<br />

Signori E 148<br />

Silvestro A 111<br />

Simeon V 111<br />

Simeoni S 57, 105<br />

Simioni C 37, 112, 133<br />

Simola N 89, 96<br />

Simonato M 30, 117, 122, 146<br />

Simoncini T 62<br />

Simoni D 37<br />

Sindona G<br />

Siniscalchi Anna 122<br />

Siniscalchi Antonio 105, 142<br />

Siniscalco D 43, 129<br />

Siracusano MR<br />

Sirca D 131<br />

Sirigu R 85<br />

Sironi L 43, 126<br />

Sirtori C 48, 54<br />

Sitzia F 77<br />

Smid K 147<br />

Smits J 33<br />

Soffia S 78<br />

Sofianos I 36<br />

Soglian A 98<br />

Sogliano C 88<br />

Sogos V 85<br />

Sokolova E<br />

Soldani G 105<br />

Soldovieri MV<br />

Solenghi E<br />

Soleti A 134<br />

Solinas M 31, 125<br />

Solito E 79<br />

Solito R 91, 114<br />

Sollai L 111<br />

Soma R 143<br />

Somaini L 96<br />

Sommer W 132<br />

Sor<strong>di</strong> A 53<br />

162


Sorrentino Raffaella<br />

Sorrentino Rosalinda<br />

Sortino MA 60<br />

Soverchia L 123<br />

Spaccamiglio A 108<br />

Spadaro M 59<br />

Spagnolo B 78, 122<br />

Spampinato S 58, 113, 123, 130,<br />

137<br />

Spampinato U 51<br />

Spano PF 55, 106<br />

Spano MS 30, 130<br />

Sparatore A 48<br />

Sparnacci K 103<br />

Spartà AM<br />

Speciale A 109, 128<br />

Spina O<br />

Spina S<br />

Spina E 30, 107, 124<br />

Spinsanti P 65, 78<br />

Spinzia C 128<br />

Spisani S 113<br />

Sportiello L 143<br />

Sprio AE 58<br />

Squadrito F 54, 58, 101, 117,<br />

120, 126, 127, 135, 136<br />

Squassina A 146, 147<br />

Stark H 98<br />

Starowicz K 76, 100<br />

Stasi MA 86<br />

Steardo L 43, 90, 91, 98<br />

Stein EA<br />

Stephan H<br />

Sternieri E 105, 130<br />

Sternini C 135<br />

Steven C 81<br />

Sticozzi C 78<br />

Stillitano F<br />

Stocco A 107<br />

Stocco G 109, 110<br />

Stocchino ME<br />

Stopponi S 97, 132<br />

Storm-Mathisen J<br />

Storto M 88, 97<br />

Straface E 57<br />

Straub RH<br />

Stroik J 31<br />

Strongoli C<br />

Strongoli MC 87<br />

Suarez D 141<br />

Succu S 101, 130<br />

Suffre<strong>di</strong>ni S<br />

Sullo N 110, 132, 133, 139<br />

Sumberaz A 108<br />

Summa D 108, 120, 121<br />

Sumner C 141<br />

Sutton V 141<br />

Suzuki H<br />

Svensson HT<br />

Tabrizi MA 89<br />

Tabucchi A 117<br />

Tacchetti C 90<br />

Tacchi R 31, 125,<br />

Tacchi S 125<br />

Tacconelli S 54, 84, 102<br />

Taglialatela M 35, 37, 45, 81<br />

Talani G 36, 77<br />

Tambaro S 121<br />

Tamborra R 91<br />

Tamburella A 117<br />

Tamiazzo L 136<br />

Tammaro E 124<br />

Tanda G 86<br />

Tanganelli S<br />

Tani C 110<br />

Tanzarella C<br />

Tar<strong>di</strong>to D 118, 85<br />

Tari M 143<br />

Tari U 143<br />

Tarozzi A 88<br />

Tarquini E 137<br />

Tarquinio M 48, 119<br />

Tarzia G 132<br />

Tascedda F 62, 85<br />

Tasdemir E 116<br />

Tatarelli R 86<br />

Taylor G 65, 110, 111<br />

Tazzari V 48<br />

Tebano MT 82<br />

Tedesco M 130<br />

Tekle C 147<br />

Temperilli F 95<br />

Terdoslavich M 119<br />

Teresa M 118<br />

Terragna C 147<br />

Terrazzani G 48<br />

Terstappen G 92<br />

Terzolo M 58<br />

Terzuoli E 113<br />

Tesi F 100<br />

Testa M 142<br />

Testa N 57, 64, 90<br />

Testino G 108<br />

Thellung S 79<br />

Thiemermann C 48, 133<br />

Thorsten B<br />

Tiraboschi E 85<br />

Tirolo C 90<br />

Tita B 104<br />

Togna AR 120<br />

Togna G 96<br />

Tognolini 134<br />

Tolu S 30<br />

Tomaino A 109, 144<br />

Tomasini MC 65<br />

Tommasini I<br />

Tonacchera M 113<br />

Tonachini L 79<br />

Tonazzini I<br />

Tonini A 132<br />

Tonini M 42, 60, 99, 133, 135<br />

Tonini S 133<br />

Tonon G 65, 111, 148<br />

Torres Y 114<br />

Torsello A 136<br />

Torta R 66<br />

Tortiglione A 126<br />

Tortorella P 115<br />

Tortorella V 114<br />

Toscano A 116<br />

Tosco A 59<br />

Tosi A 112, 133<br />

Tosi G 31, 125<br />

Totani L 47<br />

Tozzi M 139<br />

Trabace L 57, 90, 91<br />

Traficante A 65<br />

Traini C 113<br />

Tramentozzi E 37<br />

Trapella C 78<br />

Trautman M 99<br />

Traversa S 137<br />

Trefiletti G 96<br />

Tremoli E 38, 43, 53, 54, 119,<br />

126<br />

Trevisani M 99, 120, 129, 131,<br />

132<br />

Trevisi L 78<br />

Trezza V 31, 94<br />

Tricarico D 45<br />

Trifirò G 124, 143<br />

Trimarco B 110<br />

Trimarco V 110<br />

Trincavelli ML 35<br />

Tringali G 123, 136<br />

Triolo F 110<br />

Trisolini P 135<br />

Trombetta D 145<br />

Tronci E 89<br />

Trovato AE 129<br />

Tucci P 57<br />

Tuccori M 29, 143, 144<br />

Tumminello FM 138<br />

Turriziani M 104<br />

Ubal<strong>di</strong> M 123<br />

Uberti D 65<br />

Uccelli A 82<br />

Uliva C 132, 142<br />

Ullu LM 86<br />

Uras Roberta 77<br />

Ursino MG 134<br />

Usai C 82<br />

Uvec Group 143<br />

Uziel G 124<br />

Uzzo M 119<br />

Vacca F<br />

Vaglini F 89<br />

Vago T 119<br />

Vairetti M 117<br />

Valenti LP 106<br />

Valenti M 80<br />

Valenti S 104<br />

Valentini V 86, 96<br />

Valeri A 127<br />

Valle G 60<br />

Valoti M 104, 109<br />

Valsecchi AE 129<br />

Valsecchi V 126<br />

Valtancoli B 102<br />

Van Gaal LF 99<br />

Van Luijtelaar G 87<br />

Vanacore N 107<br />

Vandelli MA 31, 125<br />

Vanderschuren LJMJ 31<br />

Vannacci A 29, 107, 143<br />

Vannucchi MG 61<br />

Varani K 28, 37, 61, 112, 133<br />

Varano E 136<br />

Vargiu G 136<br />

Varoni MV 108<br />

Vasina V 134<br />

Vassanelli C 37<br />

Vecchio I 87, 128<br />

Vecchione C 113<br />

Vegeto E 57, 103<br />

Velar<strong>di</strong> E 58, 80, 137<br />

Vella S 39, 46, 52<br />

Vellecco V 54, 83, 133<br />

Venco A 139, 140<br />

Vendemiale G 91<br />

Venezia V 90<br />

Ventrice D<br />

Ventura A 109, 110<br />

Verderio C 35, 81<br />

Vergoni AV 31, 125<br />

Vergura R 93<br />

Veronese F 111<br />

Verri M 84, 142, 99<br />

163


Vetrice D 93, 128<br />

Vettorato E 130<br />

Vezzalini F 137<br />

Viaggi C 89<br />

Viano I 57, 104<br />

Viaro R 43<br />

Viganò D 31, 61<br />

Vighi E 99<br />

Viglio S 142<br />

Villa G<br />

Villa LM 146<br />

Villa R 130<br />

Villa RF 89<br />

Villa V 79<br />

Villarosa F 95<br />

Villetti G 91<br />

Vincenzi F 112, 133<br />

Vinci MC 48, 54, 59<br />

Vinci S 96, 130<br />

Viola S 80<br />

Vir<strong>di</strong>s A 134<br />

Vir<strong>di</strong>s F 131<br />

Visalli V 84, 128, 146<br />

Vita D 92<br />

Vita G 127<br />

Vitale G 92, 122<br />

Vitali F 104<br />

Vitellaro-Zuccarelli L 102<br />

Vitelli MR 84, 37<br />

Vitiello M 102<br />

Vitti P 113<br />

Viviani B 44<br />

Vivoli E 43, 92, 116<br />

Vizzini G 110<br />

Volonté C 35<br />

Volonterio A 121<br />

Volpe AR 60, 109<br />

Volpe Giampiero 129, 130<br />

Volpe Gisellla 140<br />

Volpi I 146<br />

Volpini R 35<br />

Volta R 91<br />

Volta U 99<br />

Volterra A<br />

Wang J 124<br />

Wang ZQ 66<br />

Warne J<br />

Weksler BB 54<br />

Wertheim CE 31<br />

Widel MH<br />

Wilson S<br />

Wotjak CT 47<br />

Wren P<br />

Yasar S 125<br />

Yemul S 124<br />

Zaccheddu R 36<br />

Zafar B<br />

Zaffani S 107<br />

Zaffaroni M 50<br />

Zaffe D 117, 126<br />

Zaggia B 58<br />

Zagli G 83, 120, 129<br />

Zagotto G 81<br />

Zambon A 40<br />

Zambrano N 65<br />

Zanda M 104, 121<br />

Zanelli U 92<br />

Zanetti E 98<br />

Zangla A 111<br />

Zani A 61, 97<br />

Zaninetti R 125<br />

Zanoli P 57, 101, 137<br />

Zanotti I 121<br />

Zappettini Simona<br />

Zappettini Stefania 36, 81, 82<br />

Zara G 104, 106, 111<br />

Zavatti M 57, 101, 137<br />

Zecchi S 131<br />

Zeppegno P 35<br />

Zhang J 66<br />

Zhao Z 124<br />

Ziche M 55, 80, 91, 101, 113,<br />

114, 118, 119, 137<br />

Zieglgansberger W 118<br />

Zinellu A 57<br />

Zinman B 100<br />

Zoccali R 124<br />

Zoja C 43<br />

Zonca A 130<br />

Zonta F 117<br />

Zoppellaro C 134<br />

Zotti M 123<br />

Zucca S<br />

Zuccaro P 97<br />

Zucchini S 117, 122, 146<br />

Zuccotti A 137<br />

Zuddas A 56<br />

Zuena AR<br />

Zupi G 138<br />

Zusso M 78, 86<br />

164


pag_sx.indd 1 28/05/2007 21.41.19

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!